ID	Gene Name	Species	BBID	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KEYWORDS	UP_SEQ_FEATURE
P10272	(pol)	Baboon endogenous virus strain M7				GO:0006310~DNA recombination,GO:0015074~DNA integration,GO:0046718~viral entry into host cell,GO:0075713~establishment of integrated proviral latency,		GO:0003676~nucleic acid binding,GO:0003964~RNA-directed DNA polymerase activity,GO:0004190~aspartic-type endopeptidase activity,GO:0004523~RNA-DNA hybrid ribonuclease activity,	IPR000477:Reverse transcriptase,IPR001584:Integrase, catalytic core,IPR001969:Peptidase aspartic, active site,IPR001995:Peptidase A2A, retrovirus, catalytic,IPR002156:Ribonuclease H domain,IPR012337:Ribonuclease H-like domain,IPR015416:Zinc finger, H2C2-type, histone UAS binding,IPR018061:Peptidase A2A, retrovirus RVP subgroup,IPR021109:Aspartic peptidase,					Aspartyl protease,Complete proteome,DNA integration,DNA recombination,Endonuclease,Hydrolase,Multifunctional enzyme,Nuclease,Nucleotidyltransferase,Protease,RNA suppression of termination,RNA-directed DNA polymerase,Transferase,Viral genome integration,Virus entry into host cell,
Q6EAS5	1,4-alpha-glucan branching enzyme 1(GBE1)	Equus caballus			Carbohydrate transport and metabolism,	GO:0005978~glycogen biosynthetic process,	GO:0070062~extracellular exosome,	GO:0003844~1,4-alpha-glucan branching enzyme activity,GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0043169~cation binding,	IPR004193:Glycoside hydrolase, family 13, N-terminal,IPR006047:Glycosyl hydrolase, family 13, catalytic domain,IPR006048:Alpha-amylase, C-terminal all beta,IPR006407:1,4-alpha-glucan-branching enzyme,IPR013780:Glycosyl hydrolase, family 13, all-beta,IPR013781:Glycoside hydrolase, catalytic domain,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR015902:Glycoside hydrolase, family 13,IPR017853:Glycoside hydrolase, superfamily,	ecb00500:Starch and sucrose metabolism,ecb01100:Metabolic pathways,		PIRSF000463:1,4-alpha-glucan branching enzyme,	SM00642:Aamy,	Complete proteome,Glycogen biosynthesis,Glycogen storage disease,Glycosyltransferase,Phosphoprotein,Reference proteome,Transferase,	chain:1,4-alpha-glucan-branching enzyme,modified residue,
P28897	150K protein(SMYEVgp1)	Strawberry mild yellow edge virus				GO:0006351~transcription, DNA-templated,GO:0006396~RNA processing,GO:0039694~viral RNA genome replication,		GO:0003723~RNA binding,GO:0003968~RNA-directed RNA polymerase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008174~mRNA methyltransferase activity,	IPR001788:Tymovirus, RNA-dependent RNA polymerase,IPR002588:Tymovirus methyltransferase,IPR007094:RNA-directed RNA polymerase,  catalytic domain,IPR027351:(+) RNA virus helicase core domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					ATP-binding,Complete proteome,Helicase,Hydrolase,Multifunctional enzyme,Nucleotide-binding,Nucleotidyltransferase,RNA-directed RNA polymerase,Transferase,Viral RNA replication,	chain:RNA replication protein,domain:RdRp catalytic,nucleotide phosphate-binding region:ATP,
Q6DH46	2-phosphoxylose phosphatase 1(pxylp1)	Danio rerio				GO:0006024~glycosaminoglycan biosynthetic process,GO:0010909~positive regulation of heparan sulfate proteoglycan biosynthetic process,GO:0050650~chondroitin sulfate proteoglycan biosynthetic process,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003993~acid phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0008330~protein tyrosine/threonine phosphatase activity,GO:0008579~JUN kinase phosphatase activity,GO:0008969~phosphohistidine phosphatase activity,GO:0016312~inositol bisphosphate phosphatase activity,GO:0016787~hydrolase activity,GO:0016791~phosphatase activity,GO:0017017~MAP kinase tyrosine/serine/threonine phosphatase activity,GO:0017161~inositol-1,3,4-trisphosphate 4-phosphatase activity,GO:0019178~NADP phosphatase activity,GO:0019198~transmembrane receptor protein phosphatase activity,GO:0030351~inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,GO:0030352~inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity,GO:0030487~inositol-4,5-bisphosphate 5-phosphatase activity,GO:0043726~5-amino-6-(5-phosphoribitylamino)uracil phosphatase activity,GO:0043812~phosphatidylinositol-4-phosphate phosphatase activity,GO:0043813~phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,GO:0052629~phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,GO:0052745~inositol phosphate phosphatase activity,GO:0052825~inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,GO:0052828~inositol-3,4-bisphosphate 4-phosphatase activity,GO:0052829~inositol-1,3,4-trisphosphate 1-phosphatase activity,GO:0052830~inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,GO:0052831~inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,GO:0052867~phosphatidylinositol-1,4,5-trisphosphate 5-phosphatase activity,GO:1990003~IDP phosphatase activity,	IPR000560:Histidine phosphatase superfamily, clade-2,					Complete proteome,Glycoprotein,Golgi apparatus,Hydrolase,Membrane,Reference proteome,Signal,Signal-anchor,Transmembrane,Transmembrane helix,	active site:Nucleophile,active site:Proton donor,chain:Acid phosphatase-like protein 2,glycosylation site:N-linked (GlcNAc...),signal peptide,
P31937	3-hydroxyisobutyrate dehydrogenase(HIBADH)	Homo sapiens				GO:0006574~valine catabolic process,GO:0009083~branched-chain amino acid catabolic process,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0004616~phosphogluconate dehydrogenase (decarboxylating) activity,GO:0008442~3-hydroxyisobutyrate dehydrogenase activity,GO:0051287~NAD binding,	IPR002204:3-hydroxyisobutyrate dehydrogenase-related, conserved site,IPR006115:6-phosphogluconate dehydrogenase, NADP-binding,IPR008927:6-phosphogluconate dehydrogenase, C-terminal-like,IPR011548:3-hydroxyisobutyrate dehydrogenase,IPR013328:Dehydrogenase, multihelical,IPR015815:Hydroxy monocarboxylic acid anion dehydrogenase, HIBADH-type,IPR016040:NAD(P)-binding domain,	hsa00280:Valine, leucine and isoleucine degradation,hsa01100:Metabolic pathways,		PIRSF000103:hydroxy monocarboxylic acid anion dehydrogenase, HIBADH type,		3D-structure,Acetylation,Branched-chain amino acid catabolism,Complete proteome,Direct protein sequencing,Mitochondrion,NAD,Oxidoreductase,Proteomics identification,Reference proteome,Signal,Transit peptide,	binding site:NAD,chain:3-hydroxyisobutyrate dehydrogenase, mitochondrial,helix,nucleotide phosphate-binding region:NAD,strand,transit peptide:Mitochondrion,turn,
Q29448	3-hydroxymethyl-3-methylglutaryl-CoA lyase(HMGCL)	Bos taurus				GO:0007005~mitochondrion organization,GO:0046951~ketone body biosynthetic process,GO:0051262~protein tetramerization,	GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005777~peroxisome,	GO:0000287~magnesium ion binding,GO:0004419~hydroxymethylglutaryl-CoA lyase activity,GO:0005102~receptor binding,GO:0030145~manganese ion binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,	IPR000138:Hydroxymethylglutaryl-CoA lyase, active site,IPR000891:Pyruvate carboxyltransferase,IPR013785:Aldolase-type TIM barrel,	bta00072:Synthesis and degradation of ketone bodies,bta00280:Valine, leucine and isoleucine degradation,bta00650:Butanoate metabolism,bta01100:Metabolic pathways,bta04146:Peroxisome,				Acetylation,Complete proteome,Disulfide bond,Lyase,Metal-binding,Mitochondrion,Peroxisome,Reference proteome,Transit peptide,	binding site:Substrate,chain:Hydroxymethylglutaryl-CoA lyase, mitochondrial,metal ion-binding site:Divalent metal cation,modified residue,sequence conflict,transit peptide:Mitochondrion,
P56935	3-isopropylmalate dehydratase small subunit(leuD)	Buchnera aphidicola str. APS (Acyrthosiphon pisum)				GO:0009098~leucine biosynthetic process,	GO:0009316~3-isopropylmalate dehydratase complex,	GO:0003861~3-isopropylmalate dehydratase activity,	IPR000573:Aconitase A/isopropylmalate dehydratase small subunit, swivel,IPR004431:3-isopropylmalate dehydratase, small subunit,IPR015928:Aconitase/3-isopropylmalate dehydratase, swivel,IPR015937:Aconitase/isopropylmalate dehydratase,	buc00290:Valine, leucine and isoleucine biosynthesis,buc00660:C5-Branched dibasic acid metabolism,buc01100:Metabolic pathways,buc01110:Biosynthesis of secondary metabolites,buc01210:2-Oxocarboxylic acid metabolism,buc01230:Biosynthesis of amino acids,				Amino-acid biosynthesis,Branched-chain amino acid biosynthesis,Complete proteome,Leucine biosynthesis,Lyase,Plasmid,Reference proteome,	chain:3-isopropylmalate dehydratase small subunit,
A9CB92	33K(SnAdV-1p18)	Snake adenovirus 1				GO:0016032~viral process,			IPR021304:Adenovirus 33kDa/22kDa phosphoprotein,
Q6NY77	4-hydroxy-2-oxoglutarate aldolase 1(hoga1)	Danio rerio			Amino acid transport and metabolism / Cell envelope biogenesis, outer membrane,	GO:0008152~metabolic process,GO:0009436~glyoxylate catabolic process,	GO:0005739~mitochondrion,	GO:0003824~catalytic activity,GO:0008700~4-hydroxy-2-oxoglutarate aldolase activity,GO:0016829~lyase activity,	IPR002220:Dihydrodipicolinate synthetase-like,IPR013785:Aldolase-type TIM barrel,IPR020625:Dihydrodipicolinate synthetase, active site,	dre00330:Arginine and proline metabolism,dre00630:Glyoxylate and dicarboxylate metabolism,dre01100:Metabolic pathways,		PIRSF001365:dihydrodipicolinate synthase,	SM01130:SM01130,	Complete proteome,Lyase,Mitochondrion,Proteomics identification,Reference proteome,Schiff base,Transit peptide,	active site:Schiff-base intermediate with substrate,chain:Dihydrodipicolinate synthase-like, mitochondrial,region of interest:Substrate binding,site:Involved in proton transfer during cleavage,transit peptide:Mitochondrion,
Q6Q311	40S ribosomal protein S25(LOC101110758)	Ovis aries					GO:0005840~ribosome,		IPR004977:Ribosomal protein S25,	oas03010:Ribosome,				Acetylation,Complete proteome,Reference proteome,Ribonucleoprotein,Ribosomal protein,
Q91F89	436R(IIV6gp432)	Invertebrate iridescent virus 6												Complete proteome,Reference proteome,	chain:Uncharacterized protein 436R,
Q5ZIZ4	5'-nucleotidase, cytosolic II(NT5C2)	Gallus gallus				GO:0016311~dephosphorylation,GO:0046040~IMP metabolic process,GO:0046085~adenosine metabolic process,	GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0008253~5'-nucleotidase activity,GO:0046872~metal ion binding,	IPR008380:HAD-superfamily hydrolase, subfamily IG, 5'-nucleotidase,IPR016695:Purine 5'-nucleotidase,IPR023214:HAD-like domain,	gga00230:Purine metabolism,gga00240:Pyrimidine metabolism,gga00760:Nicotinate and nicotinamide metabolism,gga01100:Metabolic pathways,		PIRSF017434:cytosolic purine 5'-nucleotidase,		Allosteric enzyme,Coiled coil,Complete proteome,Cytoplasm,Hydrolase,Magnesium,Metal-binding,Nucleotide metabolism,Nucleotide-binding,Reference proteome,	active site:Nucleophile,active site:Proton donor,binding site:Allosteric activator 1,binding site:Allosteric activator 1; via carbonyl oxygen,binding site:Allosteric activator 2,chain:Cytosolic purine 5'-nucleotidase,compositionally biased region:Asp/Glu-rich (acidic),metal ion-binding site:Magnesium,metal ion-binding site:Magnesium; via carbonyl oxygen,region of interest:Substrate binding,
P49914	5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase)(MTHFS)	Homo sapiens				GO:0006536~glutamate metabolic process,GO:0009396~folic acid-containing compound biosynthetic process,GO:0015942~formate metabolic process,GO:0035999~tetrahydrofolate interconversion,GO:0046653~tetrahydrofolate metabolic process,GO:0046655~folic acid metabolic process,GO:0046657~folic acid catabolic process,	GO:0005737~cytoplasm,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,	GO:0005524~ATP binding,GO:0005542~folic acid binding,GO:0030272~5-formyltetrahydrofolate cyclo-ligase activity,GO:0046872~metal ion binding,	IPR002698:5-formyltetrahydrofolate cyclo-ligase,IPR024185:5-formyltetrahydrofolate cyclo-ligase-like domain,	hsa00670:One carbon pool by folate,hsa01100:Metabolic pathways,		PIRSF006806:5-formyltetrahydrofolate cyclo-ligase,		3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Folate-binding,Ligase,Magnesium,Metal-binding,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,	binding site:ATP,binding site:Substrate,chain:5-formyltetrahydrofolate cyclo-ligase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Substrate binding,sequence variant,
Q975Y9	5-formaminoimidazole-4-carboxamide-1-(beta)-D-ribofuranosyl 5'-monophosphate synthetase(STK_RS01625)	Sulfolobus tokodaii str. 7				GO:0006189~'de novo' IMP biosynthetic process,		GO:0000287~magnesium ion binding,GO:0005524~ATP binding,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0030145~manganese ion binding,	IPR009720:IMP biosynthesis enzyme PurP, C-terminal,IPR010672:IMP biosynthesis enzyme PurP, N-terminal,IPR011761:ATP-grasp fold,IPR013815:ATP-grasp fold, subdomain 1,IPR013816:ATP-grasp fold, subdomain 2,IPR016185:Pre-ATP-grasp domain,IPR023656:IMP biosynthesis enzyme PurP,			PIRSF004602:conserved hypothetical protein MJ0136,		ATP-binding,Complete proteome,Ligase,Magnesium,Manganese,Metal-binding,Nucleotide-binding,Purine biosynthesis,Reference proteome,	binding site:ATP,binding site:Substrate,chain:5-formaminoimidazole-4-carboxamide-1- (beta)-D-ribofuranosyl 5'-monophosphate synthetase,domain:ATP-grasp,metal ion-binding site:Magnesium or manganese,nucleotide phosphate-binding region:ATP,
P35382	5-hydroxytryptamine receptor 2A(Htr2a)	Cavia porcellus				GO:0006939~smooth muscle contraction,GO:0007202~activation of phospholipase C activity,GO:0007610~behavior,GO:0010513~positive regulation of phosphatidylinositol biosynthetic process,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0033674~positive regulation of kinase activity,GO:0042493~response to drug,GO:0044380~protein localization to cytoskeleton,GO:0045600~positive regulation of fat cell differentiation,GO:0045821~positive regulation of glycolytic process,GO:0046883~regulation of hormone secretion,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050795~regulation of behavior,GO:0051209~release of sequestered calcium ion into cytosol,GO:0070374~positive regulation of ERK1 and ERK2 cascade,	GO:0005622~intracellular,GO:0005887~integral component of plasma membrane,GO:0005901~caveola,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030424~axon,GO:0043198~dendritic shaft,	GO:0004993~G-protein coupled serotonin receptor activity,GO:0008144~drug binding,GO:0051378~serotonin binding,GO:0071886~1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000455:5-Hydroxytryptamine 2A receptor,IPR002231:5-Hydroxytryptamine receptor family,IPR017452:GPCR, rhodopsin-like, 7TM,				SM01381:SM01381,	Behavior,Cell membrane,Cell projection,Complete proteome,Cytoplasmic vesicle,Disulfide bond,G-protein coupled receptor,Membrane,Phosphoprotein,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:5-hydroxytryptamine receptor 2A,disulfide bond,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P57238	50S ribosomal protein L25(rplY)	Buchnera aphidicola str. APS (Acyrthosiphon pisum)				GO:0006412~translation,	GO:0005840~ribosome,	GO:0003735~structural constituent of ribosome,GO:0008097~5S rRNA binding,	IPR011035:Ribosomal protein L25/Gln-tRNA synthetase, anti-codon-binding domain,IPR020055:Ribosomal protein L25, short-form,IPR020056:Ribosomal protein L25/Gln-tRNA synthetase, beta-barrel domain,	buc03010:Ribosome,				Complete proteome,Reference proteome,Ribonucleoprotein,Ribosomal protein,RNA-binding,rRNA-binding,	chain:50S ribosomal protein L25,
Q5E896	50S ribosomal protein L30(rpmD)	Vibrio fischeri ES114				GO:0006412~translation,	GO:0015934~large ribosomal subunit,	GO:0003735~structural constituent of ribosome,	IPR005996:Ribosomal protein L30, bacterial-type,IPR016082:Ribosomal protein L30, ferredoxin-like fold domain,	vfi03010:Ribosome,		PIRSF002211:ribosomal protein L30p,		Complete proteome,Reference proteome,Ribonucleoprotein,Ribosomal protein,	chain:50S ribosomal protein L30,
P32794	AAA family ATPase AFG2(AFG2)	Saccharomyces cerevisiae S288c				GO:0042273~ribosomal large subunit biogenesis,GO:0042493~response to drug,	GO:0005622~intracellular,GO:0030687~preribosome, large subunit precursor,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR003960:ATPase, AAA-type, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	sce03008:Ribosome biogenesis in eukaryotes,			SM00382:AAA,	ATP-binding,Complete proteome,Nucleotide-binding,Reference proteome,Repeat,	chain:ATPase family gene 2 protein,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,
Q9SIT6	ABC-2 type transporter family protein(ABCG5)	Arabidopsis thaliana				GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005524~ATP binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR013525:ABC-2 type transporter,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00382:AAA,	ATP-binding,Complete proteome,Membrane,Nucleotide-binding,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ABC transporter G family member 5,domain:ABC transmembrane type-2,domain:ABC transporter,nucleotide phosphate-binding region:ATP,transmembrane region,
Q75CD6	ACL027Cp(AGOS_ACL027C)	Eremothecium gossypii ATCC 10895				GO:0010388~cullin deneddylation,	GO:0005737~cytoplasm,GO:0008180~COP9 signalosome,							Complete proteome,Cytoplasm,Nucleus,Reference proteome,Signalosome,	chain:COP9 signalosome complex subunit 11,domain:PCI,
Q752U2	AFR481Wp(AGOS_AFR481W)	Eremothecium gossypii ATCC 10895				GO:0006364~rRNA processing,	GO:0005730~nucleolus,GO:0030687~preribosome, large subunit precursor,		IPR005579:Cgr1,					Coiled coil,Complete proteome,Nucleus,Reference proteome,Ribosome biogenesis,rRNA processing,	chain:rRNA-processing protein CGR1,
P25054	APC, WNT signaling pathway regulator(APC)	Homo sapiens	84.Ubiquitination_Pathways_Cell_Cycle,90.IB_and-cat-Arm_processing_of_Ci,97.Immune_injury_MS-lesions_MS_antigen,	h_alkPathway:ALK in cardiac myocytes,H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2,h_ps1Pathway:Presenilin action in Notch and Wnt signaling,h_tgfbPathway:TGF beta signaling pathway,h_wntPathway:WNT Signaling Pathway,		GO:0000281~mitotic cytokinesis,GO:0001708~cell fate specification,GO:0006461~protein complex assembly,GO:0006921~cellular component disassembly involved in execution phase of apoptosis,GO:0006974~cellular response to DNA damage stimulus,GO:0007026~negative regulation of microtubule depolymerization,GO:0007050~cell cycle arrest,GO:0007094~mitotic spindle assembly checkpoint,GO:0007155~cell adhesion,GO:0007163~establishment or maintenance of cell polarity,GO:0007389~pattern specification process,GO:0008285~negative regulation of cell proliferation,GO:0016055~Wnt signaling pathway,GO:0016477~cell migration,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030335~positive regulation of cell migration,GO:0031016~pancreas development,GO:0031175~neuron projection development,GO:0031274~positive regulation of pseudopodium assembly,GO:0032886~regulation of microtubule-based process,GO:0042493~response to drug,GO:0043065~positive regulation of apoptotic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045595~regulation of cell differentiation,GO:0045732~positive regulation of protein catabolic process,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0051988~regulation of attachment of spindle microtubules to kinetochore,GO:0060070~canonical Wnt signaling pathway,GO:0070830~bicellular tight junction assembly,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0097305~response to alcohol,GO:1904885~beta-catenin destruction complex assembly,GO:1904886~beta-catenin destruction complex disassembly,GO:1990090~cellular response to nerve growth factor stimulus,GO:2000211~regulation of glutamate metabolic process,	GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0005923~bicellular tight junction,GO:0005938~cell cortex,GO:0016328~lateral plasma membrane,GO:0016342~catenin complex,GO:0030027~lamellipodium,GO:0030425~dendrite,GO:0030877~beta-catenin destruction complex,GO:0031965~nuclear membrane,GO:0032587~ruffle membrane,GO:0043025~neuronal cell body,GO:0044295~axonal growth cone,GO:0044306~neuron projection terminus,GO:0045202~synapse,GO:0070852~cell body fiber,GO:1990909~Wnt signalosome,	GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008017~microtubule binding,GO:0019887~protein kinase regulator activity,GO:0019901~protein kinase binding,GO:0045295~gamma-catenin binding,GO:0045296~cadherin binding,GO:0051010~microtubule plus-end binding,	IPR000225:Armadillo,IPR009223:Adenomatous polyposis coli protein, cysteine-rich repeat,IPR009224:SAMP,IPR009232:EB-1 binding,IPR009234:Adenomatous polyposis coli protein basic domain,IPR009240:Adenomatous polyposis coli protein, 15 residue repeat,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR026818:Adenomatous polyposis coli (APC)  family,IPR026831:Adenomatous polyposis coli domain,IPR026836:Adenomatous polyposis coli,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04810:Regulation of actin cytoskeleton,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05217:Basal cell carcinoma,	114500~Colorectal cancer, somatic,114550~Hepatoblastoma, somatic,135290~Desmoid disease, hereditary,175100~Adenomatous polyposis coli,175100~Brain tumor-polyposis syndrome 2,175100~Gardner syndrome,613659~Gastric cancer, somatic,Adenoma, periampullary, somatic~Adenoma, periampullary, somatic,		SM00185:ARM,	3D-structure,Acetylation,Alternative splicing,Cell junction,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Membrane,Microtubule,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Tumor suppressor,Ubl conjugation,Wnt signaling pathway,	chain:Adenomatous polyposis coli protein,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Leu-rich,compositionally biased region:Ser-rich,helix,modified residue,mutagenesis site,region of interest:Highly charged,region of interest:Responsible for down-regulation through a process mediated by direct ubiquitination,repeat:ARM 1,repeat:ARM 2,repeat:ARM 3,repeat:ARM 4,repeat:ARM 5,repeat:ARM 6,repeat:ARM 7,sequence conflict,sequence variant,short sequence motif:PDZ-binding,splice variant,turn,
Q13315	ATM serine/threonine kinase(ATM)	Homo sapiens		h_atmPathway:ATM Signaling Pathway,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,H_cdc25Pathway:cdc25 and chk1 Regulatory Pathway in response to DNA damage,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_p53Pathway:p53 Signaling Pathway,h_plk3Pathway:Regulation of cell cycle progression by Plk3,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,		GO:0000077~DNA damage checkpoint,GO:0000723~telomere maintenance,GO:0000724~double-strand break repair via homologous recombination,GO:0000729~DNA double-strand break processing,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0001666~response to hypoxia,GO:0001756~somitogenesis,GO:0002331~pre-B cell allelic exclusion,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0006975~DNA damage induced protein phosphorylation,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007004~telomere maintenance via telomerase,GO:0007050~cell cycle arrest,GO:0007094~mitotic spindle assembly checkpoint,GO:0007131~reciprocal meiotic recombination,GO:0007165~signal transduction,GO:0007420~brain development,GO:0007507~heart development,GO:0008340~determination of adult lifespan,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010212~response to ionizing radiation,GO:0010506~regulation of autophagy,GO:0016572~histone phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0030889~negative regulation of B cell proliferation,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0033129~positive regulation of histone phosphorylation,GO:0033151~V(D)J recombination,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0036289~peptidyl-serine autophosphorylation,GO:0042159~lipoprotein catabolic process,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0043525~positive regulation of neuron apoptotic process,GO:0045141~meiotic telomere clustering,GO:0046777~protein autophosphorylation,GO:0048599~oocyte development,GO:0051402~neuron apoptotic process,GO:0051726~regulation of cell cycle,GO:0051972~regulation of telomerase activity,GO:0071044~histone mRNA catabolic process,GO:0071480~cellular response to gamma radiation,GO:0071481~cellular response to X-ray,GO:0071500~cellular response to nitrosative stress,GO:0072434~signal transduction involved in mitotic G2 DNA damage checkpoint,GO:0090399~replicative senescence,GO:0097694~establishment of RNA localization to telomere,GO:0097695~establishment of macromolecular complex localization to telomere,GO:1900034~regulation of cellular response to heat,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1904262~negative regulation of TORC1 signaling,GO:1904354~negative regulation of telomere capping,GO:1904358~positive regulation of telomere maintenance via telomere lengthening,GO:1904884~positive regulation of telomerase catalytic core complex assembly,	GO:0000781~chromosome, telomeric region,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:1990391~DNA repair complex,	GO:0003677~DNA binding,GO:0004674~protein serine/threonine kinase activity,GO:0004677~DNA-dependent protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0016740~transferase activity,GO:0032403~protein complex binding,GO:0046983~protein dimerization activity,GO:0047485~protein N-terminus binding,	IPR000403:Phosphatidylinositol 3-/4-kinase, catalytic domain,IPR003151:PIK-related kinase, FAT,IPR003152:PIK-related kinase, FATC,IPR011009:Protein kinase-like domain,IPR014009:PIK-related kinase,IPR015519:ATM/Tel1,IPR016024:Armadillo-type fold,IPR018936:Phosphatidylinositol 3/4-kinase, conserved site,IPR021668:Telomere-length maintenance and DNA damage repair,	hsa04064:NF-kappa B signaling pathway,hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04210:Apoptosis,hsa05166:HTLV-I infection,hsa05202:Transcriptional misregulation in cancer,hsa05206:MicroRNAs in cancer,	114480~Breast cancer, susceptibility to,208900~Ataxia-telangiectasia,Lymphoma, B-cell non-Hodgkin, somatic~Lymphoma, B-cell non-Hodgkin, somatic,Lymphoma, mantle cell~Lymphoma, mantle cell,T-cell prolymphocytic leukemia, somatic~T-cell prolymphocytic leukemia, somatic,		SM00146:PI3Kc,SM01342:SM01342,SM01343:SM01343,	Acetylation,ATP-binding,Cell cycle,Complete proteome,Cytoplasmic vesicle,Disease mutation,DNA damage,DNA-binding,Kinase,Neurodegeneration,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Tumor suppressor,	chain:Serine-protein kinase ATM,domain:FAT,domain:FATC,domain:PI3K/PI4K,modified residue,mutagenesis site,region of interest:Interaction with ABL1,sequence conflict,sequence variant,splice variant,
Q9UBJ2	ATP binding cassette subfamily D member 2(ABCD2)	Homo sapiens		h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,		GO:0000038~very long-chain fatty acid metabolic process,GO:0006635~fatty acid beta-oxidation,GO:0015909~long-chain fatty acid transport,GO:0032000~positive regulation of fatty acid beta-oxidation,GO:0042760~very long-chain fatty acid catabolic process,GO:0055085~transmembrane transport,	GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005324~long-chain fatty acid transporter activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042803~protein homodimerization activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04146:Peroxisome,			SM00382:AAA,	ATP-binding,Complete proteome,Glycoprotein,Membrane,Nucleotide-binding,Peroxisome,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family D member 2,domain:ABC transmembrane type-1,domain:ABC transporter,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP,region of interest:Interaction with PEX19,sequence conflict,sequence variant,transmembrane region,
Q35920	ATP synthase F0 subunit 6(ATP6)	Salmo salar				GO:0015986~ATP synthesis coupled proton transport,	GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0045263~proton-transporting ATP synthase complex, coupling factor F(o),	GO:0015078~hydrogen ion transmembrane transporter activity,	IPR000568:ATPase, F0 complex, subunit A,IPR023011:ATPase, F0 complex, subunit A, active site,					ATP synthesis,CF(0),Hydrogen ion transport,Ion transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Transmembrane,Transmembrane helix,Transport,	chain:ATP synthase subunit a,sequence conflict,transmembrane region,
P56384	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C3 (subunit 9)(Atp5g3)	Mus musculus				GO:0006810~transport,GO:0006811~ion transport,GO:0007568~aging,GO:0015986~ATP synthesis coupled proton transport,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0045471~response to ethanol,GO:1902600~hydrogen ion transmembrane transport,	GO:0000276~mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),GO:0005739~mitochondrion,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,GO:0033177~proton-transporting two-sector ATPase complex, proton-transporting domain,GO:0045263~proton-transporting ATP synthase complex, coupling factor F(o),	GO:0008289~lipid binding,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,	IPR000454:ATPase, F0 complex, subunit C,IPR002379:V-ATPase proteolipid subunit C-like domain,IPR020537:ATPase, F0 complex, subunit C, DCCD-binding site,	mmu00190:Oxidative phosphorylation,mmu01100:Metabolic pathways,mmu05010:Alzheimer's disease,mmu05012:Parkinson's disease,mmu05016:Huntington's disease,				CF(0),Complete proteome,Hydrogen ion transport,Ion transport,Lipid-binding,Membrane,Mitochondrion,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,Transport,	chain:ATP synthase lipid-binding protein, mitochondrial,site:Reversibly protonated during proton transport,transit peptide:Mitochondrion,transmembrane region,
Q06647	ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit(Atp5o)	Rattus norvegicus				GO:0015986~ATP synthesis coupled proton transport,GO:0042776~mitochondrial ATP synthesis coupled proton transport,GO:0046034~ATP metabolic process,	GO:0000276~mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0005886~plasma membrane,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0005496~steroid binding,GO:0008144~drug binding,GO:0016887~ATPase activity,GO:0032403~protein complex binding,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,	IPR000711:ATPase, F1 complex, OSCP/delta subunit,IPR020781:ATPase, F1 complex, OSCP/delta subunit, conserved site,IPR026015:F1F0 ATP synthase OSCP/delta subunit, N-terminal domain,	rno00190:Oxidative phosphorylation,rno01100:Metabolic pathways,rno05010:Alzheimer's disease,rno05012:Parkinson's disease,rno05016:Huntington's disease,				Acetylation,ATP synthesis,Complete proteome,Direct protein sequencing,Hydrogen ion transport,Ion transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Transit peptide,Transport,	chain:ATP synthase subunit O, mitochondrial,modified residue,transit peptide:Mitochondrion,
Q03265	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1(Atp5a1)	Mus musculus				GO:0001937~negative regulation of endothelial cell proliferation,GO:0006629~lipid metabolic process,GO:0006754~ATP biosynthetic process,GO:0006810~transport,GO:0006811~ion transport,GO:0009790~embryo development,GO:0015986~ATP synthesis coupled proton transport,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0046034~ATP metabolic process,	GO:0000275~mitochondrial proton-transporting ATP synthase complex, catalytic core F(1),GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0005886~plasma membrane,GO:0008180~COP9 signalosome,GO:0016020~membrane,GO:0031012~extracellular matrix,GO:0033178~proton-transporting two-sector ATPase complex, catalytic domain,GO:0043209~myelin sheath,GO:0045261~proton-transporting ATP synthase complex, catalytic core F(1),GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0032559~adenyl ribonucleotide binding,GO:0042288~MHC class I protein binding,GO:0043531~ADP binding,GO:0044822~poly(A) RNA binding,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR000194:ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain,IPR000793:ATPase, F1/V1/A1 complex, alpha/beta subunit, C-terminal,IPR004100:ATPase, alpha/beta subunit, N-terminal,IPR005294:ATPase, F1 complex, alpha subunit,IPR020003:ATPase, alpha/beta subunit, nucleotide-binding domain, active site,IPR023366:ATPase, F1/A1 complex, alpha subunit, N-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	mmu00190:Oxidative phosphorylation,mmu01100:Metabolic pathways,mmu05010:Alzheimer's disease,mmu05012:Parkinson's disease,mmu05016:Huntington's disease,				Acetylation,ATP synthesis,ATP-binding,Cell membrane,CF(1),Complete proteome,Direct protein sequencing,Glycoprotein,Hydrogen ion transport,Ion transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Nucleotide-binding,Phosphoprotein,Proteomics identification,Pyrrolidone carboxylic acid,Reference proteome,Transit peptide,Transport,	chain:ATP synthase subunit alpha, mitochondrial,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,site:Required for activity,transit peptide:Mitochondrion,
P15999	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle(Atp5a1)	Rattus norvegicus				GO:0001937~negative regulation of endothelial cell proliferation,GO:0006629~lipid metabolic process,GO:0015986~ATP synthesis coupled proton transport,GO:0015991~ATP hydrolysis coupled proton transport,GO:0046034~ATP metabolic process,	GO:0000275~mitochondrial proton-transporting ATP synthase complex, catalytic core F(1),GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0005886~plasma membrane,GO:0008180~COP9 signalosome,GO:0016020~membrane,GO:0043209~myelin sheath,GO:0045261~proton-transporting ATP synthase complex, catalytic core F(1),GO:0070062~extracellular exosome,	GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042288~MHC class I protein binding,GO:0043531~ADP binding,GO:0044822~poly(A) RNA binding,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR000194:ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain,IPR000793:ATPase, F1/V1/A1 complex, alpha/beta subunit, C-terminal,IPR004100:ATPase, alpha/beta subunit, N-terminal,IPR005294:ATPase, F1 complex, alpha subunit,IPR020003:ATPase, alpha/beta subunit, nucleotide-binding domain, active site,IPR023366:ATPase, F1/A1 complex, alpha subunit, N-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	rno00190:Oxidative phosphorylation,rno01100:Metabolic pathways,rno05010:Alzheimer's disease,rno05012:Parkinson's disease,rno05016:Huntington's disease,				3D-structure,Acetylation,ATP synthesis,ATP-binding,Cell membrane,CF(1),Complete proteome,Direct protein sequencing,Glycoprotein,Hydrogen ion transport,Ion transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Nucleotide-binding,Phosphoprotein,Proteomics identification,Pyrrolidone carboxylic acid,Reference proteome,Transit peptide,Transport,	chain:ATP synthase subunit alpha, mitochondrial,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,site:Required for activity,strand,transit peptide:Mitochondrion,turn,
P56382	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit(Atp5e)	Mus musculus				GO:0006754~ATP biosynthetic process,GO:0006810~transport,GO:0006811~ion transport,GO:0015986~ATP synthesis coupled proton transport,GO:0015992~proton transport,	GO:0000275~mitochondrial proton-transporting ATP synthase complex, catalytic core F(1),GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0016020~membrane,GO:0045261~proton-transporting ATP synthase complex, catalytic core F(1),	GO:0008553~hydrogen-exporting ATPase activity, phosphorylative mechanism,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR006721:ATPase, F1 complex, epsilon  subunit, mitochondrial,	mmu00190:Oxidative phosphorylation,mmu01100:Metabolic pathways,mmu05010:Alzheimer's disease,mmu05012:Parkinson's disease,mmu05016:Huntington's disease,				Acetylation,ATP synthesis,CF(1),Complete proteome,Hydrogen ion transport,Hydrolase,Ion transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Transport,	chain:ATP synthase subunit epsilon, mitochondrial,modified residue,
Q5RFH9	ATP synthase, H+ transporting, mitochondrial Fo complex subunit B1(ATP5F1)	Pongo abelii				GO:0015986~ATP synthesis coupled proton transport,GO:0021762~substantia nigra development,	GO:0000276~mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),GO:0005654~nucleoplasm,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0015078~hydrogen ion transmembrane transporter activity,GO:0016887~ATPase activity,	IPR008688:ATPase, F0 complex, B chain/subunit B/MI25,IPR013837:ATPase, F0 complex, B chain/subunit B,	pon00190:Oxidative phosphorylation,pon01100:Metabolic pathways,pon05010:Alzheimer's disease,pon05012:Parkinson's disease,pon05016:Huntington's disease,				Acetylation,CF(0),Coiled coil,Complete proteome,Hydrogen ion transport,Ion transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Transit peptide,Transport,	chain:ATP synthase subunit b, mitochondrial,modified residue,transit peptide:Mitochondrion,
P21571	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6(Atp5j)	Rattus norvegicus				GO:0015986~ATP synthesis coupled proton transport,GO:0021762~substantia nigra development,GO:0046034~ATP metabolic process,	GO:0000276~mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,	GO:0015078~hydrogen ion transmembrane transporter activity,GO:0016887~ATPase activity,	IPR008387:ATPase, F0 complex, subunit F6, mitochondrial,IPR016349:ATPase, F0 complex, subunit F6, mitochondrial subgroup,	rno00190:Oxidative phosphorylation,rno01100:Metabolic pathways,rno05010:Alzheimer's disease,rno05012:Parkinson's disease,rno05016:Huntington's disease,		PIRSF002455:ATP synthase coupling factor 6,		Acetylation,CF(0),Complete proteome,Direct protein sequencing,Hydrogen ion transport,Ion transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Reference proteome,Transit peptide,Transport,	chain:ATP synthase-coupling factor 6, mitochondrial,modified residue,transit peptide:Mitochondrion,
P21447	ATP-binding cassette, sub-family B (MDR/TAP), member 1A(Abcb1a)	Mus musculus		m_mrpPathway:Multi-Drug Resistance Factors,m_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,	Amino acid transport and metabolism,Defense mechanisms,	GO:0000086~G2/M transition of mitotic cell cycle,GO:0002481~antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,GO:0002485~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent,GO:0002489~antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,GO:0002591~positive regulation of antigen processing and presentation of peptide antigen via MHC class I,GO:0006810~transport,GO:0006855~drug transmembrane transport,GO:0009914~hormone transport,GO:0015893~drug transport,GO:0033231~carbohydrate export,GO:0035633~maintenance of blood-brain barrier,GO:0043215~daunorubicin transport,GO:0045332~phospholipid translocation,GO:0046618~drug export,GO:0050892~intestinal absorption,GO:0055085~transmembrane transport,GO:0060548~negative regulation of cell death,GO:0060856~establishment of blood-brain barrier,GO:0072089~stem cell proliferation,GO:1990962~drug transport across blood-brain barrier,GO:1990963~establishment of blood-retinal barrier,GO:2001025~positive regulation of response to drug,	GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0031526~brush border membrane,GO:0045177~apical part of cell,GO:0046581~intercellular canaliculus,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0008559~xenobiotic-transporting ATPase activity,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0042623~ATPase activity, coupled,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0090554~phosphatidylcholine-translocating ATPase activity,GO:0090555~phosphatidylethanolamine-translocating ATPase activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	mmu02010:ABC transporters,mmu04976:Bile secretion,mmu05206:MicroRNAs in cancer,			SM00382:AAA,	3D-structure,ATP-binding,Cell membrane,Complete proteome,Direct protein sequencing,Glycoprotein,Hydrolase,Membrane,Nucleotide-binding,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Multidrug resistance protein 3,domain:ABC transmembrane type-1 1,domain:ABC transmembrane type-1 2,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
Q9DBM0	ATP-binding cassette, sub-family G (WHITE), member 8(Abcg8)	Mus musculus				GO:0006810~transport,GO:0007584~response to nutrient,GO:0007588~excretion,GO:0010949~negative regulation of intestinal phytosterol absorption,GO:0015914~phospholipid transport,GO:0015918~sterol transport,GO:0030299~intestinal cholesterol absorption,GO:0033344~cholesterol efflux,GO:0042493~response to drug,GO:0042632~cholesterol homeostasis,GO:0045796~negative regulation of intestinal cholesterol absorption,GO:0055092~sterol homeostasis,	GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0043190~ATP-binding cassette (ABC) transporter complex,GO:0043235~receptor complex,	GO:0005524~ATP binding,GO:0015248~sterol transporter activity,GO:0016887~ATPase activity,GO:0017127~cholesterol transporter activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0046982~protein heterodimerization activity,	IPR003439:ABC transporter-like,IPR013525:ABC-2 type transporter,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	mmu02010:ABC transporters,mmu04975:Fat digestion and absorption,mmu04976:Bile secretion,				Alternative splicing,ATP-binding,Complete proteome,Glycoprotein,Membrane,Nucleotide-binding,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family G member 8,domain:ABC transmembrane type-2,domain:ABC transporter,glycosylation site:N-linked (GlcNAc...),splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q794C0	ATPase H+ transporting V0 subunit e1(Atp6v0e1)	Rattus norvegicus				GO:0015991~ATP hydrolysis coupled proton transport,GO:0016049~cell growth,GO:0043200~response to amino acid,	GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0033179~proton-transporting V-type ATPase, V0 domain,	GO:0015078~hydrogen ion transmembrane transporter activity,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR008389:ATPase, V0 complex, subunit e1/e2,IPR017385:ATPase, V0 complex, subunit e1/e2, metazoa,	rno00190:Oxidative phosphorylation,rno01100:Metabolic pathways,rno04145:Phagosome,rno04721:Synaptic vesicle cycle,rno04966:Collecting duct acid secretion,rno05323:Rheumatoid arthritis,		PIRSF038097:V-type ATPase, subunits e1/e2,		Complete proteome,Hydrogen ion transport,Hydrolase,Ion transport,Membrane,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:V-type proton ATPase subunit E 1,transmembrane region,
P21188	ATPase, Na+/K+ transporting, beta 3 polypeptide S homeolog(atp1b3.S)	Xenopus laevis				GO:0006813~potassium ion transport,GO:0006814~sodium ion transport,	GO:0005890~sodium:potassium-exchanging ATPase complex,		IPR000402:Sodium/potassium-transporting ATPase subunit beta,	xla04260:Cardiac muscle contraction,xla04261:Adrenergic signaling in cardiomyocytes,				Disulfide bond,Glycoprotein,Ion transport,Membrane,Potassium,Potassium transport,Signal-anchor,Sodium,Sodium transport,Sodium/potassium transport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/potassium-transporting ATPase subunit beta-3,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q96P48	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1(ARAP1)	Homo sapiens		h_arapPathway:ADP-Ribosylation Factor,		GO:0001921~positive regulation of receptor recycling,GO:0007165~signal transduction,GO:0008360~regulation of cell shape,GO:0030037~actin filament reorganization involved in cell cycle,GO:0043547~positive regulation of GTPase activity,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051270~regulation of cellular component movement,GO:0051491~positive regulation of filopodium assembly,GO:0051497~negative regulation of stress fiber assembly,	GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0032580~Golgi cisterna membrane,	GO:0005096~GTPase activator activity,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0031702~type 1 angiotensin receptor binding,GO:0046872~metal ion binding,	IPR000159:Ras-association,IPR000198:Rho GTPase-activating protein domain,IPR001164:Arf GTPase activating protein,IPR001660:Sterile alpha motif domain,IPR001849:Pleckstrin homology domain,IPR008936:Rho GTPase activation protein,IPR011993:Pleckstrin homology-like domain,IPR013761:Sterile alpha motif/pointed domain,	hsa04144:Endocytosis,			SM00105:ArfGap,SM00233:PH,SM00324:RhoGAP,SM00454:SAM,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Golgi apparatus,GTPase activation,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1,domain:Arf-GAP,domain:PH 1,domain:PH 2,domain:PH 3,domain:PH 4,domain:Ras-associating,domain:Rho-GAP,domain:SAM,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C4-type,
P50615	B cell translocation gene 3(Btg3)	Mus musculus				GO:0045930~negative regulation of mitotic cell cycle,	GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR002087:Anti-proliferative protein,	mmu03018:RNA degradation,			SM00099:btg1,	Complete proteome,Reference proteome,	chain:Protein BTG3,compositionally biased region:Poly-Ser,sequence conflict,
Q10GM4	B3 domain-containing protein Os03g0622100(LOC4333473)	Oryza sativa Japonica Group				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,	IPR003340:B3 DNA binding domain,IPR015300:DNA-binding pseudobarrel domain,				SM01019:SM01019,	Complete proteome,DNA-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:B3 domain-containing protein Os03g0622100,DNA-binding region:TF-B3 1,DNA-binding region:TF-B3 2,
Q8HYS5	BCL2 family apoptosis regulator(MCL1)	Canis lupus familiaris				GO:0007275~multicellular organism development,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008637~apoptotic mitochondrial changes,GO:0030154~cell differentiation,GO:0034097~response to cytokine,GO:0042981~regulation of apoptotic process,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:1903378~positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,GO:2000811~negative regulation of anoikis,GO:2001020~regulation of response to DNA damage stimulus,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005741~mitochondrial outer membrane,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0097136~Bcl-2 family protein complex,	GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR002475:Bcl2-like,IPR013281:Apoptosis regulator, Mcl-1,IPR020717:Apoptosis regulator, Bcl-2, BH1 motif, conserved site,IPR020726:Apoptosis regulator, Bcl-2, BH2 motif, conserved site,IPR020728:Apoptosis regulator, Bcl-2, BH3 motif, conserved site,IPR026298:Blc2 family,	cfa04151:PI3K-Akt signaling pathway,cfa05206:MicroRNAs in cancer,				Apoptosis,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Isopeptide bond,Membrane,Mitochondrion,Nucleus,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Induced myeloid leukemia cell differentiation protein Mcl-1 homolog,compositionally biased region:Gly-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,region of interest:PEST-like,short sequence motif:BH1,short sequence motif:BH2,short sequence motif:BH3,site:Cleavage; by caspase-3,transmembrane region,
Q9Z1P3	BCL2 family apoptosis regulator(Mcl1)	Rattus norvegicus				GO:0007275~multicellular organism development,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008637~apoptotic mitochondrial changes,GO:0030154~cell differentiation,GO:0034097~response to cytokine,GO:0043066~negative regulation of apoptotic process,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:1903378~positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,GO:2000811~negative regulation of anoikis,GO:2001020~regulation of response to DNA damage stimulus,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0097136~Bcl-2 family protein complex,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0051400~BH domain binding,GO:0051434~BH3 domain binding,	IPR002475:Bcl2-like,IPR013281:Apoptosis regulator, Mcl-1,IPR020717:Apoptosis regulator, Bcl-2, BH1 motif, conserved site,IPR020726:Apoptosis regulator, Bcl-2, BH2 motif, conserved site,IPR020728:Apoptosis regulator, Bcl-2, BH3 motif, conserved site,IPR026298:Blc2 family,	rno04151:PI3K-Akt signaling pathway,rno05206:MicroRNAs in cancer,				Apoptosis,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Isopeptide bond,Membrane,Mitochondrion,Nucleus,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Induced myeloid leukemia cell differentiation protein Mcl-1 homolog,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,region of interest:PEST-like,sequence conflict,short sequence motif:BH1,short sequence motif:BH2,short sequence motif:BH3,site:Cleavage; by caspase-3,transmembrane region,
P78543	BTG anti-proliferation factor 2(BTG2)	Homo sapiens		h_btg2Pathway:BTG family proteins and cell cycle regulation,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006479~protein methylation,GO:0006974~cellular response to DNA damage stimulus,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0008285~negative regulation of cell proliferation,GO:0008306~associative learning,GO:0009612~response to mechanical stimulus,GO:0009952~anterior/posterior pattern specification,GO:0014070~response to organic cyclic compound,GO:0017148~negative regulation of translation,GO:0021542~dentate gyrus development,GO:0021954~central nervous system neuron development,GO:0031175~neuron projection development,GO:0035914~skeletal muscle cell differentiation,GO:0043434~response to peptide hormone,GO:0043524~negative regulation of neuron apoptotic process,GO:0051602~response to electrical stimulus,GO:0060213~positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,GO:2000178~negative regulation of neural precursor cell proliferation,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0005515~protein binding,	IPR002087:Anti-proliferative protein,	hsa03018:RNA degradation,			SM00099:btg1,	3D-structure,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Protein BTG2,helix,sequence variant,strand,
Q16627	C-C motif chemokine ligand 14(CCL14)	Homo sapiens	109.Chemokine_families,			GO:0002548~monocyte chemotaxis,GO:0006874~cellular calcium ion homeostasis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,	GO:0008009~chemokine activity,GO:0048020~CCR chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04062:Chemokine signaling pathway,			SM00199:SCY,	3D-structure,Alternative splicing,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 14,chain:C-C motif chemokine 15,chain:CCL15(22-92),chain:CCL15(25-92),chain:CCL15(29-92),chain:HCC-1(3-74),chain:HCC-1(4-74),chain:HCC-1(9-74),disulfide bond,glycosylation site:O-linked (GalNAc...); partial,helix,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
P78556	C-C motif chemokine ligand 20(CCL20)	Homo sapiens	109.Chemokine_families,			GO:0002548~monocyte chemotaxis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0030593~neutrophil chemotaxis,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0042060~wound healing,GO:0042742~defense response to bacterium,GO:0043547~positive regulation of GTPase activity,GO:0048247~lymphocyte chemotaxis,GO:0050726~positive regulation of interleukin-1 alpha biosynthetic process,GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071222~cellular response to lipopolysaccharide,GO:0071223~cellular response to lipoteichoic acid,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0072678~T cell migration,GO:0072679~thymocyte migration,GO:2000406~positive regulation of T cell migration,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,	GO:0008009~chemokine activity,GO:0031731~CCR6 chemokine receptor binding,GO:0048020~CCR chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04668:TNF signaling pathway,hsa05323:Rheumatoid arthritis,			SM00199:SCY,	3D-structure,Alternative splicing,Antibiotic,Antimicrobial,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Inflammatory response,Polymorphism,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 20,chain:CCL20(1-64),chain:CCL20(1-67),chain:CCL20(2-70),disulfide bond,helix,sequence variant,signal peptide,splice variant,strand,turn,
Q1WLP9	C-C motif chemokine receptor 9(CCR9)	Ovis aries				GO:0006935~chemotaxis,GO:0006955~immune response,	GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0016493~C-C chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR004069:CC chemokine receptor 9,IPR017452:GPCR, rhodopsin-like, 7TM,	oas04060:Cytokine-cytokine receptor interaction,oas04062:Chemokine signaling pathway,oas04672:Intestinal immune network for IgA production,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-C chemokine receptor type 9,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
A9QWP9	C-X-C motif chemokine ligand 9(CXCL9)	Bos taurus				GO:0002690~positive regulation of leukocyte chemotaxis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0030816~positive regulation of cAMP metabolic process,GO:0032496~response to lipopolysaccharide,GO:0042127~regulation of cell proliferation,GO:0043950~positive regulation of cAMP-mediated signaling,GO:0045663~positive regulation of myoblast differentiation,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0051607~defense response to virus,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:1901741~positive regulation of myoblast fusion,	GO:0005615~extracellular space,GO:0009897~external side of plasma membrane,	GO:0008009~chemokine activity,GO:0045236~CXCR chemokine receptor binding,GO:0048248~CXCR3 chemokine receptor binding,	IPR001089:CXC chemokine,IPR001811:Chemokine interleukin-8-like domain,IPR018048:CXC chemokine, conserved site,IPR027225:CXC chemokine 9,	bta04060:Cytokine-cytokine receptor interaction,bta04062:Chemokine signaling pathway,bta04620:Toll-like receptor signaling pathway,			SM00199:SCY,	Complete proteome,Cytokine,Disulfide bond,Inflammatory response,Reference proteome,Secreted,Signal,	chain:C-X-C motif chemokine 9,disulfide bond,signal peptide,
O08565	C-X-C motif chemokine receptor 4(Cxcr4)	Rattus norvegicus				GO:0001569~patterning of blood vessels,GO:0001666~response to hypoxia,GO:0001667~ameboidal-type cell migration,GO:0001764~neuron migration,GO:0001934~positive regulation of protein phosphorylation,GO:0002064~epithelial cell development,GO:0003281~ventricular septum development,GO:0006935~chemotaxis,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007281~germ cell development,GO:0007420~brain development,GO:0008038~neuron recognition,GO:0008045~motor neuron axon guidance,GO:0008354~germ cell migration,GO:0014823~response to activity,GO:0016477~cell migration,GO:0019722~calcium-mediated signaling,GO:0022008~neurogenesis,GO:0022029~telencephalon cell migration,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0035470~positive regulation of vascular wound healing,GO:0035690~cellular response to drug,GO:0035701~hematopoietic stem cell migration,GO:0035904~aorta development,GO:0042098~T cell proliferation,GO:0043067~regulation of programmed cell death,GO:0043217~myelin maintenance,GO:0045446~endothelial cell differentiation,GO:0048699~generation of neurons,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0050792~regulation of viral process,GO:0050920~regulation of chemotaxis,GO:0051924~regulation of calcium ion transport,GO:0060048~cardiac muscle contraction,GO:0061154~endothelial tube morphogenesis,GO:0061351~neural precursor cell proliferation,GO:0070098~chemokine-mediated signaling pathway,GO:0071345~cellular response to cytokine stimulus,GO:0090280~positive regulation of calcium ion import,GO:1990478~response to ultrasound,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005768~endosome,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030054~cell junction,GO:0030426~growth cone,GO:0031252~cell leading edge,GO:0031410~cytoplasmic vesicle,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0008144~drug binding,GO:0016493~C-C chemokine receptor activity,GO:0016494~C-X-C chemokine receptor activity,GO:0019955~cytokine binding,GO:0031625~ubiquitin protein ligase binding,GO:0032027~myosin light chain binding,GO:0043130~ubiquitin binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR001277:CXC chemokine receptor 4,IPR017452:GPCR, rhodopsin-like, 7TM,IPR022726:CXC chemokine receptor 4 N-terminal domain,	rno04060:Cytokine-cytokine receptor interaction,rno04062:Chemokine signaling pathway,rno04144:Endocytosis,rno04360:Axon guidance,rno04670:Leukocyte transendothelial migration,rno04672:Intestinal immune network for IgA production,rno05200:Pathways in cancer,				Cell junction,Cell membrane,Complete proteome,Disulfide bond,Endosome,G-protein coupled receptor,Glycoprotein,Lysosome,Membrane,Phosphoprotein,Proteoglycan,Receptor,Reference proteome,Sulfation,Transducer,Transmembrane,Transmembrane helix,Ubl conjugation,
Q8WTT0	C-type lectin domain family 4 member C(CLEC4C)	Homo sapiens				GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002250~adaptive immune response,GO:0045087~innate immune response,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,				SM00034:CLECT,	3D-structure,Adaptive immunity,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Lectin,Membrane,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:C-type lectin domain family 4 member C,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q9ULY5	C-type lectin domain family 4 member E(CLEC4E)	Homo sapiens				GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002292~T cell differentiation involved in immune response,GO:0038094~Fc-gamma receptor signaling pathway,GO:0042742~defense response to bacterium,GO:0045087~innate immune response,GO:0050715~positive regulation of cytokine secretion,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,	hsa05152:Tuberculosis,			SM00034:CLECT,	3D-structure,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Lectin,Membrane,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:C-type lectin domain family 4 member E,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q05826	CCAAT/enhancer binding protein (C/EBP), beta(CEBPB)	Gallus gallus				GO:0001541~ovarian follicle development,GO:0002432~granuloma formation,GO:0006366~transcription from RNA polymerase II promoter,GO:0010628~positive regulation of gene expression,GO:0030182~neuron differentiation,GO:0032496~response to lipopolysaccharide,GO:0032753~positive regulation of interleukin-4 production,GO:0035711~T-helper 1 cell activation,GO:0042130~negative regulation of T cell proliferation,GO:0042742~defense response to bacterium,GO:0043524~negative regulation of neuron apoptotic process,GO:0045408~regulation of interleukin-6 biosynthetic process,GO:0045444~fat cell differentiation,GO:0045600~positive regulation of fat cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045670~regulation of osteoclast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0050873~brown fat cell differentiation,GO:0060850~regulation of transcription involved in cell fate commitment,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0071230~cellular response to amino acid stimulus,GO:0072574~hepatocyte proliferation,GO:0097421~liver regeneration,GO:1990440~positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,GO:2000144~positive regulation of DNA-templated transcription, initiation,GO:2000617~positive regulation of histone H3-K9 acetylation,	GO:0000779~condensed chromosome, centromeric region,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001158~enhancer sequence-specific DNA binding,GO:0003682~chromatin binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0019900~kinase binding,GO:0035035~histone acetyltransferase binding,GO:0042803~protein homodimerization activity,GO:0042826~histone deacetylase binding,GO:0044389~ubiquitin-like protein ligase binding,GO:0046982~protein heterodimerization activity,	IPR004827:Basic-leucine zipper domain,IPR016468:CCAAT/enhancer-binding,			PIRSF005879:CCAAT/enhancer-binding protein,	SM00338:BRLZ,	Activator,Complete proteome,DNA-binding,Methylation,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,	chain:CCAAT/enhancer-binding protein beta,DNA-binding region:Basic motif,domain:Leucine-zipper,
Q9JLQ0	CD2-associated protein(Cd2ap)	Mus musculus				GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0016050~vesicle organization,GO:0016337~single organismal cell-cell adhesion,GO:0016477~cell migration,GO:0032911~negative regulation of transforming growth factor beta1 production,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0048259~regulation of receptor-mediated endocytosis,GO:0051301~cell division,GO:1900182~positive regulation of protein localization to nucleus,GO:2000249~regulation of actin cytoskeleton reorganization,	GO:0001726~ruffle,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005913~cell-cell adherens junction,GO:0005938~cell cortex,GO:0030139~endocytic vesicle,GO:0031252~cell leading edge,GO:0031941~filamentous actin,GO:0042995~cell projection,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005172~vascular endothelial growth factor receptor binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008022~protein C-terminus binding,GO:0017124~SH3 domain binding,GO:0032403~protein complex binding,GO:0045296~cadherin binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001452:Src homology-3 domain,	mmu05100:Bacterial invasion of epithelial cells,			SM00326:SH3,	3D-structure,Cell cycle,Cell division,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Isopeptide bond,Mitosis,Phosphoprotein,Reference proteome,Repeat,SH3 domain,SH3-binding,Ubl conjugation,	chain:CD2-associated protein,compositionally biased region:Pro-rich,domain:SH3 1; truncated,domain:SH3 2,domain:SH3 3,helix,modified residue,region of interest:Interaction with ANLN and localization to the midbody,sequence conflict,short sequence motif:SH3-binding,strand,
F1LRS8	CD2-associated protein(Cd2ap)	Rattus norvegicus				GO:0007067~mitotic nuclear division,GO:0016050~vesicle organization,GO:0016337~single organismal cell-cell adhesion,GO:0016477~cell migration,GO:0032911~negative regulation of transforming growth factor beta1 production,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0048259~regulation of receptor-mediated endocytosis,GO:0051301~cell division,GO:1900182~positive regulation of protein localization to nucleus,GO:2000249~regulation of actin cytoskeleton reorganization,	GO:0001726~ruffle,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0030139~endocytic vesicle,GO:0031252~cell leading edge,GO:0031941~filamentous actin,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005172~vascular endothelial growth factor receptor binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008022~protein C-terminus binding,GO:0017124~SH3 domain binding,GO:0032403~protein complex binding,GO:0045296~cadherin binding,	IPR001452:Src homology-3 domain,	rno05100:Bacterial invasion of epithelial cells,			SM00326:SH3,	Cell cycle,Cell division,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Isopeptide bond,Mitosis,Phosphoprotein,Reference proteome,Repeat,SH3 domain,SH3-binding,Ubl conjugation,
Q91ZX1	CD209a antigen(Cd209a)	Mus musculus				GO:0006897~endocytosis,GO:0010468~regulation of gene expression,GO:0030193~regulation of blood coagulation,GO:0042129~regulation of T cell proliferation,	GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0001618~virus receptor activity,GO:0005537~mannose binding,GO:0030246~carbohydrate binding,GO:0046872~metal ion binding,GO:0048306~calcium-dependent protein binding,GO:0097367~carbohydrate derivative binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,	mmu04145:Phagosome,mmu05152:Tuberculosis,mmu05162:Measles,			SM00034:CLECT,	Alternative splicing,Calcium,Complete proteome,Disulfide bond,Endocytosis,Glycoprotein,Lectin,Mannose-binding,Membrane,Metal-binding,Receptor,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:CD209 antigen-like protein A,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Calcium,metal ion-binding site:Calcium; via carbonyl oxygen,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q9EP73	CD274 antigen(Cd274)	Mus musculus				GO:0006955~immune response,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0030335~positive regulation of cell migration,GO:0031295~T cell costimulation,GO:0032689~negative regulation of interferon-gamma production,GO:0032693~negative regulation of interleukin-10 production,GO:0034097~response to cytokine,GO:0042102~positive regulation of T cell proliferation,GO:0042130~negative regulation of T cell proliferation,GO:0046007~negative regulation of activated T cell proliferation,GO:1901998~toxin transport,GO:1903556~negative regulation of tumor necrosis factor superfamily cytokine production,GO:2001181~positive regulation of interleukin-10 secretion,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013162:CD80-like, immunoglobulin C2-set,IPR013783:Immunoglobulin-like fold,	mmu04514:Cell adhesion molecules (CAMs),			SM00409:IG,	Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Programmed cell death 1 ligand 1,disulfide bond,domain:Ig-like C2-type,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),mutagenesis site,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q28072	CD3d molecule(CD3D)	Bos taurus				GO:0007166~cell surface receptor signaling pathway,GO:0045059~positive thymic T cell selection,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0016021~integral component of membrane,GO:0042105~alpha-beta T cell receptor complex,	GO:0003713~transcription coactivator activity,GO:0004888~transmembrane signaling receptor activity,GO:0046982~protein heterodimerization activity,	IPR003110:Phosphorylated immunoreceptor signaling ITAM,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR015484:CD3 protein, gamma/delta subunit,IPR015485:CD3 signaling complex delta subunit,	bta04640:Hematopoietic cell lineage,bta04660:T cell receptor signaling pathway,bta05142:Chagas disease (American trypanosomiasis),bta05162:Measles,bta05166:HTLV-I infection,bta05340:Primary immunodeficiency,			SM00077:ITAM,	Complete proteome,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:T-cell surface glycoprotein CD3 delta chain,disulfide bond,domain:ITAM,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q3LRP1	CD40 molecule(CD40)	Callithrix jacchus				GO:0002376~immune system process,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0006874~cellular calcium ion homeostasis,GO:0030890~positive regulation of B cell proliferation,GO:0032735~positive regulation of interleukin-12 production,GO:0042113~B cell activation,GO:0042511~positive regulation of tyrosine phosphorylation of Stat1 protein,GO:0042832~defense response to protozoan,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043406~positive regulation of MAP kinase activity,GO:0043491~protein kinase B signaling,GO:0043547~positive regulation of GTPase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048304~positive regulation of isotype switching to IgG isotypes,GO:0051023~regulation of immunoglobulin secretion,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051607~defense response to virus,GO:0071260~cellular response to mechanical stimulus,GO:0090037~positive regulation of protein kinase C signaling,GO:2000353~positive regulation of endothelial cell apoptotic process,	GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0035631~CD40 receptor complex,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,		IPR001368:TNFR/NGFR cysteine-rich region,IPR020435:Tumour necrosis factor receptor 5,	cjc04060:Cytokine-cytokine receptor interaction,cjc04064:NF-kappa B signaling pathway,cjc04514:Cell adhesion molecules (CAMs),cjc04620:Toll-like receptor signaling pathway,cjc04672:Intestinal immune network for IgA production,cjc05144:Malaria,cjc05145:Toxoplasmosis,cjc05166:HTLV-I infection,cjc05169:Epstein-Barr virus infection,cjc05202:Transcriptional misregulation in cancer,cjc05310:Asthma,cjc05320:Autoimmune thyroid disease,cjc05322:Systemic lupus erythematosus,cjc05330:Allograft rejection,cjc05340:Primary immunodeficiency,cjc05416:Viral myocarditis,			SM00208:TNFR,	Complete proteome,Disulfide bond,Glycoprotein,Immunity,Membrane,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,
P19397	CD53 molecule(CD53)	Homo sapiens				GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:1901741~positive regulation of myoblast fusion,	GO:0001772~immunological synapse,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR000301:Tetraspanin,IPR008952:Tetraspanin, EC2 domain,IPR018499:Tetraspanin/Peripherin,IPR018503:Tetraspanin, conserved site,			PIRSF002419:tetraspanin,		Cell junction,Cell membrane,Complete proteome,Glycoprotein,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Leukocyte surface antigen CD53,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P08174	CD55 molecule (Cromer blood group)(CD55)	Homo sapiens				GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006958~complement activation, classical pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007283~spermatogenesis,GO:0030449~regulation of complement activation,GO:0031664~regulation of lipopolysaccharide-mediated signaling pathway,GO:0035743~CD4-positive, alpha-beta T cell cytokine production,GO:0043434~response to peptide hormone,GO:0045087~innate immune response,GO:0045730~respiratory burst,GO:0045916~negative regulation of complement activation,GO:0046718~viral entry into host cell,GO:0060137~maternal process involved in parturition,GO:2000516~positive regulation of CD4-positive, alpha-beta T cell activation,GO:2000563~positive regulation of CD4-positive, alpha-beta T cell proliferation,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016324~apical plasma membrane,GO:0030133~transport vesicle,GO:0031225~anchored component of membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0004857~enzyme inhibitor activity,GO:0005515~protein binding,GO:0008289~lipid binding,	IPR000436:Sushi/SCR/CCP,	hsa04610:Complement and coagulation cascades,hsa04640:Hematopoietic cell lineage,hsa05416:Viral myocarditis,	613793~Blood group Cromer,		SM00032:CCP,	3D-structure,Alternative splicing,Blood group antigen,Cell membrane,Complement pathway,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,GPI-anchor,Host cell receptor for virus entry,Host-virus interaction,Immunity,Innate immunity,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Complement decay-accelerating factor,compositionally biased region:Ser/Thr-rich,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:GPI-anchor amidated serine,modified residue,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
Q76B49	CD63 molecule(CD63)	Felis catus				GO:0002092~positive regulation of receptor internalization,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0015031~protein transport,GO:0016477~cell migration,GO:0034613~cellular protein localization,GO:0035646~endosome to melanosome transport,GO:0045807~positive regulation of endocytosis,GO:0048757~pigment granule maturation,GO:1900746~regulation of vascular endothelial growth factor signaling pathway,GO:2000680~regulation of rubidium ion transport,GO:2001046~positive regulation of integrin-mediated signaling pathway,	GO:0005615~extracellular space,GO:0005765~lysosomal membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0012505~endomembrane system,GO:0016021~integral component of membrane,GO:0031226~intrinsic component of plasma membrane,GO:0031902~late endosome membrane,GO:0031904~endosome lumen,GO:0042470~melanosome,GO:0070062~extracellular exosome,GO:0097487~multivesicular body, internal vesicle,		IPR000301:Tetraspanin,IPR008952:Tetraspanin, EC2 domain,IPR018499:Tetraspanin/Peripherin,IPR018503:Tetraspanin, conserved site,	fca04142:Lysosome,fca05205:Proteoglycans in cancer,		PIRSF002419:tetraspanin,		Cell membrane,Complete proteome,Endosome,Glycoprotein,Lipoprotein,Lysosome,Membrane,Palmitate,Protein transport,Reference proteome,Secreted,Transmembrane,Transmembrane helix,Transport,	chain:CD63 antigen,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P04233	CD74 molecule(CD74)	Homo sapiens		h_mhcPathway:Antigen Processing and Presentation,		GO:0000187~activation of MAPK activity,GO:0001516~prostaglandin biosynthetic process,GO:0001961~positive regulation of cytokine-mediated signaling pathway,GO:0002606~positive regulation of dendritic cell antigen processing and presentation,GO:0002792~negative regulation of peptide secretion,GO:0002830~positive regulation of type 2 immune response,GO:0002906~negative regulation of mature B cell apoptotic process,GO:0006461~protein complex assembly,GO:0006886~intracellular protein transport,GO:0006952~defense response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0008283~cell proliferation,GO:0016064~immunoglobulin mediated immune response,GO:0019882~antigen processing and presentation,GO:0019883~antigen processing and presentation of endogenous antigen,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0030890~positive regulation of B cell proliferation,GO:0035691~macrophage migration inhibitory factor signaling pathway,GO:0043030~regulation of macrophage activation,GO:0043066~negative regulation of apoptotic process,GO:0043518~negative regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045058~T cell selection,GO:0045059~positive thymic T cell selection,GO:0045060~negative thymic T cell selection,GO:0045581~negative regulation of T cell differentiation,GO:0045582~positive regulation of T cell differentiation,GO:0048146~positive regulation of fibroblast proliferation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050900~leukocyte migration,GO:0051085~chaperone mediated protein folding requiring cofactor,GO:0060907~positive regulation of macrophage cytokine production,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0090023~positive regulation of neutrophil chemotaxis,GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:2000343~positive regulation of chemokine (C-X-C motif) ligand 2 production,	GO:0000139~Golgi membrane,GO:0005622~intracellular,GO:0005765~lysosomal membrane,GO:0005771~multivesicular body,GO:0005773~vacuole,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0012507~ER to Golgi transport vesicle membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030658~transport vesicle membrane,GO:0030666~endocytic vesicle membrane,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0032588~trans-Golgi network membrane,GO:0035692~macrophage migration inhibitory factor receptor complex,GO:0035693~NOS2-CD74 complex,GO:0042613~MHC class II protein complex,GO:0043202~lysosomal lumen,GO:0070062~extracellular exosome,GO:0071556~integral component of lumenal side of endoplasmic reticulum membrane,	GO:0001540~beta-amyloid binding,GO:0004896~cytokine receptor activity,GO:0019955~cytokine binding,GO:0023026~MHC class II protein complex binding,GO:0035718~macrophage migration inhibitory factor binding,GO:0042289~MHC class II protein binding,GO:0042658~MHC class II protein binding, via antigen binding groove,GO:0042802~identical protein binding,GO:0044183~protein binding involved in protein folding,GO:0050998~nitric-oxide synthase binding,	IPR000716:Thyroglobulin type-1,IPR011988:MHC class II-associated invariant chain, trimerisation,IPR015386:MHC class II-associated invariant chain/CLIP, MHC II-interacting,IPR022339:MHC class II-associated invariant chain,	hsa04612:Antigen processing and presentation,hsa05152:Tuberculosis,hsa05168:Herpes simplex infection,		PIRSF001992:HLA class II histocompatibility antigen, gamma subunit,	SM00211:TY,	3D-structure,Adaptive immunity,Alternative splicing,Cell membrane,Chaperone,Complete proteome,Direct protein sequencing,Disulfide bond,Endoplasmic reticulum,Endosome,Glycoprotein,Golgi apparatus,Immunity,Lysosome,Membrane,Phosphoprotein,Proteoglycan,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:HLA class II histocompatibility antigen gamma chain,disulfide bond,domain:Thyroglobulin type-1,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Xyl...) (glycosaminoglycan),helix,modified residue,region of interest:CLIP,sequence conflict,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
P40259	CD79b molecule(CD79B)	Homo sapiens		h_bcrmolecule:B Cell Receptor Complex,h_bcrPathway:BCR Signaling Pathway,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,		GO:0002250~adaptive immune response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0030183~B cell differentiation,GO:0050853~B cell receptor signaling pathway,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0019815~B cell receptor complex,GO:0070062~extracellular exosome,	GO:0004888~transmembrane signaling receptor activity,	IPR003110:Phosphorylated immunoreceptor signaling ITAM,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04662:B cell receptor signaling pathway,	612692~Agammaglobulinemia 6,		SM00077:ITAM,SM00409:IG,	3D-structure,Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Phosphoprotein,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:B-cell antigen receptor complex- associated protein beta chain,disulfide bond,domain:Ig-like V-type,domain:ITAM,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q01151	CD83 molecule(CD83)	Homo sapiens				GO:0001817~regulation of cytokine production,GO:0006952~defense response,GO:0006959~humoral immune response,GO:0007165~signal transduction,GO:0014070~response to organic cyclic compound,GO:0032713~negative regulation of interleukin-4 production,GO:0032733~positive regulation of interleukin-10 production,GO:0032743~positive regulation of interleukin-2 production,GO:0043372~positive regulation of CD4-positive, alpha-beta T cell differentiation,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,		IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,				SM00409:IG,	Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:CD83 antigen,disulfide bond,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P39823	CDP-diacylglycerol--serine O-phosphatidyltransferase(pssA)	Bacillus subtilis subsp. subtilis str. 168				GO:0008654~phospholipid biosynthetic process,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0003882~CDP-diacylglycerol-serine O-phosphatidyltransferase activity,	IPR000462:CDP-alcohol phosphatidyltransferase,IPR004533:CDP-diacylglycerol--serine O-phosphatidyltransferase,	bsu00260:Glycine, serine and threonine metabolism,bsu00564:Glycerophospholipid metabolism,bsu01100:Metabolic pathways,bsu01110:Biosynthesis of secondary metabolites,				Cell membrane,Complete proteome,Lipid biosynthesis,Lipid metabolism,Membrane,Phospholipid biosynthesis,Phospholipid metabolism,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:CDP-diacylglycerol--serine O- phosphatidyltransferase,transmembrane region,
Q9W138	CG3570 gene product from transcript CG3570-RA(CG3570)	Drosophila melanogaster						GO:0016433~rRNA (adenine) methyltransferase activity,	IPR021867:Protein of unknown function DUF3321,					Complete proteome,Methyltransferase,Reference proteome,S-adenosyl-L-methionine,Transferase,	chain:UPF0532 protein CG3570,
P26374	CHM like, Rab escort protein 2(CHML)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0007264~small GTPase mediated signal transduction,GO:0018344~protein geranylgeranylation,GO:0043547~positive regulation of GTPase activity,GO:0055114~oxidation-reduction process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005968~Rab-protein geranylgeranyltransferase complex,	GO:0005092~GDP-dissociation inhibitor activity,GO:0005096~GTPase activator activity,GO:0016491~oxidoreductase activity,GO:0017137~Rab GTPase binding,	IPR001738:Rab escort (choroideraemia) protein,IPR018203:GDP dissociation inhibitor,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,			PIRSF016550:Rab protein geranylgeranyltransferase, component A, eukaryotic type,		Complete proteome,Cytoplasm,GTPase activation,Phosphoprotein,Reference proteome,	chain:Rab proteins geranylgeranyltransferase component A 2,modified residue,sequence conflict,
Q96FZ5	CKLF like MARVEL transmembrane domain containing 7(CMTM7)	Homo sapiens				GO:0002337~B-1a B cell differentiation,GO:0006935~chemotaxis,	GO:0005615~extracellular space,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005125~cytokine activity,	IPR008253:Marvel,					Alternative splicing,Chemotaxis,Complete proteome,Cytokine,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:CKLF-like MARVEL transmembrane domain- containing protein 7,domain:MARVEL,transmembrane region,
Q96KP4	CNDP dipeptidase 2 (metallopeptidase M20 family)(CNDP2)	Homo sapiens			Amino acid transport and metabolism,	GO:0000096~sulfur amino acid metabolic process,GO:0006508~proteolysis,GO:0006750~glutathione biosynthetic process,GO:0008152~metabolic process,GO:0043171~peptide catabolic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004180~carboxypeptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0034701~tripeptidase activity,GO:0070573~metallodipeptidase activity,GO:0102008~cytosolic dipeptidase activity,	IPR001261:ArgE/DapE/ACY1/CPG2/YscS, conserved site,IPR002933:Peptidase M20,IPR011650:Peptidase M20, dimerisation domain,IPR017153:Glutathione degradosome, DUG1,	hsa00330:Arginine and proline metabolism,hsa00340:Histidine metabolism,hsa00410:beta-Alanine metabolism,hsa01100:Metabolic pathways,		PIRSF037242:CNDP dipeptidase,		3D-structure,Acetylation,Alternative splicing,Carboxypeptidase,Complete proteome,Cytoplasm,Direct protein sequencing,Hydrolase,Manganese,Metal-binding,Metalloprotease,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,	active site:Proton acceptor,binding site:Substrate,binding site:Substrate; shared with homodimeric partner,binding site:Substrate; via amide nitrogen and carbonyl oxygen,binding site:Substrate; via carbonyl oxygen,chain:Cytosolic non-specific dipeptidase,metal ion-binding site:Manganese 1,metal ion-binding site:Manganese 2,modified residue,region of interest:Substrate binding,sequence conflict,sequence variant,site:Important for catalytic activity,splice variant,
Q12275	Cmr2p(CMR2)	Saccharomyces cerevisiae S288c			Lipid metabolism / Secondary metabolites biosynthesis, transport, and catabolism,	GO:0008152~metabolic process,	GO:0005829~cytosol,GO:0005935~cellular bud neck,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003824~catalytic activity,	IPR000873:AMP-dependent synthetase/ligase,IPR010506:DMAP1-binding,				SM01137:SM01137,	Complete proteome,Glycoprotein,Membrane,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein YOR093C,glycosylation site:N-linked (GlcNAc...),modified residue,transmembrane region,
P25007	Cyclophilin 1(Cyp1)	Drosophila melanogaster				GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,GO:0035071~salivary gland cell autophagic cell death,GO:0048102~autophagic cell death,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005875~microtubule associated complex,GO:0008024~cyclin/CDK positive transcription elongation factor complex,GO:0019908~nuclear cyclin-dependent protein kinase holoenzyme complex,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0042277~peptide binding,	IPR002130:Cyclophilin-like peptidyl-prolyl cis-trans isomerase domain,IPR020892:Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site,IPR024936:Cyclophilin-type peptidyl-prolyl cis-trans isomerase,					Complete proteome,Cyclosporin,Cytoplasm,Direct protein sequencing,Isomerase,Phosphoprotein,Reference proteome,Rotamase,	chain:Peptidyl-prolyl cis-trans isomerase,domain:PPIase cyclophilin-type,modified residue,
Q6UX65	DNA damage regulated autophagy modulator 2(DRAM2)	Homo sapiens				GO:0006914~autophagy,GO:0006915~apoptotic process,GO:0007601~visual perception,GO:0010506~regulation of autophagy,GO:0045494~photoreceptor cell maintenance,	GO:0001917~photoreceptor inner segment,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0043231~intracellular membrane-bounded organelle,		IPR019402:Frag1/DRAM/Sfk1,		616502~Cone-rod dystrophy 21,			Apoptosis,Autophagy,Cell membrane,Complete proteome,Cone-rod dystrophy,Disease mutation,Lysosome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:DNA damage-regulated autophagy modulator protein 2,modified residue,sequence conflict,transmembrane region,
Q3ZC48	DNA damage regulated autophagy modulator 2(DRAM2)	Bos taurus				GO:0006914~autophagy,GO:0006915~apoptotic process,GO:0007601~visual perception,GO:0010506~regulation of autophagy,GO:0045494~photoreceptor cell maintenance,	GO:0001917~photoreceptor inner segment,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,		IPR019402:Frag1/DRAM/Sfk1,					Apoptosis,Autophagy,Cell membrane,Complete proteome,Lysosome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:DNA damage-regulated autophagy modulator protein 2,modified residue,transmembrane region,
A4QN59	DPH2 homolog (S. cerevisiae)(dph2)	Danio rerio				GO:0017183~peptidyl-diphthamide biosynthetic process from peptidyl-histidine,			IPR010014:Diphthamide synthesis DHP2, eukaryotic,IPR016435:Diphthamide synthesis, eukaryotic DPH1/archaeal DPH2,					Complete proteome,Proteomics identification,Reference proteome,	chain:Diphthamide biosynthesis protein 2,
Q6PGY5	DnaJ (Hsp40) homolog, subfamily C, member 21(dnajc21)	Danio rerio			Translation, ribosomal structure and biogenesis / Posttranslational modification, protein turnover, chaperones,			GO:0003676~nucleic acid binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR001623:DnaJ domain,IPR003604:Zinc finger, U1-type,IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,IPR018253:DnaJ domain, conserved site,IPR022755:Zinc finger, double-stranded RNA binding,				SM00271:DnaJ,SM00355:ZnF_C2H2,SM00451:ZnF_U1,	Chaperone,Coiled coil,Complete proteome,Metal-binding,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:DnaJ homolog subfamily C member 21,compositionally biased region:Poly-Asp,compositionally biased region:Poly-Lys,domain:J,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,
Q9NX36	DnaJ heat shock protein family (Hsp40) member C28(DNAJC28)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0000301~retrograde transport, vesicle recycling within Golgi,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0007030~Golgi organization,GO:0048213~Golgi vesicle prefusion complex stabilization,	GO:0017119~Golgi transport complex,	GO:0005515~protein binding,	IPR001623:DnaJ domain,IPR018961:DnaJ homologue, subfamily C, member 28, conserved domain,				SM00271:DnaJ,	Chaperone,Coiled coil,Complete proteome,Phosphoprotein,Reference proteome,	chain:DnaJ homolog subfamily C member 28,compositionally biased region:Poly-Glu,domain:J,modified residue,sequence conflict,
Q99615	DnaJ heat shock protein family (Hsp40) member C7(DNAJC7)	Homo sapiens				GO:0006457~protein folding,GO:0032781~positive regulation of ATPase activity,GO:0070389~chaperone cofactor-dependent protein refolding,GO:1900034~regulation of cellular response to heat,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0001671~ATPase activator activity,GO:0031072~heat shock protein binding,	IPR001440:Tetratricopeptide TPR-1,IPR001623:DnaJ domain,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR013105:Tetratricopeptide TPR2,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,SM00271:DnaJ,	Acetylation,Alternative splicing,Chaperone,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:DnaJ homolog subfamily C member 7,domain:J,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,repeat:TPR 9,
Q9QYI3	DnaJ heat shock protein family (Hsp40) member C7(Dnajc7)	Mus musculus				GO:0070389~chaperone cofactor-dependent protein refolding,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0031072~heat shock protein binding,	IPR001623:DnaJ domain,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR013105:Tetratricopeptide TPR2,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,SM00271:DnaJ,	Acetylation,Chaperone,Complete proteome,Cytoplasm,Cytoskeleton,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:DnaJ homolog subfamily C member 7,domain:J,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,sequence conflict,
P78545	E74 like ETS transcription factor 3(ELF3)	Homo sapiens				GO:0001824~blastocyst development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006954~inflammatory response,GO:0007275~multicellular organism development,GO:0008544~epidermis development,GO:0030198~extracellular matrix organization,GO:0030855~epithelial cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060056~mammary gland involution,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,				SM00251:SAM_PNT,SM00413:ETS,	3D-structure,Activator,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,DNA-binding,Inflammatory response,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:ETS-related transcription factor Elf-3,DNA-binding region:ETS,domain:PNT,helix,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,
Q6PC64	ELOVL fatty acid elongase 6(elovl6)	Danio rerio				GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0006636~unsaturated fatty acid biosynthetic process,GO:0019367~fatty acid elongation, saturated fatty acid,GO:0030148~sphingolipid biosynthetic process,GO:0034625~fatty acid elongation, monounsaturated fatty acid,GO:0034626~fatty acid elongation, polyunsaturated fatty acid,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0042759~long-chain fatty acid biosynthetic process,GO:0042761~very long-chain fatty acid biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,	GO:0009922~fatty acid elongase activity,GO:0016740~transferase activity,GO:0102336~3-oxo-arachidoyl-CoA synthase activity,GO:0102337~3-oxo-cerotoyl-CoA synthase activity,GO:0102338~3-oxo-lignoceronyl-CoA synthase activity,	IPR002076:GNS1/SUR4 membrane protein,	dre00062:Fatty acid elongation,dre01040:Biosynthesis of unsaturated fatty acids,dre01212:Fatty acid metabolism,				Complete proteome,Endoplasmic reticulum,Fatty acid biosynthesis,Fatty acid metabolism,Glycoprotein,Lipid biosynthesis,Lipid metabolism,Membrane,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Elongation of very long chain fatty acids protein 6,transmembrane region,
P30042	ES1 protein homolog, mitochondrial(LOC102724023)	Homo sapiens					GO:0005739~mitochondrion,							Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Signal,Transit peptide,
Q9LUU5	F-box and associated interaction domains-containing protein(AT3G17265)	Arabidopsis thaliana				GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,	GO:0005737~cytoplasm,GO:0019005~SCF ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,	IPR001810:F-box domain, cyclin-like,IPR006527:F-box associated domain, type 1,IPR017451:F-box associated interaction domain,				SM00256:FBOX,	Complete proteome,Reference proteome,	chain:Putative F-box protein At3g17265,domain:F-box,
Q58CX2	FAST kinase domains 3(FASTKD3)	Bos taurus				GO:0006468~protein phosphorylation,GO:0045333~cellular respiration,	GO:0005739~mitochondrion,	GO:0004672~protein kinase activity,GO:0044822~poly(A) RNA binding,	IPR010622:FAST kinase leucine-rich,IPR013579:FAST kinase-like protein, subdomain 2,IPR013584:RAP domain,				SM00952:SM00952,	Alternative splicing,Complete proteome,Mitochondrion,Reference proteome,Transit peptide,	chain:FAST kinase domain-containing protein 3,domain:RAP,sequence conflict,splice variant,
P51145	FOS like 2, AP-1 transcription factor subunit(Fosl2)	Rattus norvegicus				GO:0001661~conditioned taste aversion,GO:0001666~response to hypoxia,GO:0003334~keratinocyte development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007565~female pregnancy,GO:0007568~aging,GO:0007623~circadian rhythm,GO:0009409~response to cold,GO:0009416~response to light stimulus,GO:0009612~response to mechanical stimulus,GO:0009636~response to toxic substance,GO:0009648~photoperiodism,GO:0014070~response to organic cyclic compound,GO:0030431~sleep,GO:0032355~response to estradiol,GO:0032570~response to progesterone,GO:0034097~response to cytokine,GO:0035902~response to immobilization stress,GO:0043434~response to peptide hormone,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048146~positive regulation of fibroblast proliferation,GO:0051591~response to cAMP,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR000837:Fos transforming protein,IPR004827:Basic-leucine zipper domain,	rno04380:Osteoclast differentiation,			SM00338:BRLZ,	Acetylation,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Fos-related antigen 2,DNA-binding region:Basic motif,domain:Leucine-zipper,modified residue,
Q8IVP5	FUN14 domain containing 1(FUNDC1)	Homo sapiens				GO:0000422~mitophagy,GO:0001666~response to hypoxia,	GO:0005741~mitochondrial outer membrane,GO:0031307~integral component of mitochondrial outer membrane,	GO:0005515~protein binding,	IPR007014:FUN14,					Autophagy,Complete proteome,Membrane,Mitochondrion,Mitochondrion outer membrane,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:FUN14 domain-containing protein 1,modified residue,
P26151	Fc receptor, IgG, high affinity I(Fcgr1)	Mus musculus				GO:0001788~antibody-dependent cellular cytotoxicity,GO:0001798~positive regulation of type IIa hypersensitivity,GO:0001805~positive regulation of type III hypersensitivity,GO:0002376~immune system process,GO:0006898~receptor-mediated endocytosis,GO:0006910~phagocytosis, recognition,GO:0006911~phagocytosis, engulfment,GO:0007166~cell surface receptor signaling pathway,GO:0009617~response to bacterium,GO:0019884~antigen processing and presentation of exogenous antigen,GO:0042590~antigen processing and presentation of exogenous peptide antigen via MHC class I,GO:0042742~defense response to bacterium,GO:0045087~innate immune response,GO:0050766~positive regulation of phagocytosis,GO:0050776~regulation of immune response,GO:0060100~positive regulation of phagocytosis, engulfment,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0045121~membrane raft,	GO:0019770~IgG receptor activity,GO:0019864~IgG binding,GO:0031774~leukotriene receptor binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,	mmu04145:Phagosome,mmu04380:Osteoclast differentiation,mmu04640:Hematopoietic cell lineage,mmu04666:Fc gamma R-mediated phagocytosis,mmu05140:Leishmaniasis,mmu05150:Staphylococcus aureus infection,mmu05152:Tuberculosis,mmu05202:Transcriptional misregulation in cancer,mmu05322:Systemic lupus erythematosus,			SM00408:IGc2,SM00409:IG,	Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,IgG-binding protein,Immunity,Immunoglobulin domain,Innate immunity,Membrane,Phosphoprotein,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:High affinity immunoglobulin gamma Fc receptor I,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Interaction with EPB41L2,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q6P7G9	G protein-coupled receptor 146 L homeolog(gpr146.L)	Xenopus laevis					GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 146,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q8K0Z9	G protein-coupled receptor 153(Gpr153)	Mus musculus				GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004871~signal transducer activity,GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,IPR022335:G protein-coupled receptor 153,IPR022347:G protein-coupled receptor 153/162,					Cell membrane,Complete proteome,G-protein coupled receptor,Membrane,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 153,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P81274	G-protein signaling modulator 2(GPSM2)	Homo sapiens				GO:0000132~establishment of mitotic spindle orientation,GO:0007052~mitotic spindle organization,GO:0007186~G-protein coupled receptor signaling pathway,GO:0050790~regulation of catalytic activity,GO:0051661~maintenance of centrosome location,GO:0060487~lung epithelial cell differentiation,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005938~cell cortex,GO:0045177~apical part of cell,GO:0097431~mitotic spindle pole,	GO:0000166~nucleotide binding,GO:0001965~G-protein alpha-subunit binding,GO:0005092~GDP-dissociation inhibitor activity,GO:0005515~protein binding,GO:0030695~GTPase regulator activity,GO:0042802~identical protein binding,	IPR003109:GoLoco motif,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,		604213~Chudley-McCullough syndrome,		SM00028:TPR,SM00390:GoLoco,	3D-structure,Complete proteome,Cytoplasm,Cytoskeleton,Deafness,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:G-protein-signaling modulator 2,domain:GoLoco 1,domain:GoLoco 2,domain:GoLoco 3,domain:GoLoco 4,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,sequence conflict,
P60519	GABA type A receptor associated protein like 2(GABARAPL2)	Bos taurus				GO:0000045~autophagosome assembly,GO:0000422~mitophagy,GO:0006891~intra-Golgi vesicle-mediated transport,GO:0006914~autophagy,GO:0006995~cellular response to nitrogen starvation,GO:0015031~protein transport,GO:0032781~positive regulation of ATPase activity,GO:1901799~negative regulation of proteasomal protein catabolic process,	GO:0000139~Golgi membrane,GO:0000421~autophagosome membrane,GO:0005776~autophagosome,GO:0005829~cytosol,GO:0031410~cytoplasmic vesicle,	GO:0000149~SNARE binding,GO:0051117~ATPase binding,	IPR004241:Autophagy protein Atg8 ubiquitin-like,	bta04068:FoxO signaling pathway,bta04140:Regulation of autophagy,bta04727:GABAergic synapse,				3D-structure,Acetylation,Autophagy,Complete proteome,Cytoplasmic vesicle,Direct protein sequencing,Golgi apparatus,Lipoprotein,Phosphoprotein,Protein transport,Reference proteome,Transport,	chain:Gamma-aminobutyric acid receptor- associated protein-like 2,helix,modified residue,region of interest:Interaction with beta-tubulin,region of interest:Interaction with GABRG2,strand,
P56159	GDNF family receptor alpha 1(GFRA1)	Homo sapiens				GO:0000165~MAPK cascade,GO:0007166~cell surface receptor signaling pathway,GO:0007399~nervous system development,GO:0035860~glial cell-derived neurotrophic factor receptor signaling pathway,GO:0043547~positive regulation of GTPase activity,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0019898~extrinsic component of membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,	GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005102~receptor binding,GO:0016167~glial cell-derived neurotrophic factor receptor activity,	IPR003438:Glial cell line-derived neurotrophic factor receptor,IPR003503:Glial cell line-derived neurotrophic factor receptor, alpha 1,IPR016017:GDNF/GAS1,IPR017372:Glial cell line-derived neurotrophic factor receptor, alpha 1/2,			PIRSF038071:GDNF family receptor alpha,	SM00907:SM00907,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,	chain:GDNF family receptor alpha-1,compositionally biased region:Poly-Thr,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,repeat:1,repeat:2,repeat:3,sequence conflict,sequence variant,signal peptide,splice variant,
P50395	GDP dissociation inhibitor 2(GDI2)	Homo sapiens				GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0055114~oxidation-reduction process,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0031982~vesicle,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0005093~Rab GDP-dissociation inhibitor activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0016491~oxidoreductase activity,GO:0031267~small GTPase binding,GO:0044822~poly(A) RNA binding,	IPR000806:Rab GDI protein,IPR018203:GDP dissociation inhibitor,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,					Acetylation,Alternative splicing,Complete proteome,Cytoplasm,GTPase activation,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Rab GDP dissociation inhibitor beta,modified residue,sequence conflict,
B3M383	GF18547 gene product from transcript GF18547-RA(Dana\GF18547)	Drosophila ananassae				GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0031047~gene silencing by RNA,GO:0048477~oogenesis,GO:0051321~meiotic cell cycle,	GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR001650:Helicase, C-terminal,IPR002999:Tudor domain,IPR007087:Zinc finger, C2H2,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00333:TUDOR,SM00487:DEXDc,SM00490:HELICc,SM00847:SM00847,	ATP-binding,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Helicase,Hydrolase,Meiosis,Nucleotide-binding,Oogenesis,Reference proteome,RNA-mediated gene silencing,Spermatogenesis,
P14527	Hemoglobin subunit alpha-4(hba4)	Oncorhynchus mykiss					GO:0005833~hemoglobin complex,	GO:0005344~oxygen transporter activity,GO:0005506~iron ion binding,GO:0019825~oxygen binding,GO:0020037~heme binding,	IPR000971:Globin,IPR002338:Haemoglobin, alpha,IPR009050:Globin-like,IPR012292:Globin, structural domain,					3D-structure,Acetylation,Direct protein sequencing,Heme,Iron,Metal-binding,Oxygen transport,Transport,
P02142	Hemoglobin subunit beta-1(hbb1)	Oncorhynchus mykiss					GO:0005833~hemoglobin complex,	GO:0005344~oxygen transporter activity,GO:0005506~iron ion binding,GO:0019825~oxygen binding,GO:0020037~heme binding,	IPR000971:Globin,IPR002337:Haemoglobin, beta,IPR009050:Globin-like,IPR012292:Globin, structural domain,					3D-structure,Direct protein sequencing,Heme,Iron,Metal-binding,Oxygen transport,Transport,
A6QPN6	IFI30, lysosomal thiol reductase(IFI30)	Bos taurus				GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0042590~antigen processing and presentation of exogenous peptide antigen via MHC class I,GO:0048147~negative regulation of fibroblast proliferation,GO:0050821~protein stabilization,GO:0055114~oxidation-reduction process,	GO:0005576~extracellular region,GO:0005764~lysosome,GO:0005886~plasma membrane,GO:0030054~cell junction,	GO:0016667~oxidoreductase activity, acting on a sulfur group of donors,	IPR004911:Gamma interferon inducible lysosomal thiol reductase GILT,	bta04612:Antigen processing and presentation,				Complete proteome,Disulfide bond,Glycoprotein,Immunity,Lysosome,Oxidoreductase,Redox-active center,Reference proteome,Secreted,Signal,
Q9UPP2	IQ motif and Sec7 domain 3(IQSEC3)	Homo sapiens				GO:0030036~actin cytoskeleton organization,GO:0032012~regulation of ARF protein signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0045211~postsynaptic membrane,GO:0060077~inhibitory synapse,	GO:0005086~ARF guanyl-nucleotide exchange factor activity,	IPR000048:IQ motif, EF-hand binding site,IPR000904:SEC7-like,IPR011993:Pleckstrin homology-like domain,IPR023394:SEC7-like, alpha orthogonal bundle,	hsa04144:Endocytosis,			SM00222:Sec7,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:IQ motif and SEC7 domain-containing protein 3,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:IQ,domain:PH,domain:SEC7,modified residue,sequence conflict,sequence variant,splice variant,
P0DMQ5	InaF motif containing 2(INAFM2)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,
Q95Q98	JHDM (histone demethylase) homolog(jhdm-1)	Caenorhabditis elegans				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0008340~determination of adult lifespan,GO:0043652~engulfment of apoptotic cell,GO:0055114~oxidation-reduction process,GO:0070544~histone H3-K36 demethylation,	GO:0005634~nucleus,	GO:0008168~methyltransferase activity,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,GO:0051864~histone demethylase activity (H3-K36 specific),	IPR003347:JmjC domain,				SM00558:JmjC,	Alternative splicing,Chromatin regulator,Coiled coil,Complete proteome,Dioxygenase,Iron,Metal-binding,Methyltransferase,Nucleus,Oxidoreductase,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Transferase,	binding site:Substrate,chain:JmjC domain-containing histone demethylation protein 1,compositionally biased region:Glu-rich,compositionally biased region:Lys-rich,domain:JmjC,metal ion-binding site:Iron; catalytic,splice variant,
Q7ZVE6	KDEL (Lys-Asp-Glu-Leu) containing 1(kdelc1)	Danio rerio				GO:0006664~glycolipid metabolic process,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,	GO:0046527~glucosyltransferase activity,	IPR001298:Filamin/ABP280 repeat,IPR006598:Lipopolysaccharide-modifying protein,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR017868:Filamin/ABP280 repeat-like,				SM00557:IG_FLMN,SM00672:CAP10,	Complete proteome,Endoplasmic reticulum,Glycoprotein,Proteomics identification,Reference proteome,Signal,	chain:KDEL motif-containing protein 1,glycosylation site:N-linked (GlcNAc...),repeat:Filamin,sequence conflict,short sequence motif:Prevents secretion from ER,signal peptide,
Q8K339	Kin17 DNA and RNA binding protein(Kin)	Mus musculus				GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006397~mRNA processing,GO:0006974~cellular response to DNA damage stimulus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003723~RNA binding,GO:0046872~metal ion binding,	IPR019447:DNA/RNA-binding protein Kin17, conserved domain,				SM01253:SM01253,	Coiled coil,Complete proteome,Cytoplasm,DNA damage,DNA recombination,DNA repair,DNA replication,DNA-binding,Metal-binding,Methylation,mRNA processing,Nucleus,Reference proteome,RNA-binding,Stress response,Zinc,Zinc-finger,	chain:DNA/RNA-binding protein KIN17,region of interest:C-terminal subdomain A,region of interest:C-terminal subdomain B,zinc finger region:C2H2-type,
P30759	L-arginase(arg1)	Xenopus laevis				GO:0000050~urea cycle,GO:0006525~arginine metabolic process,		GO:0004053~arginase activity,GO:0046872~metal ion binding,	IPR006035:Ureohydrolase,IPR014033:Arginase,IPR020855:Ureohydrolase, manganese-binding site,IPR023696:Ureohydrolase domain,			PIRSF036979:ureohydrolase/formiminoglutamase/proclavaminate amidino hydrolase,		Arginine metabolism,Hydrolase,Manganese,Metal-binding,Urea cycle,	binding site:Substrate,chain:Arginase-1,metal ion-binding site:Manganese 1,metal ion-binding site:Manganese 2,region of interest:Substrate binding,
P20373	L-lactate dehydrogenase B chain(LOC105929819)	Fundulus heteroclitus				GO:0005975~carbohydrate metabolic process,GO:0019752~carboxylic acid metabolic process,	GO:0005737~cytoplasm,	GO:0004459~L-lactate dehydrogenase activity,	IPR001236:Lactate/malate dehydrogenase, N-terminal,IPR001557:L-lactate/malate dehydrogenase,IPR011304:L-lactate dehydrogenase,IPR015955:Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal,IPR016040:NAD(P)-binding domain,IPR018177:L-lactate dehydrogenase, active site,IPR022383:Lactate/malate dehydrogenase, C-terminal,			PIRSF000102:L-lactate/malate dehydrogenase,		Cytoplasm,NAD,Oxidoreductase,
Q496Y0	LON peptidase N-terminal domain and ring finger 3(LONRF3)	Homo sapiens				GO:0006508~proteolysis,		GO:0004176~ATP-dependent peptidase activity,GO:0008270~zinc ion binding,	IPR001841:Zinc finger, RING-type,IPR003111:Peptidase S16, lon N-terminal,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR015947:PUA-like domain,IPR017907:Zinc finger, RING-type, conserved site,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,SM00184:RING,SM00464:LON,	Alternative splicing,Coiled coil,Complete proteome,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,TPR repeat,Zinc,Zinc-finger,	chain:LON peptidase N-terminal domain and RING finger protein 3,domain:Lon,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,sequence variant,splice variant,zinc finger region:RING-type 1,zinc finger region:RING-type 2,
Q07014	LYN proto-oncogene, Src family tyrosine kinase(Lyn)	Rattus norvegicus				GO:0001782~B cell homeostasis,GO:0001817~regulation of cytokine production,GO:0001933~negative regulation of protein phosphorylation,GO:0002250~adaptive immune response,GO:0002431~Fc receptor mediated stimulatory signaling pathway,GO:0002513~tolerance induction to self antigen,GO:0002553~histamine secretion by mast cell,GO:0002576~platelet degranulation,GO:0002762~negative regulation of myeloid leukocyte differentiation,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0002774~Fc receptor mediated inhibitory signaling pathway,GO:0002902~regulation of B cell apoptotic process,GO:0006468~protein phosphorylation,GO:0006935~chemotaxis,GO:0006974~cellular response to DNA damage stimulus,GO:0006991~response to sterol depletion,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009636~response to toxic substance,GO:0009725~response to hormone,GO:0009743~response to carbohydrate,GO:0010976~positive regulation of neuron projection development,GO:0014003~oligodendrocyte development,GO:0014070~response to organic cyclic compound,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030097~hemopoiesis,GO:0030218~erythrocyte differentiation,GO:0030335~positive regulation of cell migration,GO:0030889~negative regulation of B cell proliferation,GO:0031175~neuron projection development,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0031668~cellular response to extracellular stimulus,GO:0032868~response to insulin,GO:0033003~regulation of mast cell activation,GO:0033628~regulation of cell adhesion mediated by integrin,GO:0034136~negative regulation of toll-like receptor 2 signaling pathway,GO:0034144~negative regulation of toll-like receptor 4 signaling pathway,GO:0034605~cellular response to heat,GO:0035556~intracellular signal transduction,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042493~response to drug,GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein,GO:0043200~response to amino acid,GO:0043304~regulation of mast cell degranulation,GO:0043407~negative regulation of MAP kinase activity,GO:0043434~response to peptide hormone,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0045087~innate immune response,GO:0045646~regulation of erythrocyte differentiation,GO:0046777~protein autophosphorylation,GO:0048678~response to axon injury,GO:0050663~cytokine secretion,GO:0050707~regulation of cytokine secretion,GO:0050727~regulation of inflammatory response,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050853~B cell receptor signaling pathway,GO:0050855~regulation of B cell receptor signaling pathway,GO:0050861~positive regulation of B cell receptor signaling pathway,GO:0051272~positive regulation of cellular component movement,GO:0051279~regulation of release of sequestered calcium ion into cytosol,GO:0060252~positive regulation of glial cell proliferation,GO:0060369~positive regulation of Fc receptor mediated stimulatory signaling pathway,GO:0070304~positive regulation of stress-activated protein kinase signaling cascade,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0070447~positive regulation of oligodendrocyte progenitor proliferation,GO:0070667~negative regulation of mast cell proliferation,GO:0070668~positive regulation of mast cell proliferation,GO:0071300~cellular response to retinoic acid,GO:0090025~regulation of monocyte chemotaxis,GO:0090330~regulation of platelet aggregation,GO:0097028~dendritic cell differentiation,GO:1902532~negative regulation of intracellular signal transduction,GO:2000670~positive regulation of dendritic cell apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005758~mitochondrial intermembrane space,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030061~mitochondrial crista,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0031966~mitochondrial membrane,GO:0034666~integrin alpha2-beta1 complex,GO:0042629~mast cell granule,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005102~receptor binding,GO:0005161~platelet-derived growth factor receptor binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0017124~SH3 domain binding,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0032403~protein complex binding,GO:0043015~gamma-tubulin binding,GO:0043208~glycosphingolipid binding,GO:0044325~ion channel binding,GO:0051219~phosphoprotein binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	rno04062:Chemokine signaling pathway,rno04064:NF-kappa B signaling pathway,rno04611:Platelet activation,rno04662:B cell receptor signaling pathway,rno04664:Fc epsilon RI signaling pathway,rno04666:Fc gamma R-mediated phagocytosis,rno04730:Long-term depression,rno05169:Epstein-Barr virus infection,rno05203:Viral carcinogenesis,			SM00219:TyrKc,SM00252:SH2,SM00326:SH3,	Adaptive immunity,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Cytoplasm,Golgi apparatus,Immunity,Inflammatory response,Innate immunity,Kinase,Lipoprotein,Membrane,Myristate,Nucleotide-binding,Nucleus,Palmitate,Phosphoprotein,Proto-oncogene,Reference proteome,SH2 domain,SH3 domain,Transferase,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase Lyn,domain:Protein kinase,domain:SH2,domain:SH3,lipid moiety-binding region:N-myristoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,splice variant,
Q6PGU2	MAF1 homolog, negative regulator of RNA polymerase III(maf1)	Danio rerio				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016480~negative regulation of transcription from RNA polymerase III promoter,GO:0070217~transcription factor TFIIIB complex assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000994~RNA polymerase III core binding,	IPR015257:Maf1 regulator,			PIRSF037240:repressor of RNA polymerase III transcription MAF1,		Complete proteome,Cytoplasm,Nucleus,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Repressor of RNA polymerase III transcription MAF1 homolog,
Q6UXC1	MAM domain containing 4(MAMDC4)	Homo sapiens				GO:0015031~protein transport,	GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR000998:MAM domain,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,				SM00137:MAM,SM00192:LDLa,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Apical endosomal glycoprotein,disulfide bond,domain:LDL-receptor class A 1; truncated,domain:LDL-receptor class A 2,domain:LDL-receptor class A 3,domain:MAM 1,domain:MAM 2,domain:MAM 3,domain:MAM 4,domain:MAM 5,domain:MAM 6,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q0II70	MAPK regulated corepressor interacting protein 2(FAM195A)	Bos taurus					GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,							Acetylation,Complete proteome,Phosphoprotein,Reference proteome,	calcium-binding region:1,calcium-binding region:2,chain:Mitochondrial Rho GTPase 2,chain:Protein FAM195A,compositionally biased region:Pro-rich,domain:EF-hand 1,domain:EF-hand 2,domain:Miro 1,domain:Miro 2,modified residue,nucleotide phosphate-binding region:GTP 1,nucleotide phosphate-binding region:GTP 2,sequence conflict,topological domain:Cytoplasmic,topological domain:Mitochondrial intermembrane,transmembrane region,
Q0VBZ9	MARCKS like 1(MARCKSL1)	Bos taurus				GO:0008284~positive regulation of cell proliferation,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005516~calmodulin binding,	IPR002101:Myristoylated alanine-rich C-kinase substrate MARCKS,	bta04666:Fc gamma R-mediated phagocytosis,bta05140:Leishmaniasis,				Actin-binding,Calmodulin-binding,Cell membrane,Complete proteome,Cytoplasm,Lipoprotein,Membrane,Myristate,Phosphoprotein,Proteomics identification,Reference proteome,	chain:MARCKS-related protein,lipid moiety-binding region:N-myristoyl glycine,modified residue,region of interest:Calmodulin-binding (PSD),
P49006	MARCKS like 1(MARCKSL1)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005516~calmodulin binding,	IPR002101:Myristoylated alanine-rich C-kinase substrate MARCKS,	hsa04666:Fc gamma R-mediated phagocytosis,hsa05140:Leishmaniasis,				Actin-binding,Calmodulin-binding,Cell membrane,Complete proteome,Cytoplasm,Lipoprotein,Membrane,Myristate,Phosphoprotein,Reference proteome,	chain:MARCKS-related protein,compositionally biased region:Poly-Lys,lipid moiety-binding region:N-myristoyl glycine,modified residue,region of interest:Calmodulin-binding (PSD),sequence conflict,
P47805	MID1 interacting protein 1a(mid1ip1a)	Danio rerio					GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005874~microtubule,		IPR009786:Spot 14 family,					Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Nucleus,Reference proteome,	chain:Mid1-interacting protein 1A,
O42097	Me-HNF3b protein(foxa2)	Oryzias latipes				GO:0006351~transcription, DNA-templated,GO:0007418~ventral midline development,GO:0007492~endoderm development,GO:0021779~oligodendrocyte cell fate commitment,GO:0032289~central nervous system myelin formation,GO:0033504~floor plate development,GO:0048319~axial mesoderm morphogenesis,	GO:0005634~nucleus,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR001766:Transcription factor, fork head,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013638:Fork-head N-terminal,IPR018122:Transcription factor, fork head, conserved site,IPR018533:Forkhead box protein, C-terminal,				SM00339:FH,	Activator,Complete proteome,DNA-binding,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:Hepatocyte nuclear factor 3-beta,compositionally biased region:Met-rich,DNA-binding region:Fork-head,
Q6DBY2	N(alpha)-acetyltransferase 50, NatE catalytic subunit(naa50)	Danio rerio				GO:0001756~somitogenesis,GO:0006474~N-terminal protein amino acid acetylation,GO:0007275~multicellular organism development,GO:0071962~mitotic sister chromatid cohesion, centromeric,	GO:0005737~cytoplasm,GO:0031248~protein acetyltransferase complex,	GO:0004147~dihydrolipoamide branched chain acyltransferase activity,GO:0004596~peptide alpha-N-acetyltransferase activity,GO:0004772~sterol O-acyltransferase activity,GO:0008080~N-acetyltransferase activity,GO:0008374~O-acyltransferase activity,GO:0008951~palmitoleoyl [acyl-carrier-protein]-dependent acyltransferase activity,GO:0010485~H4 histone acetyltransferase activity,GO:0016406~carnitine O-acyltransferase activity,GO:0016407~acetyltransferase activity,GO:0016408~C-acyltransferase activity,GO:0016409~palmitoyltransferase activity,GO:0016410~N-acyltransferase activity,GO:0016411~acylglycerol O-acyltransferase activity,GO:0016412~serine O-acyltransferase activity,GO:0016413~O-acetyltransferase activity,GO:0016414~O-octanoyltransferase activity,GO:0016415~octanoyltransferase activity,GO:0016416~O-palmitoyltransferase activity,GO:0016417~S-acyltransferase activity,GO:0016418~S-acetyltransferase activity,GO:0016419~S-malonyltransferase activity,GO:0016420~malonyltransferase activity,GO:0016454~C-palmitoyltransferase activity,GO:0016740~transferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0016748~succinyltransferase activity,GO:0016749~N-succinyltransferase activity,GO:0016750~O-succinyltransferase activity,GO:0016751~S-succinyltransferase activity,GO:0016752~sinapoyltransferase activity,GO:0016753~O-sinapoyltransferase activity,GO:0018030~peptidyl-lysine N6-myristoyltransferase activity,GO:0018031~peptidyl-lysine N6-palmitoyltransferase activity,GO:0018711~benzoyl acetate-CoA thiolase activity,GO:0018712~3-hydroxybutyryl-CoA thiolase activity,GO:0018713~3-ketopimelyl-CoA thiolase activity,GO:0019105~N-palmitoyltransferase activity,GO:0019107~myristoyltransferase activity,GO:0019186~acyl-CoA N-acyltransferase activity,GO:0019705~protein-cysteine S-myristoyltransferase activity,GO:0019707~protein-cysteine S-acyltransferase activity,GO:0030523~dihydrolipoamide S-acyltransferase activity,GO:0032216~glucosaminyl-phosphotidylinositol O-acyltransferase activity,GO:0034737~ergosterol O-acyltransferase activity,GO:0034738~lanosterol O-acyltransferase activity,GO:0034848~naphthyl-2-oxomethyl-succinyl-CoA succinyl transferase activity,GO:0034851~2,4,4-trimethyl-3-oxopentanoyl-CoA 2-C-propanoyl transferase activity,GO:0034915~2-methylhexanoyl-CoA C-acetyltransferase activity,GO:0034919~butyryl-CoA 2-C-propionyltransferase activity,GO:0034945~2,6-dimethyl-5-methylene-3-oxo-heptanoyl-CoA C-acetyltransferase activity,GO:0043741~L-2-aminoadipate N-acetyltransferase activity,GO:0043806~keto acid formate lyase activity,GO:0043849~Ras palmitoyltransferase activity,GO:0046941~azetidine-2-carboxylic acid acetyltransferase activity,GO:0052858~peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,GO:0090595~acetyl-CoA:L-lysine N6-acetyltransferase,	IPR000182:GNAT domain,IPR016181:Acyl-CoA N-acyltransferase,					Acyltransferase,Complete proteome,Cytoplasm,Developmental protein,Proteomics identification,Reference proteome,Transferase,	chain:N-acetyltransferase NAT13,domain:N-acetyltransferase,region of interest:Coenzyme A binding,
Q66IG4	N-myc downstream regulated 1(ndrg1)	Xenopus tropicalis				GO:0007165~signal transduction,GO:0032287~peripheral nervous system myelin maintenance,GO:0042127~regulation of cell proliferation,GO:0045576~mast cell activation,GO:0048793~pronephros development,	GO:0005737~cytoplasm,		IPR004142:Ndr,					Complete proteome,Developmental protein,Reference proteome,Repeat,	chain:Protein NDRG1,region of interest:4 X 10 AA tandem repeats of G-[NS]-R-S-R- [AS]-H-T-[DGN]-[DES],repeat:1,repeat:2,repeat:3,repeat:4,
Q91YT0	NADH dehydrogenase (ubiquinone) flavoprotein 1(Ndufv1)	Mus musculus				GO:0006810~transport,GO:0009060~aerobic respiration,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0016020~membrane,GO:0070469~respiratory chain,	GO:0003954~NADH dehydrogenase activity,GO:0005515~protein binding,GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0010181~FMN binding,GO:0016491~oxidoreductase activity,GO:0016651~oxidoreductase activity, acting on NAD(P)H,GO:0046872~metal ion binding,GO:0051287~NAD binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR001949:NADH:ubiquinone oxidoreductase, 51kDa subunit, conserved site,IPR011537:NADH ubiquinone oxidoreductase, F subunit,IPR011538:NADH:ubiquinone oxidoreductase, 51kDa subunit,IPR019554:Soluble ligand binding domain,IPR019575:NADH ubiquinone oxidoreductase, F subunit, iron sulphur binding,	mmu00190:Oxidative phosphorylation,mmu01100:Metabolic pathways,mmu04932:Non-alcoholic fatty liver disease (NAFLD),mmu05010:Alzheimer's disease,mmu05012:Parkinson's disease,mmu05016:Huntington's disease,			SM00928:SM00928,	4Fe-4S,Acetylation,Complete proteome,Direct protein sequencing,Electron transport,Flavoprotein,FMN,Iron,Iron-sulfur,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,NAD,Oxidoreductase,Proteomics identification,Reference proteome,Respiratory chain,Transit peptide,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial,metal ion-binding site:Iron-sulfur (4Fe-4S),modified residue,nucleotide phosphate-binding region:FMN,nucleotide phosphate-binding region:NAD(H),transit peptide:Mitochondrion,
Q9CQ54	NADH dehydrogenase [ubiquinone] 1 subunit C2(LOC102641347)	Mus musculus				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0016021~integral component of membrane,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR009423:NADH:ubiquinone oxidoreductase, subunit b14.5b,	mmu00190:Oxidative phosphorylation,mmu01100:Metabolic pathways,mmu04932:Non-alcoholic fatty liver disease (NAFLD),mmu05010:Alzheimer's disease,mmu05012:Parkinson's disease,mmu05016:Huntington's disease,		PIRSF017834:NADH dehydrogenase [ubiquinone] (complex I), subunit C2,		Complete proteome,Direct protein sequencing,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Respiratory chain,Transmembrane,Transmembrane helix,Transport,
P28331	NADH:ubiquinone oxidoreductase core subunit S1(NDUFS1)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0008637~apoptotic mitochondrial changes,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0042773~ATP synthesis coupled electron transport,GO:0045333~cellular respiration,GO:0046034~ATP metabolic process,GO:0051881~regulation of mitochondrial membrane potential,GO:0072593~reactive oxygen species metabolic process,	GO:0005739~mitochondrion,GO:0005747~mitochondrial respiratory chain complex I,GO:0005758~mitochondrial intermembrane space,GO:0005759~mitochondrial matrix,GO:0016020~membrane,GO:0043209~myelin sheath,	GO:0005515~protein binding,GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0009055~electron carrier activity,GO:0016651~oxidoreductase activity, acting on NAD(P)H,GO:0046872~metal ion binding,GO:0051536~iron-sulfur cluster binding,GO:0051537~2 iron, 2 sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR000283:NADH:ubiquinone oxidoreductase, 75kDa subunit, conserved site,IPR001041:2Fe-2S ferredoxin-type domain,IPR006656:Molybdopterin oxidoreductase,IPR006963:Molybdopterin oxidoreductase, 4Fe-4S domain,IPR010228:NADH:ubiquinone oxidoreductase, subunit G,IPR012675:Beta-grasp domain,IPR015405:NADH-quinone oxidoreductase, chain G, C-terminal,IPR019574:NADH:ubiquinone oxidoreductase, subunit G, iron-sulphur binding,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	252010~Mitochondrial complex I deficiency,		SM00929:SM00929,	2Fe-2S,4Fe-4S,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Electron transport,Iron,Iron-sulfur,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,NAD,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Respiratory chain,Transit peptide,Transport,Ubiquinone,	chain:NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial,domain:2Fe-2S ferredoxin-type,metal ion-binding site:Iron-sulfur 1 (2Fe-2S),metal ion-binding site:Iron-sulfur 2 (4Fe-4S),metal ion-binding site:Iron-sulfur 2 (4Fe-4S); via pros nitrogen,metal ion-binding site:Iron-sulfur 3 (4Fe-4S),modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
O75489	NADH:ubiquinone oxidoreductase core subunit S3(NDUFS3)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0021762~substantia nigra development,GO:0030308~negative regulation of cell growth,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0072593~reactive oxygen species metabolic process,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005747~mitochondrial respiratory chain complex I,GO:0005759~mitochondrial matrix,GO:0031966~mitochondrial membrane,GO:0043209~myelin sheath,	GO:0003954~NADH dehydrogenase activity,GO:0005515~protein binding,GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0009055~electron carrier activity,	IPR001268:NADH:ubiquinone oxidoreductase, 30kDa subunit,IPR010218:NADH dehydrogenase, subunit C,IPR020396:NADH:ubiquinone oxidoreductase, 30kDa subunit, conserved site,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	252010~Mitochondrial complex I deficiency,256000~Leigh syndrome due to mitochondrial complex I deficiency,			Alternative splicing,Complete proteome,Direct protein sequencing,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,NAD,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Respiratory chain,Signal,Transit peptide,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] iron- sulfur protein 3, mitochondrial,sequence conflict,sequence variant,transit peptide:Mitochondrion,
Q60HE3	NADH:ubiquinone oxidoreductase core subunit S8(NDUFS8)	Macaca fascicularis				GO:0006979~response to oxidative stress,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005739~mitochondrion,GO:0005747~mitochondrial respiratory chain complex I,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0046872~metal ion binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR010226:NADH-quinone oxidoreductase, chain I,IPR017896:4Fe-4S ferredoxin-type, iron-sulpur binding domain,IPR017900:4Fe-4S ferredoxin, iron-sulphur binding, conserved site,	mcf00190:Oxidative phosphorylation,mcf01100:Metabolic pathways,mcf04932:Non-alcoholic fatty liver disease (NAFLD),mcf05010:Alzheimer's disease,mcf05012:Parkinson's disease,mcf05016:Huntington's disease,				4Fe-4S,Electron transport,Iron,Iron-sulfur,Metal-binding,Mitochondrion,NAD,Oxidoreductase,Repeat,Respiratory chain,Transit peptide,Transport,Ubiquinone,
O95299	NADH:ubiquinone oxidoreductase subunit A10(NDUFA10)	Homo sapiens			Nucleotide transport and metabolism,	GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0042493~response to drug,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0005759~mitochondrial matrix,GO:0043209~myelin sheath,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR015828:NADH:ubiquinone oxidoreductase, 42kDa subunit,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	256000~Leigh syndrome,	PIRSF000543:NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex, subunit 10,		Alternative splicing,Complete proteome,Electron transport,FAD,Flavoprotein,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Respiratory chain,Transit peptide,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial,modified residue,sequence variant,transit peptide:Mitochondrion,
O95167	NADH:ubiquinone oxidoreductase subunit A3(NDUFA3)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0016021~integral component of membrane,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR026626:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Acetylation,Complete proteome,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Proteomics identification,Reference proteome,Respiratory chain,Transmembrane,Transmembrane helix,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3,sequence variant,transmembrane region,
P34943	NADH:ubiquinone oxidoreductase subunit A9(NDUFA9)	Bos taurus			Cell envelope biogenesis, outer membrane / Carbohydrate transport and metabolism,	GO:0055114~oxidation-reduction process,GO:1901006~ubiquinone-6 biosynthetic process,	GO:0005747~mitochondrial respiratory chain complex I,GO:0005759~mitochondrial matrix,	GO:0003954~NADH dehydrogenase activity,	IPR016040:NAD(P)-binding domain,	bta00190:Oxidative phosphorylation,bta01100:Metabolic pathways,bta04932:Non-alcoholic fatty liver disease (NAFLD),bta05010:Alzheimer's disease,bta05012:Parkinson's disease,bta05016:Huntington's disease,				Acetylation,Complete proteome,Direct protein sequencing,Electron transport,FAD,Flavoprotein,Mitochondrion,Reference proteome,Respiratory chain,Transit peptide,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial,transit peptide:Mitochondrion,
O43639	NCK adaptor protein 2(NCK2)	Homo sapiens				GO:0001771~immunological synapse formation,GO:0007015~actin filament organization,GO:0007165~signal transduction,GO:0007172~signal complex assembly,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007176~regulation of epidermal growth factor-activated receptor activity,GO:0008285~negative regulation of cell proliferation,GO:0016192~vesicle-mediated transport,GO:0016477~cell migration,GO:0030032~lamellipodium assembly,GO:0030838~positive regulation of actin filament polymerization,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0036493~positive regulation of translation in response to endoplasmic reticulum stress,GO:0042102~positive regulation of T cell proliferation,GO:0042110~T cell activation,GO:0043547~positive regulation of GTPase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048013~ephrin receptor signaling pathway,GO:0060996~dendritic spine development,GO:1902237~positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1903898~negative regulation of PERK-mediated unfolded protein response,GO:1903912~negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,GO:1990441~negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0012506~vesicle membrane,GO:0045202~synapse,	GO:0005070~SH3/SH2 adaptor activity,GO:0005086~ARF guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0008093~cytoskeletal adaptor activity,GO:0030159~receptor signaling complex scaffold activity,GO:0032403~protein complex binding,GO:0097110~scaffold protein binding,	IPR000980:SH2 domain,IPR001452:Src homology-3 domain,IPR017304:Cytoplasmic, NCK,	hsa04012:ErbB signaling pathway,hsa04360:Axon guidance,hsa04660:T cell receptor signaling pathway,hsa05130:Pathogenic Escherichia coli infection,		PIRSF037874:adapter protein NCK,	SM00252:SH2,SM00326:SH3,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Endoplasmic reticulum,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,SH2 domain,SH3 domain,Translation regulation,	chain:Cytoplasmic protein NCK2,domain:SH2,domain:SH3 1,domain:SH3 2,domain:SH3 3,helix,modified residue,mutagenesis site,sequence conflict,strand,turn,
P55160	NCK associated protein 1 like(NCKAP1L)	Homo sapiens				GO:0001782~B cell homeostasis,GO:0002262~myeloid cell homeostasis,GO:0006461~protein complex assembly,GO:0006935~chemotaxis,GO:0030011~maintenance of cell polarity,GO:0030593~neutrophil chemotaxis,GO:0030838~positive regulation of actin filament polymerization,GO:0030866~cortical actin cytoskeleton organization,GO:0030890~positive regulation of B cell proliferation,GO:0032147~activation of protein kinase activity,GO:0032700~negative regulation of interleukin-17 production,GO:0032715~negative regulation of interleukin-6 production,GO:0033630~positive regulation of cell adhesion mediated by integrin,GO:0035509~negative regulation of myosin-light-chain-phosphatase activity,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0042102~positive regulation of T cell proliferation,GO:0042327~positive regulation of phosphorylation,GO:0042493~response to drug,GO:0043029~T cell homeostasis,GO:0043066~negative regulation of apoptotic process,GO:0043372~positive regulation of CD4-positive, alpha-beta T cell differentiation,GO:0043378~positive regulation of CD8-positive, alpha-beta T cell differentiation,GO:0043547~positive regulation of GTPase activity,GO:0045579~positive regulation of B cell differentiation,GO:0045588~positive regulation of gamma-delta T cell differentiation,GO:0045621~positive regulation of lymphocyte differentiation,GO:0045648~positive regulation of erythrocyte differentiation,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048821~erythrocyte development,GO:0050853~B cell receptor signaling pathway,GO:0060100~positive regulation of phagocytosis, engulfment,GO:0070358~actin polymerization-dependent cell motility,GO:0090023~positive regulation of neutrophil chemotaxis,	GO:0005829~cytosol,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0031209~SCAR complex,GO:0070062~extracellular exosome,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0030295~protein kinase activator activity,GO:0032403~protein complex binding,	IPR019137:Nck-associated protein 1,	hsa04810:Regulation of actin cytoskeleton,				Alternative splicing,Cell membrane,Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Nck-associated protein 1-like,sequence conflict,sequence variant,transmembrane region,
Q9QZ23	NFU1 iron-sulfur cluster scaffold(Nfu1)	Mus musculus				GO:0016226~iron-sulfur cluster assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR001075:NIF system FeS cluster assembly, NifU, C-terminal,IPR014824:NIF system FeS cluster assembly, NifU-like scaffold, N-terminal,IPR017065:HIRA-interacting protein 5,				SM00932:SM00932,	3D-structure,Complete proteome,Cytoplasm,Mitochondrion,Proteomics identification,Reference proteome,Transit peptide,	chain:NFU1 iron-sulfur cluster scaffold homolog, mitochondrial,helix,region of interest:NifU,sequence conflict,strand,transit peptide:Mitochondrion,
O95478	NSA2, ribosome biogenesis homolog(NSA2)	Homo sapiens				GO:0000460~maturation of 5.8S rRNA,GO:0000470~maturation of LSU-rRNA,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0030687~preribosome, large subunit precursor,	GO:0044822~poly(A) RNA binding,	IPR022309:Ribosomal protein S8e/ribosomal biogenesis NSA2,					Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosome biogenesis,rRNA processing,	chain:Ribosome biogenesis protein NSA2 homolog,compositionally biased region:Lys-rich,modified residue,sequence variant,
O17082	Nuclear Hormone Receptor family(nhr-125)	Caenorhabditis elegans				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0043401~steroid hormone mediated signaling pathway,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR013088:Zinc finger, NHR/GATA-type,				SM00399:ZnF_C4,SM00430:HOLI,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Receptor,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Nuclear hormone receptor family member nhr-125,DNA-binding region:Nuclear receptor,zinc finger region:NR C4-type,
Q7SYR1	O-sialoglycoprotein endopeptidase L homeolog(osgep.L)	Xenopus laevis			Posttranslational modification, protein turnover, chaperones,	GO:0008033~tRNA processing,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0046872~metal ion binding,GO:0061711~N(6)-L-threonylcarbamoyladenine synthase,	IPR000905:Gcp-like domain,IPR017860:Peptidase M22, conserved site,IPR017861:Kae1/YgjD family,					Acyltransferase,Cytoplasm,Metal-binding,Nucleus,Transferase,tRNA processing,	chain:Probable O-sialoglycoprotein endopeptidase,metal ion-binding site:Zinc,
Q15070	OXA1L, mitochondrial inner membrane protein(OXA1L)	Homo sapiens				GO:0006461~protein complex assembly,GO:0009060~aerobic respiration,GO:0032780~negative regulation of ATPase activity,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0033615~mitochondrial proton-transporting ATP synthase complex assembly,GO:0051205~protein insertion into membrane,GO:0051262~protein tetramerization,GO:0051354~negative regulation of oxidoreductase activity,GO:0055114~oxidation-reduction process,GO:0097031~mitochondrial respiratory chain complex I biogenesis,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005746~mitochondrial respiratory chain,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,GO:0032592~integral component of mitochondrial membrane,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0097177~mitochondrial ribosome binding,	IPR001708:Membrane insertase OXA1/ALB3/YidC,	hsa03060:Protein export,				Alternative splicing,Complete proteome,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,	chain:Mitochondrial inner membrane protein OXA1L,sequence variant,splice variant,transit peptide:Mitochondrion,transmembrane region,
O94296	P-type ATPase (predicted)(SPBC887.12)	Schizosaccharomyces pombe 972h-				GO:0006886~intracellular protein transport,GO:0006892~post-Golgi vesicle-mediated transport,GO:0032456~endocytic recycling,GO:0045332~phospholipid translocation,GO:0048194~Golgi vesicle budding,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0000287~magnesium ion binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005524~ATP binding,	IPR001757:Cation-transporting P-type ATPase,IPR006539:Phospholipid-transporting  P-type ATPase, subfamily IV,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,					ATP-binding,Complete proteome,Endoplasmic reticulum,Golgi apparatus,Hydrolase,Magnesium,Membrane,Nucleotide-binding,Reference proteome,Transmembrane,Transmembrane helix,	chain:Probable phospholipid-transporting ATPase C887.12,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
Q6NXB2	PDZ domain containing 11(pdzd11)	Danio rerio				GO:0006887~exocytosis,GO:0007269~neurotransmitter secretion,GO:0045199~maintenance of epithelial cell apical/basal polarity,GO:1903361~protein localization to basolateral plasma membrane,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005911~cell-cell junction,GO:0016323~basolateral plasma membrane,GO:0045202~synapse,GO:0098793~presynapse,	GO:0008022~protein C-terminus binding,	IPR001478:PDZ domain,				SM00228:PDZ,	Complete proteome,Cytoplasm,Reference proteome,	chain:PDZ domain-containing protein 11,domain:PDZ,
Q6S5H4	POTE ankyrin domain family member B(POTEB)	Homo sapiens							IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	Alternative splicing,ANK repeat,Coiled coil,Complete proteome,Polymorphism,Reference proteome,Repeat,
P05728	PSII 'CP43' polypeptide(ycf13)	Euglena gracilis				GO:0006397~mRNA processing,	GO:0009507~chloroplast,		IPR025960:Reverse transcriptase, N-terminal domain,					Chloroplast,mRNA processing,Plastid,	chain:Maturase-like protein 1,
Q99MQ3	PTEN induced putative kinase 1(Pink1)	Mus musculus				GO:0000422~mitophagy,GO:0001934~positive regulation of protein phosphorylation,GO:0002082~regulation of oxidative phosphorylation,GO:0006468~protein phosphorylation,GO:0006914~autophagy,GO:0006950~response to stress,GO:0006979~response to oxidative stress,GO:0007005~mitochondrion organization,GO:0010310~regulation of hydrogen peroxide metabolic process,GO:0010629~negative regulation of gene expression,GO:0010821~regulation of mitochondrion organization,GO:0016239~positive regulation of macroautophagy,GO:0016242~negative regulation of macroautophagy,GO:0016310~phosphorylation,GO:0016567~protein ubiquitination,GO:0018105~peptidyl-serine phosphorylation,GO:0022904~respiratory electron transport chain,GO:0031396~regulation of protein ubiquitination,GO:0032226~positive regulation of synaptic transmission, dopaminergic,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033603~positive regulation of dopamine secretion,GO:0033605~positive regulation of catecholamine secretion,GO:0034599~cellular response to oxidative stress,GO:0035307~positive regulation of protein dephosphorylation,GO:0035556~intracellular signal transduction,GO:0036289~peptidyl-serine autophosphorylation,GO:0043066~negative regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043254~regulation of protein complex assembly,GO:0043523~regulation of neuron apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0045727~positive regulation of translation,GO:0050821~protein stabilization,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051881~regulation of mitochondrial membrane potential,GO:0071456~cellular response to hypoxia,GO:0072655~establishment of protein localization to mitochondrion,GO:0072656~maintenance of protein location in mitochondrion,GO:0090141~positive regulation of mitochondrial fission,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0090258~negative regulation of mitochondrial fission,GO:0097237~cellular response to toxic substance,GO:0098779~mitophagy in response to mitochondrial depolarization,GO:1900407~regulation of cellular response to oxidative stress,GO:1901727~positive regulation of histone deacetylase activity,GO:1902412~regulation of mitotic cytokinesis,GO:1902902~negative regulation of autophagosome assembly,GO:1902958~positive regulation of mitochondrial electron transport, NADH to ubiquinone,GO:1903147~negative regulation of mitophagy,GO:1903202~negative regulation of oxidative stress-induced cell death,GO:1903214~regulation of protein targeting to mitochondrion,GO:1903298~negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,GO:1903384~negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,GO:1903751~negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,GO:1903852~positive regulation of cristae formation,GO:1903955~positive regulation of protein targeting to mitochondrion,GO:2000377~regulation of reactive oxygen species metabolic process,GO:2000378~negative regulation of reactive oxygen species metabolic process,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005742~mitochondrial outer membrane translocase complex,GO:0005743~mitochondrial inner membrane,GO:0005758~mitochondrial intermembrane space,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0031307~integral component of mitochondrial outer membrane,GO:0031932~TORC2 complex,GO:0044297~cell body,GO:0048471~perinuclear region of cytoplasm,GO:0097449~astrocyte projection,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0002020~protease binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0010857~calcium-dependent protein kinase activity,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0031625~ubiquitin protein ligase binding,GO:0043422~protein kinase B binding,GO:0046872~metal ion binding,GO:0055131~C3HC4-type RING finger domain binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	mmu05012:Parkinson's disease,			SM00220:S_TKc,	ATP-binding,Autophagy,Complete proteome,Cytoplasm,Kinase,Magnesium,Membrane,Metal-binding,Mitochondrion,Mitochondrion outer membrane,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Transit peptide,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase PINK1, mitochondrial,domain:Protein kinase,nucleotide phosphate-binding region:ATP,sequence conflict,topological domain:Cytoplasmic,topological domain:Mitochondrial intermembrane,transit peptide:Mitochondrion,transmembrane region,
C4R4R8	Pentafunctional arom protein(PAS_chr3_0506)	Komagataella phaffii GS115				GO:0009073~aromatic amino acid family biosynthetic process,GO:0009423~chorismate biosynthetic process,	GO:0005829~cytosol,	GO:0003855~3-dehydroquinate dehydratase activity,GO:0003856~3-dehydroquinate synthase activity,GO:0003866~3-phosphoshikimate 1-carboxyvinyltransferase activity,GO:0004764~shikimate 3-dehydrogenase (NADP+) activity,GO:0004765~shikimate kinase activity,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR000623:Shikimate kinase/Threonine synthase-like 1,IPR001381:Dehydroquinase class I,IPR001986:Enolpyruvate transferase domain,IPR006264:3-phosphoshikimate 1-carboxyvinyltransferase,IPR008289:Pentafunctional AroM protein,IPR010110:Shikimate dehydrogenase, AroM-type,IPR013708:Shikimate dehydrogenase substrate binding, N-terminal,IPR013785:Aldolase-type TIM barrel,IPR013792:RNA 3'-terminal phosphate cyclase/enolpyruvate transferase, alpha/beta,IPR016037:3-dehydroquinate synthase AroB,IPR016040:NAD(P)-binding domain,IPR018508:3-dehydroquinate dehydratase, active site,IPR023193:3-phosphoshikimate 1-carboxyvinyltransferase, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	ppa00400:Phenylalanine, tyrosine and tryptophan biosynthesis,ppa01100:Metabolic pathways,ppa01110:Biosynthesis of secondary metabolites,ppa01130:Biosynthesis of antibiotics,ppa01230:Biosynthesis of amino acids,		PIRSF000514:pentafunctional AROM protein,		Amino-acid biosynthesis,Aromatic amino acid biosynthesis,ATP-binding,Complete proteome,Cytoplasm,Kinase,Lyase,Metal-binding,Multifunctional enzyme,NADP,Nucleotide-binding,Oxidoreductase,Reference proteome,Transferase,Zinc,
Q9SI53	Pentatricopeptide repeat (PPR) superfamily protein(REME1)	Arabidopsis thaliana				GO:0009451~RNA modification,	GO:0005739~mitochondrion,	GO:0008270~zinc ion binding,	IPR002885:Pentatricopeptide repeat,IPR011990:Tetratricopeptide-like helical,					Complete proteome,Mitochondrion,Reference proteome,Repeat,Transit peptide,	chain:Pentatricopeptide repeat-containing protein At2g03880, mitochondrial,region of interest:Type DYW motif,region of interest:Type E motif,region of interest:Type E(+) motif,repeat:PPR 1,repeat:PPR 10,repeat:PPR 11,repeat:PPR 2,repeat:PPR 3,repeat:PPR 4,repeat:PPR 5,repeat:PPR 6,repeat:PPR 7,repeat:PPR 8,repeat:PPR 9,sequence conflict,transit peptide:Mitochondrion,
Q95LJ0	Pim-1 proto-oncogene, serine/threonine kinase(PIM1)	Felis catus				GO:0006915~apoptotic process,GO:0007049~cell cycle,GO:0007346~regulation of mitotic cell cycle,GO:0008283~cell proliferation,GO:0031659~positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,GO:0043066~negative regulation of apoptotic process,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0046777~protein autophosphorylation,GO:0070561~vitamin D receptor signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0030145~manganese ion binding,GO:0043024~ribosomal small subunit binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017348:Proto-oncogene serine/threonine-protein kinase Pim-1,IPR017441:Protein kinase, ATP binding site,	fca04630:Jak-STAT signaling pathway,fca05206:MicroRNAs in cancer,fca05221:Acute myeloid leukemia,		PIRSF037993:proto-oncogene serine/threonine-protein kinase Pim-1,	SM00220:S_TKc,	Apoptosis,ATP-binding,Cell cycle,Complete proteome,Cytoplasm,Kinase,Magnesium,Nucleotide-binding,Nucleus,Phosphoprotein,Proto-oncogene,Reference proteome,Serine/threonine-protein kinase,Transferase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Proto-oncogene serine/threonine-protein kinase pim-1,domain:Protein kinase,nucleotide phosphate-binding region:ATP,
P26794	Pim-1 proto-oncogene, serine/threonine kinase(Pim1)	Rattus norvegicus				GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007049~cell cycle,GO:0007346~regulation of mitotic cell cycle,GO:0008283~cell proliferation,GO:0030212~hyaluronan metabolic process,GO:0031659~positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,GO:0043066~negative regulation of apoptotic process,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046777~protein autophosphorylation,GO:0050821~protein stabilization,GO:0070561~vitamin D receptor signaling pathway,GO:1902033~regulation of hematopoietic stem cell proliferation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0030145~manganese ion binding,GO:0043024~ribosomal small subunit binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017348:Proto-oncogene serine/threonine-protein kinase Pim-1,IPR017441:Protein kinase, ATP binding site,	rno04630:Jak-STAT signaling pathway,rno05206:MicroRNAs in cancer,rno05221:Acute myeloid leukemia,		PIRSF037993:proto-oncogene serine/threonine-protein kinase Pim-1,	SM00220:S_TKc,	Apoptosis,ATP-binding,Cell cycle,Cell membrane,Complete proteome,Cytoplasm,Kinase,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Proto-oncogene,Reference proteome,Serine/threonine-protein kinase,Transferase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Proto-oncogene serine/threonine-protein kinase pim-1,domain:Protein kinase,nucleotide phosphate-binding region:ATP,
Q9PU85	Pim-3 proto-oncogene, serine/threonine kinase(PIM3)	Coturnix japonica				GO:0043066~negative regulation of apoptotic process,	GO:0005737~cytoplasm,	GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017348:Proto-oncogene serine/threonine-protein kinase Pim-1,IPR017441:Protein kinase, ATP binding site,			PIRSF037993:proto-oncogene serine/threonine-protein kinase Pim-1,	SM00220:S_TKc,	ATP-binding,Cytoplasm,Kinase,Nucleotide-binding,Phosphoprotein,Serine/threonine-protein kinase,Transferase,
A8BCK6	Piwi-protein, putative(GL50803_2902)	Giardia lamblia ATCC 50803				GO:0006417~regulation of translation,GO:0007275~multicellular organism development,GO:0030154~cell differentiation,GO:0031047~gene silencing by RNA,	GO:0005737~cytoplasm,	GO:0003723~RNA binding,	IPR003165:Stem cell self-renewal protein Piwi,IPR012337:Ribonuclease H-like domain,				SM00950:SM00950,	Complete proteome,Cytoplasm,Developmental protein,Differentiation,Reference proteome,RNA-binding,RNA-mediated gene silencing,Translation regulation,
Q9LVQ8	Protein phosphatase 2C family protein(AT5G66720)	Arabidopsis thaliana					GO:0005739~mitochondrion,GO:0009507~chloroplast,GO:0009570~chloroplast stroma,	GO:0004721~phosphoprotein phosphatase activity,GO:0046872~metal ion binding,	IPR001932:Protein phosphatase 2C (PP2C)-like,				SM00331:PP2C_SIG,SM00332:PP2Cc,	Alternative splicing,Complete proteome,Hydrolase,Magnesium,Manganese,Metal-binding,Protein phosphatase,Reference proteome,	chain:Probable protein phosphatase 2C 80,domain:PP2C-like,metal ion-binding site:Manganese 1,metal ion-binding site:Manganese 1; via carbonyl oxygen,metal ion-binding site:Manganese 2,splice variant,
A5WW21	RAS and EF-hand domain containing(rasef)	Danio rerio				GO:0007264~small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0048471~perinuclear region of cytoplasm,	GO:0005509~calcium ion binding,GO:0005525~GTP binding,	IPR001806:Small GTPase superfamily,IPR002048:EF-hand domain,IPR005225:Small GTP-binding protein domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00054:EFh,	Calcium,Coiled coil,Complete proteome,Cytoplasm,GTP-binding,Metal-binding,Nucleotide-binding,Reference proteome,Repeat,
P93823	RING/U-box superfamily protein(AT1G04360)	Arabidopsis thaliana				GO:0016567~protein ubiquitination,	GO:0005634~nucleus,GO:0016021~integral component of membrane,	GO:0008270~zinc ion binding,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,	Complete proteome,Membrane,Metal-binding,Reference proteome,Transmembrane,Transmembrane helix,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:RING-H2 finger protein ATL1A,compositionally biased region:Poly-Pro,transmembrane region,zinc finger region:RING-type; atypical,
Q8CGC6	RNA binding motif protein 28(Rbm28)	Mus musculus				GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005730~nucleolus,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	mmu03008:Ribosome biogenesis in eukaryotes,			SM00360:RRM,	3D-structure,Acetylation,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Spliceosome,	chain:RNA-binding protein 28,compositionally biased region:Asp/Glu-rich (acidic),domain:RRM 1,domain:RRM 2,domain:RRM 3,domain:RRM 4,helix,modified residue,sequence conflict,strand,turn,
Q5RC80	RNA binding motif protein 39(RBM39)	Pongo abelii				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005654~nucleoplasm,GO:0005815~microtubule organizing center,GO:0016607~nuclear speck,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR006509:Splicing factor, CC1-like,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,SM00361:RRM_1,	Acetylation,Activator,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Reference proteome,Repeat,RNA-binding,Transcription,Transcription regulation,	chain:RNA-binding protein 39,compositionally biased region:Arg/Ser-rich (RS domain),compositionally biased region:Poly-Ala,domain:RRM 1,domain:RRM 2,domain:RRM 3,modified residue,region of interest:Activating domain,region of interest:Interaction with ESR1 and ESR2,region of interest:Interaction with JUN,region of interest:Interaction with NCOA6,
Q32PE0	RNA polymerase II subunit F(POLR2F)	Bos taurus				GO:0006351~transcription, DNA-templated,GO:0006360~transcription from RNA polymerase I promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006383~transcription from RNA polymerase III promoter,	GO:0005634~nucleus,GO:0005665~DNA-directed RNA polymerase II, core complex,GO:0005666~DNA-directed RNA polymerase III complex,GO:0005736~DNA-directed RNA polymerase I complex,	GO:0001054~RNA polymerase I activity,GO:0001055~RNA polymerase II activity,GO:0001056~RNA polymerase III activity,GO:0003677~DNA binding,GO:0003899~DNA-directed RNA polymerase activity,	IPR006110:RNA polymerase, subunit omega/K/RPABC2,IPR006111:DNA-directed RNA polymerase, subunit K/Rpb6,IPR012293:RNA polymerase subunit, RPB6/omega,IPR020708:DNA-directed RNA polymerase, 14-18kDa subunit, conserved site,	bta00230:Purine metabolism,bta00240:Pyrimidine metabolism,bta01100:Metabolic pathways,bta03020:RNA polymerase,bta04623:Cytosolic DNA-sensing pathway,bta05016:Huntington's disease,bta05169:Epstein-Barr virus infection,		PIRSF000778:DNA-directed RNA polymerase, subunit K/RPB6 subunit,PIRSF500154:DNA-directed RNA polymerase, RPB6 type [Parent=PIRSF000778],	SM01409:SM01409,	3D-structure,Acetylation,Complete proteome,DNA-directed RNA polymerase,Nucleus,Phosphoprotein,Reference proteome,Transcription,	chain:DNA-directed RNA polymerases I, II, and III subunit RPABC2,modified residue,
Q1KXX2	RNA polymerase beta chain(rpoB)	Helianthus annuus				GO:0006351~transcription, DNA-templated,	GO:0009507~chloroplast,	GO:0003677~DNA binding,GO:0003899~DNA-directed RNA polymerase activity,GO:0032549~ribonucleoside binding,	IPR007120:DNA-directed RNA polymerase, subunit 2, domain 6,IPR007121:RNA polymerase, beta subunit, conserved site,IPR007641:RNA polymerase Rpb2, domain 7,IPR007642:RNA polymerase Rpb2, domain 2,IPR007644:RNA polymerase, beta subunit, protrusion,IPR007645:RNA polymerase Rpb2, domain 3,IPR010243:DNA-directed RNA polymerase, beta subunit,IPR014724:RNA polymerase Rpb2, OB-fold,IPR015712:DNA-directed RNA polymerase, subunit 2,					Chloroplast,DNA-directed RNA polymerase,Nucleotidyltransferase,Plastid,Transcription,Transferase,	chain:DNA-directed RNA polymerase subunit beta,
A6MVX4	RNA polymerase beta subunit(rpoB)	Rhodomonas salina				GO:0006351~transcription, DNA-templated,	GO:0009507~chloroplast,	GO:0003677~DNA binding,GO:0003899~DNA-directed RNA polymerase activity,GO:0032549~ribonucleoside binding,	IPR007120:DNA-directed RNA polymerase, subunit 2, domain 6,IPR007121:RNA polymerase, beta subunit, conserved site,IPR007641:RNA polymerase Rpb2, domain 7,IPR007642:RNA polymerase Rpb2, domain 2,IPR007644:RNA polymerase, beta subunit, protrusion,IPR007645:RNA polymerase Rpb2, domain 3,IPR010243:DNA-directed RNA polymerase, beta subunit,IPR014724:RNA polymerase Rpb2, OB-fold,IPR015712:DNA-directed RNA polymerase, subunit 2,IPR019462:DNA-directed RNA polymerase, beta subunit, external 1 domain,					Chloroplast,DNA-directed RNA polymerase,Nucleotidyltransferase,Plastid,Transcription,Transferase,	chain:DNA-directed RNA polymerase subunit beta,
Q9Y2P8	RNA terminal phosphate cyclase like 1(RCL1)	Homo sapiens				GO:0000447~endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000480~endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0042254~ribosome biogenesis,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0003723~RNA binding,GO:0003824~catalytic activity,GO:0003963~RNA-3'-phosphate cyclase activity,GO:0004521~endoribonuclease activity,	IPR000228:RNA 3'-terminal phosphate cyclase,IPR013791:RNA 3'-terminal phosphate cyclase, insert domain,IPR013792:RNA 3'-terminal phosphate cyclase/enolpyruvate transferase, alpha/beta,IPR016443:RNA 3'-terminal phosphate cyclase type 2,IPR020719:RNA 3'-terminal phosphate cyclase-like, conserved site,IPR023797:RNA 3'-terminal phosphate cyclase domain,	hsa03008:Ribosome biogenesis in eukaryotes,		PIRSF005378:RNA 3'-terminal phosphate cyclase,		Alternative splicing,Complete proteome,Nucleus,Proteomics identification,Reference proteome,Ribosome biogenesis,	chain:RNA 3'-terminal phosphate cyclase-like protein,sequence conflict,
Q5R5R4	RUN and FYVE domain containing 2(RUFY2)	Pongo abelii					GO:0005634~nucleus,	GO:0046872~metal ion binding,	IPR000306:Zinc finger, FYVE-type,IPR004012:RUN,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017455:Zinc finger, FYVE-related,				SM00064:FYVE,SM00593:RUN,	Coiled coil,Complete proteome,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Zinc,Zinc-finger,	chain:RUN and FYVE domain-containing protein 2,domain:RUN,zinc finger region:FYVE-type,
Q52219	RepFIB replication protein A(repFIB)	Escherichia coli				GO:0006270~DNA replication initiation,GO:0006276~plasmid maintenance,	GO:0005727~extrachromosomal circular DNA,	GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,	IPR000525:Initiator Rep protein,					Complete proteome,DNA replication,DNA-binding,Plasmid,Plasmid copy control,	chain:RepFIB replication protein A,
Q8N5C6	S1 RNA binding domain 1(SRBD1)	Homo sapiens			Transcription,	GO:0006139~nucleobase-containing compound metabolic process,		GO:0003723~RNA binding,	IPR003029:Ribosomal protein S1, RNA-binding domain,IPR006641:YqgF/RNase H-like domain,IPR010994:RuvA domain 2-like,IPR012337:Ribonuclease H-like domain,IPR012340:Nucleic acid-binding, OB-fold,IPR018974:Tex-like protein, N-terminal,IPR022967:RNA-binding domain, S1,IPR023097:Tex RuvX-like domain,IPR023319:Tex-like protein, HTH domain,IPR023323:Tex-like domain,				SM00316:SM00316,SM00732:YqgFc,	Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,Phosphoprotein,Polymorphism,Reference proteome,RNA-binding,Ubl conjugation,	chain:S1 RNA-binding domain-containing protein 1,compositionally biased region:Poly-Val,domain:S1 motif,modified residue,sequence conflict,sequence variant,splice variant,
Q6PA35	SAMM50 sorting and assembly machinery component S homeolog(samm50.S)	Xenopus laevis				GO:0042407~cristae formation,	GO:0005741~mitochondrial outer membrane,GO:0016021~integral component of membrane,		IPR000184:Bacterial surface antigen (D15),					Membrane,Mitochondrion,Mitochondrion outer membrane,Transmembrane,Transmembrane beta strand,	chain:Sorting and assembly machinery component 50 homolog B,
P58875	SEC14 like lipid binding 2(SEC14L2)	Bos taurus				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006810~transport,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,	GO:0005215~transporter activity,GO:0008289~lipid binding,	IPR001071:Cellular retinaldehyde binding/alpha-tocopherol transport,IPR001251:CRAL-TRIO domain,IPR009038:GOLD,IPR011074:CRAL/TRIO, N-terminal domain,				SM00516:SEC14,SM01100:SM01100,	Activator,Complete proteome,Cytoplasm,Direct protein sequencing,Lipid-binding,Nucleus,Reference proteome,Transcription,Transcription regulation,Transport,	chain:SEC14-like protein 2,domain:CRAL-TRIO,domain:GOLD,sequence conflict,
Q53H47	SET domain and mariner transposase fusion gene(SETMAR)	Homo sapiens				GO:0000729~DNA double-strand break processing,GO:0000737~DNA catabolic process, endonucleolytic,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0008283~cell proliferation,GO:0010452~histone H3-K36 methylation,GO:0015074~DNA integration,GO:0031297~replication fork processing,GO:0044774~mitotic DNA integrity checkpoint,GO:0051568~histone H3-K4 methylation,GO:0071157~negative regulation of cell cycle arrest,GO:0090305~nucleic acid phosphodiester bond hydrolysis,GO:0097676~histone H3-K36 dimethylation,GO:2000373~positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,GO:2001034~positive regulation of double-strand break repair via nonhomologous end joining,GO:2001251~negative regulation of chromosome organization,	GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0035861~site of double-strand break,	GO:0000014~single-stranded DNA endodeoxyribonuclease activity,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0004519~endonuclease activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0042803~protein homodimerization activity,GO:0043566~structure-specific DNA binding,GO:0044547~DNA topoisomerase binding,GO:0046975~histone methyltransferase activity (H3-K36 specific),	IPR001214:SET domain,IPR001888:Transposase, type 1,IPR003616:Post-SET domain,IPR007728:Pre-SET domain,	hsa00310:Lysine degradation,			SM00317:SET,SM00468:PreSET,	3D-structure,Alternative splicing,Chromatin regulator,Chromosome,Complete proteome,DNA damage,DNA repair,DNA-binding,Endonuclease,Hydrolase,Magnesium,Metal-binding,Methylation,Methyltransferase,Multifunctional enzyme,Nuclease,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transferase,Zinc,	chain:Histone-lysine N-methyltransferase SETMAR,DNA-binding region:H-T-H motif,domain:Post-SET,domain:Pre-SET,domain:SET,helix,metal ion-binding site:Magnesium,modified residue,mutagenesis site,region of interest:Histone-lysine N-methyltransferase,region of interest:Mariner transposase Hsmar1,sequence conflict,splice variant,strand,
Q9H788	SH2 domain containing 4A(SH2D4A)	Homo sapiens				GO:0010923~negative regulation of phosphatase activity,	GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0019902~phosphatase binding,	IPR000980:SH2 domain,				SM00252:SH2,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH2 domain,	chain:SH2 domain-containing protein 4A,compositionally biased region:Poly-Ser,domain:SH2,modified residue,sequence conflict,sequence variant,
Q80VA5	SH3 domain and tetratricopeptide repeats 2(Sh3tc2)	Mus musculus				GO:0022011~myelination in peripheral nervous system,GO:0032287~peripheral nervous system myelin maintenance,GO:0033157~regulation of intracellular protein transport,GO:1901184~regulation of ERBB signaling pathway,	GO:0005886~plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0055037~recycling endosome,	GO:0005515~protein binding,	IPR001452:Src homology-3 domain,IPR011511:Variant SH3,IPR011990:Tetratricopeptide-like helical,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,SM00326:SH3,	Alternative splicing,Complete proteome,Reference proteome,Repeat,SH3 domain,TPR repeat,	chain:SH3 domain and tetratricopeptide repeats- containing protein 2,domain:SH3,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,splice variant,
Q6PKU1	Spi-1 proto-oncogene(SPI1)	Sus scrofa				GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0030154~cell differentiation,	GO:0005634~nucleus,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR011991:Winged helix-turn-helix DNA-binding domain,	ssc04380:Osteoclast differentiation,ssc05166:HTLV-I infection,ssc05169:Epstein-Barr virus infection,ssc05200:Pathways in cancer,ssc05202:Transcriptional misregulation in cancer,ssc05221:Acute myeloid leukemia,			SM00413:ETS,	Activator,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Reference proteome,RNA-binding,Transcription,Transcription regulation,	chain:Transcription factor PU.1,DNA-binding region:ETS,modified residue,
Q8R4L0	Src-like-adaptor 2(Sla2)	Mus musculus				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002250~adaptive immune response,GO:0002376~immune system process,GO:0042110~T cell activation,GO:0050849~negative regulation of calcium-mediated signaling,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005770~late endosome,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,	GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,GO:0047485~protein N-terminus binding,	IPR000980:SH2 domain,IPR001452:Src homology-3 domain,				SM00252:SH2,SM00326:SH3,	Adaptive immunity,Alternative initiation,Cell membrane,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Endosome,Immunity,Lipoprotein,Membrane,Myristate,Phosphoprotein,Reference proteome,SH2 domain,SH3 domain,	chain:Src-like-adapter 2,domain:SH2,domain:SH3,lipid moiety-binding region:N-myristoyl glycine,mutagenesis site,region of interest:SLA C-terminal,sequence conflict,splice variant,
Q8N103	T-cell activation RhoGTPase activating protein(TAGAP)	Homo sapiens				GO:0007165~signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005829~cytosol,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,	IPR000198:Rho GTPase-activating protein domain,IPR008936:Rho GTPase activation protein,				SM00324:RhoGAP,	Alternative splicing,Complete proteome,Guanine-nucleotide releasing factor,Phosphoprotein,Polymorphism,Reference proteome,	chain:T-cell activation Rho GTPase-activating protein,domain:Rho-GAP,sequence variant,splice variant,
P87121	TATA-binding protein associated factor Taf2 (predicted)(taf2)	Schizosaccharomyces pombe 972h-				GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005669~transcription factor TFIID complex,GO:0005829~cytosol,GO:0032153~cell division site,	GO:0000991~transcription factor activity, core RNA polymerase II binding,GO:0001129~RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,GO:0003682~chromatin binding,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR014782:Peptidase M1, membrane alanine aminopeptidase, N-terminal,	spo03022:Basal transcription factors,				Complete proteome,Cytoplasm,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:Transcription initiation factor TFIID subunit 2,
Q6DGZ3	THO complex 7(thoc7)	Danio rerio				GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006397~mRNA processing,GO:0006406~mRNA export from nucleus,GO:0006810~transport,GO:0008380~RNA splicing,GO:0051028~mRNA transport,	GO:0000445~THO complex part of transcription export complex,GO:0000446~nucleoplasmic THO complex,GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,	IPR008501:THO complex subunit 7/Mft1,	dre03013:RNA transport,				Coiled coil,Complete proteome,Cytoplasm,mRNA processing,mRNA splicing,mRNA transport,Nucleus,Reference proteome,RNA-binding,Transport,	chain:THO complex subunit 7 homolog,
Q4R4H5	TSC22 domain family member 1(TSC22D1)	Macaca fascicularis				GO:0006351~transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR000580:TSC-22 / Dip / Bun,					Cytoplasm,Nucleus,Repressor,Transcription,Transcription regulation,
Q06466	Tda6p(TDA6)	Saccharomyces cerevisiae S288c				GO:0006810~transport,GO:0015031~protein transport,	GO:0000324~fungal-type vacuole,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0071944~cell periphery,							Complete proteome,Glycoprotein,Membrane,Protein transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Putative vacuolar protein sorting- associated protein YPR157W,glycosylation site:N-linked (GlcNAc...),transmembrane region,
P70691	UDP glucuronosyltransferase 1 family, polypeptide A2(Ugt1a2)	Mus musculus				GO:0008152~metabolic process,GO:0009813~flavonoid biosynthetic process,GO:0052695~cellular glucuronidation,GO:0052696~flavonoid glucuronidation,GO:0052697~xenobiotic glucuronidation,	GO:0005783~endoplasmic reticulum,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0001972~retinoic acid binding,GO:0015020~glucuronosyltransferase activity,GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0016758~transferase activity, transferring hexosyl groups,GO:0019899~enzyme binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR002213:UDP-glucuronosyl/UDP-glucosyltransferase,	mmu00040:Pentose and glucuronate interconversions,mmu00053:Ascorbate and aldarate metabolism,mmu00140:Steroid hormone biosynthesis,mmu00830:Retinol metabolism,mmu00860:Porphyrin and chlorophyll metabolism,mmu00980:Metabolism of xenobiotics by cytochrome P450,mmu00982:Drug metabolism - cytochrome P450,mmu00983:Drug metabolism - other enzymes,mmu01100:Metabolic pathways,mmu05204:Chemical carcinogenesis,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Membrane,Microsome,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:UDP-glucuronosyltransferase 1-1,chain:UDP-glucuronosyltransferase 1-2,chain:UDP-glucuronosyltransferase 1-6,chain:UDP-glucuronosyltransferase 1-7C,chain:UDP-glucuronosyltransferase 1-9,compositionally biased region:Poly-Val,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,signal peptide,transmembrane region,
Q9Y4X1	UDP glucuronosyltransferase family 2 member A1 complex locus(UGT2A1)	Homo sapiens				GO:0007608~sensory perception of smell,GO:0008152~metabolic process,GO:0009593~detection of chemical stimulus,GO:0009813~flavonoid biosynthetic process,GO:0052695~cellular glucuronidation,GO:0052696~flavonoid glucuronidation,	GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0015020~glucuronosyltransferase activity,GO:0016758~transferase activity, transferring hexosyl groups,	IPR002213:UDP-glucuronosyl/UDP-glucosyltransferase,	hsa00040:Pentose and glucuronate interconversions,hsa00053:Ascorbate and aldarate metabolism,hsa00140:Steroid hormone biosynthesis,hsa00830:Retinol metabolism,hsa00860:Porphyrin and chlorophyll metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,				Alternative splicing,Complete proteome,Glycoprotein,Glycosyltransferase,Membrane,Olfaction,Polymorphism,Reference proteome,Sensory transduction,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:UDP-glucuronosyltransferase 2A1,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q8DMS9	UDP-3-O-(R-3-hydroxymyristoyl)-glucosamine N-acyltransferase(tll0032)	Thermosynechococcus elongatus BP-1				GO:0009245~lipid A biosynthetic process,		GO:0016410~N-acyltransferase activity,	IPR001451:Bacterial transferase hexapeptide repeat,IPR007691:UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase,IPR011004:Trimeric LpxA-like,IPR020573:UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase, non-repeat region,	tel00540:Lipopolysaccharide biosynthesis,tel01100:Metabolic pathways,				Acyltransferase,Complete proteome,Lipid A biosynthesis,Lipid biosynthesis,Lipid metabolism,Reference proteome,Repeat,Transferase,	chain:UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase,
O54905	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2(B3galt2)	Mus musculus		m_aMANpathway:Steps in the Glycosylation of Mammalian N-linked Oligosaccarides,		GO:0006486~protein glycosylation,GO:0009312~oligosaccharide biosynthetic process,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0008378~galactosyltransferase activity,GO:0008499~UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,	IPR002659:Glycosyl transferase, family 31,	mmu00601:Glycosphingolipid biosynthesis - lacto and neolacto series,mmu01100:Metabolic pathways,				Complete proteome,Glycoprotein,Glycosyltransferase,Golgi apparatus,Manganese,Membrane,Polymorphism,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Beta-1,3-galactosyltransferase 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
Q16851	UDP-glucose pyrophosphorylase 2(UGP2)	Homo sapiens				GO:0005978~glycogen biosynthetic process,GO:0006011~UDP-glucose metabolic process,GO:0006065~UDP-glucuronate biosynthetic process,GO:0008152~metabolic process,GO:0019255~glucose 1-phosphate metabolic process,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003983~UTP:glucose-1-phosphate uridylyltransferase activity,GO:0005515~protein binding,GO:0005536~glucose binding,GO:0032557~pyrimidine ribonucleotide binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0070569~uridylyltransferase activity,	IPR002618:UTP--glucose-1-phosphate uridylyltransferase,IPR016267:UTP--glucose-1-phosphate uridylyltransferase, subgroup,	hsa00040:Pentose and glucuronate interconversions,hsa00052:Galactose metabolism,hsa00500:Starch and sucrose metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,		PIRSF000806:UTP--glucose-1-phosphate uridylyltransferase,		3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Magnesium,Metal-binding,Nucleotidyltransferase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:UTP--glucose-1-phosphate uridylyltransferase,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
Q7ZXZ2	UTP15, U3 small nucleolar ribonucleoprotein, homolog L homeolog(utp15.L)	Xenopus laevis				GO:0006364~rRNA processing,	GO:0005730~nucleolus,		IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR018983:U3 small nucleolar RNA-associated protein 15, C-terminal,IPR019775:WD40 repeat, conserved site,	xla03008:Ribosome biogenesis in eukaryotes,			SM00320:WD40,	Nucleus,Repeat,rRNA processing,WD repeat,	chain:U3 small nucleolar RNA-associated protein 15 homolog,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,
O01884	Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial(coq-6)	Caenorhabditis elegans				GO:0006744~ubiquinone biosynthetic process,GO:0044550~secondary metabolite biosynthetic process,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0031314~extrinsic component of mitochondrial inner membrane,	GO:0004497~monooxygenase activity,GO:0016491~oxidoreductase activity,GO:0016709~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0050660~flavin adenine dinucleotide binding,GO:0071949~FAD binding,	IPR000689:Ubiquinone biosynthesis monooxygenase, COQ6-type,IPR002938:Monooxygenase, FAD-binding,IPR010971:Ubiquinone biosynthesis hydroxylase, UbiH/UbiF/VisC/COQ6,IPR018168:Ubiquinone biosynthesis hydroxylase, UbiH/UbiF/VisC/COQ6, conserved site,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,	cel00130:Ubiquinone and other terpenoid-quinone biosynthesis,cel01100:Metabolic pathways,				Complete proteome,FAD,Flavoprotein,Membrane,Mitochondrion,Mitochondrion inner membrane,Monooxygenase,Oxidoreductase,Reference proteome,Transit peptide,Ubiquinone biosynthesis,	chain:Probable ubiquinone biosynthesis monooxygenase coq-6,
P34711	Vesicular acetylcholine transporter unc-17(unc-17)	Caenorhabditis elegans				GO:0002119~nematode larval development,GO:0006810~transport,GO:0006836~neurotransmitter transport,GO:0006855~drug transmembrane transport,GO:0006937~regulation of muscle contraction,GO:0007271~synaptic transmission, cholinergic,GO:0007411~axon guidance,GO:0008340~determination of adult lifespan,GO:0015870~acetylcholine transport,GO:0015893~drug transport,GO:0040011~locomotion,GO:0040012~regulation of locomotion,GO:0043051~regulation of pharyngeal pumping,GO:0046928~regulation of neurotransmitter secretion,GO:0055085~transmembrane transport,GO:0072488~ammonium transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0008021~synaptic vesicle,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030285~integral component of synaptic vesicle membrane,GO:0030672~synaptic vesicle membrane,GO:0031090~organelle membrane,GO:0031410~cytoplasmic vesicle,GO:0043005~neuron projection,GO:0045202~synapse,GO:0060076~excitatory synapse,	GO:0005277~acetylcholine transmembrane transporter activity,GO:0015238~drug transmembrane transporter activity,	IPR004734:Multidrug resistance protein,IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,					Cell junction,Complete proteome,Cytoplasmic vesicle,Glycoprotein,Membrane,Neurotransmitter transport,Reference proteome,Synapse,Transmembrane,Transmembrane helix,Transport,
E9Q4P1	WD repeat and FYVE domain containing 1(Wdfy1)	Mus musculus				GO:0034141~positive regulation of toll-like receptor 3 signaling pathway,GO:0034145~positive regulation of toll-like receptor 4 signaling pathway,	GO:0005634~nucleus,GO:0005768~endosome,GO:0005769~early endosome,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0005545~1-phosphatidylinositol binding,GO:0046872~metal ion binding,	IPR000306:Zinc finger, FYVE-type,IPR001680:WD40 repeat,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017455:Zinc finger, FYVE-related,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,				SM00064:FYVE,SM00320:WD40,	Complete proteome,Endosome,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,WD repeat,Zinc,Zinc-finger,
Q5ZHN3	WD repeat domain, phosphoinositide interacting 2(WIPI2)	Gallus gallus				GO:0000045~autophagosome assembly,GO:0000422~mitophagy,GO:0006497~protein lipidation,GO:0034497~protein localization to pre-autophagosomal structure,GO:0044804~nucleophagy,	GO:0005654~nucleoplasm,GO:0005776~autophagosome,GO:0005829~cytosol,GO:0019898~extrinsic component of membrane,GO:0034045~pre-autophagosomal structure membrane,GO:0043234~protein complex,	GO:0010314~phosphatidylinositol-5-phosphate binding,GO:0032266~phosphatidylinositol-3-phosphate binding,GO:0080025~phosphatidylinositol-3,5-bisphosphate binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,				SM00320:WD40,	Autophagy,Complete proteome,Membrane,Reference proteome,Repeat,WD repeat,	chain:WD repeat domain phosphoinositide- interacting protein 2,repeat:WD 1,repeat:WD 2,repeat:WD 3,
P87141	WD repeat-containing protein(mip1)	Schizosaccharomyces pombe 972h-				GO:0000002~mitochondrial genome maintenance,GO:0006264~mitochondrial DNA replication,GO:0030435~sporulation resulting in formation of a cellular spore,GO:0031139~positive regulation of conjugation with cellular fusion,GO:0031929~TOR signaling,GO:0051321~meiotic cell cycle,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005760~gamma DNA polymerase complex,GO:0031931~TORC1 complex,	GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0005515~protein binding,GO:0008408~3'-5' exonuclease activity,	IPR001098:DNA-directed DNA polymerase, family A, palm domain,IPR001680:WD40 repeat,IPR002297:DNA-directed DNA-polymerase, family A, mitochondria,IPR004083:Regulatory associated protein of TOR,IPR011989:Armadillo-like helical,IPR012337:Ribonuclease H-like domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016024:Armadillo-type fold,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,				SM00320:WD40,SM00482:POLAc,SM01302:SM01302,	Complete proteome,Cytoplasm,DNA replication,DNA-binding,DNA-directed DNA polymerase,Magnesium,Meiosis,Mitochondrion,Nucleotidyltransferase,Phosphoprotein,Reference proteome,Repeat,Sporulation,Transferase,WD repeat,	chain:WD repeat-containing protein mip1,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,
Q3SZZ2	X-box binding protein 1(XBP1)	Bos taurus				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001525~angiogenesis,GO:0001889~liver development,GO:0001934~positive regulation of protein phosphorylation,GO:0001935~endothelial cell proliferation,GO:0002639~positive regulation of immunoglobulin production,GO:0006366~transcription from RNA polymerase II promoter,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006990~positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,GO:0007517~muscle organ development,GO:0010506~regulation of autophagy,GO:0010508~positive regulation of autophagy,GO:0010832~negative regulation of myotube differentiation,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0016049~cell growth,GO:0031017~exocrine pancreas development,GO:0031062~positive regulation of histone methylation,GO:0031648~protein destabilization,GO:0031670~cellular response to nutrient,GO:0032008~positive regulation of TOR signaling,GO:0032869~cellular response to insulin stimulus,GO:0034599~cellular response to oxidative stress,GO:0034976~response to endoplasmic reticulum stress,GO:0035356~cellular triglyceride homeostasis,GO:0035924~cellular response to vascular endothelial growth factor stimulus,GO:0042149~cellular response to glucose starvation,GO:0042632~cholesterol homeostasis,GO:0042993~positive regulation of transcription factor import into nucleus,GO:0043066~negative regulation of apoptotic process,GO:0045348~positive regulation of MHC class II biosynthetic process,GO:0045579~positive regulation of B cell differentiation,GO:0045582~positive regulation of T cell differentiation,GO:0045600~positive regulation of fat cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048666~neuron development,GO:0051024~positive regulation of immunoglobulin secretion,GO:0055089~fatty acid homeostasis,GO:0055092~sterol homeostasis,GO:0060612~adipose tissue development,GO:0060691~epithelial cell maturation involved in salivary gland development,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0071222~cellular response to lipopolysaccharide,GO:0071230~cellular response to amino acid stimulus,GO:0071332~cellular response to fructose stimulus,GO:0071333~cellular response to glucose stimulus,GO:0071353~cellular response to interleukin-4,GO:0071375~cellular response to peptide hormone stimulus,GO:0071498~cellular response to fluid shear stress,GO:0071499~cellular response to laminar fluid shear stress,GO:1900100~positive regulation of plasma cell differentiation,GO:1900102~negative regulation of endoplasmic reticulum unfolded protein response,GO:1900103~positive regulation of endoplasmic reticulum unfolded protein response,GO:1901800~positive regulation of proteasomal protein catabolic process,GO:1901985~positive regulation of protein acetylation,GO:1902236~negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1903489~positive regulation of lactation,GO:1990418~response to insulin-like growth factor stimulus,GO:2000347~positive regulation of hepatocyte proliferation,GO:2000353~positive regulation of endothelial cell apoptotic process,GO:2000778~positive regulation of interleukin-6 secretion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001158~enhancer sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0031490~chromatin DNA binding,GO:0036312~phosphatidylinositol 3-kinase regulatory subunit binding,GO:0042826~histone deacetylase binding,GO:0044389~ubiquitin-like protein ligase binding,GO:0046982~protein heterodimerization activity,	IPR004827:Basic-leucine zipper domain,	bta04141:Protein processing in endoplasmic reticulum,bta04932:Non-alcoholic fatty liver disease (NAFLD),bta05166:HTLV-I infection,			SM00338:BRLZ,	Acetylation,Activator,Alternative splicing,Angiogenesis,Apoptosis,Cleavage on pair of basic residues,Complete proteome,Cytoplasm,Developmental protein,Differentiation,DNA-binding,Endoplasmic reticulum,Membrane,Myogenesis,Nucleus,Phosphoprotein,Reference proteome,Signal-anchor,Stress response,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Ubl conjugation,Unfolded protein response,	chain:X-box-binding protein 1,DNA-binding region:Basic motif,domain:Leucine-zipper,modified residue,
Q7ZUN8	YKT6 v-SNARE homolog (S. cerevisiae)(ykt6)	Danio rerio			Intracellular trafficking and secretion,	GO:0006810~transport,GO:0006887~exocytosis,GO:0006906~vesicle fusion,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031201~SNARE complex,GO:0031410~cytoplasmic vesicle,	GO:0000149~SNARE binding,GO:0004147~dihydrolipoamide branched chain acyltransferase activity,GO:0004772~sterol O-acyltransferase activity,GO:0005484~SNAP receptor activity,GO:0008080~N-acetyltransferase activity,GO:0008374~O-acyltransferase activity,GO:0008951~palmitoleoyl [acyl-carrier-protein]-dependent acyltransferase activity,GO:0016406~carnitine O-acyltransferase activity,GO:0016407~acetyltransferase activity,GO:0016408~C-acyltransferase activity,GO:0016409~palmitoyltransferase activity,GO:0016410~N-acyltransferase activity,GO:0016411~acylglycerol O-acyltransferase activity,GO:0016412~serine O-acyltransferase activity,GO:0016413~O-acetyltransferase activity,GO:0016414~O-octanoyltransferase activity,GO:0016415~octanoyltransferase activity,GO:0016416~O-palmitoyltransferase activity,GO:0016417~S-acyltransferase activity,GO:0016418~S-acetyltransferase activity,GO:0016419~S-malonyltransferase activity,GO:0016420~malonyltransferase activity,GO:0016454~C-palmitoyltransferase activity,GO:0016740~transferase activity,GO:0016748~succinyltransferase activity,GO:0016749~N-succinyltransferase activity,GO:0016750~O-succinyltransferase activity,GO:0016751~S-succinyltransferase activity,GO:0016752~sinapoyltransferase activity,GO:0016753~O-sinapoyltransferase activity,GO:0018030~peptidyl-lysine N6-myristoyltransferase activity,GO:0018031~peptidyl-lysine N6-palmitoyltransferase activity,GO:0018711~benzoyl acetate-CoA thiolase activity,GO:0018712~3-hydroxybutyryl-CoA thiolase activity,GO:0018713~3-ketopimelyl-CoA thiolase activity,GO:0019105~N-palmitoyltransferase activity,GO:0019107~myristoyltransferase activity,GO:0019186~acyl-CoA N-acyltransferase activity,GO:0019705~protein-cysteine S-myristoyltransferase activity,GO:0019707~protein-cysteine S-acyltransferase activity,GO:0030523~dihydrolipoamide S-acyltransferase activity,GO:0032216~glucosaminyl-phosphotidylinositol O-acyltransferase activity,GO:0034737~ergosterol O-acyltransferase activity,GO:0034738~lanosterol O-acyltransferase activity,GO:0034848~naphthyl-2-oxomethyl-succinyl-CoA succinyl transferase activity,GO:0034851~2,4,4-trimethyl-3-oxopentanoyl-CoA 2-C-propanoyl transferase activity,GO:0034915~2-methylhexanoyl-CoA C-acetyltransferase activity,GO:0034919~butyryl-CoA 2-C-propionyltransferase activity,GO:0034945~2,6-dimethyl-5-methylene-3-oxo-heptanoyl-CoA C-acetyltransferase activity,GO:0043741~L-2-aminoadipate N-acetyltransferase activity,GO:0043806~keto acid formate lyase activity,GO:0043849~Ras palmitoyltransferase activity,GO:0046941~azetidine-2-carboxylic acid acetyltransferase activity,GO:0052858~peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,GO:0090595~acetyl-CoA:L-lysine N6-acetyltransferase,	IPR001388:Synaptobrevin,IPR010908:Longin domain,IPR011012:Longin-like domain,	dre04130:SNARE interactions in vesicular transport,			SM01270:SM01270,	Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,ER-Golgi transport,Golgi apparatus,Lipoprotein,Membrane,Methylation,Palmitate,Prenylation,Protein transport,Proteomics identification,Reference proteome,Transferase,Transport,	chain:Synaptobrevin homolog YKT6,domain:Longin,domain:v-SNARE coiled-coil homology,lipid moiety-binding region:S-farnesyl cysteine,lipid moiety-binding region:S-palmitoyl cysteine,
Q7ZXW9	ZFP36 ring finger protein-like 2 S homeolog(zfp36l2.S)	Xenopus laevis				GO:0000165~MAPK cascade,GO:0000288~nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:0006402~mRNA catabolic process,GO:0030097~hemopoiesis,GO:0031086~nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,GO:0035019~somatic stem cell population maintenance,GO:0043488~regulation of mRNA stability,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045599~negative regulation of fat cell differentiation,GO:0048103~somatic stem cell division,GO:0048793~pronephros development,GO:0060216~definitive hemopoiesis,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0070371~ERK1 and ERK2 cascade,GO:0071356~cellular response to tumor necrosis factor,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0071385~cellular response to glucocorticoid stimulus,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0097011~cellular response to granulocyte macrophage colony-stimulating factor stimulus,GO:1900153~positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:1904628~cellular response to phorbol 13-acetate 12-myristate,GO:2000737~negative regulation of stem cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,IPR007635:Tis11B-like protein, N-terminal,				SM00356:ZnF_C3H1,	Cytoplasm,Developmental protein,DNA-binding,Metal-binding,Nucleus,Repeat,RNA-binding,Zinc,Zinc-finger,
P24349	Zinc finger protein sdc-1(sdc-1)	Caenorhabditis elegans				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0007530~sex determination,GO:0007548~sex differentiation,GO:0030154~cell differentiation,GO:0030163~protein catabolic process,GO:0040025~vulval development,GO:0042464~dosage compensation by hypoactivation of X chromosome,GO:0051571~positive regulation of histone H3-K4 methylation,	GO:0000228~nuclear chromosome,GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,Developmental protein,Differentiation,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Sexual differentiation,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein sdc-1,compositionally biased region:Asp/Glu-rich (acidic),sequence conflict,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,
Q8R2Y0	abhydrolase domain containing 6(Abhd6)	Mus musculus				GO:0009395~phospholipid catabolic process,GO:0030336~negative regulation of cell migration,GO:0046464~acylglycerol catabolic process,GO:0046889~positive regulation of lipid biosynthetic process,GO:0060292~long term synaptic depression,GO:2000124~regulation of endocannabinoid signaling pathway,	GO:0005739~mitochondrion,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0032281~AMPA glutamate receptor complex,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0004620~phospholipase activity,GO:0016787~hydrolase activity,GO:0047372~acylglycerol lipase activity,	IPR000073:Alpha/beta hydrolase fold-1,IPR000639:Epoxide hydrolase-like,	mmu04723:Retrograde endocannabinoid signaling,				Alternative splicing,Complete proteome,Hydrolase,Membrane,Mitochondrion,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	active site:Charge relay system,chain:Monoacylglycerol lipase ABHD6,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q4V8X4	acyl-CoA binding domain containing 6(acbd6)	Danio rerio					GO:0005737~cytoplasm,	GO:0000062~fatty-acyl-CoA binding,GO:0008289~lipid binding,	IPR000582:Acyl-CoA-binding protein, ACBP,IPR002110:Ankyrin repeat,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	ANK repeat,Complete proteome,Cytoplasm,Lipid-binding,Reference proteome,Repeat,	chain:Acyl-CoA-binding domain-containing protein 6,domain:ACB,repeat:ANK 1,repeat:ANK 2,
P15650	acyl-CoA dehydrogenase, long chain(Acadl)	Rattus norvegicus			Lipid metabolism,	GO:0001659~temperature homeostasis,GO:0009062~fatty acid catabolic process,GO:0009409~response to cold,GO:0019254~carnitine metabolic process, CoA-linked,GO:0033539~fatty acid beta-oxidation using acyl-CoA dehydrogenase,GO:0042413~carnitine catabolic process,GO:0042758~long-chain fatty acid catabolic process,GO:0044242~cellular lipid catabolic process,GO:0045717~negative regulation of fatty acid biosynthetic process,GO:0046322~negative regulation of fatty acid oxidation,GO:0051289~protein homotetramerization,GO:0055088~lipid homeostasis,GO:0055114~oxidation-reduction process,GO:0090181~regulation of cholesterol metabolic process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0031966~mitochondrial membrane,	GO:0000062~fatty-acyl-CoA binding,GO:0004466~long-chain-acyl-CoA dehydrogenase activity,GO:0009055~electron carrier activity,GO:0016401~palmitoyl-CoA oxidase activity,GO:0050660~flavin adenine dinucleotide binding,GO:0052890~oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,	IPR006089:Acyl-CoA dehydrogenase, conserved site,IPR006091:Acyl-CoA oxidase/dehydrogenase, central domain,IPR009075:Acyl-CoA dehydrogenase/oxidase C-terminal,IPR009100:Acyl-CoA dehydrogenase/oxidase,IPR013786:Acyl-CoA dehydrogenase/oxidase, N-terminal,	rno00071:Fatty acid degradation,rno01100:Metabolic pathways,rno01212:Fatty acid metabolism,rno03320:PPAR signaling pathway,				Acetylation,Complete proteome,Direct protein sequencing,FAD,Fatty acid metabolism,Flavoprotein,Lipid metabolism,Mitochondrion,Oxidoreductase,Phosphoprotein,Reference proteome,Transit peptide,	chain:Long-chain specific acyl-CoA dehydrogenase, mitochondrial,transit peptide:Mitochondrion,
Q15067	acyl-CoA oxidase 1(ACOX1)	Homo sapiens		h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),		GO:0000038~very long-chain fatty acid metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006629~lipid metabolic process,GO:0006635~fatty acid beta-oxidation,GO:0006693~prostaglandin metabolic process,GO:0007283~spermatogenesis,GO:0016559~peroxisome fission,GO:0019395~fatty acid oxidation,GO:0033539~fatty acid beta-oxidation using acyl-CoA dehydrogenase,GO:0033540~fatty acid beta-oxidation using acyl-CoA oxidase,GO:0036109~alpha-linolenic acid metabolic process,GO:0055088~lipid homeostasis,GO:2000189~positive regulation of cholesterol homeostasis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005782~peroxisomal matrix,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0000062~fatty-acyl-CoA binding,GO:0003995~acyl-CoA dehydrogenase activity,GO:0003997~acyl-CoA oxidase activity,GO:0005102~receptor binding,GO:0009055~electron carrier activity,GO:0016401~palmitoyl-CoA oxidase activity,GO:0016627~oxidoreductase activity, acting on the CH-CH group of donors,GO:0030165~PDZ domain binding,GO:0047485~protein N-terminus binding,GO:0050660~flavin adenine dinucleotide binding,GO:0052890~oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,GO:0071949~FAD binding,	IPR002655:Acyl-CoA oxidase, C-terminal,IPR006091:Acyl-CoA oxidase/dehydrogenase, central domain,IPR009075:Acyl-CoA dehydrogenase/oxidase C-terminal,IPR009100:Acyl-CoA dehydrogenase/oxidase,IPR012258:Acyl-CoA oxidase,IPR013786:Acyl-CoA dehydrogenase/oxidase, N-terminal,	hsa00071:Fatty acid degradation,hsa00592:alpha-Linolenic acid metabolism,hsa01040:Biosynthesis of unsaturated fatty acids,hsa01100:Metabolic pathways,hsa01212:Fatty acid metabolism,hsa03320:PPAR signaling pathway,hsa04024:cAMP signaling pathway,hsa04146:Peroxisome,	264470~Peroxisomal acyl-CoA oxidase deficiency,	PIRSF000168:acyl-CoA oxidase,		Acetylation,Alternative splicing,Complete proteome,Disease mutation,FAD,Fatty acid metabolism,Flavoprotein,Lipid metabolism,Oxidoreductase,Peroxisome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	active site:Proton acceptor,binding site:FAD,binding site:FAD; via amide nitrogen,chain:Peroxisomal acyl-coenzyme A oxidase 1,modified residue,sequence conflict,sequence variant,short sequence motif:Microbody targeting signal,splice variant,
Q7ZYC4	acyl-CoA synthetase bubblegum family member 2 L homeolog(acsbg2.L)	Xenopus laevis			Lipid metabolism,		GO:0005737~cytoplasm,	GO:0004467~long-chain fatty acid-CoA ligase activity,GO:0005524~ATP binding,GO:0102391~decanoate--CoA ligase activity,	IPR000873:AMP-dependent synthetase/ligase,IPR020845:AMP-binding, conserved site,	xla00061:Fatty acid biosynthesis,xla00071:Fatty acid degradation,xla01100:Metabolic pathways,xla01212:Fatty acid metabolism,xla03320:PPAR signaling pathway,xla04920:Adipocytokine signaling pathway,				ATP-binding,Cytoplasm,Fatty acid metabolism,Ligase,Lipid metabolism,Nucleotide-binding,	binding site:ATP,chain:Long-chain-fatty-acid--CoA ligase ACSBG2,nucleotide phosphate-binding region:ATP,sequence conflict,
Q9DBS4	acyl-Coenzyme A oxidase-like(Acoxl)	Mus musculus				GO:0006631~fatty acid metabolic process,GO:0006635~fatty acid beta-oxidation,GO:0008152~metabolic process,GO:0033539~fatty acid beta-oxidation using acyl-CoA dehydrogenase,GO:0055088~lipid homeostasis,GO:0055114~oxidation-reduction process,	GO:0005777~peroxisome,	GO:0000062~fatty-acyl-CoA binding,GO:0003995~acyl-CoA dehydrogenase activity,GO:0003997~acyl-CoA oxidase activity,GO:0009055~electron carrier activity,GO:0016491~oxidoreductase activity,GO:0016627~oxidoreductase activity, acting on the CH-CH group of donors,GO:0050660~flavin adenine dinucleotide binding,GO:0052890~oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,	IPR002655:Acyl-CoA oxidase, C-terminal,IPR006091:Acyl-CoA oxidase/dehydrogenase, central domain,IPR009075:Acyl-CoA dehydrogenase/oxidase C-terminal,IPR009100:Acyl-CoA dehydrogenase/oxidase,IPR012258:Acyl-CoA oxidase,			PIRSF000168:acyl-CoA oxidase,		Alternative splicing,Complete proteome,FAD,Flavoprotein,Oxidoreductase,Reference proteome,	chain:Acyl-coenzyme A oxidase-like protein,nucleotide phosphate-binding region:FAD,splice variant,
P22892	adaptor protein complex AP-1, gamma 1 subunit(Ap1g1)	Mus musculus				GO:0000226~microtubule cytoskeleton organization,GO:0006810~transport,GO:0006886~intracellular protein transport,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0035646~endosome to melanosome transport,GO:0043323~positive regulation of natural killer cell degranulation,GO:0045954~positive regulation of natural killer cell mediated cytotoxicity,GO:0090160~Golgi to lysosome transport,	GO:0005622~intracellular,GO:0005623~cell,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0015630~microtubule cytoskeleton,GO:0016020~membrane,GO:0030117~membrane coat,GO:0030131~clathrin adaptor complex,GO:0030136~clathrin-coated vesicle,GO:0030665~clathrin-coated vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,GO:0055037~recycling endosome,	GO:0005515~protein binding,GO:0005518~collagen binding,GO:0008022~protein C-terminus binding,GO:0008565~protein transporter activity,GO:0017137~Rab GTPase binding,GO:0019894~kinesin binding,GO:0030742~GTP-dependent protein binding,	IPR002553:Clathrin/coatomer adaptor, adaptin-like, N-terminal,IPR008152:Clathrin adaptor, alpha/beta/gamma-adaptin, appendage, Ig-like subdomain,IPR008153:Clathrin adaptor, gamma-adaptin, appendage,IPR011989:Armadillo-like helical,IPR013041:Coatomer/clathrin adaptor appendage, Ig-like subdomain,IPR016024:Armadillo-type fold,IPR017107:Adaptor protein complex AP-1, gamma subunit,	mmu04142:Lysosome,		PIRSF037094:adaptor protein complex AP-1, gamma subunit,	SM00809:Alpha_adaptinC2,	3D-structure,Complete proteome,Cytoplasmic vesicle,Direct protein sequencing,Golgi apparatus,Membrane,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:AP-1 complex subunit gamma-1,domain:GAE,helix,modified residue,mutagenesis site,strand,turn,
P84092	adaptor-related protein complex 2, mu 1 subunit(Ap2m1)	Rattus norvegicus				GO:0006886~intracellular protein transport,GO:0006897~endocytosis,GO:0016192~vesicle-mediated transport,GO:1903077~negative regulation of protein localization to plasma membrane,	GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0030125~clathrin vesicle coat,GO:0030131~clathrin adaptor complex,GO:0030133~transport vesicle,GO:0043195~terminal bouton,GO:0070062~extracellular exosome,	GO:0005048~signal sequence binding,GO:0005515~protein binding,GO:0008289~lipid binding,GO:0044325~ion channel binding,GO:0050750~low-density lipoprotein particle receptor binding,	IPR001392:Clathrin adaptor, mu subunit,IPR011012:Longin-like domain,IPR018240:Clathrin adaptor, mu subunit, conserved site,IPR022775:AP complex, mu/sigma subunit,	rno04144:Endocytosis,rno04721:Synaptic vesicle cycle,rno04961:Endocrine and other factor-regulated calcium reabsorption,rno05016:Huntington's disease,		PIRSF005992:adaptor protein complex, mu subunit,		3D-structure,Cell membrane,Coated pit,Complete proteome,Endocytosis,Lipid-binding,Membrane,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Transport,	binding site:Phosphatidylinositol lipid headgroup,chain:AP-2 complex subunit mu,domain:MHD,helix,modified residue,mutagenesis site,strand,turn,
Q8DZA4	adenine phosphoribosyltransferase(apt)	Streptococcus agalactiae 2603V/R				GO:0006168~adenine salvage,GO:0044209~AMP salvage,	GO:0005737~cytoplasm,	GO:0003999~adenine phosphoribosyltransferase activity,	IPR000836:Phosphoribosyltransferase domain,IPR005764:Adenine phosphoribosyl transferase,	sag00230:Purine metabolism,sag01100:Metabolic pathways,				Complete proteome,Cytoplasm,Glycosyltransferase,Purine salvage,Reference proteome,Transferase,	chain:Adenine phosphoribosyltransferase,
P21265	adenylosuccinate lyase(ADSL)	Gallus gallus				GO:0006163~purine nucleotide metabolic process,GO:0006189~'de novo' IMP biosynthetic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0044208~'de novo' AMP biosynthetic process,GO:0051262~protein tetramerization,	GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0004018~N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,GO:0070626~(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,	IPR000362:Fumarate lyase,IPR004769:Adenylosuccinate lyase,IPR008948:L-Aspartase-like,IPR019468:Adenylosuccinate lyase C-terminal,IPR020557:Fumarate lyase, conserved site,IPR022761:Fumarate lyase, N-terminal,IPR024083:Fumarase/histidase, N-terminal,	gga00230:Purine metabolism,gga00250:Alanine, aspartate and glutamate metabolism,gga01100:Metabolic pathways,gga01130:Biosynthesis of antibiotics,			SM00998:SM00998,	Complete proteome,Lyase,Purine biosynthesis,Reference proteome,	active site:Proton acceptor,active site:Proton donor,chain:Adenylosuccinate lyase,sequence conflict,
P48960	adhesion G protein-coupled receptor E5(ADGRE5)	Homo sapiens				GO:0006928~movement of cell or subcellular component,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000203:GPS domain,IPR000742:Epidermal growth factor-like domain,IPR000832:GPCR, family 2, secretin-like,IPR001881:EGF-like calcium-binding,IPR003056:GPCR, family 2, CD97 antigen,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR017981:GPCR, family 2-like,IPR017983:GPCR, family 2, secretin-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,				SM00179:EGF_CA,SM00181:EGF,SM00303:GPS,	Alternative splicing,Calcium,Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,EGF-like domain,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:CD97 antigen,chain:CD97 antigen subunit alpha,chain:CD97 antigen subunit beta,disulfide bond,domain:EGF-like 1,domain:EGF-like 2; calcium-binding,domain:EGF-like 3; calcium-binding,domain:EGF-like 4; calcium-binding,domain:EGF-like 5; calcium-binding,domain:GPS,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,site:Cleavage,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q7Z4H4	adrenomedullin 2(ADM2)	Homo sapiens				GO:0001525~angiogenesis,GO:0006468~protein phosphorylation,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007586~digestion,GO:0007631~feeding behavior,GO:0010628~positive regulation of gene expression,GO:0045766~positive regulation of angiogenesis,GO:0045776~negative regulation of blood pressure,	GO:0005576~extracellular region,	GO:0005179~hormone activity,GO:0032403~protein complex binding,	IPR021116:Procalcitonin/adrenomedullin,					Amidation,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Hormone,Reference proteome,Secreted,Signal,	disulfide bond,modified residue,peptide:Adrenomedullin-2,peptide:Intermedin-short,signal peptide,
Q90XD2	agmatine ureohydrolase (agmatinase)(AGMAT)	Gallus gallus				GO:0008295~spermidine biosynthetic process,GO:0033388~putrescine biosynthetic process from arginine,	GO:0005739~mitochondrion,GO:0070062~extracellular exosome,	GO:0008783~agmatinase activity,GO:0046872~metal ion binding,	IPR005925:Agmatinase-related,IPR006035:Ureohydrolase,IPR020855:Ureohydrolase, manganese-binding site,IPR023696:Ureohydrolase domain,	gga00330:Arginine and proline metabolism,gga01100:Metabolic pathways,		PIRSF036979:ureohydrolase/formiminoglutamase/proclavaminate amidino hydrolase,		Complete proteome,Hydrolase,Manganese,Metal-binding,Mitochondrion,Putrescine biosynthesis,Reference proteome,Spermidine biosynthesis,Transit peptide,	chain:Agmatinase, mitochondrial,metal ion-binding site:Manganese 1,metal ion-binding site:Manganese 2,transit peptide:Mitochondrion,
P12762	aldehyde dehydrogenase 2 family (mitochondrial)(ALDH2)	Equus caballus				GO:0006068~ethanol catabolic process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0004029~aldehyde dehydrogenase (NAD) activity,GO:0016620~oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,	IPR015590:Aldehyde dehydrogenase domain,IPR016160:Aldehyde dehydrogenase, conserved site,IPR016161:Aldehyde/histidinol dehydrogenase,IPR016162:Aldehyde dehydrogenase, N-terminal,IPR016163:Aldehyde dehydrogenase, C-terminal,	ecb00010:Glycolysis / Gluconeogenesis,ecb00040:Pentose and glucuronate interconversions,ecb00053:Ascorbate and aldarate metabolism,ecb00071:Fatty acid degradation,ecb00280:Valine, leucine and isoleucine degradation,ecb00310:Lysine degradation,ecb00330:Arginine and proline metabolism,ecb00340:Histidine metabolism,ecb00380:Tryptophan metabolism,ecb00410:beta-Alanine metabolism,ecb00561:Glycerolipid metabolism,ecb00620:Pyruvate metabolism,ecb01100:Metabolic pathways,ecb01130:Biosynthesis of antibiotics,				Acetylation,Complete proteome,Direct protein sequencing,Mitochondrion,NAD,Oxidoreductase,Reference proteome,
P11884	aldehyde dehydrogenase 2 family (mitochondrial)(Aldh2)	Rattus norvegicus				GO:0001889~liver development,GO:0006068~ethanol catabolic process,GO:0032355~response to estradiol,GO:0032496~response to lipopolysaccharide,GO:0032570~response to progesterone,GO:0032870~cellular response to hormone stimulus,GO:0033574~response to testosterone,GO:0035094~response to nicotine,GO:0043066~negative regulation of apoptotic process,GO:0055093~response to hyperoxia,GO:0055114~oxidation-reduction process,GO:0071398~cellular response to fatty acid,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0070062~extracellular exosome,	GO:0004029~aldehyde dehydrogenase (NAD) activity,GO:0005515~protein binding,GO:0016620~oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,GO:0042802~identical protein binding,GO:0070404~NADH binding,	IPR015590:Aldehyde dehydrogenase domain,IPR016160:Aldehyde dehydrogenase, conserved site,IPR016161:Aldehyde/histidinol dehydrogenase,IPR016162:Aldehyde dehydrogenase, N-terminal,IPR016163:Aldehyde dehydrogenase, C-terminal,	rno00010:Glycolysis / Gluconeogenesis,rno00040:Pentose and glucuronate interconversions,rno00053:Ascorbate and aldarate metabolism,rno00071:Fatty acid degradation,rno00280:Valine, leucine and isoleucine degradation,rno00310:Lysine degradation,rno00330:Arginine and proline metabolism,rno00340:Histidine metabolism,rno00380:Tryptophan metabolism,rno00410:beta-Alanine metabolism,rno00561:Glycerolipid metabolism,rno00620:Pyruvate metabolism,rno01100:Metabolic pathways,rno01130:Biosynthesis of antibiotics,				3D-structure,Acetylation,Complete proteome,Direct protein sequencing,Mitochondrion,NAD,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	active site:Nucleophile,active site:Proton acceptor,chain:Aldehyde dehydrogenase, mitochondrial,helix,modified residue,nucleotide phosphate-binding region:NAD,sequence variant,site:Transition state stabilizer,transit peptide:Mitochondrion,
Q7SY23	aldehyde dehydrogenase 4 family, member A1(aldh4a1)	Danio rerio				GO:0006537~glutamate biosynthetic process,GO:0006560~proline metabolic process,GO:0006561~proline biosynthetic process,GO:0008152~metabolic process,GO:0010133~proline catabolic process to glutamate,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0003842~1-pyrroline-5-carboxylate dehydrogenase activity,GO:0004029~aldehyde dehydrogenase (NAD) activity,GO:0016491~oxidoreductase activity,GO:0016620~oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,	IPR005931:1-pyrroline-5-carboxylate dehydrogenase,IPR015590:Aldehyde dehydrogenase domain,IPR016160:Aldehyde dehydrogenase, conserved site,IPR016161:Aldehyde/histidinol dehydrogenase,IPR016162:Aldehyde dehydrogenase, N-terminal,IPR016163:Aldehyde dehydrogenase, C-terminal,	dre00250:Alanine, aspartate and glutamate metabolism,dre00330:Arginine and proline metabolism,dre01100:Metabolic pathways,				Complete proteome,Mitochondrion,NAD,Oxidoreductase,Proline metabolism,Proteomics identification,Reference proteome,Transit peptide,	chain:Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial,nucleotide phosphate-binding region:NAD,transit peptide:Mitochondrion,
Q2KJC9	aldehyde dehydrogenase 7 family member A1(ALDH7A1)	Bos taurus				GO:0019285~glycine betaine biosynthetic process from choline,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004029~aldehyde dehydrogenase (NAD) activity,GO:0004043~L-aminoadipate-semialdehyde dehydrogenase activity,GO:0008802~betaine-aldehyde dehydrogenase activity,	IPR015590:Aldehyde dehydrogenase domain,IPR016161:Aldehyde/histidinol dehydrogenase,IPR016162:Aldehyde dehydrogenase, N-terminal,IPR016163:Aldehyde dehydrogenase, C-terminal,	bta00010:Glycolysis / Gluconeogenesis,bta00053:Ascorbate and aldarate metabolism,bta00071:Fatty acid degradation,bta00260:Glycine, serine and threonine metabolism,bta00280:Valine, leucine and isoleucine degradation,bta00300:Lysine biosynthesis,bta00310:Lysine degradation,bta00330:Arginine and proline metabolism,bta00340:Histidine metabolism,bta00380:Tryptophan metabolism,bta00410:beta-Alanine metabolism,bta00561:Glycerolipid metabolism,bta00620:Pyruvate metabolism,bta01100:Metabolic pathways,bta01130:Biosynthesis of antibiotics,bta01230:Biosynthesis of amino acids,				Acetylation,Complete proteome,Cytoplasm,Mitochondrion,NAD,Nucleus,Oxidoreductase,Proteomics identification,Reference proteome,Transit peptide,	active site:Nucleophile,active site:Proton acceptor,chain:Alpha-aminoadipic semialdehyde dehydrogenase,nucleotide phosphate-binding region:NAD,site:Transition state stabilizer,
Q66I21	aldehyde dehydrogenase 8 family, member A1(aldh8a1)	Danio rerio				GO:0001889~liver development,GO:0008152~metabolic process,GO:0055114~oxidation-reduction process,	GO:0005737~cytoplasm,	GO:0001758~retinal dehydrogenase activity,GO:0004028~3-chloroallyl aldehyde dehydrogenase activity,GO:0004029~aldehyde dehydrogenase (NAD) activity,GO:0016491~oxidoreductase activity,GO:0016620~oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,GO:0018472~1-hydroxy-2-naphthaldehyde dehydrogenase activity,GO:0018473~cis-2-methyl-5-isopropylhexa-2,5-dienal dehydrogenase activity,GO:0018474~2-carboxybenzaldehyde dehydrogenase activity,GO:0018475~trans-2-methyl-5-isopropylhexa-2,5-dienal dehydrogenase activity,GO:0019115~benzaldehyde dehydrogenase activity,GO:0034520~2-naphthaldehyde dehydrogenase activity,GO:0034525~1-naphthaldehyde dehydrogenase activity,GO:0034530~4-hydroxymethylsalicyaldehyde dehydrogenase activity,GO:0034538~3-methylsalicylaldehyde dehydrogenase activity,GO:0034601~oxoglutarate dehydrogenase [NAD(P)+] activity,GO:0034602~oxoglutarate dehydrogenase (NAD+) activity,GO:0034603~pyruvate dehydrogenase [NAD(P)+] activity,GO:0034604~pyruvate dehydrogenase (NAD+) activity,GO:0034822~citronellal dehydrogenase activity,GO:0034832~geranial dehydrogenase activity,GO:0043745~N2-acetyl-L-aminoadipate semialdehyde dehydrogenase activity,GO:0043796~glyceraldehyde dehydrogenase (NADP) activity,GO:0043870~N-acetyl-gamma-aminoadipyl-phosphate reductase activity,GO:0043878~glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity,GO:0044104~2,5-dioxovalerate dehydrogenase (NAD+) activity,GO:0052814~medium-chain-aldehyde dehydrogenase activity,	IPR015590:Aldehyde dehydrogenase domain,IPR016160:Aldehyde dehydrogenase, conserved site,IPR016161:Aldehyde/histidinol dehydrogenase,IPR016162:Aldehyde dehydrogenase, N-terminal,IPR016163:Aldehyde dehydrogenase, C-terminal,					Complete proteome,Cytoplasm,NAD,Oxidoreductase,Reference proteome,	active site:Nucleophile,active site:Proton acceptor,chain:Aldehyde dehydrogenase family 8 member A1,nucleotide phosphate-binding region:NAD,site:Transition state stabilizer,
Q7ZVB2	aldehyde dehydrogenase 9 family, member A1a, tandem duplicate 1(aldh9a1a.1)	Danio rerio				GO:0008152~metabolic process,GO:0055114~oxidation-reduction process,	GO:0005737~cytoplasm,	GO:0004029~aldehyde dehydrogenase (NAD) activity,GO:0016491~oxidoreductase activity,GO:0016620~oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,GO:0019145~aminobutyraldehyde dehydrogenase activity,GO:0047105~4-trimethylammoniobutyraldehyde dehydrogenase activity,	IPR015590:Aldehyde dehydrogenase domain,IPR016160:Aldehyde dehydrogenase, conserved site,IPR016161:Aldehyde/histidinol dehydrogenase,IPR016162:Aldehyde dehydrogenase, N-terminal,IPR016163:Aldehyde dehydrogenase, C-terminal,	dre00010:Glycolysis / Gluconeogenesis,dre00053:Ascorbate and aldarate metabolism,dre00071:Fatty acid degradation,dre00280:Valine, leucine and isoleucine degradation,dre00310:Lysine degradation,dre00330:Arginine and proline metabolism,dre00340:Histidine metabolism,dre00380:Tryptophan metabolism,dre00410:beta-Alanine metabolism,dre00561:Glycerolipid metabolism,dre00620:Pyruvate metabolism,dre01100:Metabolic pathways,dre01130:Biosynthesis of antibiotics,				Complete proteome,Cytoplasm,NAD,Oxidoreductase,Proteomics identification,Reference proteome,	chain:Aldehyde dehydrogenase family 9 member A1-A,nucleotide phosphate-binding region:NAD,sequence conflict,
Q802W2	aldehyde dehydrogenase 9 family, member A1b(aldh9a1b)	Danio rerio				GO:0008152~metabolic process,GO:0055114~oxidation-reduction process,	GO:0005737~cytoplasm,	GO:0004029~aldehyde dehydrogenase (NAD) activity,GO:0016491~oxidoreductase activity,GO:0016620~oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,GO:0019145~aminobutyraldehyde dehydrogenase activity,GO:0047105~4-trimethylammoniobutyraldehyde dehydrogenase activity,	IPR015590:Aldehyde dehydrogenase domain,IPR016160:Aldehyde dehydrogenase, conserved site,IPR016161:Aldehyde/histidinol dehydrogenase,IPR016162:Aldehyde dehydrogenase, N-terminal,IPR016163:Aldehyde dehydrogenase, C-terminal,	dre00010:Glycolysis / Gluconeogenesis,dre00053:Ascorbate and aldarate metabolism,dre00071:Fatty acid degradation,dre00280:Valine, leucine and isoleucine degradation,dre00310:Lysine degradation,dre00330:Arginine and proline metabolism,dre00340:Histidine metabolism,dre00380:Tryptophan metabolism,dre00410:beta-Alanine metabolism,dre00561:Glycerolipid metabolism,dre00620:Pyruvate metabolism,dre01100:Metabolic pathways,dre01130:Biosynthesis of antibiotics,				Complete proteome,Cytoplasm,NAD,Oxidoreductase,Proteomics identification,Reference proteome,	chain:Aldehyde dehydrogenase family 9 member A1-B,nucleotide phosphate-binding region:NAD,sequence conflict,
Q9EQ20	aldehyde dehydrogenase family 6, subfamily A1(Aldh6a1)	Mus musculus				GO:0006210~thymine catabolic process,GO:0006573~valine metabolic process,GO:0006574~valine catabolic process,GO:0008152~metabolic process,GO:0019484~beta-alanine catabolic process,GO:0019859~thymine metabolic process,GO:0050873~brown fat cell differentiation,GO:0055114~oxidation-reduction process,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0070062~extracellular exosome,	GO:0004029~aldehyde dehydrogenase (NAD) activity,GO:0004491~methylmalonate-semialdehyde dehydrogenase (acylating) activity,GO:0016491~oxidoreductase activity,GO:0016620~oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,GO:0016790~thiolester hydrolase activity,GO:0018478~malonate-semialdehyde dehydrogenase (acetylating) activity,GO:0044822~poly(A) RNA binding,	IPR010061:Methylmalonate-semialdehyde dehydrogenase,IPR015590:Aldehyde dehydrogenase domain,IPR016160:Aldehyde dehydrogenase, conserved site,IPR016161:Aldehyde/histidinol dehydrogenase,IPR016162:Aldehyde dehydrogenase, N-terminal,IPR016163:Aldehyde dehydrogenase, C-terminal,	mmu00280:Valine, leucine and isoleucine degradation,mmu00410:beta-Alanine metabolism,mmu00562:Inositol phosphate metabolism,mmu00640:Propanoate metabolism,mmu01100:Metabolic pathways,mmu01200:Carbon metabolism,				Acetylation,Complete proteome,Mitochondrion,NAD,Oxidoreductase,Phosphoprotein,Reference proteome,Transit peptide,	active site:Nucleophile,binding site:NAD,chain:Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial,modified residue,nucleotide phosphate-binding region:NAD,sequence conflict,transit peptide:Mitochondrion,
Q8BWF0	aldhehyde dehydrogenase family 5, subfamily A1(Aldh5a1)	Mus musculus				GO:0006006~glucose metabolic process,GO:0006083~acetate metabolic process,GO:0006105~succinate metabolic process,GO:0006536~glutamate metabolic process,GO:0006541~glutamine metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0006678~glucosylceramide metabolic process,GO:0006681~galactosylceramide metabolic process,GO:0006749~glutathione metabolic process,GO:0007417~central nervous system development,GO:0008152~metabolic process,GO:0009448~gamma-aminobutyric acid metabolic process,GO:0009450~gamma-aminobutyric acid catabolic process,GO:0009791~post-embryonic development,GO:0022904~respiratory electron transport chain,GO:0042135~neurotransmitter catabolic process,GO:0046459~short-chain fatty acid metabolic process,GO:0051289~protein homotetramerization,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,	GO:0004029~aldehyde dehydrogenase (NAD) activity,GO:0004777~succinate-semialdehyde dehydrogenase (NAD+) activity,GO:0009013~succinate-semialdehyde dehydrogenase [NAD(P)+] activity,GO:0016491~oxidoreductase activity,GO:0016620~oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,GO:0031406~carboxylic acid binding,GO:0051287~NAD binding,	IPR010102:Succinate semialdehyde dehydrogenase,IPR015590:Aldehyde dehydrogenase domain,IPR016160:Aldehyde dehydrogenase, conserved site,IPR016161:Aldehyde/histidinol dehydrogenase,IPR016162:Aldehyde dehydrogenase, N-terminal,IPR016163:Aldehyde dehydrogenase, C-terminal,	mmu00250:Alanine, aspartate and glutamate metabolism,mmu00650:Butanoate metabolism,mmu01100:Metabolic pathways,				Acetylation,Complete proteome,Direct protein sequencing,Disulfide bond,Mitochondrion,NAD,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Transit peptide,	active site:Nucleophile,active site:Proton acceptor,binding site:NAD,binding site:Substrate,chain:Succinate-semialdehyde dehydrogenase, mitochondrial,disulfide bond,modified residue,nucleotide phosphate-binding region:NAD,site:Transition state stabilizer,transit peptide:Mitochondrion,
Q8CG45	aldo-keto reductase family 7, member A2(Akr7a2)	Rattus norvegicus				GO:0044597~daunorubicin metabolic process,GO:0044598~doxorubicin metabolic process,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0070062~extracellular exosome,	GO:0004032~alditol:NADP+ 1-oxidoreductase activity,GO:0004033~aldo-keto reductase (NADP) activity,GO:0019119~phenanthrene-9,10-epoxide hydrolase activity,	IPR001395:Aldo/keto reductase,IPR023210:NADP-dependent oxidoreductase domain,	rno00980:Metabolism of xenobiotics by cytochrome P450,				Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Golgi apparatus,NADP,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,	active site:Proton donor,binding site:NADP,binding site:Substrate,chain:Aflatoxin B1 aldehyde reductase member 2,modified residue,nucleotide phosphate-binding region:NADP,sequence conflict,site:Lowers pKa of active site Tyr,
Q6DGA6	allantoicase(allc)	Danio rerio				GO:0000256~allantoin catabolic process,GO:0006144~purine nucleobase metabolic process,		GO:0004037~allantoicase activity,GO:0016787~hydrolase activity,	IPR005164:Allantoicase,IPR008979:Galactose-binding domain-like,IPR015908:Allantoicase domain,	dre00230:Purine metabolism,dre01100:Metabolic pathways,		PIRSF016516:allantoicase,		Alternative splicing,Complete proteome,Hydrolase,Purine metabolism,Reference proteome,	chain:Allantoicase,splice variant,
P49638	alpha tocopherol transfer protein(TTPA)	Homo sapiens				GO:0001892~embryonic placenta development,GO:0006629~lipid metabolic process,GO:0006810~transport,GO:0007584~response to nutrient,GO:0009268~response to pH,GO:0009636~response to toxic substance,GO:0042360~vitamin E metabolic process,GO:0046909~intermembrane transport,GO:0051180~vitamin transport,GO:0051452~intracellular pH reduction,GO:0060548~negative regulation of cell death,GO:0090212~negative regulation of establishment of blood-brain barrier,	GO:0005770~late endosome,GO:0005829~cytosol,	GO:0005215~transporter activity,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0008431~vitamin E binding,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,	IPR001071:Cellular retinaldehyde binding/alpha-tocopherol transport,IPR001251:CRAL-TRIO domain,IPR011074:CRAL/TRIO, N-terminal domain,		277460~Ataxia with isolated vitamin E deficiency,		SM00516:SEC14,SM01100:SM01100,	3D-structure,Complete proteome,Cytoplasm,Disease mutation,Lipid-binding,Reference proteome,Transport,	chain:Alpha-tocopherol transfer protein,domain:CRAL-TRIO,helix,sequence conflict,sequence variant,strand,turn,
Q924C5	alpha-kinase 3(Alpk3)	Mus musculus				GO:0006468~protein phosphorylation,GO:0007275~multicellular organism development,GO:0007507~heart development,GO:0016310~phosphorylation,GO:0055013~cardiac muscle cell development,	GO:0005634~nucleus,	GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR004166:MHCK/EF2 kinase,IPR007110:Immunoglobulin-like domain,IPR011009:Protein kinase-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,SM00811:Alpha_kinase,	Complete proteome,Developmental protein,Direct protein sequencing,Disulfide bond,Immunoglobulin domain,Kinase,Nucleus,Phosphoprotein,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,	chain:Alpha-protein kinase 3,disulfide bond,domain:Alpha-type protein kinase,domain:Ig-like 1,domain:Ig-like 2,sequence conflict,
A8E657	aminoadipate-semialdehyde synthase(AASS)	Bos taurus				GO:0019477~L-lysine catabolic process,GO:0033512~L-lysine catabolic process to acetyl-CoA via saccharopine,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,	GO:0047130~saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,GO:0047131~saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,	IPR005097:Saccharopine dehydrogenase / Homospermidine synthase,IPR007698:Alanine dehydrogenase/PNT, NAD(H)-binding domain,IPR007886:Alanine dehydrogenase/pyridine nucleotide transhydrogenase, N-terminal,IPR016040:NAD(P)-binding domain,	bta00310:Lysine degradation,bta01100:Metabolic pathways,bta01130:Biosynthesis of antibiotics,			SM01002:SM01002,SM01003:SM01003,	Acetylation,Complete proteome,Mitochondrion,Multifunctional enzyme,NAD,NADP,Oxidoreductase,Reference proteome,Transit peptide,	chain:Alpha-aminoadipic semialdehyde synthase, mitochondrial,modified residue,region of interest:Lysine-ketoglutarate reductase,region of interest:Saccharopine dehydrogenase,transit peptide:Mitochondrion,
Q86XS5	angiopoietin like 5(ANGPTL5)	Homo sapiens					GO:0005576~extracellular region,		IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain,IPR014715:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 2,IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1,IPR020837:Fibrinogen, conserved site,				SM00186:FBG,	Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Polymorphism,Reference proteome,Secreted,Signal,	chain:Angiopoietin-related protein 5,disulfide bond,domain:Fibrinogen C-terminal,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
Q6UXH0	angiopoietin like 8(ANGPTL8)	Homo sapiens				GO:0010954~positive regulation of protein processing,GO:0019216~regulation of lipid metabolic process,GO:0044255~cellular lipid metabolic process,GO:0044342~type B pancreatic cell proliferation,GO:0045444~fat cell differentiation,GO:0048469~cell maturation,GO:0050746~regulation of lipoprotein metabolic process,GO:0070328~triglyceride homeostasis,	GO:0005576~extracellular region,	GO:0005179~hormone activity,	IPR026614:Hepatocellular carcinoma-associated protein TD26,					Complete proteome,Diabetes mellitus,Hormone,Lipid metabolism,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Hepatocellular carcinoma-associated protein TD26,sequence variant,signal peptide,
Q9R182	angiopoietin-like 3(Angptl3)	Mus musculus				GO:0001525~angiogenesis,GO:0006071~glycerol metabolic process,GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006641~triglyceride metabolic process,GO:0006644~phospholipid metabolic process,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007165~signal transduction,GO:0008203~cholesterol metabolic process,GO:0009395~phospholipid catabolic process,GO:0009725~response to hormone,GO:0010519~negative regulation of phospholipase activity,GO:0019915~lipid storage,GO:0030335~positive regulation of cell migration,GO:0042632~cholesterol homeostasis,GO:0045766~positive regulation of angiogenesis,GO:0045834~positive regulation of lipid metabolic process,GO:0048844~artery morphogenesis,GO:0050996~positive regulation of lipid catabolic process,GO:0051005~negative regulation of lipoprotein lipase activity,GO:0055088~lipid homeostasis,GO:0055090~acylglycerol homeostasis,GO:0055091~phospholipid homeostasis,GO:0070328~triglyceride homeostasis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0009986~cell surface,GO:0030027~lamellipodium,GO:0042995~cell projection,	GO:0004857~enzyme inhibitor activity,GO:0004859~phospholipase inhibitor activity,GO:0005178~integrin binding,GO:0008083~growth factor activity,GO:0008201~heparin binding,	IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain,IPR014715:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 2,IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1,				SM00186:FBG,	Angiogenesis,Cell adhesion,Cell projection,Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Heparin-binding,Lipid metabolism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Angiopoietin-related protein 3,disulfide bond,domain:Fibrinogen C-terminal,glycosylation site:N-linked (GlcNAc...),signal peptide,
P01015	angiotensinogen(Agt)	Rattus norvegicus				GO:0001543~ovarian follicle rupture,GO:0001568~blood vessel development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001822~kidney development,GO:0001991~regulation of systemic arterial blood pressure by circulatory renin-angiotensin,GO:0001998~angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure,GO:0001999~renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,GO:0002018~renin-angiotensin regulation of aldosterone production,GO:0002019~regulation of renal output by angiotensin,GO:0002027~regulation of heart rate,GO:0002035~brain renin-angiotensin system,GO:0003014~renal system process,GO:0003051~angiotensin-mediated drinking behavior,GO:0003331~positive regulation of extracellular matrix constituent secretion,GO:0006883~cellular sodium ion homeostasis,GO:0007160~cell-matrix adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007202~activation of phospholipase C activity,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007250~activation of NF-kappaB-inducing kinase activity,GO:0007565~female pregnancy,GO:0007568~aging,GO:0007588~excretion,GO:0008065~establishment of blood-nerve barrier,GO:0008217~regulation of blood pressure,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009409~response to cold,GO:0009651~response to salt stress,GO:0010468~regulation of gene expression,GO:0010535~positive regulation of activation of JAK2 kinase activity,GO:0010595~positive regulation of endothelial cell migration,GO:0010613~positive regulation of cardiac muscle hypertrophy,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010666~positive regulation of cardiac muscle cell apoptotic process,GO:0010873~positive regulation of cholesterol esterification,GO:0010951~negative regulation of endopeptidase activity,GO:0014061~regulation of norepinephrine secretion,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0014824~artery smooth muscle contraction,GO:0014873~response to muscle activity involved in regulation of muscle adaptation,GO:0016525~negative regulation of angiogenesis,GO:0030198~extracellular matrix organization,GO:0030308~negative regulation of cell growth,GO:0030432~peristalsis,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032930~positive regulation of superoxide anion generation,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0034104~negative regulation of tissue remodeling,GO:0035411~catenin import into nucleus,GO:0035813~regulation of renal sodium excretion,GO:0035815~positive regulation of renal sodium excretion,GO:0038166~angiotensin-activated signaling pathway,GO:0040018~positive regulation of multicellular organism growth,GO:0042310~vasoconstriction,GO:0042311~vasodilation,GO:0042445~hormone metabolic process,GO:0042756~drinking behavior,GO:0042981~regulation of apoptotic process,GO:0043085~positive regulation of catalytic activity,GO:0043410~positive regulation of MAPK cascade,GO:0043524~negative regulation of neuron apoptotic process,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045723~positive regulation of fatty acid biosynthetic process,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0045777~positive regulation of blood pressure,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045909~positive regulation of vasodilation,GO:0046622~positive regulation of organ growth,GO:0048143~astrocyte activation,GO:0048144~fibroblast proliferation,GO:0048146~positive regulation of fibroblast proliferation,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048659~smooth muscle cell proliferation,GO:0050663~cytokine secretion,GO:0050715~positive regulation of cytokine secretion,GO:0050727~regulation of inflammatory response,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0051145~smooth muscle cell differentiation,GO:0051387~negative regulation of neurotrophin TRK receptor signaling pathway,GO:0051403~stress-activated MAPK cascade,GO:0051924~regulation of calcium ion transport,GO:0051969~regulation of transmission of nerve impulse,GO:0061049~cell growth involved in cardiac muscle cell development,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0070371~ERK1 and ERK2 cascade,GO:0070471~uterine smooth muscle contraction,GO:0071260~cellular response to mechanical stimulus,GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis,GO:1900020~positive regulation of protein kinase C activity,GO:1901201~regulation of extracellular matrix assembly,GO:1902632~positive regulation of membrane hyperpolarization,GO:1902828~positive regulation of L-arginine import into cell,GO:1903598~positive regulation of gap junction assembly,GO:1903779~regulation of cardiac conduction,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,GO:1904754~positive regulation of vascular associated smooth muscle cell migration,GO:1905010~positive regulation of L-lysine import into cell,GO:2001238~positive regulation of extrinsic apoptotic signaling pathway,GO:2001275~positive regulation of glucose import in response to insulin stimulus,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005179~hormone activity,GO:0017080~sodium channel regulator activity,GO:0031701~angiotensin receptor binding,GO:0031702~type 1 angiotensin receptor binding,GO:0031703~type 2 angiotensin receptor binding,GO:0048018~receptor agonist activity,	IPR000215:Serpin family,IPR000227:Angiotensinogen,IPR023796:Serpin domain,	rno04614:Renin-angiotensin system,rno04924:Renin secretion,			SM00093:SERPIN,	3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Reference proteome,Secreted,Signal,Vasoactive,Vasoconstrictor,	chain:Angiotensinogen,glycosylation site:N-linked (GlcNAc...),peptide:Angiotensin-1,peptide:Angiotensin-2,peptide:Angiotensin-3,signal peptide,
Q4R3S3	ankyrin repeat domain 7(ANKRD7)	Macaca fascicularis							IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	ANK repeat,Repeat,
P17153	annexin A5(ANXA5)	Gallus gallus				GO:0002230~positive regulation of defense response to virus by host,GO:0010033~response to organic substance,GO:0050819~negative regulation of coagulation,GO:0055074~calcium ion homeostasis,GO:0070588~calcium ion transmembrane transport,GO:0098779~mitophagy in response to mitochondrial depolarization,GO:0098792~xenophagy,	GO:0005622~intracellular,GO:0005925~focal adhesion,GO:0009897~external side of plasma membrane,GO:0031982~vesicle,GO:0034704~calcium channel complex,GO:0070062~extracellular exosome,GO:0072563~endothelial microparticle,	GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0005544~calcium-dependent phospholipid binding,	IPR001464:Annexin,IPR002392:Annexin, type V,IPR015473:Annexin V,IPR018252:Annexin repeat, conserved site,IPR018502:Annexin repeat,				SM00335:ANX,	3D-structure,Annexin,Calcium,Calcium/phospholipid-binding,Complete proteome,Direct protein sequencing,Reference proteome,Repeat,	chain:Annexin A5,helix,repeat:Annexin 1,repeat:Annexin 2,repeat:Annexin 3,repeat:Annexin 4,sequence conflict,strand,turn,
P33005	anosmin 1(ANOS1)	Gallus gallus				GO:0007155~cell adhesion,GO:0010951~negative regulation of endopeptidase activity,	GO:0005576~extracellular region,GO:0009986~cell surface,	GO:0004867~serine-type endopeptidase inhibitor activity,	IPR003961:Fibronectin, type III,IPR008197:Whey acidic protein-type  4-disulphide core,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,SM00217:WAP,	Cell adhesion,Complete proteome,Disulfide bond,Glycoprotein,Protease inhibitor,Reference proteome,Repeat,Serine protease inhibitor,Signal,	chain:Anosmin-1,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:WAP,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,
P04114	apolipoprotein B(APOB)	Homo sapiens			DNA replication, recombination, and repair,	GO:0001523~retinoid metabolic process,GO:0001701~in utero embryonic development,GO:0006642~triglyceride mobilization,GO:0006898~receptor-mediated endocytosis,GO:0007283~spermatogenesis,GO:0007399~nervous system development,GO:0008203~cholesterol metabolic process,GO:0009566~fertilization,GO:0009615~response to virus,GO:0009743~response to carbohydrate,GO:0009791~post-embryonic development,GO:0010269~response to selenium ion,GO:0010628~positive regulation of gene expression,GO:0010744~positive regulation of macrophage derived foam cell differentiation,GO:0010884~positive regulation of lipid storage,GO:0010886~positive regulation of cholesterol storage,GO:0019433~triglyceride catabolic process,GO:0030301~cholesterol transport,GO:0030317~sperm motility,GO:0032496~response to lipopolysaccharide,GO:0033344~cholesterol efflux,GO:0034374~low-density lipoprotein particle remodeling,GO:0034379~very-low-density lipoprotein particle assembly,GO:0034383~low-density lipoprotein particle clearance,GO:0042157~lipoprotein metabolic process,GO:0042158~lipoprotein biosynthetic process,GO:0042159~lipoprotein catabolic process,GO:0042632~cholesterol homeostasis,GO:0042953~lipoprotein transport,GO:0044257~cellular protein catabolic process,GO:0045540~regulation of cholesterol biosynthetic process,GO:0048844~artery morphogenesis,GO:0050900~leukocyte migration,GO:0071356~cellular response to tumor necrosis factor,GO:0071379~cellular response to prostaglandin stimulus,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0015629~actin cytoskeleton,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0031904~endosome lumen,GO:0034359~mature chylomicron,GO:0034360~chylomicron remnant,GO:0034361~very-low-density lipoprotein particle,GO:0034362~low-density lipoprotein particle,GO:0034363~intermediate-density lipoprotein particle,GO:0042627~chylomicron,GO:0043025~neuronal cell body,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,GO:0070971~endoplasmic reticulum exit site,GO:0071682~endocytic vesicle lumen,	GO:0005319~lipid transporter activity,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0008201~heparin binding,GO:0017127~cholesterol transporter activity,GO:0035473~lipase binding,GO:0050750~low-density lipoprotein particle receptor binding,	IPR001747:Lipid transport protein, N-terminal,IPR009454:Lipid transport, open beta-sheet,IPR011030:Vitellinogen, superhelical,IPR015255:Vitellinogen, open beta-sheet,IPR015816:Vitellinogen, beta-sheet N-terminal,IPR015817:Vitellinogen, open beta-sheet, subdomain 1,IPR015818:Vitellinogen, open beta-sheet, subdomain 2,IPR015819:Lipid transport protein, beta-sheet shell,IPR016024:Armadillo-type fold,IPR022176:Apolipoprotein B100 C-terminal,	hsa04975:Fat digestion and absorption,hsa04977:Vitamin digestion and absorption,	144010~Hypercholesterolemia, due to ligand-defective apo B,615558~Hypobetalipoproteinemia,		SM00638:LPD_N,SM01169:SM01169,	Acetylation,Atherosclerosis,Cholesterol metabolism,Chylomicron,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Heparin-binding,LDL,Lipid metabolism,Lipid transport,Lipoprotein,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA editing,Secreted,Signal,Steroid metabolism,Sterol metabolism,Transport,VLDL,	chain:Apolipoprotein B-100,chain:Apolipoprotein B-48,disulfide bond,domain:Vitellogenin,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,region of interest:Basic (possible receptor binding region),region of interest:Heparin-binding,region of interest:LDL receptor binding,sequence conflict,sequence variant,signal peptide,
Q13790	apolipoprotein F(APOF)	Homo sapiens				GO:0006629~lipid metabolic process,GO:0006869~lipid transport,GO:0008203~cholesterol metabolic process,	GO:0005576~extracellular region,GO:0034362~low-density lipoprotein particle,GO:0034364~high-density lipoprotein particle,	GO:0005102~receptor binding,GO:0005319~lipid transporter activity,GO:0015485~cholesterol binding,	IPR026114:Apolipoprotein F,					Cholesterol metabolism,Complete proteome,Direct protein sequencing,Glycoprotein,HDL,LDL,Lipid metabolism,Lipid transport,Phosphoprotein,Polymorphism,Reference proteome,Secreted,Signal,Steroid metabolism,Sterol metabolism,Transport,	chain:Apolipoprotein F,sequence variant,signal peptide,
P17690	apolipoprotein H(APOH)	Bos taurus					GO:0005576~extracellular region,	GO:0008201~heparin binding,	IPR000436:Sushi/SCR/CCP,IPR015104:Beta-2-glycoprotein-1 fifth domain,				SM00032:CCP,	Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Heparin-binding,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Beta-2-glycoprotein 1,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,glycosylation site:N-linked (GlcNAc...),region of interest:Sushi-like,sequence conflict,signal peptide,
P26644	apolipoprotein H(Apoh)	Rattus norvegicus				GO:0001937~negative regulation of endothelial cell proliferation,GO:0006641~triglyceride metabolic process,GO:0007568~aging,GO:0007596~blood coagulation,GO:0007597~blood coagulation, intrinsic pathway,GO:0010596~negative regulation of endothelial cell migration,GO:0010898~positive regulation of triglyceride catabolic process,GO:0016525~negative regulation of angiogenesis,GO:0030193~regulation of blood coagulation,GO:0030195~negative regulation of blood coagulation,GO:0031100~organ regeneration,GO:0031639~plasminogen activation,GO:0033033~negative regulation of myeloid cell apoptotic process,GO:0034014~response to triglyceride,GO:0034197~triglyceride transport,GO:0034392~negative regulation of smooth muscle cell apoptotic process,GO:0051006~positive regulation of lipoprotein lipase activity,GO:0051917~regulation of fibrinolysis,GO:0051918~negative regulation of fibrinolysis,GO:0060268~negative regulation of respiratory burst,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0031012~extracellular matrix,GO:0034361~very-low-density lipoprotein particle,GO:0034364~high-density lipoprotein particle,GO:0042627~chylomicron,GO:0070062~extracellular exosome,	GO:0001948~glycoprotein binding,GO:0005543~phospholipid binding,GO:0008201~heparin binding,GO:0008289~lipid binding,GO:0042802~identical protein binding,GO:0060230~lipoprotein lipase activator activity,	IPR000436:Sushi/SCR/CCP,IPR015104:Beta-2-glycoprotein-1 fifth domain,				SM00032:CCP,	Complete proteome,Disulfide bond,Glycoprotein,Heparin-binding,Lipoprotein,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Beta-2-glycoprotein 1,disulfide bond,domain:Sushi 1; incomplete,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,glycosylation site:N-linked (GlcNAc...),region of interest:Sushi-like,signal peptide,
Q9JM53	apoptosis inducing factor, mitochondria associated 1(Aifm1)	Rattus norvegicus				GO:0002931~response to ischemia,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0009636~response to toxic substance,GO:0010942~positive regulation of cell death,GO:0030182~neuron differentiation,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0043525~positive regulation of neuron apoptotic process,GO:0045454~cell redox homeostasis,GO:0051402~neuron apoptotic process,GO:0055114~oxidation-reduction process,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0070301~cellular response to hydrogen peroxide,GO:0071392~cellular response to estradiol stimulus,GO:0071732~cellular response to nitric oxide,GO:0090650~cellular response to oxygen-glucose deprivation,GO:1902065~response to L-glutamate,GO:1902510~regulation of apoptotic DNA fragmentation,GO:1904045~cellular response to aldosterone,	GO:0005623~cell,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005758~mitochondrial intermembrane space,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0003677~DNA binding,GO:0016174~NAD(P)H oxidase activity,GO:0016491~oxidoreductase activity,GO:0016651~oxidoreductase activity, acting on NAD(P)H,GO:0046983~protein dimerization activity,GO:0050660~flavin adenine dinucleotide binding,GO:0071949~FAD binding,	IPR004099:Pyridine nucleotide-disulphide oxidoreductase, dimerisation,IPR016156:FAD/NAD-linked reductase, dimerisation,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,	rno04210:Apoptosis,				Acetylation,Apoptosis,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,FAD,Flavoprotein,Isopeptide bond,Membrane,Mitochondrion,Mitochondrion inner membrane,NAD,Nucleus,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,Ubl conjugation,	binding site:FAD,binding site:FAD; via amide nitrogen and carbonyl oxygen,binding site:FAD; via carbonyl oxygen,chain:Apoptosis-inducing factor 1, mitochondrial,modified residue,nucleotide phosphate-binding region:FAD,region of interest:FAD-dependent oxidoreductase,short sequence motif:Nuclear localization signal,transit peptide:Mitochondrion,
P56404	aquaporin 8(Aqp8)	Mus musculus				GO:0006810~transport,GO:0006833~water transport,GO:0009992~cellular water homeostasis,GO:0015722~canalicular bile acid transport,GO:0034220~ion transmembrane transport,GO:0071320~cellular response to cAMP,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0045177~apical part of cell,GO:0046691~intracellular canaliculus,	GO:0005215~transporter activity,GO:0015250~water channel activity,GO:0015254~glycerol channel activity,	IPR000425:Major intrinsic protein,IPR022357:Major intrinsic protein, conserved site,IPR023271:Aquaporin-like,IPR023277:Aquaporin 8,	mmu04976:Bile secretion,				Complete proteome,Glycoprotein,Membrane,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Aquaporin-8,glycosylation site:N-linked (GlcNAc...),sequence conflict,short sequence motif:NPA 1,short sequence motif:NPA 2,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q95JC8	arginase 1(ARG1)	Sus scrofa				GO:0000050~urea cycle,GO:0006525~arginine metabolic process,	GO:0005737~cytoplasm,	GO:0004053~arginase activity,GO:0046872~metal ion binding,	IPR006035:Ureohydrolase,IPR014033:Arginase,IPR020855:Ureohydrolase, manganese-binding site,IPR023696:Ureohydrolase domain,	ssc00220:Arginine biosynthesis,ssc00330:Arginine and proline metabolism,ssc01100:Metabolic pathways,ssc01130:Biosynthesis of antibiotics,ssc01230:Biosynthesis of amino acids,ssc05146:Amoebiasis,		PIRSF036979:ureohydrolase/formiminoglutamase/proclavaminate amidino hydrolase,		Arginine metabolism,Complete proteome,Cytoplasm,Hydrolase,Manganese,Metal-binding,Phosphoprotein,Reference proteome,Urea cycle,	binding site:Substrate,chain:Arginase-1,metal ion-binding site:Manganese 1,metal ion-binding site:Manganese 2,modified residue,region of interest:Substrate binding,
P05089	arginase 1(ARG1)	Homo sapiens		h_argininecPathway:Catabolic Pathways for Arginine , Histidine, Glutamate, Glutamine, and Proline,		GO:0000050~urea cycle,GO:0001889~liver development,GO:0001938~positive regulation of endothelial cell proliferation,GO:0006527~arginine catabolic process,GO:0007568~aging,GO:0009635~response to herbicide,GO:0010042~response to manganese ion,GO:0010043~response to zinc ion,GO:0010269~response to selenium ion,GO:0010963~regulation of L-arginine import,GO:0014075~response to amine,GO:0019547~arginine catabolic process to ornithine,GO:0030324~lung development,GO:0032964~collagen biosynthetic process,GO:0033189~response to vitamin A,GO:0033197~response to vitamin E,GO:0042493~response to drug,GO:0043200~response to amino acid,GO:0046686~response to cadmium ion,GO:0048678~response to axon injury,GO:0051597~response to methylmercury,GO:0060056~mammary gland involution,GO:0060135~maternal process involved in female pregnancy,GO:0070207~protein homotrimerization,GO:0070301~cellular response to hydrogen peroxide,GO:0071222~cellular response to lipopolysaccharide,GO:0071353~cellular response to interleukin-4,GO:0071377~cellular response to glucagon stimulus,GO:0071549~cellular response to dexamethasone stimulus,GO:0071560~cellular response to transforming growth factor beta stimulus,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0070062~extracellular exosome,	GO:0004053~arginase activity,GO:0030145~manganese ion binding,	IPR006035:Ureohydrolase,IPR014033:Arginase,IPR020855:Ureohydrolase, manganese-binding site,IPR023696:Ureohydrolase domain,	hsa00220:Arginine biosynthesis,hsa00330:Arginine and proline metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01230:Biosynthesis of amino acids,hsa05146:Amoebiasis,	207800~Argininemia,	PIRSF036979:ureohydrolase/formiminoglutamase/proclavaminate amidino hydrolase,		3D-structure,Alternative splicing,Arginine metabolism,Complete proteome,Cytoplasm,Disease mutation,Hydrolase,Manganese,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Urea cycle,	binding site:Substrate,chain:Arginase-1,helix,metal ion-binding site:Manganese 1,metal ion-binding site:Manganese 2,modified residue,region of interest:Substrate binding,sequence conflict,sequence variant,splice variant,strand,turn,
Q96B67	arrestin domain containing 3(ARRDC3)	Homo sapiens				GO:0001659~temperature homeostasis,GO:0007165~signal transduction,GO:0031651~negative regulation of heat generation,GO:0043588~skin development,GO:0044252~negative regulation of multicellular organismal metabolic process,GO:0051443~positive regulation of ubiquitin-protein transferase activity,GO:0060613~fat pad development,GO:0071879~positive regulation of adrenergic receptor signaling pathway,GO:0090327~negative regulation of locomotion involved in locomotory behavior,	GO:0005764~lysosome,GO:0005768~endosome,GO:0005769~early endosome,GO:0005886~plasma membrane,	GO:0005515~protein binding,GO:0031699~beta-3 adrenergic receptor binding,	IPR011021:Arrestin-like, N-terminal,IPR011022:Arrestin C-terminal-like domain,IPR014756:Immunoglobulin E-set,				SM01017:SM01017,	3D-structure,Cell membrane,Complete proteome,Cytoplasm,Endosome,Lysosome,Membrane,Reference proteome,Repeat,	chain:Arrestin domain-containing protein 3,sequence conflict,
Q8NHH9	atlastin GTPase 2(ATL2)	Homo sapiens				GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007029~endoplasmic reticulum organization,GO:0007030~Golgi organization,GO:0051260~protein homooligomerization,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0042802~identical protein binding,	IPR003191:Guanylate-binding protein, C-terminal,IPR015894:Guanylate-binding protein, N-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Coiled coil,Complete proteome,Endoplasmic reticulum,GTP-binding,Hydrolase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Atlastin-2,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
Q3T0W7	autophagy related 12(ATG12)	Bos taurus				GO:0000045~autophagosome assembly,GO:0000422~mitophagy,GO:0006501~C-terminal protein lipidation,GO:0044804~nucleophagy,GO:0045087~innate immune response,	GO:0034045~pre-autophagosomal structure membrane,GO:0034274~Atg12-Atg5-Atg16 complex,	GO:0019776~Atg8 ligase activity,	IPR007242:Ubiquitin-like protein Atg12,	bta04068:FoxO signaling pathway,bta04140:Regulation of autophagy,bta04622:RIG-I-like receptor signaling pathway,				Acetylation,Autophagy,Complete proteome,Cytoplasm,Immunity,Innate immunity,Isopeptide bond,Membrane,Reference proteome,Ubl conjugation pathway,	chain:Autophagy-related protein 12,cross-link:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-130 in ATG5),
P02701	avidin(AVD)	Gallus gallus				GO:0019731~antibacterial humoral response,	GO:0005576~extracellular region,	GO:0009374~biotin binding,	IPR005468:Avidin/streptavidin,IPR005469:Avidin,IPR017889:Avidin-like, conserved site,					3D-structure,Biotin,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Polymorphism,Reference proteome,Secreted,Signal,	binding site:Biotin,chain:Avidin,disulfide bond,domain:Avidin-like,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,strand,
O42197	beta-2-microglobulin(b2m)	Ictalurus punctatus				GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0006955~immune response,	GO:0005576~extracellular region,GO:0042612~MHC class I protein complex,		IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR015707:Beta-2-Microglobulin,				SM00407:IGc1,	Disulfide bond,Immunity,Immunoglobulin domain,MHC I,Secreted,Signal,
A1JTC4	beta-D-galactosidase(lacZ)	Yersinia enterocolitica subsp. enterocolitica 8081				GO:0005975~carbohydrate metabolic process,	GO:0009341~beta-galactosidase complex,	GO:0000287~magnesium ion binding,GO:0004565~beta-galactosidase activity,GO:0030246~carbohydrate binding,	IPR004199:Beta galactosidase small chain/ domain 5,IPR006101:Glycoside hydrolase, family 2,IPR006102:Glycoside hydrolase, family 2, immunoglobulin-like beta-sandwich,IPR006103:Glycoside hydrolase, family 2, TIM barrel,IPR006104:Glycoside hydrolase, family 2, N-terminal,IPR008979:Galactose-binding domain-like,IPR011013:Galactose mutarotase-like domain,IPR013781:Glycoside hydrolase, catalytic domain,IPR013812:Glycoside hydrolase, family 2/20, immunoglobulin-like beta-sandwich domain,IPR014718:Glycoside hydrolase-type carbohydrate-binding, subgroup,IPR017853:Glycoside hydrolase, superfamily,IPR023230:Glycoside hydrolase, family 2, conserved site,IPR023232:Glycoside hydrolase, family 2, active site,IPR023933:Glycoside hydrolase, family 2, beta-galactosidase,	yen00052:Galactose metabolism,yen00511:Other glycan degradation,yen01100:Metabolic pathways,			SM01038:SM01038,	Complete proteome,Glycosidase,Hydrolase,Magnesium,Metal-binding,Sodium,	active site:Nucleophile,active site:Proton donor,binding site:Substrate,chain:Beta-galactosidase,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,metal ion-binding site:Sodium,metal ion-binding site:Sodium; via carbonyl oxygen,region of interest:Substrate binding,site:Transition state stabilizer,
Q9FM68	beta-amylase 4(BAM4)	Arabidopsis thaliana				GO:0000272~polysaccharide catabolic process,GO:0005983~starch catabolic process,	GO:0009507~chloroplast,	GO:0016161~beta-amylase activity,	IPR001371:Glycoside hydrolase, family 14B, plant,IPR001554:Glycoside hydrolase, family 14,IPR013781:Glycoside hydrolase, catalytic domain,IPR017853:Glycoside hydrolase, superfamily,					Alternative splicing,Carbohydrate metabolism,Chloroplast,Complete proteome,Glycosidase,Hydrolase,Plastid,Polysaccharide degradation,Reference proteome,Transit peptide,
P02141	beta-globin(LOC100136291)	Oncorhynchus mykiss					GO:0005833~hemoglobin complex,	GO:0005344~oxygen transporter activity,GO:0005506~iron ion binding,GO:0019825~oxygen binding,GO:0020037~heme binding,	IPR000971:Globin,IPR002337:Haemoglobin, beta,IPR009050:Globin-like,IPR012292:Globin, structural domain,					3D-structure,Direct protein sequencing,Heme,Iron,Metal-binding,Oxygen transport,Transport,	chain:Hemoglobin subunit beta-4,helix,metal ion-binding site:Iron (heme distal ligand),metal ion-binding site:Iron (heme proximal ligand),sequence conflict,turn,
Q5RBM6	beta-ureidopropionase 1(UPB1)	Pongo abelii			General function prediction only,	GO:0006807~nitrogen compound metabolic process,GO:0019483~beta-alanine biosynthetic process,	GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0003837~beta-ureidopropionase activity,GO:0046872~metal ion binding,	IPR003010:Carbon-nitrogen hydrolase,	pon00240:Pyrimidine metabolism,pon00410:beta-Alanine metabolism,pon00770:Pantothenate and CoA biosynthesis,pon00983:Drug metabolism - other enzymes,pon01100:Metabolic pathways,				Allosteric enzyme,Complete proteome,Cytoplasm,Hydrolase,Metal-binding,Phosphoprotein,Reference proteome,Zinc,	chain:Beta-ureidopropionase,domain:CN hydrolase,metal ion-binding site:Zinc,
Q32LQ4	betaine-homocysteine methyltransferase(bhmt)	Danio rerio				GO:0003323~type B pancreatic cell development,GO:0006579~amino-acid betaine catabolic process,GO:0009086~methionine biosynthetic process,GO:0032259~methylation,GO:0055123~digestive system development,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0008168~methyltransferase activity,GO:0008270~zinc ion binding,GO:0008898~S-adenosylmethionine-homocysteine S-methyltransferase activity,GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:0047150~betaine-homocysteine S-methyltransferase activity,	IPR003726:Homocysteine S-methyltransferase,IPR017226:Betaine-homocysteine S-methyltransferase, BHMT,	dre00260:Glycine, serine and threonine metabolism,dre00270:Cysteine and methionine metabolism,dre01100:Metabolic pathways,		PIRSF037505:betaine--homocysteine S-methyltransferase, BHMT type,		Complete proteome,Cytoplasm,Metal-binding,Methyltransferase,Proteomics identification,Reference proteome,Transferase,Zinc,	chain:Betaine--homocysteine S-methyltransferase 1,domain:Hcy-binding,metal ion-binding site:Zinc,sequence conflict,
P0DKX7	bifunctional hemolysin-adenylate cyclase(cyaA)	Bordetella pertussis Tohama I				GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0009405~pathogenesis,GO:0044179~hemolysis in other organism,	GO:0005576~extracellular region,GO:0005623~cell,	GO:0004016~adenylate cyclase activity,GO:0005509~calcium ion binding,GO:0005524~ATP binding,GO:0008294~calcium- and calmodulin-responsive adenylate cyclase activity,	IPR001343:Haemolysin-type calcium-binding repeat,IPR003995:RTX toxin determinant A,IPR005165:Anthrax toxin, edema factor, central,IPR011049:Serralysin-like metalloprotease, C-terminal,IPR018504:RTX N-terminal,IPR018511:Hemolysin-type calcium-binding conserved site,	bpe00230:Purine metabolism,bpe05133:Pertussis,				3D-structure,ATP-binding,Calcium,Calmodulin-binding,cAMP biosynthesis,Complete proteome,Cytolysis,Hemolysis,Lipoprotein,Lyase,Nucleotide-binding,Palmitate,Reference proteome,Repeat,Secreted,Toxin,Virulence,Whooping cough,	chain:Calmodulin-sensitive adenylate cyclase,chain:Hemolysin,helix,lipid moiety-binding region:N6-palmitoyl lysine,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:A, catalytic,region of interest:B, Ala/Gly-rich,region of interest:C,region of interest:D, Asp/Gly-rich,repeat:Hemolysin-type calcium-binding 1,repeat:Hemolysin-type calcium-binding 10,repeat:Hemolysin-type calcium-binding 11,repeat:Hemolysin-type calcium-binding 12,repeat:Hemolysin-type calcium-binding 13,repeat:Hemolysin-type calcium-binding 14,repeat:Hemolysin-type calcium-binding 15,repeat:Hemolysin-type calcium-binding 16,repeat:Hemolysin-type calcium-binding 17,repeat:Hemolysin-type calcium-binding 2,repeat:Hemolysin-type calcium-binding 3,repeat:Hemolysin-type calcium-binding 4,repeat:Hemolysin-type calcium-binding 5,repeat:Hemolysin-type calcium-binding 6,repeat:Hemolysin-type calcium-binding 7,repeat:Hemolysin-type calcium-binding 8,repeat:Hemolysin-type calcium-binding 9,sequence conflict,strand,turn,
P30043	biliverdin reductase B(BLVRB)	Homo sapiens		h_il10Pathway:IL-10 Anti-inflammatory Signaling Pathway,		GO:0042167~heme catabolic process,GO:0055114~oxidation-reduction process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0004074~biliverdin reductase activity,GO:0042602~riboflavin reductase (NADPH) activity,	IPR016040:NAD(P)-binding domain,	hsa00740:Riboflavin metabolism,hsa00860:Porphyrin and chlorophyll metabolism,				3D-structure,Complete proteome,Cytoplasm,Direct protein sequencing,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Flavin reductase,helix,nucleotide phosphate-binding region:NAD or NADP,sequence conflict,sequence variant,strand,turn,
P97583	bradykinin receptor B1(Bdkrb1)	Rattus norvegicus				GO:0001933~negative regulation of protein phosphorylation,GO:0002687~positive regulation of leukocyte migration,GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0009612~response to mechanical stimulus,GO:0016477~cell migration,GO:0019233~sensory perception of pain,GO:0030308~negative regulation of cell growth,GO:0032496~response to lipopolysaccharide,GO:0045776~negative regulation of blood pressure,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043005~neuron projection,	GO:0004947~bradykinin receptor activity,GO:0042277~peptide binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000496:Bradykinin receptor family,IPR001186:Bradykinin receptor B1,IPR017452:GPCR, rhodopsin-like, 7TM,	rno04020:Calcium signaling pathway,rno04080:Neuroactive ligand-receptor interaction,rno04610:Complement and coagulation cascades,rno04750:Inflammatory mediator regulation of TRP channels,rno04810:Regulation of actin cytoskeleton,rno05200:Pathways in cancer,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:B1 bradykinin receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P21953	branched chain keto acid dehydrogenase E1 subunit beta(BCKDHB)	Homo sapiens		h_methioninePathway:Catabolic Pathways for Methionine, Isoleucine, Threonine and Valine,		GO:0008152~metabolic process,GO:0009083~branched-chain amino acid catabolic process,GO:0046487~glyoxylate metabolic process,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005947~mitochondrial alpha-ketoglutarate dehydrogenase complex,	GO:0003824~catalytic activity,GO:0003826~alpha-ketoacid dehydrogenase activity,GO:0003863~3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,GO:0005515~protein binding,GO:0016831~carboxy-lyase activity,	IPR005475:Transketolase-like, pyrimidine-binding domain,IPR009014:Transketolase, C-terminal/Pyruvate-ferredoxin oxidoreductase, domain II,	hsa00280:Valine, leucine and isoleucine degradation,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,	248600~Maple syrup urine disease, type Ib,		SM00861:SM00861,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Maple syrup urine disease,Mitochondrion,Oxidoreductase,Polymorphism,Reference proteome,Signal,Transit peptide,	chain:2-oxoisovalerate dehydrogenase subunit beta, mitochondrial,helix,modified residue,sequence conflict,sequence variant,strand,transit peptide:Mitochondrion,turn,
Q7ZUF2	bromodomain containing 9(brd9)	Danio rerio			Chromatin structure and dynamics / Transcription,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,		GO:0070577~lysine-acetylated histone binding,	IPR001487:Bromodomain,IPR021900:Protein of unknown function DUF3512,				SM00297:BROMO,	Bromodomain,Chromatin regulator,Complete proteome,Reference proteome,Transcription,Transcription regulation,	chain:Bromodomain-containing protein 9,compositionally biased region:Lys-rich,compositionally biased region:Poly-Glu,domain:Bromo,
P27925	cAMP responsive element binding protein 1(CREB1)	Bos taurus				GO:0006351~transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0007409~axonogenesis,GO:0007595~lactation,GO:0007613~memory,GO:0007623~circadian rhythm,GO:0008361~regulation of cell size,GO:0010944~negative regulation of transcription by competitive promoter binding,GO:0021983~pituitary gland development,GO:0030154~cell differentiation,GO:0033363~secretory granule organization,GO:0033762~response to glucagon,GO:0035729~cellular response to hepatocyte growth factor stimulus,GO:0040018~positive regulation of multicellular organism growth,GO:0042493~response to drug,GO:0045600~positive regulation of fat cell differentiation,GO:0045672~positive regulation of osteoclast differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046887~positive regulation of hormone secretion,GO:0046889~positive regulation of lipid biosynthetic process,GO:0050821~protein stabilization,GO:0060430~lung saccule development,GO:0060509~Type I pneumocyte differentiation,GO:0071294~cellular response to zinc ion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005719~nuclear euchromatin,GO:1990589~ATF4-CREB1 transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001190~transcriptional activator activity, RNA polymerase II transcription factor binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0035497~cAMP response element binding,GO:0043565~sequence-specific DNA binding,	IPR001630:cAMP response element binding (CREB) protein,IPR003102:Coactivator CBP, pKID,IPR004827:Basic-leucine zipper domain,	bta04022:cGMP-PKG signaling pathway,bta04024:cAMP signaling pathway,bta04151:PI3K-Akt signaling pathway,bta04152:AMPK signaling pathway,bta04261:Adrenergic signaling in cardiomyocytes,bta04380:Osteoclast differentiation,bta04612:Antigen processing and presentation,bta04668:TNF signaling pathway,bta04710:Circadian rhythm,bta04713:Circadian entrainment,bta04725:Cholinergic synapse,bta04728:Dopaminergic synapse,bta04911:Insulin secretion,bta04915:Estrogen signaling pathway,bta04916:Melanogenesis,bta04918:Thyroid hormone synthesis,bta04922:Glucagon signaling pathway,bta04924:Renin secretion,bta04925:Aldosterone synthesis and secretion,bta04931:Insulin resistance,bta04962:Vasopressin-regulated water reabsorption,bta05016:Huntington's disease,bta05030:Cocaine addiction,bta05031:Amphetamine addiction,bta05034:Alcoholism,bta05152:Tuberculosis,bta05161:Hepatitis B,bta05166:HTLV-I infection,bta05203:Viral carcinogenesis,bta05215:Prostate cancer,			SM00338:BRLZ,	Activator,Biological rhythms,Coiled coil,Complete proteome,Differentiation,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Cyclic AMP-responsive element-binding protein 1,DNA-binding region:Basic motif,domain:KID,domain:Leucine-zipper,modified residue,sequence conflict,site:Required for binding TORCs,
O18737	calcium binding and coiled-coil domain 2(CALCOCO2)	Bos taurus				GO:0034341~response to interferon-gamma,GO:0098792~xenophagy,GO:1901098~positive regulation of autophagosome maturation,	GO:0000421~autophagosome membrane,GO:0005776~autophagosome,GO:0005856~cytoskeleton,GO:0016020~membrane,GO:0031410~cytoplasmic vesicle,GO:0048471~perinuclear region of cytoplasm,	GO:0042803~protein homodimerization activity,	IPR012852:Coiled-coil transcriptional coactivator-like,					Autophagy,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Membrane,Reference proteome,	chain:Calcium-binding and coiled-coil domain- containing protein 2,region of interest:Interaction with MYO6,
Q9DG02	calcium/calmodulin-dependent protein kinase (CaM kinase) II delta S homeolog(camk2d.S)	Xenopus laevis						GO:0004683~calmodulin-dependent protein kinase activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013543:Calcium/calmodulin-dependent protein kinase II, association-domain,IPR017441:Protein kinase, ATP binding site,IPR020636:Calcium/calmodulin-dependent/calcium-dependent protein kinase,	xla04012:ErbB signaling pathway,xla04020:Calcium signaling pathway,xla04114:Oocyte meiosis,xla04261:Adrenergic signaling in cardiomyocytes,xla04310:Wnt signaling pathway,xla04912:GnRH signaling pathway,xla04916:Melanogenesis,			SM00220:S_TKc,	ATP-binding,Calmodulin-binding,Kinase,Nucleotide-binding,Phosphoprotein,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Calcium/calmodulin-dependent protein kinase type II delta chain,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,
Q99439	calponin 2(CNN2)	Homo sapiens			Cytoskeleton,	GO:0007010~cytoskeleton organization,GO:0010628~positive regulation of gene expression,GO:0030097~hemopoiesis,GO:0030336~negative regulation of cell migration,GO:0031032~actomyosin structure organization,GO:0032970~regulation of actin filament-based process,GO:0042060~wound healing,GO:0042127~regulation of cell proliferation,GO:0050765~negative regulation of phagocytosis,GO:0071260~cellular response to mechanical stimulus,GO:0098609~cell-cell adhesion,	GO:0001725~stress fiber,GO:0005856~cytoskeleton,GO:0005911~cell-cell junction,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005516~calmodulin binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000557:Calponin repeat,IPR001715:Calponin homology domain,IPR001997:Calponin,IPR003096:Smooth muscle protein/calponin,				SM00033:CH,	3D-structure,Acetylation,Actin-binding,Alternative splicing,Calmodulin-binding,Complete proteome,Direct protein sequencing,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Calponin-2,domain:CH,helix,modified residue,repeat:Calponin-like 1,repeat:Calponin-like 2,repeat:Calponin-like 3,sequence conflict,strand,
Q05A80	caprin family member 2(Caprin2)	Mus musculus				GO:0017148~negative regulation of translation,GO:0030154~cell differentiation,GO:0030308~negative regulation of cell growth,GO:0032092~positive regulation of protein binding,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0040008~regulation of growth,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050775~positive regulation of dendrite morphogenesis,GO:0061003~positive regulation of dendritic spine morphogenesis,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005813~centrosome,GO:0043235~receptor complex,	GO:0003723~RNA binding,GO:0005102~receptor binding,	IPR001073:Complement C1q protein,IPR008983:Tumour necrosis factor-like domain,IPR022070:Cytoplasmic activation/proliferation-associated protein-1 C term,				SM00110:C1Q,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Differentiation,Growth regulation,Phosphoprotein,Protein synthesis inhibitor,Reference proteome,RNA-binding,	chain:Caprin-2,domain:C1q,modified residue,sequence conflict,splice variant,
Q9USY1	carbohydrate kinase (predicted)(SPBC1861.05)	Schizosaccharomyces pombe 972h-				GO:0001522~pseudouridine synthesis,GO:0006399~tRNA metabolic process,	GO:0005737~cytoplasm,	GO:0004730~pseudouridylate synthase activity,GO:0005524~ATP binding,GO:0016798~hydrolase activity, acting on glycosyl bonds,GO:0046872~metal ion binding,GO:0050225~pseudouridine kinase activity,	IPR002173:Carbohydrate/puine kinase, PfkB, conserved site,IPR007342:Pseudouridine-5'-phosphate glycosidase,IPR011611:Carbohydrate kinase PfkB,	spo00240:Pyrimidine metabolism,				ATP-binding,Complete proteome,Cytoplasm,Glycosidase,Hydrolase,Kinase,Lyase,Manganese,Metal-binding,Nucleotide-binding,Reference proteome,Transferase,	chain:Pseudouridine-metabolizing bifunctional protein C1861.05,region of interest:Pseudouridine kinase,region of interest:Pseudouridine-5'-phosphate glycosidase,
Q92051	carbonic anhydrase(cahz)	Danio rerio				GO:0006730~one-carbon metabolic process,GO:0015670~carbon dioxide transport,GO:0042539~hypotonic salinity response,		GO:0004089~carbonate dehydratase activity,GO:0008270~zinc ion binding,GO:0016829~lyase activity,GO:0046872~metal ion binding,	IPR001148:Alpha carbonic anhydrase,IPR018338:Carbonic anhydrase, alpha-class, conserved site,IPR023561:Carbonic anhydrase, alpha-class,	dre00910:Nitrogen metabolism,			SM01057:SM01057,	Complete proteome,Direct protein sequencing,Lyase,Metal-binding,Reference proteome,Zinc,	chain:Carbonic anhydrase,metal ion-binding site:Zinc; catalytic,
Q2WEN9	carcinoembryonic antigen related cell adhesion molecule 16(CEACAM16)	Homo sapiens				GO:0007605~sensory perception of sound,	GO:0005615~extracellular space,GO:0032426~stereocilium tip,	GO:0042802~identical protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,		614614~Deafness, autosomal dominant 4B,		SM00408:IGc2,SM00409:IG,	Complete proteome,Deafness,Disease mutation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Non-syndromic deafness,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:Carcinoembryonic antigen-related cell adhesion molecule 16,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P06731	carcinoembryonic antigen related cell adhesion molecule 5(CEACAM5)	Homo sapiens				GO:0010832~negative regulation of myotube differentiation,GO:0034109~homotypic cell-cell adhesion,GO:0043066~negative regulation of apoptotic process,GO:2000811~negative regulation of anoikis,	GO:0005887~integral component of plasma membrane,GO:0016323~basolateral plasma membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,GO:0071575~integral component of external side of plasma membrane,	GO:0034235~GPI anchor binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,	chain:Carcinoembryonic antigen-related cell adhesion molecule 5,domain:Ig-like 1,domain:Ig-like 2,domain:Ig-like 3,domain:Ig-like 4,domain:Ig-like 5,domain:Ig-like 6,domain:Ig-like 7,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:GPI-anchor amidated alanine,mutagenesis site,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,strand,turn,
P19139	casein kinase 2 alpha 1(Csnk2a1)	Rattus norvegicus				GO:0001558~regulation of cell growth,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0008284~positive regulation of cell proliferation,GO:0016055~Wnt signaling pathway,GO:0030177~positive regulation of Wnt signaling pathway,GO:0030307~positive regulation of cell growth,GO:0042127~regulation of cell proliferation,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045732~positive regulation of protein catabolic process,GO:0046777~protein autophosphorylation,GO:0048511~rhythmic process,GO:0071174~mitotic spindle checkpoint,	GO:0005634~nucleus,GO:0005956~protein kinase CK2 complex,GO:0016580~Sin3 complex,GO:0016581~NuRD complex,GO:0031519~PcG protein complex,	GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0008013~beta-catenin binding,GO:0016301~kinase activity,GO:0019888~protein phosphatase regulator activity,GO:0047485~protein N-terminus binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	rno03008:Ribosome biogenesis in eukaryotes,rno04064:NF-kappa B signaling pathway,rno04310:Wnt signaling pathway,rno04520:Adherens junction,rno04530:Tight junction,rno05162:Measles,rno05168:Herpes simplex infection,rno05169:Epstein-Barr virus infection,			SM00220:S_TKc,	3D-structure,Apoptosis,ATP-binding,Biological rhythms,Cell cycle,Complete proteome,Direct protein sequencing,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Reference proteome,Serine/threonine-protein kinase,Transcription,Transcription regulation,Transferase,Wnt signaling pathway,	active site:Proton acceptor,binding site:ATP,chain:Casein kinase II subunit alpha,domain:Protein kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,strand,turn,
Q8CIS0	caspase recruitment domain family, member 11(Card11)	Mus musculus			Cell division and chromosome partitioning,	GO:0001819~positive regulation of cytokine production,GO:0002377~immunoglobulin production,GO:0007165~signal transduction,GO:0030183~B cell differentiation,GO:0030890~positive regulation of B cell proliferation,GO:0031295~T cell costimulation,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042100~B cell proliferation,GO:0042102~positive regulation of T cell proliferation,GO:0042110~T cell activation,GO:0042981~regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045061~thymic T cell selection,GO:0045086~positive regulation of interleukin-2 biosynthetic process,GO:0045577~regulation of B cell differentiation,GO:0045580~regulation of T cell differentiation,GO:0046649~lymphocyte activation,GO:0048872~homeostasis of number of cells,GO:0050776~regulation of immune response,GO:0050870~positive regulation of T cell activation,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0070970~interleukin-2 secretion,	GO:0001772~immunological synapse,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0042101~T cell receptor complex,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0050700~CARD domain binding,	IPR001315:Caspase Recruitment,IPR001478:PDZ domain,IPR011029:Death-like domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	mmu04064:NF-kappa B signaling pathway,mmu04660:T cell receptor signaling pathway,mmu04662:B cell receptor signaling pathway,				3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Reference proteome,	chain:Caspase recruitment domain-containing protein 11,compositionally biased region:Poly-Ser,domain:CARD,domain:Guanylate kinase-like,domain:PDZ,modified residue,sequence conflict,splice variant,
P10619	cathepsin A(CTSA)	Homo sapiens				GO:0006508~proteolysis,GO:0006687~glycosphingolipid metabolic process,GO:0006886~intracellular protein transport,GO:0031647~regulation of protein stability,GO:0043085~positive regulation of catalytic activity,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0061684~chaperone-mediated autophagy,GO:1904714~regulation of chaperone-mediated autophagy,GO:1904715~negative regulation of chaperone-mediated autophagy,	GO:0005654~nucleoplasm,GO:0005764~lysosome,GO:0005783~endoplasmic reticulum,GO:0016020~membrane,GO:0043202~lysosomal lumen,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,GO:0098575~lumenal side of lysosomal membrane,	GO:0004180~carboxypeptidase activity,GO:0004185~serine-type carboxypeptidase activity,GO:0004308~exo-alpha-sialidase activity,GO:0008047~enzyme activator activity,	IPR001563:Peptidase S10, serine carboxypeptidase,IPR018202:Peptidase S10, serine carboxypeptidase, active site,	hsa04142:Lysosome,hsa04614:Renin-angiotensin system,	256540~Galactosialidosis,			3D-structure,Alternative splicing,Carboxypeptidase,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hydrolase,Lysosome,Protease,Proteomics identification,Reference proteome,Signal,Zymogen,	chain:Lysosomal protective protein,chain:Lysosomal protective protein 20 kDa chain,chain:Lysosomal protective protein 32 kDa chain,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,sequence conflict,sequence variant,signal peptide,strand,turn,
Q3ZCJ8	cathepsin C(CTSC)	Bos taurus				GO:0001913~T cell mediated cytotoxicity,GO:0031638~zymogen activation,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005615~extracellular space,GO:0005764~lysosome,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0004197~cysteine-type endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016505~peptidase activator activity involved in apoptotic process,	IPR000169:Cysteine peptidase, cysteine active site,IPR000668:Peptidase C1A, papain C-terminal,IPR013128:Peptidase C1A, papain,IPR014882:Cathepsin C exclusion,IPR025660:Cysteine peptidase, histidine active site,IPR025661:Cysteine peptidase, asparagine active site,	bta04142:Lysosome,			SM00645:Pept_C1,	Chloride,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Lysosome,Protease,Proteomics identification,Reference proteome,Signal,Thiol protease,Zymogen,	binding site:Chloride,binding site:Chloride; via amide nitrogen,chain:Dipeptidyl-peptidase 1 exclusion domain chain,chain:Dipeptidyl-peptidase 1 heavy chain,chain:Dipeptidyl-peptidase 1 light chain,disulfide bond,glycosylation site:N-linked (GlcNAc...),signal peptide,
O46427	cathepsin H(CTSH)	Sus scrofa				GO:0001656~metanephros development,GO:0001913~T cell mediated cytotoxicity,GO:0002764~immune response-regulating signaling pathway,GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006955~immune response,GO:0008284~positive regulation of cell proliferation,GO:0010628~positive regulation of gene expression,GO:0010634~positive regulation of epithelial cell migration,GO:0010813~neuropeptide catabolic process,GO:0010815~bradykinin catabolic process,GO:0010952~positive regulation of peptidase activity,GO:0030335~positive regulation of cell migration,GO:0031638~zymogen activation,GO:0031648~protein destabilization,GO:0032526~response to retinoic acid,GO:0033619~membrane protein proteolysis,GO:0043066~negative regulation of apoptotic process,GO:0043129~surfactant homeostasis,GO:0045766~positive regulation of angiogenesis,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060448~dichotomous subdivision of terminal units involved in lung branching,GO:0070371~ERK1 and ERK2 cascade,GO:0097067~cellular response to thyroid hormone stimulus,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005829~cytosol,GO:0070062~extracellular exosome,GO:0097208~alveolar lamellar body,	GO:0004175~endopeptidase activity,GO:0004177~aminopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0008656~cysteine-type endopeptidase activator activity involved in apoptotic process,GO:0030108~HLA-A specific activating MHC class I receptor activity,GO:0070324~thyroid hormone binding,	IPR000169:Cysteine peptidase, cysteine active site,IPR000668:Peptidase C1A, papain C-terminal,IPR013128:Peptidase C1A, papain,IPR013201:Proteinase inhibitor I29, cathepsin propeptide,IPR025660:Cysteine peptidase, histidine active site,IPR025661:Cysteine peptidase, asparagine active site,	ssc04142:Lysosome,			SM00645:Pept_C1,SM00848:SM00848,	3D-structure,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Lysosome,Protease,Proteomics identification,Reference proteome,Signal,Thiol protease,Zymogen,	chain:Cathepsin H,chain:Cathepsin H heavy chain,chain:Cathepsin H light chain,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,peptide:Cathepsin H mini chain,signal peptide,strand,turn,
Q5E968	cathepsin K(CTSK)	Bos taurus				GO:0051603~proteolysis involved in cellular protein catabolic process,	GO:0005615~extracellular space,GO:0005764~lysosome,	GO:0004197~cysteine-type endopeptidase activity,GO:0008234~cysteine-type peptidase activity,	IPR000169:Cysteine peptidase, cysteine active site,IPR000668:Peptidase C1A, papain C-terminal,IPR013128:Peptidase C1A, papain,IPR013201:Proteinase inhibitor I29, cathepsin propeptide,IPR015644:Peptidase C1A, cathepsin K,IPR025660:Cysteine peptidase, histidine active site,IPR025661:Cysteine peptidase, asparagine active site,	bta04142:Lysosome,bta04380:Osteoclast differentiation,bta04620:Toll-like receptor signaling pathway,bta05323:Rheumatoid arthritis,			SM00645:Pept_C1,SM00848:SM00848,	Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Lysosome,Protease,Reference proteome,Signal,Thiol protease,Zymogen,	chain:Cathepsin K,disulfide bond,glycosylation site:N-linked (GlcNAc...),propeptide:Activation peptide,signal peptide,
Q8HY81	cathepsin S(CTSS)	Canis lupus familiaris				GO:0002250~adaptive immune response,GO:0006955~immune response,GO:0010447~response to acidic pH,GO:0016485~protein processing,GO:0019882~antigen processing and presentation,GO:0030574~collagen catabolic process,GO:0034769~basement membrane disassembly,GO:0048002~antigen processing and presentation of peptide antigen,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0097067~cellular response to thyroid hormone stimulus,GO:2001259~positive regulation of cation channel activity,	GO:0005615~extracellular space,GO:0005764~lysosome,	GO:0004197~cysteine-type endopeptidase activity,	IPR000169:Cysteine peptidase, cysteine active site,IPR000668:Peptidase C1A, papain C-terminal,IPR013128:Peptidase C1A, papain,IPR013201:Proteinase inhibitor I29, cathepsin propeptide,IPR025660:Cysteine peptidase, histidine active site,IPR025661:Cysteine peptidase, asparagine active site,	cfa04142:Lysosome,cfa04145:Phagosome,cfa04612:Antigen processing and presentation,cfa05152:Tuberculosis,			SM00645:Pept_C1,SM00848:SM00848,	Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Lysosome,Protease,Reference proteome,Signal,Thiol protease,Zymogen,	chain:Cathepsin S,disulfide bond,glycosylation site:N-linked (GlcNAc...),propeptide:Activation peptide,signal peptide,
O89033	cell division cycle 6(Cdc6)	Mus musculus		m_mcmPathway:CDK Regulation of DNA Replication,	DNA replication, recombination, and repair / Posttranslational modification, protein turnover, chaperones,	GO:0006260~DNA replication,GO:0006270~DNA replication initiation,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0030071~regulation of mitotic metaphase/anaphase transition,GO:0032467~positive regulation of cytokinesis,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0048146~positive regulation of fibroblast proliferation,GO:0051301~cell division,GO:0051984~positive regulation of chromosome segregation,	GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005819~spindle,GO:0051233~spindle midzone,	GO:0000166~nucleotide binding,GO:0003682~chromatin binding,GO:0005524~ATP binding,GO:0019900~kinase binding,	IPR003593:AAA+ ATPase domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR015163:CDC6, C-terminal domain,IPR016314:Cell division protein Cdc6/18,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	mmu04110:Cell cycle,		PIRSF001767:cell division control protein Cdc6,	SM00382:AAA,SM01074:SM01074,	ATP-binding,Cell cycle,Cell division,Complete proteome,Cytoplasm,DNA replication,Mitosis,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Cell division control protein 6 homolog,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,
Q99674	cell growth regulator with EF-hand domain 1(CGREF1)	Homo sapiens				GO:0006950~response to stress,GO:0007050~cell cycle arrest,GO:0007155~cell adhesion,GO:0008285~negative regulation of cell proliferation,GO:0030308~negative regulation of cell growth,	GO:0005576~extracellular region,	GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,					Alternative splicing,Calcium,Cell adhesion,Cell cycle,Complete proteome,Growth arrest,Metal-binding,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	calcium-binding region:1,calcium-binding region:2,chain:Cell growth regulator with EF hand domain protein 1,domain:EF-hand 1,domain:EF-hand 2,sequence conflict,sequence variant,signal peptide,
Q99675	cell growth regulator with ring finger domain 1(CGRRF1)	Homo sapiens				GO:0006950~response to stress,GO:0007050~cell cycle arrest,GO:0008285~negative regulation of cell proliferation,	GO:0005654~nucleoplasm,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0008270~zinc ion binding,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,	3D-structure,Cell cycle,Complete proteome,Growth arrest,Membrane,Metal-binding,Nucleus,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Zinc,Zinc-finger,	chain:Cell growth regulator with RING finger domain protein 1,sequence conflict,sequence variant,strand,turn,zinc finger region:RING-type,
Q5HZ92	ceramide-1-phosphate transfer protein L homeolog(cptp.L)	Xenopus laevis				GO:1902389~ceramide 1-phosphate transport,	GO:0005640~nuclear outer membrane,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0010008~endosome membrane,	GO:0005543~phospholipid binding,GO:0005548~phospholipid transporter activity,GO:0017089~glycolipid transporter activity,GO:0051861~glycolipid binding,GO:1902387~ceramide 1-phosphate binding,GO:1902388~ceramide 1-phosphate transporter activity,	IPR014830:Glycolipid transfer protein domain,					Cell membrane,Cytoplasm,Endosome,Golgi apparatus,Lipid transport,Lipid-binding,Membrane,Nucleus,Transport,	chain:Glycolipid transfer protein domain- containing protein 1,
Q68EH9	cereblon(crbn)	Danio rerio				GO:0006508~proteolysis,GO:0016567~protein ubiquitination,GO:0033333~fin development,GO:0035118~embryonic pectoral fin morphogenesis,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0060173~limb development,GO:0071599~otic vesicle development,GO:0071600~otic vesicle morphogenesis,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0031464~Cul4A-RING E3 ubiquitin ligase complex,	GO:0004176~ATP-dependent peptidase activity,GO:0046872~metal ion binding,	IPR003111:Peptidase S16, lon N-terminal,IPR004910:Yippee-like protein,IPR015947:PUA-like domain,				SM00464:LON,	Complete proteome,Cytoplasm,Metal-binding,Nucleus,Reference proteome,Ubl conjugation pathway,Zinc,
Q503V0	charged multivesicular body protein 6b(chmp6b)	Danio rerio				GO:0006810~transport,GO:0007034~vacuolar transport,GO:0015031~protein transport,	GO:0005622~intracellular,GO:0005768~endosome,GO:0016020~membrane,GO:0031902~late endosome membrane,		IPR005024:Snf7,	dre04144:Endocytosis,				Coiled coil,Complete proteome,Endosome,Lipoprotein,Membrane,Myristate,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Charged multivesicular body protein 6,lipid moiety-binding region:N-myristoyl glycine,sequence conflict,short sequence motif:Type-2 MIT-interacting motif,
Q6PBQ2	charged multivesicular body protein 7(chmp7)	Danio rerio				GO:0006810~transport,GO:0007034~vacuolar transport,GO:0010458~exit from mitosis,GO:0015031~protein transport,GO:0031468~nuclear envelope reassembly,GO:0045324~late endosome to vacuole transport,	GO:0000815~ESCRT III complex,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005737~cytoplasm,	GO:0008565~protein transporter activity,	IPR005024:Snf7,	dre04144:Endocytosis,				Coiled coil,Complete proteome,Cytoplasm,Nucleus,Protein transport,Reference proteome,Transport,	chain:Charged multivesicular body protein 7,sequence conflict,
O89093	chemokine (C-C motif) ligand 20(Ccl20)	Mus musculus				GO:0002548~monocyte chemotaxis,GO:0002724~regulation of T cell cytokine production,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0030593~neutrophil chemotaxis,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0042060~wound healing,GO:0043547~positive regulation of GTPase activity,GO:0048247~lymphocyte chemotaxis,GO:0050726~positive regulation of interleukin-1 alpha biosynthetic process,GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071222~cellular response to lipopolysaccharide,GO:0071223~cellular response to lipoteichoic acid,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0072678~T cell migration,GO:0072679~thymocyte migration,GO:2000319~regulation of T-helper 17 cell differentiation,GO:2000406~positive regulation of T cell migration,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,	GO:0005125~cytokine activity,GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0031731~CCR6 chemokine receptor binding,GO:0048020~CCR chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	mmu04060:Cytokine-cytokine receptor interaction,mmu04062:Chemokine signaling pathway,mmu04668:TNF signaling pathway,mmu05323:Rheumatoid arthritis,			SM00199:SCY,	3D-structure,Alternative splicing,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Inflammatory response,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 20,disulfide bond,helix,signal peptide,splice variant,strand,
P97468	chemokine-like receptor 1(Cmklr1)	Mus musculus				GO:0006935~chemotaxis,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0010759~positive regulation of macrophage chemotaxis,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032695~negative regulation of interleukin-12 production,GO:0045600~positive regulation of fat cell differentiation,GO:0050848~regulation of calcium-mediated signaling,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004871~signal transducer activity,GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR002258:DEZ orphan receptor,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Chemokine receptor-like 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P35790	choline kinase alpha(CHKA)	Homo sapiens				GO:0006580~ethanolamine metabolic process,GO:0006629~lipid metabolic process,GO:0006646~phosphatidylethanolamine biosynthetic process,GO:0006656~phosphatidylcholine biosynthetic process,GO:0006657~CDP-choline pathway,GO:0006869~lipid transport,GO:0007165~signal transduction,GO:0009636~response to toxic substance,GO:0016310~phosphorylation,GO:0019695~choline metabolic process,GO:1904681~response to 3-methylcholanthrene,	GO:0005829~cytosol,	GO:0004103~choline kinase activity,GO:0004104~cholinesterase activity,GO:0004305~ethanolamine kinase activity,GO:0004871~signal transducer activity,GO:0005524~ATP binding,GO:0008144~drug binding,GO:0016301~kinase activity,GO:0033265~choline binding,GO:0042803~protein homodimerization activity,	IPR011009:Protein kinase-like domain,	hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,hsa05231:Choline metabolism in cancer,				3D-structure,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Lipid biosynthesis,Lipid metabolism,Nucleotide-binding,Phospholipid biosynthesis,Phospholipid metabolism,Polymorphism,Proteomics identification,Reference proteome,Transferase,	binding site:ATP,chain:Choline kinase alpha,compositionally biased region:Pro-rich,helix,nucleotide phosphate-binding region:ATP,region of interest:Substrate binding,sequence conflict,sequence variant,splice variant,strand,
Q5R6X7	chromobox 3(CBX3)	Pongo abelii				GO:0006351~transcription, DNA-templated,GO:0016568~chromatin modification,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,	GO:0000779~condensed chromosome, centromeric region,GO:0000784~nuclear chromosome, telomeric region,GO:0000785~chromatin,GO:0005635~nuclear envelope,GO:0005719~nuclear euchromatin,GO:0005720~nuclear heterochromatin,GO:0005819~spindle,GO:0031618~nuclear pericentric heterochromatin,	GO:0019904~protein domain specific binding,	IPR000953:Chromo domain/shadow,IPR008251:Chromo shadow domain,IPR016197:Chromo domain-like,IPR017984:Chromo domain subgroup,IPR023779:Chromo domain, conserved site,IPR023780:Chromo domain,				SM00298:CHROMO,SM00300:ChSh,	Acetylation,Biological rhythms,Chromatin regulator,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Chromobox protein homolog 3,domain:Chromo 1,domain:Chromo 2; shadow subtype,modified residue,
Q8N6F1	claudin 19(CLDN19)	Homo sapiens				GO:0007601~visual perception,GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,GO:0019227~neuronal action potential propagation,GO:0043297~apical junction assembly,GO:0050896~response to stimulus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005923~bicellular tight junction,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0043296~apical junction complex,	GO:0005198~structural molecule activity,GO:0042802~identical protein binding,	IPR004031:PMP-22/EMP/MP20/Claudin,IPR006187:Claudin,IPR017974:Claudin, conserved site,	hsa04514:Cell adhesion molecules (CAMs),hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,hsa05160:Hepatitis C,	248190~Hypomagnesemia 5, renal, with ocular involvement,			Alternative splicing,Cell junction,Cell membrane,Complete proteome,Disease mutation,Magnesium,Membrane,Primary hypomagnesemia,Reference proteome,Sensory transduction,Tight junction,Transmembrane,Transmembrane helix,Vision,	chain:Claudin-19,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P26824	coagulation factor II (thrombin) receptor(F2r)	Rattus norvegicus				GO:0000186~activation of MAPKK activity,GO:0002248~connective tissue replacement involved in inflammatory response wound healing,GO:0003105~negative regulation of glomerular filtration,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0007260~tyrosine phosphorylation of STAT protein,GO:0007262~STAT protein import into nucleus,GO:0007529~establishment of synaptic specificity at neuromuscular junction,GO:0007596~blood coagulation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009611~response to wounding,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0030168~platelet activation,GO:0030193~regulation of blood coagulation,GO:0030194~positive regulation of blood coagulation,GO:0030335~positive regulation of cell migration,GO:0032496~response to lipopolysaccharide,GO:0032651~regulation of interleukin-1 beta production,GO:0032967~positive regulation of collagen biosynthetic process,GO:0035025~positive regulation of Rho protein signal transduction,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0043524~negative regulation of neuron apoptotic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045907~positive regulation of vasoconstriction,GO:0045987~positive regulation of smooth muscle contraction,GO:0046427~positive regulation of JAK-STAT cascade,GO:0048873~homeostasis of number of cells within a tissue,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0051928~positive regulation of calcium ion transport,GO:0051930~regulation of sensory perception of pain,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070493~thrombin receptor signaling pathway,GO:1900134~negative regulation of renin secretion into blood stream,GO:2000484~positive regulation of interleukin-8 secretion,GO:2000778~positive regulation of interleukin-6 secretion,	GO:0005769~early endosome,GO:0005770~late endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0031094~platelet dense tubular network,GO:0031594~neuromuscular junction,GO:0045211~postsynaptic membrane,	GO:0001965~G-protein alpha-subunit binding,GO:0004930~G-protein coupled receptor activity,GO:0005102~receptor binding,GO:0015057~thrombin receptor activity,GO:0031681~G-protein beta-subunit binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000935:Thrombin receptor,IPR003912:Protease-activated receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	rno04015:Rap1 signaling pathway,rno04020:Calcium signaling pathway,rno04024:cAMP signaling pathway,rno04080:Neuroactive ligand-receptor interaction,rno04144:Endocytosis,rno04151:PI3K-Akt signaling pathway,rno04610:Complement and coagulation cascades,rno04611:Platelet activation,rno04810:Regulation of actin cytoskeleton,rno05200:Pathways in cancer,				Blood coagulation,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Hemostasis,Membrane,Phosphoprotein,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Proteinase-activated receptor 1,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Pro,disulfide bond,glycosylation site:N-linked (GlcNAc...),propeptide:Removed for receptor activation,signal peptide,site:Cleavage; by thrombin,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P25116	coagulation factor II thrombin receptor(F2R)	Homo sapiens		h_amiPathway:Acute Myocardial Infarction,h_extrinsicPathway:Extrinsic Prothrombin Activation Pathway,h_fibrinolysisPathway:Fibrinolysis Pathway,h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway,h_par1pathway:Thrombin signaling and protease-activated receptors,h_sppaPathway:Aspirin Blocks Signaling Pathway Involved in Platelet Activation,		GO:0000186~activation of MAPKK activity,GO:0002248~connective tissue replacement involved in inflammatory response wound healing,GO:0003105~negative regulation of glomerular filtration,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0007260~tyrosine phosphorylation of STAT protein,GO:0007262~STAT protein import into nucleus,GO:0007529~establishment of synaptic specificity at neuromuscular junction,GO:0007596~blood coagulation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009611~response to wounding,GO:0009653~anatomical structure morphogenesis,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0030168~platelet activation,GO:0030193~regulation of blood coagulation,GO:0030194~positive regulation of blood coagulation,GO:0030335~positive regulation of cell migration,GO:0032496~response to lipopolysaccharide,GO:0032651~regulation of interleukin-1 beta production,GO:0032967~positive regulation of collagen biosynthetic process,GO:0035025~positive regulation of Rho protein signal transduction,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0043524~negative regulation of neuron apoptotic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045907~positive regulation of vasoconstriction,GO:0045987~positive regulation of smooth muscle contraction,GO:0046427~positive regulation of JAK-STAT cascade,GO:0048873~homeostasis of number of cells within a tissue,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0051928~positive regulation of calcium ion transport,GO:0051930~regulation of sensory perception of pain,GO:0060155~platelet dense granule organization,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070493~thrombin receptor signaling pathway,GO:1900134~negative regulation of renin secretion into blood stream,GO:2000484~positive regulation of interleukin-8 secretion,GO:2000778~positive regulation of interleukin-6 secretion,	GO:0005576~extracellular region,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005901~caveola,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0031094~platelet dense tubular network,GO:0031594~neuromuscular junction,GO:0045211~postsynaptic membrane,	GO:0001965~G-protein alpha-subunit binding,GO:0004930~G-protein coupled receptor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0015057~thrombin receptor activity,GO:0031681~G-protein beta-subunit binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000935:Thrombin receptor,IPR003912:Protease-activated receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04015:Rap1 signaling pathway,hsa04020:Calcium signaling pathway,hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04144:Endocytosis,hsa04151:PI3K-Akt signaling pathway,hsa04610:Complement and coagulation cascades,hsa04611:Platelet activation,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,				3D-structure,Blood coagulation,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Hemostasis,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Proteinase-activated receptor 1,compositionally biased region:Asp/Glu-rich (acidic),disulfide bond,glycosylation site:N-linked (GlcNAc...),propeptide:Removed for receptor activation,sequence conflict,sequence variant,signal peptide,site:Cleavage; by thrombin,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P05160	coagulation factor XIII B chain(F13B)	Homo sapiens				GO:0007596~blood coagulation,	GO:0005576~extracellular region,		IPR000436:Sushi/SCR/CCP,	hsa04610:Complement and coagulation cascades,	613235~Factor XIIIB deficiency,		SM00032:CCP,	Blood coagulation,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hemostasis,Polymorphism,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Coagulation factor XIII B chain,disulfide bond,domain:Sushi 1,domain:Sushi 10,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,domain:Sushi 9,glycosylation site:N-linked (GlcNAc...),sequence variant,short sequence motif:Cell attachment site,signal peptide,
Q07968	coagulation factor XIII, beta subunit(F13b)	Mus musculus				GO:0007596~blood coagulation,GO:0007599~hemostasis,	GO:0005576~extracellular region,		IPR000436:Sushi/SCR/CCP,	mmu04610:Complement and coagulation cascades,			SM00032:CCP,	Blood coagulation,Complete proteome,Disulfide bond,Glycoprotein,Hemostasis,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Coagulation factor XIII B chain,disulfide bond,domain:Sushi 1,domain:Sushi 10,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,domain:Sushi 9,glycosylation site:N-linked (GlcNAc...),signal peptide,
A7I9K5	cobyric acid synthase(MBOO_RS09900)	Methanoregula boonei 6A8				GO:0006541~glutamine metabolic process,GO:0009236~cobalamin biosynthetic process,		GO:0015420~cobalamin-transporting ATPase activity,	IPR002586:CobQ/CobB/MinD/ParA nucleotide binding domain,IPR004459:Cobyric acid synthase CobQ,IPR011698:CobB/CobQ-like glutamine amidotransferase,IPR017929:CobB/CobQ glutamine amidotransferase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	mbn00860:Porphyrin and chlorophyll metabolism,mbn01100:Metabolic pathways,				Cobalamin biosynthesis,Complete proteome,Glutamine amidotransferase,Reference proteome,	active site:Nucleophile,chain:Probable cobyric acid synthase,domain:GATase cobBQ-type,
Q63ZW2	coiled-coil-helix-coiled-coil-helix domain containing 6a(chchd6a)	Danio rerio				GO:0006974~cellular response to DNA damage stimulus,GO:0042407~cristae formation,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0061617~MICOS complex,		IPR007964:Protein of unknown function DUF737,					Coiled coil,Complete proteome,Disulfide bond,Lipoprotein,Membrane,Mitochondrion,Mitochondrion inner membrane,Myristate,Proteomics identification,Reference proteome,
P02457	collagen, type I, alpha 1(COL1A1)	Gallus gallus					GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,	GO:0005201~extracellular matrix structural constituent,GO:0046872~metal ion binding,	IPR000885:Fibrillar collagen, C-terminal,IPR001007:von Willebrand factor, type C,IPR008160:Collagen triple helix repeat,				SM00038:COLFI,SM00214:VWC,	Calcium,Collagen,Complete proteome,Direct protein sequencing,Disulfide bond,Extracellular matrix,Glycoprotein,Hydroxylation,Metal-binding,Pyrrolidone carboxylic acid,Reference proteome,Repeat,Secreted,Signal,	chain:Collagen alpha-1(I) chain,domain:Fibrillar collagen NC1,domain:VWFC,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Gal...); partial,modified residue,propeptide:C-terminal propeptide,propeptide:N-terminal propeptide,sequence conflict,signal peptide,site:Not glycosylated,
O93484	collagen, type I, alpha 2(col1a2)	Oncorhynchus mykiss					GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,	GO:0005201~extracellular matrix structural constituent,GO:0046872~metal ion binding,	IPR000885:Fibrillar collagen, C-terminal,IPR008160:Collagen triple helix repeat,				SM00038:COLFI,	Calcium,Collagen,Disulfide bond,Extracellular matrix,Glycoprotein,Hydroxylation,Metal-binding,Repeat,Secreted,Signal,	chain:Collagen alpha-2(I) chain,domain:Fibrillar collagen NC1,glycosylation site:N-linked (GlcNAc...),propeptide:C-terminal propeptide,propeptide:N-terminal propeptide,signal peptide,
Q9I8N6	colony stimulating factor 1 receptor, a(csf1ra)	Danio rerio				GO:0002376~immune system process,GO:0006468~protein phosphorylation,GO:0006954~inflammatory response,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0010759~positive regulation of macrophage chemotaxis,GO:0014004~microglia differentiation,GO:0016310~phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0030318~melanocyte differentiation,GO:0036035~osteoclast development,GO:0043473~pigmentation,GO:0045087~innate immune response,GO:0048066~developmental pigmentation,GO:0048246~macrophage chemotaxis,GO:0050936~xanthophore differentiation,GO:0061075~positive regulation of neural retina development,GO:0097324~melanocyte migration,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0019955~cytokine binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001824:Tyrosine-protein kinase, receptor class III, conserved site,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013783:Immunoglobulin-like fold,IPR016243:Tyrosine-protein kinase, CSF-1/PDGF receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	dre04060:Cytokine-cytokine receptor interaction,dre04144:Endocytosis,		PIRSF000615:tyrosine-protein kinase, CSF-1/PDGF receptor type,PIRSF500947:macrophage colony-stimulating factor 1 receptor [Parent=PIRSF000615],	SM00219:TyrKc,SM00408:IGc2,SM00409:IG,	ATP-binding,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Inflammatory response,Innate immunity,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Macrophage colony-stimulating factor 1 receptor,compositionally biased region:Poly-Leu,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q2KIV9	complement C1q B chain(C1QB)	Bos taurus				GO:0006958~complement activation, classical pathway,GO:0045087~innate immune response,GO:0048839~inner ear development,	GO:0005581~collagen trimer,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0042803~protein homodimerization activity,	IPR001073:Complement C1q protein,IPR008160:Collagen triple helix repeat,IPR008983:Tumour necrosis factor-like domain,	bta04610:Complement and coagulation cascades,bta05020:Prion diseases,bta05133:Pertussis,bta05142:Chagas disease (American trypanosomiasis),bta05150:Staphylococcus aureus infection,bta05322:Systemic lupus erythematosus,			SM00110:C1Q,	Collagen,Complement pathway,Complete proteome,Disulfide bond,Glycoprotein,Hydroxylation,Immunity,Innate immunity,Pyrrolidone carboxylic acid,Reference proteome,Repeat,Secreted,Signal,	chain:Complement C1q subcomponent subunit B,disulfide bond,domain:C1q,domain:Collagen-like,glycosylation site:O-linked (Gal...),modified residue,signal peptide,
P31722	complement C1q C chain(C1qc)	Rattus norvegicus				GO:0006958~complement activation, classical pathway,GO:0030853~negative regulation of granulocyte differentiation,GO:0045087~innate immune response,GO:0045650~negative regulation of macrophage differentiation,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005615~extracellular space,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,		IPR001073:Complement C1q protein,IPR008160:Collagen triple helix repeat,IPR008983:Tumour necrosis factor-like domain,	rno04610:Complement and coagulation cascades,rno05020:Prion diseases,rno05133:Pertussis,rno05142:Chagas disease (American trypanosomiasis),rno05150:Staphylococcus aureus infection,rno05322:Systemic lupus erythematosus,			SM00110:C1Q,	Collagen,Complement pathway,Complete proteome,Direct protein sequencing,Disulfide bond,Hydroxylation,Immunity,Innate immunity,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Complement C1q subcomponent subunit C,disulfide bond,domain:C1q,domain:Collagen-like,modified residue,signal peptide,
Q7Z5L3	complement C1q like 2(C1QL2)	Homo sapiens				GO:0051259~protein oligomerization,	GO:0005576~extracellular region,GO:0005581~collagen trimer,	GO:0042802~identical protein binding,	IPR001073:Complement C1q protein,IPR004345:TB2/DP1/HVA22-related protein,IPR008160:Collagen triple helix repeat,IPR008983:Tumour necrosis factor-like domain,				SM00110:C1Q,	Collagen,Complete proteome,Reference proteome,Secreted,Signal,	chain:Complement C1q-like protein 2,domain:C1q,domain:Collagen-like,signal peptide,
Q3SYW2	complement C2(C2)	Bos taurus				GO:0006508~proteolysis,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0045087~innate immune response,GO:2000427~positive regulation of apoptotic cell clearance,	GO:0005576~extracellular region,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,GO:0046872~metal ion binding,	IPR000436:Sushi/SCR/CCP,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR002035:von Willebrand factor, type A,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR011360:Complement B/C2,IPR018114:Peptidase S1, trypsin family, active site,	bta04610:Complement and coagulation cascades,bta05133:Pertussis,bta05150:Staphylococcus aureus infection,bta05322:Systemic lupus erythematosus,		PIRSF001154:complement B/C2,	SM00020:Tryp_SPc,SM00032:CCP,SM00327:VWA,	Complement pathway,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Immunity,Innate immunity,Metal-binding,Protease,Reference proteome,Repeat,Secreted,Serine protease,Signal,Sushi,	active site:Charge relay system,chain:Complement C2,chain:Complement C2a fragment,chain:Complement C2b fragment,disulfide bond,domain:Peptidase S1,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:VWFA,glycosylation site:N-linked (GlcNAc...),signal peptide,
P06681	complement C2(C2)	Homo sapiens		h_classicPathway:Classical Complement Pathway,h_compPathway:Complement Pathway,h_lectinPathway:Lectin Induced Complement Pathway,		GO:0006508~proteolysis,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0007584~response to nutrient,GO:0030449~regulation of complement activation,GO:0045087~innate immune response,GO:2000427~positive regulation of apoptotic cell clearance,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,GO:0046872~metal ion binding,	IPR000436:Sushi/SCR/CCP,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR002035:von Willebrand factor, type A,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR011360:Complement B/C2,IPR018114:Peptidase S1, trypsin family, active site,	hsa04610:Complement and coagulation cascades,hsa05133:Pertussis,hsa05150:Staphylococcus aureus infection,hsa05322:Systemic lupus erythematosus,	217000~C2 deficiency,615489~Macular degeneration, age-related, 14, reduced risk of,	PIRSF001154:complement B/C2,	SM00020:Tryp_SPc,SM00032:CCP,SM00327:VWA,	3D-structure,Alternative splicing,Complement pathway,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hydrolase,Immunity,Innate immunity,Magnesium,Manganese,Metal-binding,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Secreted,Serine protease,Signal,Sushi,	active site:Charge relay system,chain:Complement C2,chain:Complement C2a fragment,chain:Complement C2b fragment,disulfide bond,domain:Peptidase S1,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:VWFA,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,strand,turn,
Q8SQ74	complement C2(C2)	Pan troglodytes				GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0045087~innate immune response,GO:2000427~positive regulation of apoptotic cell clearance,	GO:0005576~extracellular region,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,GO:0046872~metal ion binding,	IPR000436:Sushi/SCR/CCP,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR002035:von Willebrand factor, type A,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR011360:Complement B/C2,IPR018114:Peptidase S1, trypsin family, active site,	ptr04610:Complement and coagulation cascades,ptr05133:Pertussis,ptr05150:Staphylococcus aureus infection,ptr05322:Systemic lupus erythematosus,		PIRSF001154:complement B/C2,	SM00020:Tryp_SPc,SM00032:CCP,SM00327:VWA,	Complement pathway,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Immunity,Innate immunity,Metal-binding,Protease,Reference proteome,Repeat,Secreted,Serine protease,Signal,Sushi,
Q2UVX4	complement C3(C3)	Bos taurus			General function prediction only,	GO:0001798~positive regulation of type IIa hypersensitivity,GO:0001934~positive regulation of protein phosphorylation,GO:0001970~positive regulation of activation of membrane attack complex,GO:0006631~fatty acid metabolic process,GO:0006954~inflammatory response,GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,GO:0006958~complement activation, classical pathway,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010828~positive regulation of glucose transport,GO:0010866~regulation of triglyceride biosynthetic process,GO:0010884~positive regulation of lipid storage,GO:0010951~negative regulation of endopeptidase activity,GO:0045745~positive regulation of G-protein coupled receptor protein signaling pathway,GO:0045766~positive regulation of angiogenesis,GO:2000427~positive regulation of apoptotic cell clearance,	GO:0005615~extracellular space,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0004866~endopeptidase inhibitor activity,GO:0031715~C5L2 anaphylatoxin chemotactic receptor binding,	IPR000020:Anaphylatoxin/fibulin,IPR001134:Netrin domain,IPR001599:Alpha-2-macroglobulin,IPR001840:Complement C3a/C4a/C5a anaphylatoxin,IPR002890:Alpha-2-macroglobulin, N-terminal,IPR008930:Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid,IPR008993:Tissue inhibitor of metalloproteinases-like, OB-fold,IPR009048:Alpha-macroglobulin, receptor-binding,IPR011625:Alpha-2-macroglobulin, N-terminal 2,IPR011626:A-macroglobulin complement component,IPR018081:Anaphylatoxin,IPR018933:Netrin module, non-TIMP type,IPR019565:Alpha-2-macroglobulin, thiol-ester bond-forming,IPR019742:Alpha-2-macroglobulin, conserved site,	bta04145:Phagosome,bta04610:Complement and coagulation cascades,bta05133:Pertussis,bta05134:Legionellosis,bta05140:Leishmaniasis,bta05142:Chagas disease (American trypanosomiasis),bta05150:Staphylococcus aureus infection,bta05152:Tuberculosis,bta05168:Herpes simplex infection,bta05203:Viral carcinogenesis,bta05322:Systemic lupus erythematosus,			SM00104:ANATO,SM00643:C345C,SM01359:SM01359,SM01360:SM01360,SM01361:SM01361,	3D-structure,Cleavage on pair of basic residues,Complement alternate pathway,Complement pathway,Complete proteome,Disulfide bond,Fatty acid metabolism,Glycoprotein,Immunity,Inflammatory response,Innate immunity,Lipid metabolism,Phosphoprotein,Proteomics identification,Reference proteome,Secreted,Signal,Thioester bond,	chain:C3a anaphylatoxin,chain:Complement C3,chain:Complement C3 alpha chain,chain:complement C3 beta chain,chain:Complement C3b alpha' chain,chain:Complement C3c alpha' chain fragment 1,chain:Complement C3c alpha' chain fragment 2,chain:Complement C3d fragment,chain:Complement C3dg fragment,chain:Complement C3g fragment,cross-link:Isoglutamyl cysteine thioester (Cys-Gln),disulfide bond,domain:Anaphylatoxin-like,domain:NTR,glycosylation site:N-linked (GlcNAc...),helix,modified residue,peptide:Complement C3f fragment,region of interest:Properdin-binding,sequence conflict,signal peptide,site:Cleavage; by C3 convertase,site:Cleavage; by factor I,strand,turn,
P12387	complement C3(C3)	Cavia porcellus				GO:0001798~positive regulation of type IIa hypersensitivity,GO:0001934~positive regulation of protein phosphorylation,GO:0001970~positive regulation of activation of membrane attack complex,GO:0006954~inflammatory response,GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,GO:0006958~complement activation, classical pathway,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010828~positive regulation of glucose transport,GO:0010866~regulation of triglyceride biosynthetic process,GO:0010884~positive regulation of lipid storage,GO:0045745~positive regulation of G-protein coupled receptor protein signaling pathway,GO:0045766~positive regulation of angiogenesis,GO:2000427~positive regulation of apoptotic cell clearance,	GO:0005615~extracellular space,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0004866~endopeptidase inhibitor activity,GO:0031715~C5L2 anaphylatoxin chemotactic receptor binding,	IPR000020:Anaphylatoxin/fibulin,IPR001134:Netrin domain,IPR001599:Alpha-2-macroglobulin,IPR001840:Complement C3a/C4a/C5a anaphylatoxin,IPR002890:Alpha-2-macroglobulin, N-terminal,IPR008930:Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid,IPR008993:Tissue inhibitor of metalloproteinases-like, OB-fold,IPR009048:Alpha-macroglobulin, receptor-binding,IPR011625:Alpha-2-macroglobulin, N-terminal 2,IPR011626:A-macroglobulin complement component,IPR018081:Anaphylatoxin,IPR018933:Netrin module, non-TIMP type,IPR019565:Alpha-2-macroglobulin, thiol-ester bond-forming,IPR019742:Alpha-2-macroglobulin, conserved site,				SM00104:ANATO,SM00643:C345C,SM01359:SM01359,SM01360:SM01360,SM01361:SM01361,	Cleavage on pair of basic residues,Complement alternate pathway,Complement pathway,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Inflammatory response,Innate immunity,Phosphoprotein,Reference proteome,Secreted,Signal,Thioester bond,	chain:C3a anaphylatoxin,chain:Complement C3,chain:Complement C3 alpha chain,chain:complement C3 beta chain,chain:Complement C3b alpha' chain,chain:Complement C3c alpha' chain fragment 1,chain:Complement C3c alpha' chain fragment 2,chain:Complement C3d fragment,chain:Complement C3dg fragment,chain:Complement C3g fragment,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Leu,cross-link:Isoglutamyl cysteine thioester (Cys-Gln),disulfide bond,domain:Anaphylatoxin-like,domain:NTR,glycosylation site:N-linked (GlcNAc...),modified residue,peptide:Complement C3f fragment,region of interest:Properdin-binding,sequence conflict,signal peptide,site:Cleavage; by C3 convertase,site:Cleavage; by elastase,site:Cleavage; by factor I,
P01025	complement C3(C3)	Sus scrofa				GO:0001934~positive regulation of protein phosphorylation,GO:0006631~fatty acid metabolic process,GO:0006954~inflammatory response,GO:0006957~complement activation, alternative pathway,GO:0006958~complement activation, classical pathway,GO:0010828~positive regulation of glucose transport,GO:0010866~regulation of triglyceride biosynthetic process,GO:0010884~positive regulation of lipid storage,GO:0010951~negative regulation of endopeptidase activity,GO:0045087~innate immune response,GO:0045745~positive regulation of G-protein coupled receptor protein signaling pathway,	GO:0005615~extracellular space,	GO:0004866~endopeptidase inhibitor activity,GO:0005515~protein binding,GO:0031715~C5L2 anaphylatoxin chemotactic receptor binding,	IPR000020:Anaphylatoxin/fibulin,IPR001134:Netrin domain,IPR001599:Alpha-2-macroglobulin,IPR001840:Complement C3a/C4a/C5a anaphylatoxin,IPR002890:Alpha-2-macroglobulin, N-terminal,IPR008930:Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid,IPR008993:Tissue inhibitor of metalloproteinases-like, OB-fold,IPR009048:Alpha-macroglobulin, receptor-binding,IPR011625:Alpha-2-macroglobulin, N-terminal 2,IPR011626:A-macroglobulin complement component,IPR018081:Anaphylatoxin,IPR018933:Netrin module, non-TIMP type,IPR019565:Alpha-2-macroglobulin, thiol-ester bond-forming,IPR019742:Alpha-2-macroglobulin, conserved site,	ssc04145:Phagosome,ssc04610:Complement and coagulation cascades,ssc05133:Pertussis,ssc05134:Legionellosis,ssc05140:Leishmaniasis,ssc05142:Chagas disease (American trypanosomiasis),ssc05150:Staphylococcus aureus infection,ssc05152:Tuberculosis,ssc05168:Herpes simplex infection,ssc05203:Viral carcinogenesis,ssc05322:Systemic lupus erythematosus,			SM00104:ANATO,SM00643:C345C,SM01359:SM01359,SM01360:SM01360,SM01361:SM01361,	Cleavage on pair of basic residues,Complement alternate pathway,Complement pathway,Complete proteome,Direct protein sequencing,Disulfide bond,Fatty acid metabolism,Glycoprotein,Immunity,Inflammatory response,Innate immunity,Lipid metabolism,Phosphoprotein,Reference proteome,Secreted,Signal,Thioester bond,
P01024	complement C3(C3)	Homo sapiens	18.Cytokine_astocytes,	h_alternativePathway:Alternative Complement Pathway,h_classicPathway:Classical Complement Pathway,h_compPathway:Complement Pathway,h_LairPathway:Cells and Molecules involved in local acute inflammatory response,h_lectinPathway:Lectin Induced Complement Pathway,	General function prediction only,	GO:0001798~positive regulation of type IIa hypersensitivity,GO:0001934~positive regulation of protein phosphorylation,GO:0001970~positive regulation of activation of membrane attack complex,GO:0002507~tolerance induction,GO:0006508~proteolysis,GO:0006631~fatty acid metabolic process,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,GO:0006958~complement activation, classical pathway,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007596~blood coagulation,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010828~positive regulation of glucose transport,GO:0010866~regulation of triglyceride biosynthetic process,GO:0010884~positive regulation of lipid storage,GO:0010951~negative regulation of endopeptidase activity,GO:0030449~regulation of complement activation,GO:0032026~response to magnesium ion,GO:0032355~response to estradiol,GO:0032570~response to progesterone,GO:0045745~positive regulation of G-protein coupled receptor protein signaling pathway,GO:0045766~positive regulation of angiogenesis,GO:0048639~positive regulation of developmental growth,GO:0050766~positive regulation of phagocytosis,GO:0050776~regulation of immune response,GO:0051384~response to glucocorticoid,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:2000427~positive regulation of apoptotic cell clearance,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0004252~serine-type endopeptidase activity,GO:0004866~endopeptidase inhibitor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008289~lipid binding,GO:0031715~C5L2 anaphylatoxin chemotactic receptor binding,GO:0048037~cofactor binding,	IPR000020:Anaphylatoxin/fibulin,IPR001134:Netrin domain,IPR001599:Alpha-2-macroglobulin,IPR001840:Complement C3a/C4a/C5a anaphylatoxin,IPR002890:Alpha-2-macroglobulin, N-terminal,IPR008930:Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid,IPR008993:Tissue inhibitor of metalloproteinases-like, OB-fold,IPR009048:Alpha-macroglobulin, receptor-binding,IPR011625:Alpha-2-macroglobulin, N-terminal 2,IPR011626:A-macroglobulin complement component,IPR018081:Anaphylatoxin,IPR018933:Netrin module, non-TIMP type,IPR019565:Alpha-2-macroglobulin, thiol-ester bond-forming,IPR019742:Alpha-2-macroglobulin, conserved site,	hsa04145:Phagosome,hsa04610:Complement and coagulation cascades,hsa05133:Pertussis,hsa05134:Legionellosis,hsa05140:Leishmaniasis,hsa05142:Chagas disease (American trypanosomiasis),hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05168:Herpes simplex infection,hsa05203:Viral carcinogenesis,hsa05322:Systemic lupus erythematosus,	611378~Macular degeneration, age-related, 9,612925~Hemolytic uremic syndrome, atypical, susceptibility to, 5,613779~C3 deficiency,		SM00104:ANATO,SM00643:C345C,SM01359:SM01359,SM01360:SM01360,SM01361:SM01361,	3D-structure,Age-related macular degeneration,Cleavage on pair of basic residues,Complement alternate pathway,Complement pathway,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Fatty acid metabolism,Glycoprotein,Hemolytic uremic syndrome,Immunity,Inflammatory response,Innate immunity,Lipid metabolism,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Thioester bond,	chain:C3a anaphylatoxin,chain:Complement C3,chain:Complement C3 alpha chain,chain:complement C3 beta chain,chain:Complement C3b alpha' chain,chain:Complement C3c alpha' chain fragment 1,chain:Complement C3c alpha' chain fragment 2,chain:Complement C3d fragment,chain:Complement C3dg fragment,chain:Complement C3g fragment,cross-link:Isoglutamyl cysteine thioester (Cys-Gln),disulfide bond,domain:Anaphylatoxin-like,domain:NTR,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,peptide:Complement C3f fragment,region of interest:Properdin-binding,sequence conflict,sequence variant,signal peptide,site:Cleavage; by C3 convertase,site:Cleavage; by factor I,strand,turn,
P0C0L4	complement C4A (Rodgers blood group)(C4A)	Homo sapiens		h_classicPathway:Classical Complement Pathway,h_compPathway:Complement Pathway,h_lectinPathway:Lectin Induced Complement Pathway,	General function prediction only,	GO:0006508~proteolysis,GO:0006954~inflammatory response,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0010951~negative regulation of endopeptidase activity,GO:0030449~regulation of complement activation,GO:0045087~innate immune response,GO:2000427~positive regulation of apoptotic cell clearance,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0030054~cell junction,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0045202~synapse,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0001849~complement component C1q binding,GO:0004252~serine-type endopeptidase activity,GO:0004866~endopeptidase inhibitor activity,	IPR000020:Anaphylatoxin/fibulin,IPR001134:Netrin domain,IPR001599:Alpha-2-macroglobulin,IPR001840:Complement C3a/C4a/C5a anaphylatoxin,IPR002890:Alpha-2-macroglobulin, N-terminal,IPR008930:Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid,IPR008993:Tissue inhibitor of metalloproteinases-like, OB-fold,IPR009048:Alpha-macroglobulin, receptor-binding,IPR011625:Alpha-2-macroglobulin, N-terminal 2,IPR011626:A-macroglobulin complement component,IPR018081:Anaphylatoxin,IPR018933:Netrin module, non-TIMP type,IPR019565:Alpha-2-macroglobulin, thiol-ester bond-forming,IPR019742:Alpha-2-macroglobulin, conserved site,	hsa04610:Complement and coagulation cascades,hsa05133:Pertussis,hsa05150:Staphylococcus aureus infection,hsa05322:Systemic lupus erythematosus,	614374~Blood group, Rodgers,614380~C4a deficiency,		SM00104:ANATO,SM00643:C345C,SM01359:SM01359,SM01360:SM01360,SM01361:SM01361,	3D-structure,Alternative splicing,Blood group antigen,Cell junction,Cell projection,Cleavage on pair of basic residues,Complement pathway,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Immunity,Inflammatory response,Innate immunity,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Sulfation,Synapse,Systemic lupus erythematosus,Thioester bond,	chain:C4a anaphylatoxin,chain:C4b-A,chain:C4d-A,chain:Complement C4 beta chain,chain:Complement C4 gamma chain,chain:Complement C4-A alpha chain,cross-link:Isoglutamyl cysteine thioester (Cys-Gln),disulfide bond,domain:Anaphylatoxin-like,domain:NTR,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,signal peptide,turn,
P01031	complement C5(C5)	Homo sapiens		h_alternativePathway:Alternative Complement Pathway,h_classicPathway:Classical Complement Pathway,h_compPathway:Complement Pathway,h_granulocytesPathway:Adhesion and Diapedesis of Granulocytes,h_LairPathway:Cells and Molecules involved in local acute inflammatory response,h_lectinPathway:Lectin Induced Complement Pathway,		GO:0000187~activation of MAPK activity,GO:0001701~in utero embryonic development,GO:0006935~chemotaxis,GO:0006950~response to stress,GO:0006954~inflammatory response,GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,GO:0006958~complement activation, classical pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010760~negative regulation of macrophage chemotaxis,GO:0010951~negative regulation of endopeptidase activity,GO:0019835~cytolysis,GO:0030449~regulation of complement activation,GO:0045766~positive regulation of angiogenesis,GO:0060326~cell chemotaxis,GO:0090197~positive regulation of chemokine secretion,GO:0098779~mitophagy in response to mitochondrial depolarization,	GO:0005576~extracellular region,GO:0005579~membrane attack complex,GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0004866~endopeptidase inhibitor activity,GO:0005102~receptor binding,GO:0008009~chemokine activity,	IPR000020:Anaphylatoxin/fibulin,IPR001134:Netrin domain,IPR001599:Alpha-2-macroglobulin,IPR001840:Complement C3a/C4a/C5a anaphylatoxin,IPR002890:Alpha-2-macroglobulin, N-terminal,IPR008930:Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid,IPR008993:Tissue inhibitor of metalloproteinases-like, OB-fold,IPR009048:Alpha-macroglobulin, receptor-binding,IPR011625:Alpha-2-macroglobulin, N-terminal 2,IPR011626:A-macroglobulin complement component,IPR018081:Anaphylatoxin,IPR018933:Netrin module, non-TIMP type,	hsa04610:Complement and coagulation cascades,hsa05020:Prion diseases,hsa05133:Pertussis,hsa05150:Staphylococcus aureus infection,hsa05168:Herpes simplex infection,hsa05322:Systemic lupus erythematosus,	609536~C5 deficiency,615749~Eculizumab, poor response to,		SM00104:ANATO,SM00643:C345C,SM01359:SM01359,SM01360:SM01360,SM01361:SM01361,	3D-structure,Cleavage on pair of basic residues,Complement alternate pathway,Complement pathway,Complete proteome,Cytolysis,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Inflammatory response,Innate immunity,Membrane attack complex,Polymorphism,Reference proteome,Secreted,Signal,	chain:C5a anaphylatoxin,chain:Complement C5 alpha chain,chain:Complement C5 alpha' chain,chain:Complement C5 beta chain,disulfide bond,domain:Anaphylatoxin-like,domain:NTR,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,signal peptide,strand,turn,
Q29RU4	complement C6(C6)	Bos taurus				GO:0001701~in utero embryonic development,GO:0001970~positive regulation of activation of membrane attack complex,GO:0006955~immune response,GO:0006958~complement activation, classical pathway,GO:0019835~cytolysis,GO:0045087~innate immune response,GO:0045766~positive regulation of angiogenesis,	GO:0005576~extracellular region,GO:0005579~membrane attack complex,GO:0070062~extracellular exosome,		IPR000436:Sushi/SCR/CCP,IPR000884:Thrombospondin, type 1 repeat,IPR001862:Membrane attack complex component/perforin/complement C9,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR002350:Kazal domain,IPR003884:Factor I / membrane attack complex,IPR020863:Membrane attack complex component/perforin domain, conserved site,IPR020864:Membrane attack complex component/perforin (MACPF) domain,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,	bta04610:Complement and coagulation cascades,bta05020:Prion diseases,bta05322:Systemic lupus erythematosus,			SM00032:CCP,SM00057:FIMAC,SM00192:LDLa,SM00209:TSP1,SM00457:MACPF,	Complement pathway,Complete proteome,Cytolysis,Disulfide bond,EGF-like domain,Glycoprotein,Immunity,Innate immunity,Membrane attack complex,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Complement component C6,compositionally biased region:Poly-Ser,disulfide bond,domain:EGF-like,domain:Kazal-like 1,domain:Kazal-like 2,domain:LDL-receptor class A,domain:MACPF,domain:Sushi 1,domain:Sushi 2,domain:TSP type-1 1,domain:TSP type-1 2,domain:TSP type-1 3,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:C5B-binding domain,region of interest:Complement control factor I module 1,region of interest:Complement control factor I module 2,signal peptide,
P01027	complement component 3(C3)	Mus musculus		m_alternativePathway:Alternative Complement Pathway,m_classicPathway:Classical Complement Pathway,m_compPathway:Complement Pathway,m_lectinPathway:Lectin Induced Complement Pathway,		GO:0001798~positive regulation of type IIa hypersensitivity,GO:0001934~positive regulation of protein phosphorylation,GO:0001970~positive regulation of activation of membrane attack complex,GO:0002376~immune system process,GO:0002507~tolerance induction,GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006954~inflammatory response,GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,GO:0006958~complement activation, classical pathway,GO:0007596~blood coagulation,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010828~positive regulation of glucose transport,GO:0010866~regulation of triglyceride biosynthetic process,GO:0010884~positive regulation of lipid storage,GO:0032026~response to magnesium ion,GO:0032355~response to estradiol,GO:0032570~response to progesterone,GO:0045087~innate immune response,GO:0045745~positive regulation of G-protein coupled receptor protein signaling pathway,GO:0045766~positive regulation of angiogenesis,GO:0048639~positive regulation of developmental growth,GO:0050766~positive regulation of phagocytosis,GO:0051384~response to glucocorticoid,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:2000427~positive regulation of apoptotic cell clearance,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0004866~endopeptidase inhibitor activity,GO:0005515~protein binding,GO:0008289~lipid binding,GO:0031715~C5L2 anaphylatoxin chemotactic receptor binding,GO:0048037~cofactor binding,	IPR000020:Anaphylatoxin/fibulin,IPR001134:Netrin domain,IPR001599:Alpha-2-macroglobulin,IPR001840:Complement C3a/C4a/C5a anaphylatoxin,IPR002890:Alpha-2-macroglobulin, N-terminal,IPR008930:Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid,IPR008993:Tissue inhibitor of metalloproteinases-like, OB-fold,IPR009048:Alpha-macroglobulin, receptor-binding,IPR011625:Alpha-2-macroglobulin, N-terminal 2,IPR011626:A-macroglobulin complement component,IPR018081:Anaphylatoxin,IPR018933:Netrin module, non-TIMP type,IPR019565:Alpha-2-macroglobulin, thiol-ester bond-forming,IPR019742:Alpha-2-macroglobulin, conserved site,	mmu04145:Phagosome,mmu04610:Complement and coagulation cascades,mmu05133:Pertussis,mmu05134:Legionellosis,mmu05140:Leishmaniasis,mmu05142:Chagas disease (American trypanosomiasis),mmu05150:Staphylococcus aureus infection,mmu05152:Tuberculosis,mmu05168:Herpes simplex infection,mmu05203:Viral carcinogenesis,mmu05322:Systemic lupus erythematosus,			SM00104:ANATO,SM00643:C345C,SM01359:SM01359,SM01360:SM01360,SM01361:SM01361,	Alternative initiation,Cleavage on pair of basic residues,Complement alternate pathway,Complement pathway,Complete proteome,Direct protein sequencing,Disulfide bond,Fatty acid metabolism,Glycoprotein,Immunity,Inflammatory response,Innate immunity,Lipid metabolism,Phosphoprotein,Proteomics identification,Reference proteome,Secreted,Signal,Thioester bond,	chain:C3a anaphylatoxin,chain:Complement C3,chain:Complement C3 alpha chain,chain:complement C3 beta chain,chain:Complement C3b alpha' chain,chain:Complement C3c alpha' chain fragment 1,chain:Complement C3c alpha' chain fragment 2,chain:Complement C3d fragment,chain:Complement C3dg fragment,chain:Complement C3g fragment,cross-link:Isoglutamyl cysteine thioester (Cys-Gln),disulfide bond,domain:Anaphylatoxin-like,domain:NTR,glycosylation site:N-linked (GlcNAc...),modified residue,peptide:Complement C3f fragment,region of interest:Properdin-binding,sequence conflict,signal peptide,site:Cleavage; by C3 convertase,site:Cleavage; by factor I,splice variant,
Q63514	complement component 4 binding protein, alpha(C4bpa)	Rattus norvegicus				GO:0006955~immune response,GO:0006958~complement activation, classical pathway,GO:0007338~single fertilization,GO:0007339~binding of sperm to zona pellucida,GO:0045087~innate immune response,GO:0045732~positive regulation of protein catabolic process,GO:0045959~negative regulation of complement activation, classical pathway,	GO:0001669~acrosomal vesicle,GO:0002081~outer acrosomal membrane,GO:0002199~zona pellucida receptor complex,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0043159~acrosomal matrix,GO:0044216~other organism cell,GO:0044297~cell body,GO:0072562~blood microparticle,	GO:0001848~complement binding,GO:0044822~poly(A) RNA binding,	IPR000436:Sushi/SCR/CCP,	rno04610:Complement and coagulation cascades,rno05133:Pertussis,			SM00032:CCP,	Complement pathway,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:C4b-binding protein alpha chain,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,glycosylation site:N-linked (GlcNAc...),signal peptide,
P08649	complement component 4A (Rodgers blood group)(C4a)	Rattus norvegicus				GO:0006954~inflammatory response,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0010951~negative regulation of endopeptidase activity,GO:0045087~innate immune response,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0030054~cell junction,GO:0030424~axon,GO:0030425~dendrite,GO:0045202~synapse,	GO:0004866~endopeptidase inhibitor activity,	IPR000020:Anaphylatoxin/fibulin,IPR001134:Netrin domain,IPR001599:Alpha-2-macroglobulin,IPR001840:Complement C3a/C4a/C5a anaphylatoxin,IPR002890:Alpha-2-macroglobulin, N-terminal,IPR008930:Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid,IPR008993:Tissue inhibitor of metalloproteinases-like, OB-fold,IPR009048:Alpha-macroglobulin, receptor-binding,IPR011625:Alpha-2-macroglobulin, N-terminal 2,IPR011626:A-macroglobulin complement component,IPR018081:Anaphylatoxin,IPR018933:Netrin module, non-TIMP type,IPR019565:Alpha-2-macroglobulin, thiol-ester bond-forming,IPR019742:Alpha-2-macroglobulin, conserved site,	rno04610:Complement and coagulation cascades,rno05133:Pertussis,rno05150:Staphylococcus aureus infection,rno05322:Systemic lupus erythematosus,			SM00104:ANATO,SM00643:C345C,SM01359:SM01359,SM01360:SM01360,SM01361:SM01361,	Cell junction,Cell projection,Cleavage on pair of basic residues,Complement pathway,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Inflammatory response,Innate immunity,Proteomics identification,Reference proteome,Secreted,Signal,Sulfation,Synapse,Thioester bond,	chain:C4a anaphylatoxin,chain:Complement C4 alpha chain,chain:Complement C4 beta chain,chain:Complement C4 gamma chain,cross-link:Isoglutamyl cysteine thioester (Cys-Gln),disulfide bond,domain:Anaphylatoxin-like,domain:NTR,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,signal peptide,
P01030	complement component 4A(C4A)	Bos taurus				GO:0006954~inflammatory response,GO:0006958~complement activation, classical pathway,GO:0045087~innate immune response,	GO:0005615~extracellular space,GO:0030054~cell junction,GO:0030424~axon,GO:0030425~dendrite,GO:0045202~synapse,		IPR000020:Anaphylatoxin/fibulin,IPR001134:Netrin domain,IPR001840:Complement C3a/C4a/C5a anaphylatoxin,IPR008930:Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid,IPR008993:Tissue inhibitor of metalloproteinases-like, OB-fold,IPR009048:Alpha-macroglobulin, receptor-binding,IPR011626:A-macroglobulin complement component,IPR018081:Anaphylatoxin,IPR018933:Netrin module, non-TIMP type,IPR019565:Alpha-2-macroglobulin, thiol-ester bond-forming,IPR019742:Alpha-2-macroglobulin, conserved site,	bta04610:Complement and coagulation cascades,bta05133:Pertussis,bta05150:Staphylococcus aureus infection,bta05322:Systemic lupus erythematosus,			SM00104:ANATO,SM00643:C345C,SM01361:SM01361,	Cell junction,Cell projection,Cleavage on pair of basic residues,Complement pathway,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Inflammatory response,Innate immunity,Reference proteome,Secreted,Sulfation,Synapse,Thioester bond,	chain:C4a anaphylatoxin,chain:Complement C4 alpha chain,chain:Complement C4 gamma chain,cross-link:Isoglutamyl cysteine thioester (Cys-Gln),disulfide bond,domain:Anaphylatoxin-like,domain:NTR,glycosylation site:N-linked (GlcNAc...),modified residue,
P98093	complement component C3(c3-1)	Oncorhynchus mykiss				GO:0006954~inflammatory response,GO:0006957~complement activation, alternative pathway,GO:0006958~complement activation, classical pathway,GO:0042742~defense response to bacterium,	GO:0005615~extracellular space,	GO:0001848~complement binding,GO:0001872~(1->3)-beta-D-glucan binding,GO:0003823~antigen binding,GO:0004866~endopeptidase inhibitor activity,	IPR000020:Anaphylatoxin/fibulin,IPR001134:Netrin domain,IPR001599:Alpha-2-macroglobulin,IPR002890:Alpha-2-macroglobulin, N-terminal,IPR008930:Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid,IPR008993:Tissue inhibitor of metalloproteinases-like, OB-fold,IPR009048:Alpha-macroglobulin, receptor-binding,IPR011625:Alpha-2-macroglobulin, N-terminal 2,IPR011626:A-macroglobulin complement component,IPR018081:Anaphylatoxin,IPR018933:Netrin module, non-TIMP type,IPR019565:Alpha-2-macroglobulin, thiol-ester bond-forming,IPR019742:Alpha-2-macroglobulin, conserved site,				SM00104:ANATO,SM00643:C345C,SM01359:SM01359,SM01360:SM01360,SM01361:SM01361,	Cleavage on pair of basic residues,Complement alternate pathway,Complement pathway,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Inflammatory response,Innate immunity,Secreted,Thioester bond,	chain:C3a anaphylatoxin,chain:Complement C3,chain:Complement C3 alpha chain,chain:complement C3 beta chain,chain:Complement C3b alpha' chain,chain:Complement C3c alpha' chain fragment 1,chain:Complement C3c alpha' chain fragment 2,chain:Complement C3d fragment,chain:Complement C3dg fragment,chain:Complement C3g fragment,cross-link:Isoglutamyl cysteine thioester (Cys-Gln),disulfide bond,domain:Anaphylatoxin-like,domain:NTR,glycosylation site:N-linked (GlcNAc...),peptide:Complement C3f fragment,region of interest:Properdin-binding,site:Cleavage; by C3 convertase,site:Cleavage; by factor I,
P06909	complement component factor h(Cfh)	Mus musculus				GO:0002376~immune system process,GO:0006957~complement activation, alternative pathway,GO:0030449~regulation of complement activation,GO:0045087~innate immune response,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0001851~complement component C3b binding,GO:0008201~heparin binding,GO:0043395~heparan sulfate proteoglycan binding,	IPR000436:Sushi/SCR/CCP,	mmu04610:Complement and coagulation cascades,mmu05150:Staphylococcus aureus infection,			SM00032:CCP,	3D-structure,Complement alternate pathway,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Complement factor H,disulfide bond,domain:Sushi 1,domain:Sushi 10,domain:Sushi 11,domain:Sushi 12,domain:Sushi 13,domain:Sushi 14,domain:Sushi 15,domain:Sushi 16,domain:Sushi 17,domain:Sushi 18,domain:Sushi 19,domain:Sushi 2,domain:Sushi 20,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,domain:Sushi 9,glycosylation site:N-linked (GlcNAc...),signal peptide,
Q864W0	complement factor B(CFB)	Pan troglodytes				GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,	GO:0005576~extracellular region,	GO:0004252~serine-type endopeptidase activity,	IPR000436:Sushi/SCR/CCP,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR002035:von Willebrand factor, type A,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR011360:Complement B/C2,IPR018114:Peptidase S1, trypsin family, active site,	ptr04610:Complement and coagulation cascades,ptr05150:Staphylococcus aureus infection,		PIRSF001154:complement B/C2,	SM00020:Tryp_SPc,SM00032:CCP,SM00327:VWA,	Cleavage on pair of basic residues,Complement alternate pathway,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Immunity,Innate immunity,Protease,Reference proteome,Repeat,Secreted,Serine protease,Signal,Sushi,Zymogen,	active site:Charge relay system,chain:Complement factor B,chain:Complement factor B Ba fragment,chain:Complement factor B Bb fragment,disulfide bond,domain:Peptidase S1,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:VWFA,glycosylation site:N-linked (GlcNAc...),signal peptide,
P81187	complement factor B(CFB)	Bos taurus				GO:0006508~proteolysis,GO:0006957~complement activation, alternative pathway,	GO:0005576~extracellular region,	GO:0004252~serine-type endopeptidase activity,	IPR000436:Sushi/SCR/CCP,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR002035:von Willebrand factor, type A,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR011360:Complement B/C2,IPR018114:Peptidase S1, trypsin family, active site,	bta04610:Complement and coagulation cascades,bta05150:Staphylococcus aureus infection,		PIRSF001154:complement B/C2,	SM00020:Tryp_SPc,SM00032:CCP,SM00327:VWA,	Cleavage on pair of basic residues,Complement alternate pathway,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Immunity,Innate immunity,Protease,Reference proteome,Repeat,Secreted,Serine protease,Signal,Sushi,Zymogen,	active site:Charge relay system,chain:Complement factor B,chain:Complement factor B Ba fragment,chain:Complement factor B Bb fragment,disulfide bond,domain:Peptidase S1,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:VWFA,glycosylation site:N-linked (GlcNAc...),signal peptide,
P00751	complement factor B(CFB)	Homo sapiens		h_alternativePathway:Alternative Complement Pathway,h_compPathway:Complement Pathway,		GO:0006508~proteolysis,GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,GO:0030449~regulation of complement activation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0001848~complement binding,GO:0004252~serine-type endopeptidase activity,	IPR000436:Sushi/SCR/CCP,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR002035:von Willebrand factor, type A,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR011360:Complement B/C2,IPR018114:Peptidase S1, trypsin family, active site,	hsa04610:Complement and coagulation cascades,hsa05150:Staphylococcus aureus infection,	612924~Hemolytic uremic syndrome, atypical, susceptibility to, 4,615489~Macular degeneration, age-related, 14, reduced risk of,615561~Complement factor B deficiency,	PIRSF001154:complement B/C2,PIRSF500181:complement factor B [Parent=PIRSF001154],	SM00020:Tryp_SPc,SM00032:CCP,SM00327:VWA,	3D-structure,Alternative splicing,Cleavage on pair of basic residues,Complement alternate pathway,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycation,Glycoprotein,Hemolytic uremic syndrome,Hydrolase,Immunity,Innate immunity,Polymorphism,Protease,Reference proteome,Repeat,Secreted,Serine protease,Signal,Sushi,Zymogen,	active site:Charge relay system,chain:Complement factor B,chain:Complement factor B Ba fragment,chain:Complement factor B Bb fragment,disulfide bond,domain:Peptidase S1,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:VWFA,glycosylation site:N-linked (Glc) (glycation),glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
P04186	complement factor B(Cfb)	Mus musculus				GO:0002376~immune system process,GO:0006508~proteolysis,GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,GO:0008283~cell proliferation,GO:0045087~innate immune response,GO:0097066~response to thyroid hormone,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0004252~serine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0016787~hydrolase activity,	IPR000436:Sushi/SCR/CCP,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR002035:von Willebrand factor, type A,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR011360:Complement B/C2,IPR018114:Peptidase S1, trypsin family, active site,	mmu04610:Complement and coagulation cascades,mmu05150:Staphylococcus aureus infection,		PIRSF001154:complement B/C2,PIRSF500181:complement factor B [Parent=PIRSF001154],	SM00020:Tryp_SPc,SM00032:CCP,SM00327:VWA,	Cleavage on pair of basic residues,Complement alternate pathway,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Immunity,Innate immunity,Protease,Reference proteome,Repeat,Secreted,Serine protease,Signal,Sushi,Zymogen,	active site:Charge relay system,chain:Complement C2,chain:Complement C2a fragment,chain:Complement C2b fragment,chain:Complement factor B,chain:Complement factor B Ba fragment,chain:Complement factor B Bb fragment,disulfide bond,domain:Peptidase S1,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:VWFA,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,
Q03591	complement factor H related 1(CFHR1)	Homo sapiens				GO:0006956~complement activation,	GO:0005615~extracellular space,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,		IPR000436:Sushi/SCR/CCP,		235400~Hemolytic uremic syndrome, atypical, susceptibility to,603075~Macular degeneration, age-related, reduced risk of,		SM00032:CCP,	3D-structure,Complete proteome,Disulfide bond,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Complement factor H-related protein 1,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
Q9BXR6	complement factor H related 5(CFHR5)	Homo sapiens				GO:0006957~complement activation, alternative pathway,	GO:0005576~extracellular region,		IPR000436:Sushi/SCR/CCP,		614809~Nephropathy due to CFHR5 deficiency,		SM00032:CCP,	Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hemolytic uremic syndrome,Polymorphism,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Complement factor H-related protein 5,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,domain:Sushi 9,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
Q28085	complement factor H(CFH)	Bos taurus				GO:0006957~complement activation, alternative pathway,	GO:0005576~extracellular region,		IPR000436:Sushi/SCR/CCP,	bta04610:Complement and coagulation cascades,bta05150:Staphylococcus aureus infection,			SM00032:CCP,	Complement alternate pathway,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Complement factor H,disulfide bond,domain:Sushi 1,domain:Sushi 10,domain:Sushi 11,domain:Sushi 12,domain:Sushi 13,domain:Sushi 14,domain:Sushi 15,domain:Sushi 16,domain:Sushi 17,domain:Sushi 18,domain:Sushi 19,domain:Sushi 2,domain:Sushi 20,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,domain:Sushi 9,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,
P08603	complement factor H(CFH)	Homo sapiens				GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,GO:0030449~regulation of complement activation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0005515~protein binding,GO:0008201~heparin binding,GO:0043395~heparan sulfate proteoglycan binding,	IPR000436:Sushi/SCR/CCP,	hsa04610:Complement and coagulation cascades,hsa05150:Staphylococcus aureus infection,	126700~Basal laminar drusen,235400~Hemolytic uremic syndrome, atypical, susceptibility to, 1,609814~Complement factor H deficiency,610698~Macular degeneration, age-related, 4,		SM00032:CCP,	3D-structure,Age-related macular degeneration,Alternative splicing,Complement alternate pathway,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hemolytic uremic syndrome,Immunity,Innate immunity,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Complement factor H,disulfide bond,domain:Sushi 1,domain:Sushi 10,domain:Sushi 11,domain:Sushi 12,domain:Sushi 13,domain:Sushi 14,domain:Sushi 15,domain:Sushi 16,domain:Sushi 17,domain:Sushi 18,domain:Sushi 19,domain:Sushi 2,domain:Sushi 20,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,domain:Sushi 9,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,site:Not glycosylated,splice variant,strand,turn,
P29279	connective tissue growth factor(CTGF)	Homo sapiens				GO:0001502~cartilage condensation,GO:0001503~ossification,GO:0001525~angiogenesis,GO:0001558~regulation of cell growth,GO:0001894~tissue homeostasis,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007267~cell-cell signaling,GO:0007568~aging,GO:0008284~positive regulation of cell proliferation,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0008544~epidermis development,GO:0009611~response to wounding,GO:0009749~response to glucose,GO:0010260~organ senescence,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016477~cell migration,GO:0030154~cell differentiation,GO:0030324~lung development,GO:0032330~regulation of chondrocyte differentiation,GO:0032355~response to estradiol,GO:0032967~positive regulation of collagen biosynthetic process,GO:0034059~response to anoxia,GO:0035556~intracellular signal transduction,GO:0035988~chondrocyte proliferation,GO:0043200~response to amino acid,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043434~response to peptide hormone,GO:0045597~positive regulation of cell differentiation,GO:0046330~positive regulation of JNK cascade,GO:0050867~positive regulation of cell activation,GO:0051385~response to mineralocorticoid,GO:0051496~positive regulation of stress fiber assembly,GO:0060401~cytosolic calcium ion transport,GO:0060452~positive regulation of cardiac muscle contraction,GO:0060548~negative regulation of cell death,GO:0070278~extracellular matrix constituent secretion,GO:0070318~positive regulation of G0 to G1 transition,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070542~response to fatty acid,GO:0071897~DNA biosynthetic process,GO:0072593~reactive oxygen species metabolic process,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005794~Golgi apparatus,GO:0005801~cis-Golgi network,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,	GO:0001968~fibronectin binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0005520~insulin-like growth factor binding,GO:0008022~protein C-terminus binding,GO:0008083~growth factor activity,GO:0008201~heparin binding,	IPR000867:Insulin-like growth factor-binding protein, IGFBP,IPR000884:Thrombospondin, type 1 repeat,IPR001007:von Willebrand factor, type C,IPR006207:Cystine knot, C-terminal,IPR006208:Cystine knot,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR012395:IGFBP-related, CNN,IPR017891:Insulin-like growth factor binding protein, N-terminal, Cys-rich conserved site,	hsa04390:Hippo signaling pathway,		PIRSF036495:IGFBP-related protein, CNN type,	SM00041:CT,SM00121:IB,SM00209:TSP1,SM00214:VWC,	Alternative splicing,Cell adhesion,Complete proteome,Disulfide bond,DNA synthesis,Extracellular matrix,Glycoprotein,Heparin-binding,Polymorphism,Reference proteome,Secreted,Signal,	chain:Connective tissue growth factor,disulfide bond,domain:CTCK,domain:IGFBP N-terminal,domain:TSP type-1,domain:VWFC,glycosylation site:N-linked (GlcNAc...),region of interest:Heparin-binding,sequence variant,signal peptide,splice variant,
Q8IC32	conserved Plasmodium protein, unknown function(PF07_0014)	Plasmodium falciparum 3D7												Coiled coil,Complete proteome,Merozoite,Reference proteome,Repeat,	chain:Leucine-rich repeat and coiled-coil domain-containing protein PF07_0014,compositionally biased region:Asn-rich,compositionally biased region:Lys-rich,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,
Q8I480	conserved Plasmodium protein, unknown function(PFE0100w)	Plasmodium falciparum 3D7				GO:0006886~intracellular protein transport,GO:0006904~vesicle docking involved in exocytosis,GO:0007032~endosome organization,GO:0007040~lysosome organization,GO:0016192~vesicle-mediated transport,GO:0035542~regulation of SNARE complex assembly,	GO:0005768~endosome,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0020011~apicoplast,GO:0030897~HOPS complex,	GO:0008270~zinc ion binding,GO:0030674~protein binding, bridging,	IPR000547:Clathrin, heavy chain/VPS, 7-fold repeat,IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR016528:Vacuolar protein sorting-associated protein 11,IPR024763:Vacuolar protein sorting protein 11, C-terminal,					Coiled coil,Complete proteome,Membrane,Merozoite,Metal-binding,Reference proteome,Transmembrane,Transmembrane helix,Zinc,Zinc-finger,	chain:RING finger protein PFE0100w,compositionally biased region:Asn-rich,transmembrane region,zinc finger region:RING-type; atypical,
Q63198	contactin 1(Cntn1)	Rattus norvegicus				GO:0007155~cell adhesion,GO:0007219~Notch signaling pathway,GO:0010628~positive regulation of gene expression,GO:0010765~positive regulation of sodium ion transport,GO:0010976~positive regulation of neuron projection development,GO:0021549~cerebellum development,GO:0031175~neuron projection development,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,	GO:0005886~plasma membrane,GO:0031225~anchored component of membrane,GO:0043209~myelin sheath,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0001948~glycoprotein binding,GO:0005515~protein binding,GO:0030246~carbohydrate binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,	rno04514:Cell adhesion molecules (CAMs),			SM00060:FN3,SM00408:IGc2,SM00409:IG,	Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Notch signaling pathway,Reference proteome,Repeat,Signal,	chain:Contactin-1,compositionally biased region:Gly/Pro-rich,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,signal peptide,
Q9UHC6	contactin associated protein-like 2(CNTNAP2)	Homo sapiens				GO:0007155~cell adhesion,GO:0007420~brain development,GO:0007612~learning,GO:0008038~neuron recognition,GO:0019226~transmission of nerve impulse,GO:0021756~striatum development,GO:0021761~limbic system development,GO:0021794~thalamus development,GO:0021987~cerebral cortex development,GO:0030534~adult behavior,GO:0031175~neuron projection development,GO:0035176~social behavior,GO:0042297~vocal learning,GO:0045163~clustering of voltage-gated potassium channels,GO:0071109~superior temporal gyrus development,GO:0071205~protein localization to juxtaparanode region of axon,GO:0071625~vocalization behavior,	GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0008076~voltage-gated potassium channel complex,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0030673~axolemma,GO:0043025~neuronal cell body,GO:0043204~perikaryon,GO:0044224~juxtaparanode region of axon,	GO:0019899~enzyme binding,	IPR000421:Coagulation factor 5/8 C-terminal type domain,IPR000742:Epidermal growth factor-like domain,IPR001791:Laminin G domain,IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain,IPR003585:Neurexin/syndecan/glycophorin C,IPR008979:Galactose-binding domain-like,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,	hsa04514:Cell adhesion molecules (CAMs),	610042~Cortical dysplasia-focal epilepsy syndrome,610042~Pitt-Hopkins like syndrome 1,612100~Autism susceptibility 15,		SM00181:EGF,SM00231:FA58C,SM00282:LamG,SM00294:4.1m,	Alternative splicing,Autism,Autism spectrum disorder,Cell adhesion,Cell projection,Chromosomal rearrangement,Complete proteome,Disulfide bond,EGF-like domain,Epilepsy,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Contactin-associated protein-like 2,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:F5/8 type C,domain:Fibrinogen C-terminal,domain:Laminin G-like 1,domain:Laminin G-like 2,domain:Laminin G-like 3,domain:Laminin G-like 4,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P46527	cyclin dependent kinase inhibitor 1B(CDKN1B)	Homo sapiens	1.RBphosphoE2F,26.cyclin-CDK_complexes,4.cyclins_&_p27_cell_cycle,62.G1-phase_progression_by_Myc,84.Ubiquitination_Pathways_Cell_Cycle,	h_cellcyclePathway:Cyclins and Cell Cycle Regulation,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_mcmPathway:CDK Regulation of DNA Replication,h_p27Pathway:Regulation of p27 Phosphorylation during Cell Cycle Progression,h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,		GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0001666~response to hypoxia,GO:0006813~potassium ion transport,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007050~cell cycle arrest,GO:0007219~Notch signaling pathway,GO:0007605~sensory perception of sound,GO:0008219~cell death,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009749~response to glucose,GO:0010942~positive regulation of cell death,GO:0030308~negative regulation of cell growth,GO:0031116~positive regulation of microtubule polymerization,GO:0032355~response to estradiol,GO:0033673~negative regulation of kinase activity,GO:0042127~regulation of cell proliferation,GO:0042326~negative regulation of phosphorylation,GO:0042493~response to drug,GO:0043066~negative regulation of apoptotic process,GO:0043200~response to amino acid,GO:0043434~response to peptide hormone,GO:0045732~positive regulation of protein catabolic process,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045787~positive regulation of cell cycle,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045930~negative regulation of mitotic cell cycle,GO:0046686~response to cadmium ion,GO:0048102~autophagic cell death,GO:0048839~inner ear development,GO:0051271~negative regulation of cellular component movement,GO:0060770~negative regulation of epithelial cell proliferation involved in prostate gland development,GO:0071236~cellular response to antibiotic,GO:0071285~cellular response to lithium ion,GO:0071407~cellular response to organic cyclic compound,GO:0071850~mitotic cell cycle arrest,GO:1904706~negative regulation of vascular smooth muscle cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005829~cytosol,GO:0031464~Cul4A-RING E3 ubiquitin ligase complex,GO:0043234~protein complex,	GO:0004861~cyclin-dependent protein serine/threonine kinase inhibitor activity,GO:0005072~transforming growth factor beta receptor, cytoplasmic mediator activity,GO:0005515~protein binding,GO:0008656~cysteine-type endopeptidase activator activity involved in apoptotic process,GO:0016301~kinase activity,GO:0019903~protein phosphatase binding,GO:0030544~Hsp70 protein binding,GO:0032403~protein complex binding,GO:0051087~chaperone binding,	IPR003175:Cyclin-dependent kinase inhibitor,	hsa04012:ErbB signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04151:PI3K-Akt signaling pathway,hsa05161:Hepatitis B,hsa05162:Measles,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,hsa05206:MicroRNAs in cancer,hsa05215:Prostate cancer,hsa05220:Chronic myeloid leukemia,	610755~Multiple endocrine neoplasia, type IV,			3D-structure,Cell cycle,Complete proteome,Cyclin,Cytoplasm,Direct protein sequencing,Endosome,Kinase,Nucleus,Phosphoprotein,Polymorphism,Protein kinase inhibitor,Proteomics identification,Proto-oncogene,Reference proteome,Transferase,Ubl conjugation,	chain:Cyclin-dependent kinase inhibitor 1B,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,strand,turn,
P42773	cyclin dependent kinase inhibitor 2C(CDKN2C)	Homo sapiens	1.RBphosphoE2F,26.cyclin-CDK_complexes,	h_cellcyclePathway:Cyclins and Cell Cycle Regulation,		GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0007050~cell cycle arrest,GO:0008285~negative regulation of cell proliferation,GO:0030308~negative regulation of cell growth,GO:0042326~negative regulation of phosphorylation,GO:0048709~oligodendrocyte differentiation,GO:0071901~negative regulation of protein serine/threonine kinase activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004861~cyclin-dependent protein serine/threonine kinase inhibitor activity,GO:0005515~protein binding,GO:0016301~kinase activity,GO:0019901~protein kinase binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,	hsa04110:Cell cycle,hsa05166:HTLV-I infection,hsa05202:Transcriptional misregulation in cancer,			SM00248:ANK,	3D-structure,ANK repeat,Cell cycle,Complete proteome,Cyclin,Kinase,Polymorphism,Reference proteome,Repeat,Transferase,	chain:Cyclin-dependent kinase 4 inhibitor C,helix,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,sequence variant,
Q91WT9	cystathionine beta-synthase(Cbs)	Mus musculus		m_methioninePathway:Catabolic Pathways for Methionine, Isoleucine, Threonine and Valine,		GO:0001958~endochondral ossification,GO:0001974~blood vessel remodeling,GO:0006535~cysteine biosynthetic process from serine,GO:0006563~L-serine metabolic process,GO:0006801~superoxide metabolic process,GO:0008652~cellular amino acid biosynthetic process,GO:0019343~cysteine biosynthetic process via cystathionine,GO:0019344~cysteine biosynthetic process,GO:0019346~transsulfuration,GO:0021587~cerebellum morphogenesis,GO:0030823~regulation of cGMP metabolic process,GO:0043066~negative regulation of apoptotic process,GO:0043418~homocysteine catabolic process,GO:0043506~regulation of JUN kinase activity,GO:0050667~homocysteine metabolic process,GO:0050880~regulation of blood vessel size,GO:0051593~response to folic acid,GO:0060135~maternal process involved in female pregnancy,GO:0060351~cartilage development involved in endochondral bone morphogenesis,GO:0070814~hydrogen sulfide biosynthetic process,GO:0071456~cellular response to hypoxia,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004122~cystathionine beta-synthase activity,GO:0004124~cysteine synthase activity,GO:0016829~lyase activity,GO:0019825~oxygen binding,GO:0019899~enzyme binding,GO:0020037~heme binding,GO:0030170~pyridoxal phosphate binding,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0050421~nitrite reductase (NO-forming) activity,GO:0070025~carbon monoxide binding,GO:0070026~nitric oxide binding,GO:0072341~modified amino acid binding,GO:1904047~S-adenosyl-L-methionine binding,	IPR000644:Cystathionine beta-synthase, core,IPR001216:Cysteine synthase/cystathionine beta-synthase P-phosphate-binding site,IPR001926:Tryptophan synthase beta subunit-like PLP-dependent enzymes superfamily,IPR005857:Cystathionine beta-synthase,	mmu00260:Glycine, serine and threonine metabolism,mmu00270:Cysteine and methionine metabolism,mmu01100:Metabolic pathways,mmu01130:Biosynthesis of antibiotics,mmu01230:Biosynthesis of amino acids,			SM00116:CBS,	Alternative splicing,Amino-acid biosynthesis,CBS domain,Complete proteome,Cysteine biosynthesis,Cytoplasm,Heme,Iron,Isopeptide bond,Lyase,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Pyridoxal phosphate,Reference proteome,Ubl conjugation,	binding site:Pyridoxal phosphate,chain:Cystathionine beta-synthase,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),domain:CBS,metal ion-binding site:Iron (heme axial ligand),modified residue,region of interest:Pyridoxal phosphate binding,splice variant,
P32929	cystathionine gamma-lyase(CTH)	Homo sapiens		h_methioninePathway:Catabolic Pathways for Methionine, Isoleucine, Threonine and Valine,		GO:0000098~sulfur amino acid catabolic process,GO:0006534~cysteine metabolic process,GO:0018272~protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,GO:0019343~cysteine biosynthetic process via cystathionine,GO:0019344~cysteine biosynthetic process,GO:0019346~transsulfuration,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0044524~protein sulfhydration,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051289~protein homotetramerization,GO:0070814~hydrogen sulfide biosynthetic process,GO:0071266~'de novo' L-methionine biosynthetic process,GO:1904831~positive regulation of aortic smooth muscle cell differentiation,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003962~cystathionine gamma-synthase activity,GO:0004123~cystathionine gamma-lyase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0016846~carbon-sulfur lyase activity,GO:0030170~pyridoxal phosphate binding,GO:0044540~L-cystine L-cysteine-lyase (deaminating),GO:0047982~homocysteine desulfhydrase activity,GO:0080146~L-cysteine desulfhydrase activity,	IPR000277:Cys/Met metabolism, pyridoxal phosphate-dependent enzyme,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,	hsa00260:Glycine, serine and threonine metabolism,hsa00270:Cysteine and methionine metabolism,hsa00450:Selenocompound metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01230:Biosynthesis of amino acids,	219500~Cystathioninuria,Homocysteine, total plasma, elevated~Homocysteine, total plasma, elevated,	PIRSF001434:cystathionine gamma-synthase,		3D-structure,Alternative splicing,Amino-acid biosynthesis,Calmodulin-binding,Complete proteome,Cysteine biosynthesis,Cytoplasm,Disease mutation,Lyase,Polymorphism,Pyridoxal phosphate,Reference proteome,	binding site:Substrate,chain:Cystathionine gamma-lyase,helix,modified residue,sequence variant,splice variant,strand,turn,
P18757	cystathionine gamma-lyase(Cth)	Rattus norvegicus				GO:0001887~selenium compound metabolic process,GO:0006749~glutathione metabolic process,GO:0008285~negative regulation of cell proliferation,GO:0018272~protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,GO:0019343~cysteine biosynthetic process via cystathionine,GO:0019344~cysteine biosynthetic process,GO:0019346~transsulfuration,GO:0030308~negative regulation of cell growth,GO:0043066~negative regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0044524~protein sulfhydration,GO:0050667~homocysteine metabolic process,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051289~protein homotetramerization,GO:0070814~hydrogen sulfide biosynthetic process,GO:0071266~'de novo' L-methionine biosynthetic process,GO:1904831~positive regulation of aortic smooth muscle cell differentiation,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0003962~cystathionine gamma-synthase activity,GO:0004121~cystathionine beta-lyase activity,GO:0004123~cystathionine gamma-lyase activity,GO:0005516~calmodulin binding,GO:0030170~pyridoxal phosphate binding,GO:0044540~L-cystine L-cysteine-lyase (deaminating),GO:0080146~L-cysteine desulfhydrase activity,GO:0098606~selenocystathionine gamma-lyase activity,GO:0098607~methylselenocysteine deselenhydrase activity,	IPR000277:Cys/Met metabolism, pyridoxal phosphate-dependent enzyme,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,	rno00260:Glycine, serine and threonine metabolism,rno00270:Cysteine and methionine metabolism,rno00450:Selenocompound metabolism,rno01100:Metabolic pathways,rno01130:Biosynthesis of antibiotics,rno01230:Biosynthesis of amino acids,		PIRSF001434:cystathionine gamma-synthase,		Amino-acid biosynthesis,Calmodulin-binding,Complete proteome,Cysteine biosynthesis,Cytoplasm,Direct protein sequencing,Lyase,Phosphoprotein,Proteomics identification,Pyridoxal phosphate,Reference proteome,	binding site:Substrate,chain:Cystathionine gamma-lyase,modified residue,sequence conflict,
P35520	cystathionine-beta-synthase like(CBSL)	Homo sapiens				GO:0006535~cysteine biosynthetic process from serine,GO:0006563~L-serine metabolic process,GO:0006565~L-serine catabolic process,GO:0008652~cellular amino acid biosynthetic process,GO:0019343~cysteine biosynthetic process via cystathionine,GO:0019344~cysteine biosynthetic process,GO:0019346~transsulfuration,GO:0019448~L-cysteine catabolic process,GO:0042262~DNA protection,GO:0043418~homocysteine catabolic process,GO:0050667~homocysteine metabolic process,GO:0070814~hydrogen sulfide biosynthetic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004122~cystathionine beta-synthase activity,GO:0004124~cysteine synthase activity,GO:0019825~oxygen binding,GO:0019899~enzyme binding,GO:0020037~heme binding,GO:0030170~pyridoxal phosphate binding,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0050421~nitrite reductase (NO-forming) activity,GO:0070025~carbon monoxide binding,GO:0070026~nitric oxide binding,GO:0072341~modified amino acid binding,GO:1904047~S-adenosyl-L-methionine binding,	IPR000644:Cystathionine beta-synthase, core,IPR001216:Cysteine synthase/cystathionine beta-synthase P-phosphate-binding site,IPR001926:Tryptophan synthase beta subunit-like PLP-dependent enzymes superfamily,IPR005857:Cystathionine beta-synthase,	hsa00260:Glycine, serine and threonine metabolism,hsa00270:Cysteine and methionine metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01230:Biosynthesis of amino acids,			SM00116:CBS,	3D-structure,Allosteric enzyme,Alternative splicing,Amino-acid biosynthesis,CBS domain,Complete proteome,Cysteine biosynthesis,Cytoplasm,Disease mutation,Heme,Iron,Isopeptide bond,Lyase,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Pyridoxal phosphate,Reference proteome,Ubl conjugation,
Q96S65	cysteine and serine rich nuclear protein 1(CSRNP1)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0009791~post-embryonic development,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048705~skeletal system morphogenesis,GO:0060021~palate development,GO:0060325~face morphogenesis,	GO:0005634~nucleus,GO:0016021~integral component of membrane,	GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR023260:Cysteine/serine-rich nuclear protein family,					Activator,Apoptosis,Coiled coil,Complete proteome,DNA-binding,Membrane,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,	chain:Cysteine/serine-rich nuclear protein 1,compositionally biased region:Cys-rich,compositionally biased region:Ser-rich,sequence variant,
P63255	cysteine rich protein 1(Crip1)	Rattus norvegicus				GO:0006955~immune response,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010033~response to organic substance,GO:0010043~response to zinc ion,GO:0010468~regulation of gene expression,GO:0060741~prostate gland stromal morphogenesis,GO:0071236~cellular response to antibiotic,GO:0071493~cellular response to UV-B,	GO:0005737~cytoplasm,	GO:0003680~AT DNA binding,GO:0008270~zinc ion binding,GO:0008301~DNA binding, bending,GO:0042277~peptide binding,	IPR001781:Zinc finger, LIM-type,				SM00132:LIM,	3D-structure,Acetylation,Complete proteome,Direct protein sequencing,LIM domain,Metal-binding,Reference proteome,Zinc,	chain:Cysteine-rich protein 1,compositionally biased region:Gly-rich,domain:LIM zinc-binding,helix,modified residue,strand,turn,
Q07973	cytochrome P450 family 24 subfamily A member 1(CYP24A1)	Homo sapiens		h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,	Secondary metabolites biosynthesis, transport, and catabolism,	GO:0001649~osteoblast differentiation,GO:0006766~vitamin metabolic process,GO:0033280~response to vitamin D,GO:0042359~vitamin D metabolic process,GO:0042369~vitamin D catabolic process,GO:0055114~oxidation-reduction process,GO:0070561~vitamin D receptor signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005886~plasma membrane,	GO:0005506~iron ion binding,GO:0008403~25-hydroxycholecalciferol-24-hydroxylase activity,GO:0016491~oxidoreductase activity,GO:0020037~heme binding,GO:0030342~1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR017972:Cytochrome P450, conserved site,	hsa00100:Steroid biosynthesis,hsa01100:Metabolic pathways,hsa05206:MicroRNAs in cancer,	143880~Hypercalcemia, infantile,			Alternative splicing,Complete proteome,Disease mutation,Heme,Iron,Metal-binding,Mitochondrion,Monooxygenase,NADP,Oxidoreductase,Polymorphism,Reference proteome,Transit peptide,	chain:1,25-dihydroxyvitamin D(3) 24- hydroxylase, mitochondrial,metal ion-binding site:Iron (heme axial ligand),sequence conflict,sequence variant,transit peptide:Mitochondrion,
Q01741	cytochrome P450, family 1, subfamily A, polypeptide 2(CYP1A2)	Gallus gallus			Secondary metabolites biosynthesis, transport, and catabolism,	GO:0017144~drug metabolic process,GO:0043385~mycotoxin metabolic process,GO:0046677~response to antibiotic,GO:0055114~oxidation-reduction process,GO:0070989~oxidative demethylation,GO:0071615~oxidative deethylation,	GO:0005623~cell,GO:0005789~endoplasmic reticulum membrane,GO:0031090~organelle membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0070330~aromatase activity,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR008066:Cytochrome P450, E-class, group I, CYP1,IPR017972:Cytochrome P450, conserved site,	gga00140:Steroid hormone biosynthesis,gga00380:Tryptophan metabolism,gga00830:Retinol metabolism,gga00980:Metabolism of xenobiotics by cytochrome P450,gga01100:Metabolic pathways,				Complete proteome,Endoplasmic reticulum,Heme,Iron,Membrane,Metal-binding,Microsome,Monooxygenase,Oxidoreductase,Reference proteome,	chain:Cytochrome P450 1A5,metal ion-binding site:Iron (heme axial ligand),
Q64441	cytochrome P450, family 24, subfamily a, polypeptide 1(Cyp24a1)	Mus musculus		m_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,	Secondary metabolites biosynthesis, transport, and catabolism,	GO:0001649~osteoblast differentiation,GO:0033280~response to vitamin D,GO:0042359~vitamin D metabolic process,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005886~plasma membrane,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0008403~25-hydroxycholecalciferol-24-hydroxylase activity,GO:0016491~oxidoreductase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0020037~heme binding,GO:0030342~1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,GO:0046872~metal ion binding,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR002949:Cytochrome P450, E-class, CYP24A, mitochondrial,IPR017972:Cytochrome P450, conserved site,	mmu00100:Steroid biosynthesis,mmu01100:Metabolic pathways,mmu05206:MicroRNAs in cancer,				Complete proteome,Heme,Iron,Metal-binding,Mitochondrion,Monooxygenase,NADP,Oxidoreductase,Reference proteome,Transit peptide,	chain:1,25-dihydroxyvitamin D(3) 24- hydroxylase, mitochondrial,metal ion-binding site:Iron (heme axial ligand),transit peptide:Mitochondrion,
O13085	cytochrome c oxidase subunit VIa(LOC100335037)	Oncorhynchus mykiss					GO:0005751~mitochondrial respiratory chain complex IV,	GO:0004129~cytochrome-c oxidase activity,	IPR001349:Cytochrome c oxidase, subunit VIa,IPR018507:Cytochrome c oxidase, subunit VIa, conserved site,			PIRSF000277:cytochrome-c oxidase, subunit VIa,		Membrane,Mitochondrion,Mitochondrion inner membrane,Transit peptide,
P00428	cytochrome c oxidase subunit Vb(COX5B)	Bos taurus				GO:0006123~mitochondrial electron transport, cytochrome c to oxygen,GO:0042776~mitochondrial ATP synthesis coupled proton transport,	GO:0005743~mitochondrial inner membrane,GO:0005751~mitochondrial respiratory chain complex IV,GO:0045277~respiratory chain complex IV,	GO:0004129~cytochrome-c oxidase activity,GO:0046872~metal ion binding,	IPR002124:Cytochrome c oxidase, subunit Vb,IPR020893:Cytochrome c oxidase, subunit Vb, zinc binding site,	bta00190:Oxidative phosphorylation,bta01100:Metabolic pathways,bta04260:Cardiac muscle contraction,bta04932:Non-alcoholic fatty liver disease (NAFLD),bta05010:Alzheimer's disease,bta05012:Parkinson's disease,bta05016:Huntington's disease,				3D-structure,Acetylation,Complete proteome,Direct protein sequencing,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Transit peptide,Zinc,	chain:Cytochrome c oxidase subunit 5B, mitochondrial,helix,metal ion-binding site:Zinc,modified residue,strand,transit peptide:Mitochondrion,turn,
P19536	cytochrome c oxidase subunit Vb(Cox5b)	Mus musculus				GO:0006123~mitochondrial electron transport, cytochrome c to oxygen,GO:0042776~mitochondrial ATP synthesis coupled proton transport,	GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0005751~mitochondrial respiratory chain complex IV,GO:0043209~myelin sheath,	GO:0004129~cytochrome-c oxidase activity,GO:0046872~metal ion binding,	IPR002124:Cytochrome c oxidase, subunit Vb,IPR020893:Cytochrome c oxidase, subunit Vb, zinc binding site,	mmu00190:Oxidative phosphorylation,mmu01100:Metabolic pathways,mmu04260:Cardiac muscle contraction,mmu04932:Non-alcoholic fatty liver disease (NAFLD),mmu05010:Alzheimer's disease,mmu05012:Parkinson's disease,mmu05016:Huntington's disease,				Acetylation,Complete proteome,Direct protein sequencing,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Transit peptide,Zinc,	chain:Cytochrome c oxidase subunit 5B, mitochondrial,metal ion-binding site:Zinc,modified residue,transit peptide:Mitochondrion,
A4QVH4	cytochrome c peroxidase(MGG_04545)	Magnaporthe oryzae 70-15				GO:0006979~response to oxidative stress,GO:0043581~mycelium development,	GO:0005759~mitochondrial matrix,	GO:0004130~cytochrome-c peroxidase activity,GO:0020037~heme binding,GO:0046872~metal ion binding,	IPR002016:Haem peroxidase, plant/fungal/bacterial,IPR002207:Plant ascorbate peroxidase,IPR010255:Haem peroxidase,IPR019793:Peroxidases heam-ligand binding site,IPR019794:Peroxidase, active site,					Complete proteome,Heme,Iron,Metal-binding,Mitochondrion,Oxidoreductase,Peroxidase,Reference proteome,Transit peptide,	active site:Proton acceptor,active site:Tryptophan radical intermediate,chain:Cytochrome c peroxidase, mitochondrial,compositionally biased region:Poly-Ala,metal ion-binding site:Iron (heme axial ligand),site:Transition state stabilizer,transit peptide:Mitochondrion,
P00125	cytochrome c-1(CYC1)	Bos taurus			Energy production and conversion,	GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0070469~respiratory chain,	GO:0009055~electron carrier activity,GO:0020037~heme binding,GO:0046872~metal ion binding,	IPR002326:Cytochrome c1,IPR009056:Cytochrome c domain,IPR021157:Cytochrome c1, transmembrane anchor, C-terminal,	bta00190:Oxidative phosphorylation,bta01100:Metabolic pathways,bta04260:Cardiac muscle contraction,bta04932:Non-alcoholic fatty liver disease (NAFLD),bta05010:Alzheimer's disease,bta05012:Parkinson's disease,bta05016:Huntington's disease,				3D-structure,Complete proteome,Direct protein sequencing,Electron transport,Heme,Iron,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Respiratory chain,Transit peptide,Transmembrane,Transmembrane helix,Transport,	binding site:Heme (covalent),chain:Cytochrome c1, heme protein, mitochondrial,domain:Cytochrome c,helix,metal ion-binding site:Iron (heme axial ligand),strand,transit peptide:Mitochondrion,transmembrane region,turn,
Q9I426	cytochrome o ubiquinol oxidase subunit I(cyoB)	Pseudomonas aeruginosa PAO1			Energy production and conversion,	GO:0009060~aerobic respiration,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0070469~respiratory chain,	GO:0004129~cytochrome-c oxidase activity,GO:0005506~iron ion binding,GO:0016682~oxidoreductase activity, acting on diphenols and related substances as donors, oxygen as acceptor,GO:0020037~heme binding,	IPR000883:Cytochrome c oxidase, subunit I,IPR014207:Cytochrome o ubiquinol oxidase, subunit I,IPR023615:Cytochrome c oxidase, subunit I, copper-binding site,IPR023616:Cytochrome c oxidase, subunit I domain,	pae00190:Oxidative phosphorylation,pae01100:Metabolic pathways,				Cell inner membrane,Cell membrane,Complete proteome,Copper,Electron transport,Heme,Hydrogen ion transport,Ion transport,Iron,Membrane,Metal-binding,Oxidoreductase,Reference proteome,Respiratory chain,Transmembrane,Transmembrane helix,Transport,	chain:Ubiquinol oxidase subunit 1,cross-link:1'-histidyl-3'-tyrosine (His-Tyr),metal ion-binding site:Copper B,metal ion-binding site:Iron (heme B axial ligand),metal ion-binding site:Iron (heme O axial ligand),topological domain:Cytoplasmic,topological domain:Periplasmic,transmembrane region,
P38671	cytochrome-5(cyt-5)	Neurospora crassa OR74A				GO:0006351~transcription, DNA-templated,	GO:0005739~mitochondrion,	GO:0003677~DNA binding,GO:0003899~DNA-directed RNA polymerase activity,	IPR002092:DNA-directed RNA polymerase, phage-type,IPR024075:DNA-directed RNA polymerase, helix hairpin domain,				SM01311:SM01311,	Complete proteome,DNA-directed RNA polymerase,Mitochondrion,Nucleotidyltransferase,Reference proteome,Transcription,Transferase,Transit peptide,
Q9UIA0	cytohesin 4(CYTH4)	Homo sapiens		h_arapPathway:ADP-Ribosylation Factor,		GO:0032012~regulation of ARF protein signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0000139~Golgi membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005086~ARF guanyl-nucleotide exchange factor activity,GO:0008289~lipid binding,	IPR000904:SEC7-like,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR023394:SEC7-like, alpha orthogonal bundle,	hsa04144:Endocytosis,			SM00222:Sec7,SM00233:PH,	Cell membrane,Coiled coil,Complete proteome,Guanine-nucleotide releasing factor,Lipid-binding,Membrane,Polymorphism,Proteomics identification,Reference proteome,	chain:Cytohesin-4,domain:PH,domain:SEC7,modified residue,sequence variant,
Q24292	dachsous(ds)	Drosophila melanogaster				GO:0000904~cell morphogenesis involved in differentiation,GO:0001736~establishment of planar polarity,GO:0001737~establishment of imaginal disc-derived wing hair orientation,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007164~establishment of tissue polarity,GO:0007476~imaginal disc-derived wing morphogenesis,GO:0007480~imaginal disc-derived leg morphogenesis,GO:0008283~cell proliferation,GO:0016318~ommatidial rotation,GO:0016337~single organismal cell-cell adhesion,GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0018149~peptide cross-linking,GO:0030010~establishment of cell polarity,GO:0035159~regulation of tube length, open tracheal system,GO:0035222~wing disc pattern formation,GO:0042067~establishment of ommatidial planar polarity,GO:0044331~cell-cell adhesion mediated by cadherin,GO:0045198~establishment of epithelial cell apical/basal polarity,GO:0045317~equator specification,GO:0048592~eye morphogenesis,GO:0090175~regulation of establishment of planar polarity,GO:0090176~microtubule cytoskeleton organization involved in establishment of planar polarity,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004871~signal transducer activity,GO:0004872~receptor activity,GO:0005509~calcium ion binding,GO:0045296~cadherin binding,GO:0050839~cell adhesion molecule binding,	IPR002126:Cadherin,IPR015919:Cadherin-like,IPR020894:Cadherin conserved site,IPR027397:Catenin binding domain,	dme04391:Hippo signaling pathway - fly,			SM00112:CA,	Calcium,Cell adhesion,Cell membrane,Complete proteome,Developmental protein,Glycoprotein,Membrane,Phosphoprotein,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Protein dachsous,domain:Cadherin 1,domain:Cadherin 10,domain:Cadherin 11,domain:Cadherin 12,domain:Cadherin 13,domain:Cadherin 14,domain:Cadherin 15,domain:Cadherin 16,domain:Cadherin 17,domain:Cadherin 18,domain:Cadherin 19,domain:Cadherin 2,domain:Cadherin 20,domain:Cadherin 21,domain:Cadherin 22,domain:Cadherin 23,domain:Cadherin 24,domain:Cadherin 25,domain:Cadherin 26,domain:Cadherin 27,domain:Cadherin 3,domain:Cadherin 4,domain:Cadherin 5,domain:Cadherin 6,domain:Cadherin 7,domain:Cadherin 8,domain:Cadherin 9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
A3KMT2	death associated protein like 1 L homeolog(dapl1.L)	Xenopus laevis							IPR024130:DAP1/DAPL1,						chain:Death-associated protein-like 1-A,
Q5PRA2	dehydrogenase E1 and transketolase domain containing 1(dhtkd1)	Danio rerio			Energy production and conversion,	GO:0006096~glycolytic process,GO:0006099~tricarboxylic acid cycle,GO:0008152~metabolic process,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0045252~oxoglutarate dehydrogenase complex,	GO:0004591~oxoglutarate dehydrogenase (succinyl-transferring) activity,GO:0016491~oxidoreductase activity,GO:0016624~oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,GO:0030976~thiamine pyrophosphate binding,	IPR001017:Dehydrogenase, E1 component,IPR005475:Transketolase-like, pyrimidine-binding domain,IPR011603:2-oxoglutarate dehydrogenase, E1 component,			PIRSF000157:2-oxoglutarate dehydrogenase, E1 component,	SM00861:SM00861,	Complete proteome,Glycolysis,Mitochondrion,Oxidoreductase,Proteomics identification,Reference proteome,Thiamine pyrophosphate,Transit peptide,	chain:Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial,transit peptide:Mitochondrion,
Q8WNV7	dehydrogenase/reductase (SDR family) member 4(DHRS4)	Sus scrofa				GO:0042574~retinal metabolic process,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005777~peroxisome,	GO:0000253~3-keto sterol reductase activity,GO:0001758~retinal dehydrogenase activity,GO:0004090~carbonyl reductase (NADPH) activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR016040:NAD(P)-binding domain,IPR020904:Short-chain dehydrogenase/reductase, conserved site,	ssc00830:Retinol metabolism,ssc01100:Metabolic pathways,ssc04146:Peroxisome,				3D-structure,Acetylation,Complete proteome,Direct protein sequencing,NADP,Oxidoreductase,Peroxisome,Phosphoprotein,Reference proteome,	active site:Proton acceptor,chain:Dehydrogenase/reductase SDR family member 4,helix,nucleotide phosphate-binding region:NADP,short sequence motif:Microbody targeting signal,strand,turn,
Q5RBH2	diablo IAP-binding mitochondrial protein(DIABLO)	Pongo abelii				GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0008635~activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,GO:0051402~neuron apoptotic process,	GO:0005739~mitochondrion,GO:0009898~cytoplasmic side of plasma membrane,GO:0035631~CD40 receptor complex,		IPR009062:Smac/DIABLO-like,IPR015142:Smac/DIABLO protein,					Apoptosis,Coiled coil,Complete proteome,Mitochondrion,Reference proteome,Signal,Transit peptide,Ubl conjugation,	chain:Diablo homolog, mitochondrial,short sequence motif:IAP-binding,transit peptide:Mitochondrion,
Q9NR28	diablo IAP-binding mitochondrial protein(DIABLO)	Homo sapiens	126.Apoptosis-Bcl-2,127.Mito-stress,81.Structure_of_Caps_and_SMACs,	h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,		GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0008635~activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,GO:0043065~positive regulation of apoptotic process,GO:0051402~neuron apoptotic process,GO:0097193~intrinsic apoptotic signaling pathway,	GO:0005739~mitochondrion,GO:0005758~mitochondrial intermembrane space,GO:0005829~cytosol,GO:0009898~cytoplasmic side of plasma membrane,GO:0016021~integral component of membrane,GO:0035631~CD40 receptor complex,	GO:0005515~protein binding,	IPR009062:Smac/DIABLO-like,IPR015142:Smac/DIABLO protein,		614152~Deafness, autosomal dominant 64,			3D-structure,Alternative splicing,Apoptosis,Coiled coil,Complete proteome,Deafness,Direct protein sequencing,Disease mutation,Membrane,Mitochondrion,Non-syndromic deafness,Proteomics identification,Reference proteome,Signal,Transit peptide,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Diablo homolog, mitochondrial,helix,sequence conflict,short sequence motif:IAP-binding,splice variant,strand,transit peptide:Mitochondrion,
Q9JIQ3	diablo, IAP-binding mitochondrial protein(Diablo)	Mus musculus		m_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,		GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0008635~activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,GO:0043065~positive regulation of apoptotic process,GO:0051402~neuron apoptotic process,GO:0097193~intrinsic apoptotic signaling pathway,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005758~mitochondrial intermembrane space,GO:0009898~cytoplasmic side of plasma membrane,GO:0035631~CD40 receptor complex,		IPR009062:Smac/DIABLO-like,IPR015142:Smac/DIABLO protein,					Apoptosis,Coiled coil,Complete proteome,Mitochondrion,Phosphoprotein,Proteomics identification,Reference proteome,Transit peptide,Ubl conjugation,	chain:Diablo homolog, mitochondrial,sequence conflict,short sequence motif:IAP-binding,transit peptide:Mitochondrion,
Q8VZG1	diacylglycerol kinase 3(DGK3)	Arabidopsis thaliana				GO:0006952~defense response,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0016310~phosphorylation,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0009506~plasmodesma,GO:0016020~membrane,	GO:0004143~diacylglycerol kinase activity,GO:0005524~ATP binding,	IPR000756:Diacylglycerol kinase, accessory domain,IPR001206:Diacylglycerol kinase, catalytic domain,IPR016064:ATP-NAD kinase-like domain,IPR016961:Diacylglycerol kinase, plant,	ath00561:Glycerolipid metabolism,ath00564:Glycerophospholipid metabolism,ath01100:Metabolic pathways,ath01110:Biosynthesis of secondary metabolites,ath04070:Phosphatidylinositol signaling system,		PIRSF030829:diacylglycerol kinase, plant type,	SM00045:DAGKa,SM00046:DAGKc,	ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Plant defense,Reference proteome,Stress response,Transferase,
Q920P0	dicarbonyl and L-xylulose reductase(Dcxr)	Rattus norvegicus				GO:0005997~xylulose metabolic process,GO:0006006~glucose metabolic process,GO:0006739~NADP metabolic process,GO:0042732~D-xylose metabolic process,GO:0051289~protein homotetramerization,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005881~cytoplasmic microtubule,GO:0005902~microvillus,GO:0005903~brush border,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0016491~oxidoreductase activity,GO:0016614~oxidoreductase activity, acting on CH-OH group of donors,GO:0016655~oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,GO:0050038~L-xylulose reductase (NADP+) activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR016040:NAD(P)-binding domain,IPR020904:Short-chain dehydrogenase/reductase, conserved site,	rno00040:Pentose and glucuronate interconversions,rno01100:Metabolic pathways,				Acetylation,Carbohydrate metabolism,Complete proteome,Glucose metabolism,Membrane,NADP,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Xylose metabolism,	active site:Proton acceptor,binding site:Substrate,chain:L-xylulose reductase,modified residue,mutagenesis site,nucleotide phosphate-binding region:NADP,
Q8VEJ3	dickkopf WNT signaling pathway inhibitor 4(Dkk4)	Mus musculus				GO:0007275~multicellular organism development,GO:0016055~Wnt signaling pathway,GO:0030178~negative regulation of Wnt signaling pathway,GO:0061170~negative regulation of hair follicle placode formation,	GO:0005576~extracellular region,		IPR006796:Dickkopf, N-terminal cysteine-rich,IPR023569:Prokineticin domain,	mmu04310:Wnt signaling pathway,				Complete proteome,Developmental protein,Disulfide bond,Reference proteome,Secreted,Signal,Wnt signaling pathway,	chain:Dickkopf-related protein 4,disulfide bond,region of interest:DKK-type Cys-1,region of interest:DKK-type Cys-2,signal peptide,
P11179	dihydrolipoamide S-succinyltransferase(DLST)	Bos taurus				GO:0006099~tricarboxylic acid cycle,GO:0033512~L-lysine catabolic process to acetyl-CoA via saccharopine,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0016020~membrane,GO:0043209~myelin sheath,GO:0045252~oxoglutarate dehydrogenase complex,GO:0070062~extracellular exosome,	GO:0004149~dihydrolipoyllysine-residue succinyltransferase activity,	IPR000089:Biotin/lipoyl attachment,IPR001078:2-oxoacid dehydrogenase acyltransferase, catalytic domain,IPR003016:2-oxo acid dehydrogenase, lipoyl-binding site,IPR006255:Dihydrolipoamide succinyltransferase,IPR011053:Single hybrid motif,IPR023213:Chloramphenicol acetyltransferase-like domain,	bta00020:Citrate cycle (TCA cycle),bta00310:Lysine degradation,bta01100:Metabolic pathways,bta01130:Biosynthesis of antibiotics,bta01200:Carbon metabolism,				Acetylation,Acyltransferase,Coiled coil,Complete proteome,Direct protein sequencing,Lipoyl,Mitochondrion,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,Transit peptide,Tricarboxylic acid cycle,	chain:Dihydrolipoyllysine-residue succinyltransferase component of 2- oxoglutarate dehydrogenase complex, mitochondrial,domain:Lipoyl-binding,modified residue,transit peptide:Mitochondrion,
P36957	dihydrolipoamide S-succinyltransferase(DLST)	Homo sapiens				GO:0006091~generation of precursor metabolites and energy,GO:0006099~tricarboxylic acid cycle,GO:0006103~2-oxoglutarate metabolic process,GO:0006554~lysine catabolic process,GO:0006734~NADH metabolic process,GO:0008152~metabolic process,GO:0033512~L-lysine catabolic process to acetyl-CoA via saccharopine,GO:0046487~glyoxylate metabolic process,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043209~myelin sheath,GO:0045252~oxoglutarate dehydrogenase complex,GO:0070062~extracellular exosome,	GO:0004149~dihydrolipoyllysine-residue succinyltransferase activity,GO:0016740~transferase activity,GO:0016746~transferase activity, transferring acyl groups,	IPR000089:Biotin/lipoyl attachment,IPR001078:2-oxoacid dehydrogenase acyltransferase, catalytic domain,IPR003016:2-oxo acid dehydrogenase, lipoyl-binding site,IPR006255:Dihydrolipoamide succinyltransferase,IPR011053:Single hybrid motif,IPR023213:Chloramphenicol acetyltransferase-like domain,	hsa00020:Citrate cycle (TCA cycle),hsa00310:Lysine degradation,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,				Acetylation,Acyltransferase,Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Lipoyl,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transit peptide,Tricarboxylic acid cycle,	chain:Dihydrolipoyllysine-residue succinyltransferase component of 2- oxoglutarate dehydrogenase complex, mitochondrial,domain:Lipoyl-binding,modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
P11181	dihydrolipoamide branched chain transacylase E2(DBT)	Bos taurus			Energy production and conversion,	GO:0008152~metabolic process,	GO:0042645~mitochondrial nucleoid,	GO:0031625~ubiquitin protein ligase binding,GO:0043754~dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,	IPR000089:Biotin/lipoyl attachment,IPR001078:2-oxoacid dehydrogenase acyltransferase, catalytic domain,IPR003016:2-oxo acid dehydrogenase, lipoyl-binding site,IPR004167:E3 binding,IPR011053:Single hybrid motif,IPR015761:Lipoamide Acyltransferase,IPR023213:Chloramphenicol acetyltransferase-like domain,	bta00280:Valine, leucine and isoleucine degradation,bta01100:Metabolic pathways,bta01130:Biosynthesis of antibiotics,				3D-structure,Acetylation,Acyltransferase,Complete proteome,Direct protein sequencing,Lipoyl,Mitochondrion,Phosphoprotein,Reference proteome,Transferase,Transit peptide,	chain:Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial,domain:Lipoyl-binding,helix,modified residue,sequence conflict,strand,transit peptide:Mitochondrion,turn,
P09623	dihydrolipoamide dehydrogenase(DLD)	Sus scrofa				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0006508~proteolysis,GO:0007369~gastrulation,GO:0042391~regulation of membrane potential,GO:0045454~cell redox homeostasis,GO:0048240~sperm capacitation,GO:0055114~oxidation-reduction process,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005929~cilium,GO:0043159~acrosomal matrix,GO:0043209~myelin sheath,GO:0045254~pyruvate dehydrogenase complex,	GO:0004148~dihydrolipoyl dehydrogenase activity,GO:0016668~oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,GO:0034604~pyruvate dehydrogenase (NAD+) activity,GO:0050660~flavin adenine dinucleotide binding,	IPR004099:Pyridine nucleotide-disulphide oxidoreductase, dimerisation,IPR006258:Dihydrolipoamide dehydrogenase,IPR012999:Pyridine nucleotide-disulphide oxidoreductase, class I, active site,IPR016156:FAD/NAD-linked reductase, dimerisation,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,	ssc00010:Glycolysis / Gluconeogenesis,ssc00020:Citrate cycle (TCA cycle),ssc00260:Glycine, serine and threonine metabolism,ssc00280:Valine, leucine and isoleucine degradation,ssc00620:Pyruvate metabolism,ssc00630:Glyoxylate and dicarboxylate metabolism,ssc01100:Metabolic pathways,ssc01130:Biosynthesis of antibiotics,ssc01200:Carbon metabolism,				Acetylation,Complete proteome,Direct protein sequencing,Disulfide bond,FAD,Flavoprotein,Mitochondrion,NAD,Oxidoreductase,Phosphoprotein,Proteomics identification,Redox-active center,Reference proteome,Transit peptide,	active site:Proton acceptor,binding site:FAD,binding site:FAD; via amide nitrogen and carbonyl oxygen,binding site:NAD,binding site:NAD; via amide nitrogen,binding site:NAD; via amide nitrogen and carbonyl oxygen,chain:Dihydrolipoyl dehydrogenase, mitochondrial,disulfide bond,modified residue,nucleotide phosphate-binding region:FAD,nucleotide phosphate-binding region:NAD,sequence conflict,transit peptide:Mitochondrion,
B1AZP2	discs, large homolog-associated protein 4 (Drosophila)(Dlgap4)	Mus musculus				GO:0023052~signaling,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0045202~synapse,	GO:0005515~protein binding,GO:0019904~protein domain specific binding,	IPR005026:Guanylate-kinase-associated protein,					Alternative splicing,Complete proteome,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Disks large-associated protein 4,modified residue,sequence conflict,splice variant,
P70610	double C2 domain beta(Doc2b)	Rattus norvegicus				GO:0006887~exocytosis,GO:0008104~protein localization,GO:0031340~positive regulation of vesicle fusion,GO:0032024~positive regulation of insulin secretion,GO:0045956~positive regulation of calcium ion-dependent exocytosis,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0031201~SNARE complex,GO:0098793~presynapse,	GO:0005509~calcium ion binding,GO:0005544~calcium-dependent phospholipid binding,GO:0019905~syntaxin binding,GO:0030276~clathrin binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR001565:Synaptotagmin,IPR014638:Double C2 protein, alpha/beta/gamma type,			PIRSF036931:double C2 protein, alpha/beta/gamma types,	SM00239:C2,	3D-structure,Calcium,Calcium/phospholipid-binding,Cell membrane,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Reference proteome,Repeat,	chain:Double C2-like domain-containing protein beta,domain:C2 1,domain:C2 2,
Q6ZRR9	doublecortin domain containing 5(DCDC5)	Homo sapiens				GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,GO:0005737~cytoplasm,		IPR000772:Ricin B lectin domain,IPR003533:Doublecortin domain,				SM00537:DCX,	Complete proteome,Reference proteome,Repeat,
Q13115	dual specificity phosphatase 4(DUSP4)	Homo sapiens		h_dspPathway:Regulation of MAP Kinase Pathways Through Dual Specificity Phosphatases,		GO:0000188~inactivation of MAPK activity,GO:0001706~endoderm formation,GO:0016311~dephosphorylation,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0035970~peptidyl-threonine dephosphorylation,GO:0070373~negative regulation of ERK1 and ERK2 cascade,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0004725~protein tyrosine phosphatase activity,GO:0008330~protein tyrosine/threonine phosphatase activity,GO:0016791~phosphatase activity,GO:0017017~MAP kinase tyrosine/serine/threonine phosphatase activity,GO:1990439~MAP kinase threonine phosphatase activity,	IPR000340:Dual specificity phosphatase, catalytic domain,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR001763:Rhodanese-like domain,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR008343:Mitogen-activated protein (MAP) kinase phosphatase,IPR016130:Protein-tyrosine phosphatase, active site,IPR020422:Dual specificity phosphatase, subgroup, catalytic domain,IPR024950:Dual specificity phosphatase,	hsa04010:MAPK signaling pathway,		PIRSF000939:dual specificity protein phosphatase (MAP kinase phosphatase),	SM00195:DSPc,SM00404:PTPc_motif,SM00450:RHOD,	3D-structure,Alternative splicing,Complete proteome,Hydrolase,Nucleus,Phosphoprotein,Protein phosphatase,Reference proteome,	active site:Phosphocysteine intermediate,chain:Dual specificity protein phosphatase 4,domain:Rhodanese,domain:Tyrosine-protein phosphatase,helix,sequence conflict,strand,turn,
Q7ZWE6	dystrobrevin binding protein 1a(dtnbp1a)	Danio rerio				GO:0008089~anterograde axonal transport,GO:0031175~neuron projection development,GO:0048490~anterograde synaptic vesicle transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030054~cell junction,GO:0030672~synaptic vesicle membrane,GO:0031083~BLOC-1 complex,GO:0031410~cytoplasmic vesicle,GO:0033162~melanosome membrane,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:1904115~axon cytoplasm,		IPR007531:Dysbindin,					Cell junction,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Endoplasmic reticulum,Endosome,Membrane,Nucleus,Postsynaptic cell membrane,Reference proteome,Synapse,	chain:Dysbindin-A,
P26632	early growth response 1(egr1)	Danio rerio			Transcription / Cell division and chromosome partitioning,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0043010~camera-type eye development,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048703~embryonic viscerocranium morphogenesis,GO:0060059~embryonic retina morphogenesis in camera-type eye,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0010385~double-stranded methylated DNA binding,GO:0043565~sequence-specific DNA binding,GO:0044729~hemi-methylated DNA-binding,GO:0046872~metal ion binding,GO:1990841~promoter-specific chromatin binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,IPR021839:Protein of unknown function DUF3432,IPR021849:Protein of unknown function DUF3446,				SM00355:ZnF_C2H2,	Activator,Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Early growth response protein 1,compositionally biased region:Poly-Ser,sequence conflict,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
P13804	electron transfer flavoprotein alpha subunit(ETFA)	Homo sapiens			Energy production and conversion,	GO:0022904~respiratory electron transport chain,GO:0033539~fatty acid beta-oxidation using acyl-CoA dehydrogenase,GO:0055088~lipid homeostasis,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0070062~extracellular exosome,	GO:0000062~fatty-acyl-CoA binding,GO:0003995~acyl-CoA dehydrogenase activity,GO:0005515~protein binding,GO:0009055~electron carrier activity,GO:0016491~oxidoreductase activity,GO:0050660~flavin adenine dinucleotide binding,GO:0052890~oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,	IPR001308:Electron transfer flavoprotein, alpha subunit,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR014730:Electron transfer flavoprotein, alpha/beta-subunit, N-terminal,IPR014731:Electron transfer flavoprotein, alpha subunit, C-terminal,IPR018206:Electron transfer flavoprotein, alpha subunit, C-terminal, conserved site,		231680~Glutaric acidemia IIA,	PIRSF000089:electron transfer flavoprotein, alpha subunit,	SM00893:SM00893,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Electron transport,FAD,Flavoprotein,Glutaricaciduria,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,Transport,	chain:Electron transfer flavoprotein subunit alpha, mitochondrial,helix,modified residue,nucleotide phosphate-binding region:FAD,sequence variant,strand,transit peptide:Mitochondrion,turn,
Q68FU3	electron transfer flavoprotein beta subunit(Etfb)	Rattus norvegicus				GO:0033539~fatty acid beta-oxidation using acyl-CoA dehydrogenase,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0017133~mitochondrial electron transfer flavoprotein complex,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0009055~electron carrier activity,	IPR000049:Electron transfer flavoprotein, beta-subunit, conserved site,IPR012255:Electron transfer flavoprotein, beta subunit,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR014730:Electron transfer flavoprotein, alpha/beta-subunit, N-terminal,			PIRSF000090:electron transfer flavoprotein, beta subunit,	SM00893:SM00893,	Acetylation,Complete proteome,Electron transport,FAD,Flavoprotein,Methylation,Mitochondrion,Phosphoprotein,Reference proteome,Transport,	chain:Electron transfer flavoprotein subunit beta,modified residue,
Q5RIC0	elongator acetyltransferase complex subunit 3(elp3)	Danio rerio				GO:0002098~tRNA wobble uridine modification,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0007399~nervous system development,GO:0007409~axonogenesis,	GO:0000123~histone acetyltransferase complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0008023~transcription elongation factor complex,GO:0033588~Elongator holoenzyme complex,	GO:0003824~catalytic activity,GO:0004402~histone acetyltransferase activity,GO:0008080~N-acetyltransferase activity,GO:0008607~phosphorylase kinase regulator activity,GO:0016740~transferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0046872~metal ion binding,GO:0051536~iron-sulfur cluster binding,	IPR000182:GNAT domain,IPR005910:Histone acetyltransferase ELP3,IPR006638:Elongator protein 3/MiaB/NifB,IPR007197:Radical SAM,IPR016181:Acyl-CoA N-acyltransferase,IPR023404:Radical SAM, alpha/beta horseshoe,			PIRSF005669:histone acetyltransferase with radical SAM domain, Elp3 type,	SM00729:Elp3,	Acyltransferase,Alternative splicing,Complete proteome,Iron,Iron-sulfur,Metal-binding,Neurogenesis,Nucleus,Reference proteome,S-adenosyl-L-methionine,Transcription,Transcription regulation,Transferase,	chain:Elongator complex protein 3,domain:N-acetyltransferase,metal ion-binding site:Iron-sulfur (4Fe-4S-S-AdoMet),sequence conflict,splice variant,
Q566T0	embryonic ectoderm development(eed)	Danio rerio				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,	GO:0005634~nucleus,GO:0035098~ESC/E(Z) complex,		IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,				SM00320:WD40,	Chromatin regulator,Complete proteome,Nucleus,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,WD repeat,	chain:Polycomb protein eed,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,
P60509	endogenous retrovirus group PABLB member 1(ERVPABLB-1)	Homo sapiens					GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR018154:TLV/ENV coat polyprotein,					Cell membrane,Complete proteome,Disulfide bond,ERV,Glycoprotein,Membrane,Reference proteome,Transmembrane,Transmembrane helix,Transposable element,
Q1LUM3	endonuclease, polyU-specific C(endouc)	Danio rerio					GO:0005576~extracellular region,	GO:0003723~RNA binding,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004521~endoribonuclease activity,GO:0016787~hydrolase activity,GO:0016788~hydrolase activity, acting on ester bonds,GO:0042578~phosphoric ester hydrolase activity,GO:0043765~T/G mismatch-specific endonuclease activity,GO:0044824~retroviral 3' processing activity,GO:0046872~metal ion binding,	IPR018998:Endoribonuclease XendoU,					Complete proteome,Endonuclease,Glycoprotein,Hydrolase,Manganese,Metal-binding,Nuclease,Reference proteome,RNA-binding,Secreted,Signal,
B5DGQ7	enolase 3-2(LOC100194636)	Salmo salar				GO:0006096~glycolytic process,	GO:0000015~phosphopyruvate hydratase complex,	GO:0000287~magnesium ion binding,GO:0004634~phosphopyruvate hydratase activity,	IPR000941:Enolase,IPR020809:Enolase, conserved site,IPR020810:Enolase, C-terminal,IPR020811:Enolase, N-terminal,			PIRSF001400:enolase,	SM01192:SM01192,SM01193:SM01193,	Allergen,Cytoplasm,Direct protein sequencing,Glycolysis,Lyase,Magnesium,Metal-binding,
Q62651	enoyl-CoA hydratase 1(Ech1)	Rattus norvegicus			Lipid metabolism,	GO:0006635~fatty acid beta-oxidation,GO:0009062~fatty acid catabolic process,	GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0005102~receptor binding,GO:0016853~isomerase activity,	IPR001753:Crotonase superfamily,IPR014748:Crontonase, C-terminal,IPR018376:Enoyl-CoA hydratase/isomerase, conserved site,	rno04146:Peroxisome,				3D-structure,Acetylation,Complete proteome,Direct protein sequencing,Fatty acid metabolism,Isomerase,Lipid metabolism,Mitochondrion,Peroxisome,Phosphoprotein,Reference proteome,Transit peptide,	binding site:Substrate; via amide nitrogen,chain:Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial,helix,modified residue,sequence conflict,short sequence motif:Microbody targeting signal,site:Important for catalytic activity,strand,transit peptide:Mitochondrion,
Q9ET47	espin(Espn)	Mus musculus				GO:0007605~sensory perception of sound,GO:0007626~locomotory behavior,GO:0030046~parallel actin filament bundle assembly,GO:0051017~actin filament bundle assembly,GO:0051491~positive regulation of filopodium assembly,GO:0051494~negative regulation of cytoskeleton organization,GO:0051639~actin filament network formation,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005902~microvillus,GO:0005903~brush border,GO:0015629~actin cytoskeleton,GO:0030054~cell junction,GO:0031941~filamentous actin,GO:0032421~stereocilium bundle,GO:0032426~stereocilium tip,GO:0042995~cell projection,GO:0043197~dendritic spine,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0051015~actin filament binding,	IPR000095:PAK-box/P21-Rho-binding,IPR002110:Ankyrin repeat,IPR003124:WH2 domain,IPR020683:Ankyrin repeat-containing domain,				SM00246:WH2,SM00248:ANK,	3D-structure,Actin-binding,Alternative splicing,ANK repeat,Cell junction,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Hearing,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Espin,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:WH2,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,sequence conflict,splice variant,
Q9HDX3	esterase/lipase (predicted)(SPAPB1A11.02)	Schizosaccharomyces pombe 972h-				GO:0008152~metabolic process,		GO:0016787~hydrolase activity,	IPR013094:Alpha/beta hydrolase fold-3,					Complete proteome,Hydrolase,Reference proteome,	chain:AB hydrolase superfamily protein B1A11.02,
Q9D4V0	ethanolamine kinase 1(Etnk1)	Mus musculus				GO:0006629~lipid metabolic process,GO:0006646~phosphatidylethanolamine biosynthetic process,GO:0008654~phospholipid biosynthetic process,GO:0016310~phosphorylation,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0000166~nucleotide binding,GO:0004305~ethanolamine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR011009:Protein kinase-like domain,	mmu00564:Glycerophospholipid metabolism,mmu01100:Metabolic pathways,				ATP-binding,Complete proteome,Cytoplasm,Kinase,Lipid biosynthesis,Lipid metabolism,Membrane,Nucleotide-binding,Phospholipid biosynthesis,Phospholipid metabolism,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Ethanolamine kinase 1,compositionally biased region:Poly-Val,modified residue,
Q9DCM0	ethylmalonic encephalopathy 1(Ethe1)	Mus musculus				GO:0006749~glutathione metabolic process,GO:0055114~oxidation-reduction process,GO:0070813~hydrogen sulfide metabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0005506~iron ion binding,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,GO:0050313~sulfur dioxygenase activity,GO:0051213~dioxygenase activity,	IPR001279:Beta-lactamase-like,	mmu00920:Sulfur metabolism,			SM00849:SM00849,	Acetylation,Complete proteome,Cytoplasm,Dioxygenase,Metal-binding,Mitochondrion,Nucleus,Oxidoreductase,Phosphoprotein,Reference proteome,Transit peptide,	chain:Protein ETHE1, mitochondrial,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,modified residue,transit peptide:Mitochondrion,
Q90705	eukaryotic translation elongation factor 2(EEF2)	Gallus gallus			Translation, ribosomal structure and biogenesis,	GO:0002244~hematopoietic progenitor cell differentiation,GO:0006412~translation,GO:0006414~translational elongation,GO:0045727~positive regulation of translation,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005844~polysome,GO:0005886~plasma membrane,GO:0016235~aggresome,GO:0070062~extracellular exosome,	GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR000640:Translation elongation factor EFG, V domain,IPR000795:Elongation factor, GTP-binding domain,IPR004161:Translation elongation factor EFTu/EF1A, domain 2,IPR005225:Small GTP-binding protein domain,IPR005517:Translation elongation factor EFG/EF2, domain IV,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR009022:Elongation factor G, III-V domain,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00838:SM00838,SM00889:SM00889,	Complete proteome,Cytoplasm,Direct protein sequencing,Elongation factor,GTP-binding,Nucleotide-binding,Phosphoprotein,Protein biosynthesis,Reference proteome,	chain:Elongation factor 2,modified residue,nucleotide phosphate-binding region:GTP,
A2VD00	eukaryotic translation initiation factor 3 subunit A S homeolog(eif3a.S)	Xenopus laevis			DNA replication, recombination, and repair,	GO:0001731~formation of translation preinitiation complex,GO:0001732~formation of cytoplasmic translation initiation complex,GO:0006446~regulation of translational initiation,	GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0016282~eukaryotic 43S preinitiation complex,GO:0033290~eukaryotic 48S preinitiation complex,	GO:0003743~translation initiation factor activity,	IPR000717:Proteasome component (PCI) domain,IPR027512:Eukaryotic translation initiation factor 3 subunit A,	xla03013:RNA transport,			SM00088:PINT,	Cytoplasm,Initiation factor,Protein biosynthesis,Repeat,	chain:Eukaryotic translation initiation factor 3 subunit A,compositionally biased region:Asp-rich,compositionally biased region:Glu-rich,domain:PCI,region of interest:26 X 10 AA approximate tandem repeats of [DE]-[DE]-[DE]-R-[GTV]-[PS]-R-R-G- [AFGLM],repeat:10; approximate,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16,repeat:17,repeat:18,repeat:19,repeat:1; approximate,repeat:2,repeat:20,repeat:21,repeat:22; approximate,repeat:23,repeat:24,repeat:25,repeat:26,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,
Q2M3D2	exocyst complex component 3 like 2(EXOC3L2)	Homo sapiens				GO:0006887~exocytosis,GO:0051601~exocyst localization,	GO:0000145~exocyst,	GO:0000149~SNARE binding,	IPR010326:Exocyst complex component Sec6,					Coiled coil,Complete proteome,Polymorphism,Reference proteome,	chain:Exocyst complex component 3-like protein 2,sequence conflict,sequence variant,
Q9NUQ9	family with sequence similarity 49 member B(FAM49B)	Homo sapiens					GO:0005929~cilium,GO:0016020~membrane,GO:0070062~extracellular exosome,		IPR009828:Protein of unknown function DUF1394,					Alternative splicing,Complete proteome,Lipoprotein,Membrane,Myristate,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein FAM49B,sequence variant,
Q8BXQ8	family with sequence similarity 53, member C(Fam53c)	Mus musculus												Acetylation,Complete proteome,Phosphoprotein,Reference proteome,	chain:Protein FAM53C,modified residue,
Q1LU99	family with sequence similarity 65, member B(fam65b)	Danio rerio				GO:0007605~sensory perception of sound,GO:0048741~skeletal muscle fiber development,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0042995~cell projection,GO:0060171~stereocilium membrane,		IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR026136:Protein FAM65,					Alternative splicing,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Hearing,Membrane,Reference proteome,	chain:Protein FAM65B,sequence conflict,splice variant,
Q8K1B8	fermitin family member 3(Fermt3)	Mus musculus				GO:0007155~cell adhesion,GO:0007159~leukocyte cell-cell adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0030335~positive regulation of cell migration,GO:0033622~integrin activation,GO:0033632~regulation of cell-cell adhesion mediated by integrin,GO:0034446~substrate adhesion-dependent cell spreading,GO:0070527~platelet aggregation,	GO:0002102~podosome,GO:0016020~membrane,GO:0030054~cell junction,GO:0042995~cell projection,GO:0070062~extracellular exosome,	GO:0005178~integrin binding,GO:0005515~protein binding,	IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,	mmu04611:Platelet activation,			SM00233:PH,SM00295:B41,	Cell adhesion,Cell junction,Cell projection,Complete proteome,Phosphoprotein,Reference proteome,	chain:Fermitin family homolog 3,domain:FERM,domain:PH,modified residue,mutagenesis site,
P49946	ferritin heavy subunit(LOC100136564)	Salmo salar				GO:0006826~iron ion transport,GO:0006879~cellular iron ion homeostasis,	GO:0005623~cell,	GO:0004322~ferroxidase activity,GO:0008199~ferric iron binding,	IPR001519:Ferritin,IPR008331:Ferritin/DPS protein domain,IPR009040:Ferritin- like diiron domain,IPR009078:Ferritin-like superfamily,IPR012347:Ferritin-related,IPR014034:Ferritin, conserved site,					Iron,Iron storage,Metal-binding,Oxidoreductase,	chain:Ferritin, heavy subunit,domain:Ferritin-like diiron,metal ion-binding site:Iron 1,metal ion-binding site:Iron 2,
P49947	ferritin middle subunit(LOC100136565)	Salmo salar				GO:0006826~iron ion transport,GO:0006879~cellular iron ion homeostasis,	GO:0005623~cell,	GO:0004322~ferroxidase activity,GO:0008199~ferric iron binding,	IPR001519:Ferritin,IPR008331:Ferritin/DPS protein domain,IPR009040:Ferritin- like diiron domain,IPR009078:Ferritin-like superfamily,IPR012347:Ferritin-related,IPR014034:Ferritin, conserved site,					Iron,Iron storage,Metal-binding,Oxidoreductase,	chain:Ferritin, middle subunit,domain:Ferritin-like diiron,metal ion-binding site:Iron 1,metal ion-binding site:Iron 2,
P17634	fibrinogen gamma chain L homeolog(fgg.L)	Xenopus laevis				GO:0007165~signal transduction,GO:0030168~platelet activation,GO:0051258~protein polymerization,	GO:0005577~fibrinogen complex,	GO:0046872~metal ion binding,	IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain,IPR012290:Fibrinogen, alpha/beta/gamma chain, coiled coil domain,IPR014715:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 2,IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1,IPR020837:Fibrinogen, conserved site,				SM00186:FBG,SM01212:SM01212,	Blood coagulation,Calcium,Coiled coil,Disulfide bond,Glycoprotein,Hemostasis,Metal-binding,Secreted,Signal,	chain:Fibrinogen gamma chain,disulfide bond,domain:Fibrinogen C-terminal,glycosylation site:N-linked (GlcNAc...),signal peptide,
P12799	fibrinogen gamma chain(FGG)	Bos taurus				GO:0007160~cell-matrix adhesion,GO:0007165~signal transduction,GO:0009306~protein secretion,GO:0030168~platelet activation,GO:0031639~plasminogen activation,GO:0034116~positive regulation of heterotypic cell-cell adhesion,GO:0042730~fibrinolysis,GO:0045907~positive regulation of vasoconstriction,GO:0045921~positive regulation of exocytosis,GO:0050714~positive regulation of protein secretion,GO:0051258~protein polymerization,GO:0051592~response to calcium ion,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070527~platelet aggregation,GO:0072378~blood coagulation, fibrin clot formation,GO:0090277~positive regulation of peptide hormone secretion,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000352~negative regulation of endothelial cell apoptotic process,	GO:0005577~fibrinogen complex,GO:0005938~cell cortex,GO:0009897~external side of plasma membrane,GO:0031091~platelet alpha granule,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0005102~receptor binding,GO:0005198~structural molecule activity,GO:0030674~protein binding, bridging,GO:0046872~metal ion binding,	IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain,IPR012290:Fibrinogen, alpha/beta/gamma chain, coiled coil domain,IPR014715:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 2,IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1,IPR020837:Fibrinogen, conserved site,	bta04610:Complement and coagulation cascades,bta04611:Platelet activation,bta05150:Staphylococcus aureus infection,			SM00186:FBG,SM01212:SM01212,	3D-structure,Blood coagulation,Calcium,Coiled coil,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hemostasis,Metal-binding,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Fibrinogen gamma-B chain,disulfide bond,domain:Fibrinogen C-terminal,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,signal peptide,strand,turn,
P02679	fibrinogen gamma chain(FGG)	Homo sapiens		h_amiPathway:Acute Myocardial Infarction,h_extrinsicPathway:Extrinsic Prothrombin Activation Pathway,h_fibrinolysisPathway:Fibrinolysis Pathway,h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway,		GO:0002576~platelet degranulation,GO:0007160~cell-matrix adhesion,GO:0007165~signal transduction,GO:0007596~blood coagulation,GO:0009306~protein secretion,GO:0030168~platelet activation,GO:0030198~extracellular matrix organization,GO:0031639~plasminogen activation,GO:0034116~positive regulation of heterotypic cell-cell adhesion,GO:0042730~fibrinolysis,GO:0043623~cellular protein complex assembly,GO:0045907~positive regulation of vasoconstriction,GO:0045921~positive regulation of exocytosis,GO:0050714~positive regulation of protein secretion,GO:0051258~protein polymerization,GO:0051592~response to calcium ion,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070527~platelet aggregation,GO:0072378~blood coagulation, fibrin clot formation,GO:0090277~positive regulation of peptide hormone secretion,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000352~negative regulation of endothelial cell apoptotic process,	GO:0005576~extracellular region,GO:0005577~fibrinogen complex,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0031091~platelet alpha granule,GO:0031093~platelet alpha granule lumen,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0005102~receptor binding,GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0030674~protein binding, bridging,GO:0046872~metal ion binding,GO:0050839~cell adhesion molecule binding,	IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain,IPR012290:Fibrinogen, alpha/beta/gamma chain, coiled coil domain,IPR014715:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 2,IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1,IPR020837:Fibrinogen, conserved site,	hsa04610:Complement and coagulation cascades,hsa04611:Platelet activation,hsa05150:Staphylococcus aureus infection,	202400~Afibrinogenemia, congenital,202400~Hypofibrinogenemia, congenital,616004~Dysfibrinogenemia, congenital,616004~Hypodysfibrinogenemia,		SM00186:FBG,SM01212:SM01212,	3D-structure,Alternative splicing,Blood coagulation,Calcium,Coiled coil,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hemostasis,Isopeptide bond,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Sulfation,	chain:Fibrinogen gamma chain,cross-link:Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-432),cross-link:Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-424),disulfide bond,domain:Fibrinogen C-terminal,glycosylation site:N-linked (GlcNAc...),glycosylation site:N-linked (GlcNAc...); in variant Asahi,helix,modified residue,region of interest:Gamma-chain polymerization, binding amino end of another fibrin alpha chain,region of interest:Platelet aggregation and Staphylococcus clumping,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
Q29RY7	fibrinogen like 2(FGL2)	Bos taurus			Function unknown,	GO:0006508~proteolysis,GO:0010952~positive regulation of peptidase activity,	GO:0009986~cell surface,GO:0070062~extracellular exosome,	GO:0008233~peptidase activity,GO:0016504~peptidase activator activity,	IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain,IPR014715:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 2,IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1,IPR020837:Fibrinogen, conserved site,				SM00186:FBG,	Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Reference proteome,Secreted,Signal,	chain:Fibroleukin,domain:Fibrinogen C-terminal,glycosylation site:N-linked (GlcNAc...),signal peptide,
P35846	folate receptor 1 (adult)(Folr1)	Mus musculus				GO:0001947~heart looping,GO:0003147~neural crest cell migration involved in heart formation,GO:0003253~cardiac neural crest cell migration involved in outflow tract morphogenesis,GO:0006620~posttranslational protein targeting to membrane,GO:0006810~transport,GO:0015884~folic acid transport,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0031103~axon regeneration,GO:0046655~folic acid metabolic process,GO:0048678~response to axon injury,GO:0060828~regulation of canonical Wnt signaling pathway,GO:0061626~pharyngeal arch artery morphogenesis,GO:0061713~anterior neural tube closure,GO:0071231~cellular response to folic acid,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0009986~cell surface,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0030136~clathrin-coated vesicle,GO:0031225~anchored component of membrane,GO:0031362~anchored component of external side of plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0031526~brush border membrane,GO:0046658~anchored component of plasma membrane,GO:0070062~extracellular exosome,	GO:0004872~receptor activity,GO:0005542~folic acid binding,GO:0008144~drug binding,GO:0008517~folic acid transporter activity,GO:0051870~methotrexate binding,	IPR004269:Folate receptor,IPR018143:Folate receptor-like,	mmu04144:Endocytosis,				Cell membrane,Complete proteome,Cytoplasmic vesicle,Disulfide bond,Endosome,Folate-binding,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Proteomics identification,Receptor,Reference proteome,Secreted,Signal,Transport,	chain:Folate receptor alpha,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,signal peptide,
Q9YH58	formimidoyltransferase cyclodeaminase(FTCD)	Gallus gallus				GO:0019556~histidine catabolic process to glutamate and formamide,GO:0019557~histidine catabolic process to glutamate and formate,GO:0035999~tetrahydrofolate interconversion,GO:0044237~cellular metabolic process,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0005814~centriole,GO:0005829~cytosol,GO:0030868~smooth endoplasmic reticulum membrane,GO:0070062~extracellular exosome,	GO:0005542~folic acid binding,GO:0016740~transferase activity,GO:0030409~glutamate formimidoyltransferase activity,GO:0030412~formimidoyltetrahydrofolate cyclodeaminase activity,	IPR004227:Formiminotransferase catalytic domain,IPR007044:Cyclodeaminase/cyclohydrolase,IPR012886:Formiminotransferase, N-terminal subdomain,IPR013802:Formiminotransferase, C-terminal subdomain,IPR022384:Formiminotransferas, N- and C-terminal subdomains,	gga00340:Histidine metabolism,gga00670:One carbon pool by folate,gga01100:Metabolic pathways,			SM01221:SM01221,SM01222:SM01222,	Complete proteome,Cytoplasm,Cytoskeleton,Folate-binding,Golgi apparatus,Histidine metabolism,Lyase,Multifunctional enzyme,Pyridoxal phosphate,Reference proteome,Transferase,	active site:For cyclodeaminase activity,active site:For formimidoyltransferase activity,chain:Formimidoyltransferase-cyclodeaminase,region of interest:Cyclodeaminase/cyclohydrolase,region of interest:Folate binding,region of interest:Formiminotransferase C-subdomain,region of interest:Formiminotransferase N-subdomain,region of interest:Linker,
P16930	fumarylacetoacetate hydrolase(FAH)	Homo sapiens				GO:0006527~arginine catabolic process,GO:0006559~L-phenylalanine catabolic process,GO:0006572~tyrosine catabolic process,GO:0009072~aromatic amino acid family metabolic process,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004334~fumarylacetoacetase activity,GO:0046872~metal ion binding,	IPR005959:Fumarylacetoacetase,IPR011234:Fumarylacetoacetase, C-terminal-related,IPR015377:Fumarylacetoacetase, N-terminal,	hsa00350:Tyrosine metabolism,hsa01100:Metabolic pathways,	276700~Tyrosinemia, type I,			Acetylation,Alternative splicing,Calcium,Complete proteome,Direct protein sequencing,Disease mutation,Hydrolase,Magnesium,Metal-binding,Phenylalanine catabolism,Phosphoprotein,Proteomics identification,Reference proteome,Tyrosine catabolism,	active site:Proton acceptor,binding site:Substrate,chain:Fumarylacetoacetase,metal ion-binding site:Calcium,metal ion-binding site:Magnesium,modified residue,mutagenesis site,sequence variant,
Q3MHZ8	galectin 9(LGALS9)	Bos taurus				GO:0002376~immune system process,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0030246~carbohydrate binding,	IPR001079:Galectin, carbohydrate recognition domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,				SM00276:GLECT,SM00908:SM00908,	Complete proteome,Cytoplasm,Immunity,Lectin,Nucleus,Reference proteome,Repeat,Secreted,	binding site:Beta-galactoside,chain:Galectin-9,domain:Galectin 1,domain:Galectin 2,region of interest:Beta-galactoside binding 1,region of interest:Beta-galactoside binding 2,
P23576	gamma-aminobutyric acid type A receptor alpha2 subunit(Gabra2)	Rattus norvegicus				GO:0001505~regulation of neurotransmitter levels,GO:0006821~chloride transport,GO:0006836~neurotransmitter transport,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0034220~ion transmembrane transport,GO:1902476~chloride transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030285~integral component of synaptic vesicle membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0032590~dendrite membrane,GO:0034707~chloride channel complex,GO:0043025~neuronal cell body,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0060077~inhibitory synapse,GO:0098794~postsynapse,GO:1902711~GABA-A receptor complex,	GO:0004890~GABA-A receptor activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005254~chloride channel activity,GO:0008503~benzodiazepine receptor activity,	IPR001390:Gamma-aminobutyric-acid A receptor, alpha subunit,IPR005432:Gamma-aminobutyric-acid A receptor, alpha 2 subunit,IPR006028:Gamma-aminobutyric acid A receptor,IPR006029:Neurotransmitter-gated ion-channel transmembrane domain,IPR006201:Neurotransmitter-gated ion-channel,IPR006202:Neurotransmitter-gated ion-channel ligand-binding,IPR018000:Neurotransmitter-gated ion-channel, conserved site,	rno04080:Neuroactive ligand-receptor interaction,rno04723:Retrograde endocannabinoid signaling,rno04727:GABAergic synapse,rno05032:Morphine addiction,rno05033:Nicotine addiction,				Cell junction,Cell membrane,Chloride,Chloride channel,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Ligand-gated ion channel,Membrane,Postsynaptic cell membrane,Receptor,Reference proteome,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,	chain:Gamma-aminobutyric acid receptor subunit alpha-2,disulfide bond,glycosylation site:N-linked (GlcNAc...),signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
O93533	gap junction protein, beta 6, 30kDa(GJB6)	Gallus gallus				GO:0007154~cell communication,GO:0007605~sensory perception of sound,	GO:0005922~connexon complex,GO:0016021~integral component of membrane,		IPR000500:Connexin,IPR013092:Connexin, N-terminal,IPR017990:Connexin, conserved site,IPR019570:Gap junction protein, cysteine-rich domain,				SM00037:CNX,SM01089:SM01089,	Cell junction,Cell membrane,Complete proteome,Gap junction,Hearing,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Gap junction beta-6 protein,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P95493	gingipain R2(PG_RS02240)	Porphyromonas gingivalis W83				GO:0006508~proteolysis,GO:0009405~pathogenesis,	GO:0005576~extracellular region,	GO:0004198~calcium-dependent cysteine-type endopeptidase activity,GO:0005509~calcium ion binding,	IPR001769:Peptidase C25,IPR005536:Peptidase C25, Ig-like domain,IPR012600:Propeptide, peptidase C25,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR026444:Secretion system C-terminal sorting domain,	pgi01503:Cationic antimicrobial peptide (CAMP) resistance,				3D-structure,Calcium,Complete proteome,Direct protein sequencing,Hydrolase,Metal-binding,Protease,Reference proteome,Secreted,Signal,Thiol protease,Virulence,Zymogen,	active site:Nucleophile,active site:Proton donor,chain:Gingipain R2,helix,sequence conflict,signal peptide,strand,turn,
P35576	glucose-6-phosphatase, catalytic(G6pc)	Mus musculus				GO:0005977~glycogen metabolic process,GO:0005980~glycogen catabolic process,GO:0006094~gluconeogenesis,GO:0006641~triglyceride metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0008202~steroid metabolic process,GO:0010468~regulation of gene expression,GO:0015760~glucose-6-phosphate transport,GO:0032094~response to food,GO:0035264~multicellular organism growth,GO:0042593~glucose homeostasis,GO:0042632~cholesterol homeostasis,GO:0046415~urate metabolic process,GO:0046838~phosphorylated carbohydrate dephosphorylation,GO:0051156~glucose 6-phosphate metabolic process,GO:0055088~lipid homeostasis,	GO:0005783~endoplasmic reticulum,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004346~glucose-6-phosphatase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0016787~hydrolase activity,GO:0042301~phosphate ion binding,	IPR000326:Phosphatidic acid phosphatase type 2/haloperoxidase,IPR016275:Glucose-6-phosphatase,	mmu00010:Glycolysis / Gluconeogenesis,mmu00052:Galactose metabolism,mmu00500:Starch and sucrose metabolism,mmu01100:Metabolic pathways,mmu04068:FoxO signaling pathway,mmu04151:PI3K-Akt signaling pathway,mmu04152:AMPK signaling pathway,mmu04910:Insulin signaling pathway,mmu04920:Adipocytokine signaling pathway,mmu04922:Glucagon signaling pathway,mmu04931:Insulin resistance,mmu04973:Carbohydrate digestion and absorption,		PIRSF000905:glucose-6-phosphatase,	SM00014:acidPPc,	Complete proteome,Endoplasmic reticulum,Gluconeogenesis,Glycoprotein,Hydrolase,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	active site:Nucleophile,active site:Proton donor,binding site:Substrate,chain:Glucose-6-phosphatase,glycosylation site:N-linked (GlcNAc...),short sequence motif:Prevents secretion from ER,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
P00367	glutamate dehydrogenase 1(GLUD1)	Homo sapiens		h_argininecPathway:Catabolic Pathways for Arginine , Histidine, Glutamate, Glutamine, and Proline,	Amino acid transport and metabolism,	GO:0006520~cellular amino acid metabolic process,GO:0006537~glutamate biosynthetic process,GO:0006538~glutamate catabolic process,GO:0006541~glutamine metabolic process,GO:0008652~cellular amino acid biosynthetic process,GO:0021762~substantia nigra development,GO:0032024~positive regulation of insulin secretion,GO:0055114~oxidation-reduction process,GO:0072350~tricarboxylic acid metabolic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0004352~glutamate dehydrogenase (NAD+) activity,GO:0004353~glutamate dehydrogenase [NAD(P)+] activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0016491~oxidoreductase activity,GO:0042802~identical protein binding,GO:0043531~ADP binding,GO:0070403~NAD+ binding,GO:0070728~leucine binding,	IPR006095:Glutamate/phenylalanine/leucine/valine dehydrogenase,IPR006096:Glutamate/phenylalanine/leucine/valine dehydrogenase, C-terminal,IPR006097:Glutamate/phenylalanine/leucine/valine dehydrogenase, dimerisation domain,IPR016040:NAD(P)-binding domain,	hsa00220:Arginine biosynthesis,hsa00250:Alanine, aspartate and glutamate metabolism,hsa00471:D-Glutamine and D-glutamate metabolism,hsa00910:Nitrogen metabolism,hsa01100:Metabolic pathways,hsa01200:Carbon metabolism,hsa04964:Proximal tubule bicarbonate reclamation,	606762~Hyperinsulinism-hyperammonemia syndrome,		SM00839:SM00839,	3D-structure,Acetylation,ADP-ribosylation,Alternative splicing,ATP-binding,Complete proteome,Direct protein sequencing,Disease mutation,GTP-binding,Mitochondrion,NADP,Nucleotide-binding,Oxidoreductase,Phosphoprotein,Reference proteome,Transit peptide,	binding site:ADP,binding site:GTP,binding site:NAD,binding site:Substrate,chain:Glutamate dehydrogenase 1, mitochondrial,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:NAD,sequence variant,strand,transit peptide:Mitochondrion,turn,
Q6NYL5	glutamic pyruvate transaminase (alanine aminotransferase) 2, like(gpt2l)	Danio rerio				GO:0006103~2-oxoglutarate metabolic process,GO:0009058~biosynthetic process,GO:0042851~L-alanine metabolic process,GO:0042853~L-alanine catabolic process,		GO:0003824~catalytic activity,GO:0004021~L-alanine:2-oxoglutarate aminotransferase activity,GO:0008483~transaminase activity,GO:0016740~transferase activity,GO:0030170~pyridoxal phosphate binding,	IPR004839:Aminotransferase, class I/classII,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,	dre00220:Arginine biosynthesis,dre00250:Alanine, aspartate and glutamate metabolism,dre01100:Metabolic pathways,dre01200:Carbon metabolism,dre01210:2-Oxocarboxylic acid metabolism,dre01230:Biosynthesis of amino acids,				Alternative splicing,Aminotransferase,Complete proteome,Proteomics identification,Pyridoxal phosphate,Reference proteome,Transferase,	chain:Alanine aminotransferase 2-like,modified residue,sequence conflict,splice variant,
P00504	glutamic-oxaloacetic transaminase 1, soluble(GOT1)	Gallus gallus				GO:0006094~gluconeogenesis,GO:0006103~2-oxoglutarate metabolic process,GO:0006107~oxaloacetate metabolic process,GO:0006114~glycerol biosynthetic process,GO:0006520~cellular amino acid metabolic process,GO:0006531~aspartate metabolic process,GO:0006532~aspartate biosynthetic process,GO:0006533~aspartate catabolic process,GO:0006536~glutamate metabolic process,GO:0007219~Notch signaling pathway,GO:0019550~glutamate catabolic process to aspartate,GO:0019551~glutamate catabolic process to 2-oxoglutarate,GO:0032869~cellular response to insulin stimulus,GO:0051384~response to glucocorticoid,GO:0055089~fatty acid homeostasis,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004069~L-aspartate:2-oxoglutarate aminotransferase activity,GO:0004609~phosphatidylserine decarboxylase activity,GO:0030170~pyridoxal phosphate binding,GO:0042802~identical protein binding,GO:0047801~L-cysteine:2-oxoglutarate aminotransferase activity,GO:0080130~L-phenylalanine:2-oxoglutarate aminotransferase activity,	IPR000796:Aspartate/other aminotransferase,IPR004838:Aminotransferases, class-I, pyridoxal-phosphate-binding site,IPR004839:Aminotransferase, class I/classII,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015424:Pyridoxal phosphate-dependent transferase,	gga00220:Arginine biosynthesis,gga00250:Alanine, aspartate and glutamate metabolism,gga00270:Cysteine and methionine metabolism,gga00330:Arginine and proline metabolism,gga00350:Tyrosine metabolism,gga00360:Phenylalanine metabolism,gga00400:Phenylalanine, tyrosine and tryptophan biosynthesis,gga01100:Metabolic pathways,gga01130:Biosynthesis of antibiotics,gga01200:Carbon metabolism,gga01210:2-Oxocarboxylic acid metabolism,gga01230:Biosynthesis of amino acids,				3D-structure,Acetylation,Amino-acid biosynthesis,Aminotransferase,Complete proteome,Cytoplasm,Direct protein sequencing,Pyridoxal phosphate,Reference proteome,Transferase,	binding site:Aspartate,binding site:Aspartate; via amide nitrogen,chain:Aspartate aminotransferase, cytoplasmic,helix,modified residue,sequence conflict,strand,turn,
P00508	glutamic-oxaloacetic transaminase 2(GOT2)	Gallus gallus				GO:0006094~gluconeogenesis,GO:0006103~2-oxoglutarate metabolic process,GO:0006107~oxaloacetate metabolic process,GO:0006520~cellular amino acid metabolic process,GO:0006531~aspartate metabolic process,GO:0006532~aspartate biosynthetic process,GO:0006533~aspartate catabolic process,GO:0006536~glutamate metabolic process,GO:0015908~fatty acid transport,GO:0019550~glutamate catabolic process to aspartate,GO:0019551~glutamate catabolic process to 2-oxoglutarate,GO:0045471~response to ethanol,GO:0097052~L-kynurenine metabolic process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005886~plasma membrane,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0004069~L-aspartate:2-oxoglutarate aminotransferase activity,GO:0016212~kynurenine-oxoglutarate transaminase activity,GO:0030170~pyridoxal phosphate binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,GO:0080130~L-phenylalanine:2-oxoglutarate aminotransferase activity,	IPR000796:Aspartate/other aminotransferase,IPR004838:Aminotransferases, class-I, pyridoxal-phosphate-binding site,IPR004839:Aminotransferase, class I/classII,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015424:Pyridoxal phosphate-dependent transferase,	gga00220:Arginine biosynthesis,gga00250:Alanine, aspartate and glutamate metabolism,gga00270:Cysteine and methionine metabolism,gga00330:Arginine and proline metabolism,gga00350:Tyrosine metabolism,gga00360:Phenylalanine metabolism,gga00400:Phenylalanine, tyrosine and tryptophan biosynthesis,gga01100:Metabolic pathways,gga01130:Biosynthesis of antibiotics,gga01200:Carbon metabolism,gga01210:2-Oxocarboxylic acid metabolism,gga01230:Biosynthesis of amino acids,				3D-structure,Aminotransferase,Complete proteome,Direct protein sequencing,Mitochondrion,Pyridoxal phosphate,Reference proteome,Transferase,Transit peptide,	binding site:Aspartate,binding site:Aspartate; via amide nitrogen,chain:Aspartate aminotransferase, mitochondrial,helix,modified residue,sequence conflict,strand,transit peptide:Mitochondrion,turn,
P15623	glutamine synthetase(BF1040)	Bacteroides fragilis YCH46			General function prediction only,	GO:0006807~nitrogen compound metabolic process,		GO:0004356~glutamate-ammonia ligase activity,GO:0005524~ATP binding,	IPR008146:Glutamine synthetase, catalytic domain,IPR014746:Glutamine synthetase/guanido kinase, catalytic domain,IPR022147:Glutamine synthetase type III N-terminal,IPR027303:Glutamine synthetase, glycine-rich site,	bfr00220:Arginine biosynthesis,bfr00250:Alanine, aspartate and glutamate metabolism,bfr00630:Glyoxylate and dicarboxylate metabolism,bfr00910:Nitrogen metabolism,bfr01100:Metabolic pathways,bfr01120:Microbial metabolism in diverse environments,bfr01230:Biosynthesis of amino acids,bfr02020:Two-component system,			SM01230:SM01230,	ATP-binding,Complete proteome,Ligase,Nucleotide-binding,	chain:Glutamine synthetase,sequence conflict,
O83759	glutamine-dependent NAD+ synthetase(TP_RS03945)	Treponema pallidum subsp. pallidum str. Nichols				GO:0009435~NAD biosynthetic process,		GO:0003952~NAD+ synthase (glutamine-hydrolyzing) activity,GO:0005524~ATP binding,GO:0016810~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,	IPR003010:Carbon-nitrogen hydrolase,IPR003694:NAD synthase,IPR014445:Glutamine-dependent NAD(+) synthetase,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR022310:NAD/GMP synthase,			PIRSF006630:glutamine-dependent NAD(+) synthetase with GAT domain,		ATP-binding,Complete proteome,Ligase,NAD,Nucleotide-binding,Reference proteome,	chain:Probable glutamine-dependent NAD(+) synthetase,nucleotide phosphate-binding region:ATP,region of interest:Ligase,
Q2KHZ9	glutaryl-CoA dehydrogenase(GCDH)	Bos taurus			Lipid metabolism,	GO:0006568~tryptophan metabolic process,GO:0033539~fatty acid beta-oxidation using acyl-CoA dehydrogenase,GO:0055088~lipid homeostasis,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0000062~fatty-acyl-CoA binding,GO:0003995~acyl-CoA dehydrogenase activity,GO:0004361~glutaryl-CoA dehydrogenase activity,GO:0009055~electron carrier activity,GO:0050660~flavin adenine dinucleotide binding,GO:0052890~oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,	IPR006089:Acyl-CoA dehydrogenase, conserved site,IPR006091:Acyl-CoA oxidase/dehydrogenase, central domain,IPR009075:Acyl-CoA dehydrogenase/oxidase C-terminal,IPR009100:Acyl-CoA dehydrogenase/oxidase,IPR013786:Acyl-CoA dehydrogenase/oxidase, N-terminal,	bta00071:Fatty acid degradation,bta00310:Lysine degradation,bta00380:Tryptophan metabolism,bta01100:Metabolic pathways,bta01130:Biosynthesis of antibiotics,				Acetylation,Complete proteome,FAD,Flavoprotein,Mitochondrion,Oxidoreductase,Reference proteome,Transit peptide,	active site:Proton acceptor,binding site:FAD,binding site:FAD; via carbonyl oxygen,binding site:Substrate,binding site:Substrate; via amide nitrogen,binding site:Substrate; via carbonyl oxygen,chain:Glutaryl-CoA dehydrogenase, mitochondrial,nucleotide phosphate-binding region:FAD,region of interest:Substrate binding,transit peptide:Mitochondrion,
Q60759	glutaryl-Coenzyme A dehydrogenase(Gcdh)	Mus musculus			Lipid metabolism,	GO:0006568~tryptophan metabolic process,GO:0006637~acyl-CoA metabolic process,GO:0008152~metabolic process,GO:0019395~fatty acid oxidation,GO:0033539~fatty acid beta-oxidation using acyl-CoA dehydrogenase,GO:0046949~fatty-acyl-CoA biosynthetic process,GO:0055088~lipid homeostasis,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,	GO:0000062~fatty-acyl-CoA binding,GO:0003995~acyl-CoA dehydrogenase activity,GO:0004361~glutaryl-CoA dehydrogenase activity,GO:0009055~electron carrier activity,GO:0016491~oxidoreductase activity,GO:0016627~oxidoreductase activity, acting on the CH-CH group of donors,GO:0050660~flavin adenine dinucleotide binding,GO:0052890~oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,	IPR006089:Acyl-CoA dehydrogenase, conserved site,IPR006091:Acyl-CoA oxidase/dehydrogenase, central domain,IPR009075:Acyl-CoA dehydrogenase/oxidase C-terminal,IPR009100:Acyl-CoA dehydrogenase/oxidase,IPR013786:Acyl-CoA dehydrogenase/oxidase, N-terminal,	mmu00071:Fatty acid degradation,mmu00310:Lysine degradation,mmu00380:Tryptophan metabolism,mmu01100:Metabolic pathways,mmu01130:Biosynthesis of antibiotics,				Acetylation,Complete proteome,FAD,Flavoprotein,Mitochondrion,Oxidoreductase,Proteomics identification,Reference proteome,Transit peptide,	active site:Proton acceptor,binding site:FAD,binding site:FAD; via carbonyl oxygen,binding site:Substrate,binding site:Substrate; via amide nitrogen,binding site:Substrate; via carbonyl oxygen,chain:Glutaryl-CoA dehydrogenase, mitochondrial,nucleotide phosphate-binding region:FAD,region of interest:Substrate binding,transit peptide:Mitochondrion,
Q7ZV14	glutathione peroxidase 8 (putative)(gpx8)	Danio rerio				GO:0006979~response to oxidative stress,GO:0055114~oxidation-reduction process,	GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004601~peroxidase activity,GO:0004602~glutathione peroxidase activity,GO:0016491~oxidoreductase activity,	IPR000889:Glutathione peroxidase,IPR012336:Thioredoxin-like fold,IPR013376:Glutathione peroxidase Gpx7, putative,	dre00480:Glutathione metabolism,dre00590:Arachidonic acid metabolism,				Complete proteome,Membrane,Oxidoreductase,Peroxidase,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Probable glutathione peroxidase 8,transmembrane region,
O57656	glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic(LOC101071719)	Takifugu rubripes				GO:0005975~carbohydrate metabolic process,GO:0046168~glycerol-3-phosphate catabolic process,	GO:0009331~glycerol-3-phosphate dehydrogenase complex,	GO:0004367~glycerol-3-phosphate dehydrogenase [NAD+] activity,GO:0051287~NAD binding,	IPR006109:Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal,IPR006168:Glycerol-3-phosphate dehydrogenase, NAD-dependent,IPR008927:6-phosphogluconate dehydrogenase, C-terminal-like,IPR011128:Glycerol-3-phosphate dehydrogenase, NAD-dependent, N-terminal,IPR013328:Dehydrogenase, multihelical,IPR016040:NAD(P)-binding domain,IPR017751:Glycerol-3-phosphate dehydrogenase, NAD-dependent, eukaryotic,	tru00564:Glycerophospholipid metabolism,		PIRSF000114:glycerol-3-phosphate dehydrogenase (NAD),		Complete proteome,Cytoplasm,NAD,Oxidoreductase,Reference proteome,
Q5I0P2	glycine cleavage system protein H(Gcsh)	Rattus norvegicus				GO:0019464~glycine decarboxylation via glycine cleavage system,GO:0032259~methylation,	GO:0005739~mitochondrion,GO:0005960~glycine cleavage complex,	GO:0004047~aminomethyltransferase activity,GO:0019899~enzyme binding,	IPR000089:Biotin/lipoyl attachment,IPR002930:Glycine cleavage H-protein,IPR003016:2-oxo acid dehydrogenase, lipoyl-binding site,IPR011053:Single hybrid motif,IPR017453:Glycine cleavage H-protein, subgroup,	rno00260:Glycine, serine and threonine metabolism,rno00630:Glyoxylate and dicarboxylate metabolism,rno01100:Metabolic pathways,rno01130:Biosynthesis of antibiotics,				Complete proteome,Lipoyl,Mitochondrion,Reference proteome,Transit peptide,	chain:Glycine cleavage system H protein, mitochondrial,modified residue,transit peptide:Mitochondrion,
P51655	glypican 4(Gpc4)	Mus musculus				GO:0006024~glycosaminoglycan biosynthetic process,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,	GO:0043395~heparan sulfate proteoglycan binding,	IPR001863:Glypican,IPR019803:Glypican, conserved site,	mmu04310:Wnt signaling pathway,				Cell membrane,Complete proteome,Glycoprotein,GPI-anchor,Heparan sulfate,Lipoprotein,Membrane,Phosphoprotein,Proteoglycan,Reference proteome,Secreted,Signal,	chain:Glypican-4,chain:Secreted glypican-4,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Xyl...) (glycosaminoglycan),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence conflict,signal peptide,
O75293	growth arrest and DNA damage inducible beta(GADD45B)	Homo sapiens				GO:0000185~activation of MAPKKK activity,GO:0000186~activation of MAPKK activity,GO:0006469~negative regulation of protein kinase activity,GO:0006915~apoptotic process,GO:0006950~response to stress,GO:0007275~multicellular organism development,GO:0030154~cell differentiation,GO:0043065~positive regulation of apoptotic process,GO:0046330~positive regulation of JNK cascade,GO:0051726~regulation of cell cycle,GO:1900745~positive regulation of p38MAPK cascade,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR004038:Ribosomal protein L7Ae/L30e/S12e/Gadd45,IPR024824:Growth arrest and DNA damage-inducible protein GADD45,	hsa04010:MAPK signaling pathway,hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,				Apoptosis,Complete proteome,Developmental protein,Differentiation,Proteomics identification,Reference proteome,	chain:Growth arrest and DNA-damage-inducible protein GADD45 beta,sequence conflict,
P22339	growth arrest and DNA-damage-inducible 45 beta(Gadd45b)	Mus musculus				GO:0000185~activation of MAPKKK activity,GO:0000186~activation of MAPKK activity,GO:0006469~negative regulation of protein kinase activity,GO:0006915~apoptotic process,GO:0006950~response to stress,GO:0007275~multicellular organism development,GO:0030154~cell differentiation,GO:0043065~positive regulation of apoptotic process,GO:0046330~positive regulation of JNK cascade,GO:0051726~regulation of cell cycle,GO:1900745~positive regulation of p38MAPK cascade,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR004038:Ribosomal protein L7Ae/L30e/S12e/Gadd45,IPR024824:Growth arrest and DNA damage-inducible protein GADD45,	mmu04010:MAPK signaling pathway,mmu04068:FoxO signaling pathway,mmu04110:Cell cycle,mmu04115:p53 signaling pathway,				Apoptosis,Complete proteome,Developmental protein,Differentiation,Reference proteome,	chain:Growth arrest and DNA-damage-inducible protein GADD45 beta,
Q99L27	guanosine monophosphate reductase 2(Gmpr2)	Mus musculus				GO:0006144~purine nucleobase metabolic process,GO:0009117~nucleotide metabolic process,GO:0015951~purine ribonucleotide interconversion,GO:0030224~monocyte differentiation,GO:0046037~GMP metabolic process,GO:0046038~GMP catabolic process,GO:0055114~oxidation-reduction process,	GO:0005737~cytoplasm,GO:1902560~GMP reductase complex,	GO:0003824~catalytic activity,GO:0003920~GMP reductase activity,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,	IPR001093:IMP dehydrogenase/GMP reductase,IPR005993:Guanosine monophosphate reductase 1,IPR013785:Aldolase-type TIM barrel,IPR015875:IMP dehydrogenase / GMP reductase, conserved site,	mmu00230:Purine metabolism,		PIRSF000235:GMP reductase,		Acetylation,Complete proteome,Metal-binding,NADP,Oxidoreductase,Potassium,Purine metabolism,Reference proteome,	active site:Thioimidate intermediate,binding site:NADP,chain:GMP reductase 2,metal ion-binding site:Potassium; via carbonyl oxygen,modified residue,nucleotide phosphate-binding region:NADP,sequence conflict,
O51216	guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase(BB_0198)	Borrelia burgdorferi B31				GO:0015970~guanosine tetraphosphate biosynthetic process,		GO:0008893~guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,	IPR003607:HD/PDEase domain,IPR004095:TGS,IPR004811:RelA/SpoT family,IPR007685:RelA/SpoT,IPR012675:Beta-grasp domain,IPR012676:TGS-like,				SM00471:HDc,SM00954:SM00954,	Complete proteome,Hydrolase,Manganese,Reference proteome,	chain:Guanosine-3',5'-bis(diphosphate) 3'- pyrophosphohydrolase,domain:HD,
Q9A7N9	guanylate kinase(CC_1681)	Caulobacter crescentus CB15					GO:0005737~cytoplasm,	GO:0004385~guanylate kinase activity,GO:0005524~ATP binding,	IPR008144:Guanylate kinase,IPR008145:Guanylate kinase/L-type calcium channel,IPR017665:Guanylate kinase, sub-group,IPR020590:Guanylate kinase, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	ccr00230:Purine metabolism,ccr01100:Metabolic pathways,			SM00072:GuKc,	ATP-binding,Complete proteome,Cytoplasm,Kinase,Nucleotide-binding,Reference proteome,Transferase,	chain:Guanylate kinase,domain:Guanylate kinase-like,nucleotide phosphate-binding region:ATP,
Q90474	heat shock protein 90, alpha (cytosolic), class A member 1, tandem duplicate 1(hsp90aa1.1)	Danio rerio				GO:0006457~protein folding,GO:0006950~response to stress,GO:0007517~muscle organ development,GO:0010038~response to metal ion,GO:0014866~skeletal myofibril assembly,GO:0030239~myofibril assembly,GO:0030240~skeletal muscle thin filament assembly,GO:0030241~skeletal muscle myosin thick filament assembly,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0048769~sarcomerogenesis,GO:0050900~leukocyte migration,GO:0071688~striated muscle myosin thick filament assembly,	GO:0005737~cytoplasm,GO:0030018~Z disc,GO:0031672~A band,GO:0042470~melanosome,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0030235~nitric-oxide synthase regulator activity,GO:0051082~unfolded protein binding,	IPR001404:Heat shock protein Hsp90,IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR019805:Heat shock protein Hsp90, conserved site,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR020575:Heat shock protein Hsp90, N-terminal,	dre04141:Protein processing in endoplasmic reticulum,dre04621:NOD-like receptor signaling pathway,dre04914:Progesterone-mediated oocyte maturation,		PIRSF002583:heat shock protein, HSP90/HTPG types,	SM00387:HATPase_c,	ATP-binding,Chaperone,Complete proteome,Cytoplasm,Myogenesis,Nucleotide-binding,Reference proteome,Stress response,	chain:Heat shock protein HSP 90-alpha 1,sequence conflict,
D3YXG0	hemicentin 1(Hmcn1)	Mus musculus					GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005938~cell cortex,GO:0030054~cell junction,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR000884:Thrombospondin, type 1 repeat,IPR001881:EGF-like calcium-binding,IPR002035:von Willebrand factor, type A,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR006605:G2 nidogen/fibulin G2F,IPR007110:Immunoglobulin-like domain,IPR009017:Green fluorescent protein,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,IPR018097:EGF-like calcium-binding, conserved site,IPR023413:Green fluorescent protein-like,IPR026823:Complement Clr-like EGF domain,				SM00179:EGF_CA,SM00181:EGF,SM00209:TSP1,SM00406:IGv,SM00408:IGc2,SM00409:IG,SM00682:G2F,	Calcium,Complete proteome,Disulfide bond,EGF-like domain,Proteomics identification,Reference proteome,Repeat,Signal,
P02019	hemoglobin, alpha 1(hba1)	Oncorhynchus mykiss					GO:0005833~hemoglobin complex,	GO:0005344~oxygen transporter activity,GO:0005506~iron ion binding,GO:0019825~oxygen binding,GO:0020037~heme binding,	IPR000971:Globin,IPR002338:Haemoglobin, alpha,IPR009050:Globin-like,IPR012292:Globin, structural domain,					3D-structure,Acetylation,Direct protein sequencing,Heme,Iron,Metal-binding,Oxygen transport,Transport,
P49312	heterogeneous nuclear ribonucleoprotein A1(Hnrnpa1)	Mus musculus				GO:0000380~alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0006810~transport,GO:0008380~RNA splicing,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0051028~mRNA transport,GO:0051168~nuclear export,GO:0051170~nuclear import,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,GO:0061752~telomeric repeat-containing RNA binding,GO:0098505~G-rich strand telomeric DNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR021662:Nuclear factor hnRNPA1,	mmu03040:Spliceosome,			SM00360:RRM,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,mRNA transport,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Spliceosome,Transport,Ubl conjugation,Viral nucleoprotein,Virion,	chain:Heterogeneous nuclear ribonucleoprotein A1,compositionally biased region:Gly-rich,compositionally biased region:Poly-Ser,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),domain:RRM 1,domain:RRM 2,modified residue,region of interest:Globular A domain,region of interest:Globular B domain,region of interest:Nuclear targeting sequence,region of interest:RNA-binding RGG-box,splice variant,
P19367	hexokinase 1(HK1)	Homo sapiens		h_glycolysisPathway:Glycolysis Pathway,	Carbohydrate transport and metabolism,	GO:0001678~cellular glucose homeostasis,GO:0006096~glycolytic process,GO:0015758~glucose transport,GO:0046835~carbohydrate phosphorylation,GO:0051156~glucose 6-phosphate metabolic process,GO:0061621~canonical glycolysis,GO:0072655~establishment of protein localization to mitochondrion,GO:0072656~maintenance of protein location in mitochondrion,	GO:0005623~cell,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0045121~membrane raft,GO:0097228~sperm principal piece,	GO:0004340~glucokinase activity,GO:0004396~hexokinase activity,GO:0005524~ATP binding,GO:0005536~glucose binding,GO:0008865~fructokinase activity,GO:0019158~mannokinase activity,	IPR001312:Hexokinase,IPR019807:Hexokinase, conserved site,IPR022672:Hexokinase, N-terminal,IPR022673:Hexokinase, C-terminal,	hsa00010:Glycolysis / Gluconeogenesis,hsa00051:Fructose and mannose metabolism,hsa00052:Galactose metabolism,hsa00500:Starch and sucrose metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,hsa00524:Butirosin and neomycin biosynthesis,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa04066:HIF-1 signaling pathway,hsa04910:Insulin signaling pathway,hsa04930:Type II diabetes mellitus,hsa04973:Carbohydrate digestion and absorption,hsa05230:Central carbon metabolism in cancer,	235700~Hemolytic anemia due to hexokinase deficiency,605285~Neuropathy, hereditary motor and sensory, Russe type,			3D-structure,Acetylation,Allosteric enzyme,Alternative splicing,ATP-binding,Charcot-Marie-Tooth disease,Complete proteome,Direct protein sequencing,Disease mutation,Glycolysis,Kinase,Membrane,Mitochondrion,Mitochondrion outer membrane,Neurodegeneration,Neuropathy,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transferase,	binding site:ATP 1,binding site:ATP 2,binding site:Glucose-6-phosphate 1,binding site:Glucose-6-phosphate 2,binding site:Substrate 1,binding site:Substrate 1 binding,binding site:Substrate 2,chain:Hexokinase-1,helix,modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,region of interest:Catalytic,region of interest:Glucose-6-phosphate 1 binding,region of interest:Glucose-6-phosphate 2 binding,region of interest:Hydrophobic,region of interest:Regulatory,region of interest:Substrate 1 binding,region of interest:Substrate 2 binding,sequence conflict,sequence variant,splice variant,strand,turn,
O95479	hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase(H6PD)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0006006~glucose metabolic process,GO:0006098~pentose-phosphate shunt,GO:0055114~oxidation-reduction process,GO:0097305~response to alcohol,	GO:0005739~mitochondrion,GO:0005788~endoplasmic reticulum lumen,	GO:0004345~glucose-6-phosphate dehydrogenase activity,GO:0017057~6-phosphogluconolactonase activity,GO:0030246~carbohydrate binding,GO:0047936~glucose 1-dehydrogenase [NAD(P)] activity,GO:0050661~NADP binding,	IPR001282:Glucose-6-phosphate dehydrogenase,IPR005900:6-phosphogluconolactonase, DevB-type,IPR006148:Glucosamine/galactosamine-6-phosphate isomerase,IPR016040:NAD(P)-binding domain,IPR019796:Glucose-6-phosphate dehydrogenase, active site,IPR022674:Glucose-6-phosphate dehydrogenase, NAD-binding,IPR022675:Glucose-6-phosphate dehydrogenase, C-terminal,	hsa00030:Pentose phosphate pathway,hsa01100:Metabolic pathways,hsa01200:Carbon metabolism,	604931~Cortisone reductase deficiency 1,			Carbohydrate metabolism,Complete proteome,Disease mutation,Endoplasmic reticulum,Glucose metabolism,Glycoprotein,Hydrolase,Multifunctional enzyme,NAD,NADP,Oxidoreductase,Polymorphism,Proteomics identification,Pyrrolidone carboxylic acid,Reference proteome,Signal,	active site:Proton acceptor,binding site:NADP,binding site:Substrate,chain:GDH/6PGL endoplasmic bifunctional protein,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:6-phosphogluconolactonase,region of interest:Glucose 1-dehydrogenase,region of interest:Linker,sequence conflict,sequence variant,signal peptide,
P12902	high mobility group nucleosome binding domain 5(HMGN5)	Gallus gallus					GO:0000785~chromatin,GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0031492~nucleosomal DNA binding,	IPR000079:High mobility group nucleosome-binding domain-containing family,				SM00527:HMG17,	Complete proteome,DNA-binding,Nucleus,Reference proteome,	chain:Non-histone chromosomal protein HMG-14A,
Q09101	hikaru genki(hig)	Drosophila melanogaster				GO:0007155~cell adhesion,GO:0008039~synaptic target recognition,	GO:0005576~extracellular region,GO:0043025~neuronal cell body,GO:0043083~synaptic cleft,		IPR000436:Sushi/SCR/CCP,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00032:CCP,	Alternative splicing,Complete proteome,Developmental protein,Differentiation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Neurogenesis,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Locomotion-related protein Hikaru genki,compositionally biased region:Lys-rich,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Glu,disulfide bond,domain:Ig-like C2-type,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,glycosylation site:N-linked (GlcNAc...),sequence conflict,short sequence motif:Cell attachment site,signal peptide,splice variant,
P35492	histidine ammonia lyase(Hal)	Mus musculus				GO:0006547~histidine metabolic process,GO:0006548~histidine catabolic process,GO:0019556~histidine catabolic process to glutamate and formamide,GO:0019557~histidine catabolic process to glutamate and formate,	GO:0005737~cytoplasm,	GO:0003824~catalytic activity,GO:0004397~histidine ammonia-lyase activity,GO:0016829~lyase activity,GO:0016841~ammonia-lyase activity,	IPR001106:Aromatic amino acid lyase,IPR005921:Histidine ammonia-lyase,IPR008948:L-Aspartase-like,IPR021922:Protein of unknown function DUF3534,IPR022313:Phenylalanine/histidine ammonia-lyases, active site,IPR024083:Fumarase/histidase, N-terminal,	mmu00340:Histidine metabolism,mmu01100:Metabolic pathways,				Complete proteome,Disease mutation,Histidine metabolism,Lyase,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Histidine ammonia-lyase,cross-link:5-imidazolinone (Ala-Gly),modified residue,sequence variant,
P21213	histidine ammonia lyase(Hal)	Rattus norvegicus				GO:0006547~histidine metabolic process,GO:0006548~histidine catabolic process,GO:0019556~histidine catabolic process to glutamate and formamide,GO:0019557~histidine catabolic process to glutamate and formate,	GO:0005829~cytosol,	GO:0004397~histidine ammonia-lyase activity,	IPR001106:Aromatic amino acid lyase,IPR005921:Histidine ammonia-lyase,IPR008948:L-Aspartase-like,IPR021922:Protein of unknown function DUF3534,IPR022313:Phenylalanine/histidine ammonia-lyases, active site,IPR024083:Fumarase/histidase, N-terminal,	rno00340:Histidine metabolism,rno01100:Metabolic pathways,				Complete proteome,Direct protein sequencing,Histidine metabolism,Lyase,Phosphoprotein,Reference proteome,	chain:Histidine ammonia-lyase,cross-link:5-imidazolinone (Ala-Gly),modified residue,mutagenesis site,
Q9BX68	histidine triad nucleotide binding protein 2(HINT2)	Homo sapiens				GO:0006694~steroid biosynthetic process,GO:0006915~apoptotic process,	GO:0005730~nucleolus,GO:0005739~mitochondrion,	GO:0000166~nucleotide binding,GO:0016787~hydrolase activity,	IPR001310:Histidine triad (HIT) protein,IPR011146:HIT-like domain,IPR019808:Histidine triad, conserved site,					3D-structure,Acetylation,Apoptosis,Complete proteome,Hydrolase,Lipid biosynthesis,Lipid metabolism,Mitochondrion,Nucleotide-binding,Reference proteome,Steroid biosynthesis,Transit peptide,	chain:Histidine triad nucleotide-binding protein 2, mitochondrial,domain:HIT,mutagenesis site,short sequence motif:Histidine triad motif,transit peptide:Mitochondrion,
P18468	histocompatibility 2, class II antigen E beta(H2-Eb1)	Mus musculus				GO:0002376~immune system process,GO:0002504~antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,GO:0006955~immune response,GO:0019882~antigen processing and presentation,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0034341~response to interferon-gamma,	GO:0005615~extracellular space,GO:0005765~lysosomal membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031902~late endosome membrane,GO:0042613~MHC class II protein complex,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR000353:MHC class II, beta chain, N-terminal,IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,IPR014745:MHC class II, alpha/beta chain, N-terminal,	mmu04145:Phagosome,mmu04514:Cell adhesion molecules (CAMs),mmu04612:Antigen processing and presentation,mmu04640:Hematopoietic cell lineage,mmu04672:Intestinal immune network for IgA production,mmu04940:Type I diabetes mellitus,mmu05140:Leishmaniasis,mmu05145:Toxoplasmosis,mmu05150:Staphylococcus aureus infection,mmu05152:Tuberculosis,mmu05164:Influenza A,mmu05166:HTLV-I infection,mmu05168:Herpes simplex infection,mmu05310:Asthma,mmu05320:Autoimmune thyroid disease,mmu05321:Inflammatory bowel disease (IBD),mmu05322:Systemic lupus erythematosus,mmu05323:Rheumatoid arthritis,mmu05330:Allograft rejection,mmu05332:Graft-versus-host disease,mmu05416:Viral myocarditis,			SM00407:IGc1,SM00921:SM00921,	3D-structure,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Membrane,MHC II,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:H-2 class II histocompatibility antigen, E-B beta chain,chain:H-2 class II histocompatibility antigen, E-D beta chain,chain:H-2 class II histocompatibility antigen, E-Q beta chain,chain:H-2 class II histocompatibility antigen, E-S beta chain,chain:H-2 class II histocompatibility antigen, I-A beta chain,chain:H-2 class II histocompatibility antigen, I-E beta chain,chain:H2-IE-beta, mature peptide,chain:MHC class II E-beta (p haplotype),chain:MHC class II E-beta (r haplotype),disulfide bond,domain:Ig-like C1-type,glycosylation site:N-linked (GlcNAc...),helix,region of interest:Beta-1,region of interest:Beta-2,region of interest:Connecting peptide,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
P06353	histone H3 protein(H3)	Hordeum vulgare					GO:0000786~nucleosome,GO:0005634~nucleus,	GO:0003677~DNA binding,	IPR000164:Histone H3,IPR007125:Histone core,IPR009072:Histone-fold,				SM00428:H3,	Chromosome,DNA-binding,Nucleosome core,Nucleus,	chain:Histone H3.3,
P84245	histone H3.3B-like(LOC100361558)	Rattus norvegicus				GO:0001649~osteoblast differentiation,GO:0006334~nucleosome assembly,GO:0006336~DNA replication-independent nucleosome assembly,GO:0006997~nucleus organization,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0007338~single fertilization,GO:0007420~brain development,GO:0007566~embryo implantation,GO:0008283~cell proliferation,GO:0008584~male gonad development,GO:0009725~response to hormone,GO:0030307~positive regulation of cell growth,GO:0031508~pericentric heterochromatin assembly,GO:0031509~telomeric heterochromatin assembly,GO:0035264~multicellular organism growth,GO:0042692~muscle cell differentiation,GO:0048477~oogenesis,GO:0090230~regulation of centromere complex assembly,GO:1902340~negative regulation of chromosome condensation,	GO:0000228~nuclear chromosome,GO:0000784~nuclear chromosome, telomeric region,GO:0000786~nucleosome,GO:0000788~nuclear nucleosome,GO:0001740~Barr body,GO:0005634~nucleus,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0031492~nucleosomal DNA binding,GO:0042393~histone binding,GO:0046982~protein heterodimerization activity,	IPR000164:Histone H3,IPR007125:Histone core,IPR009072:Histone-fold,	rno05034:Alcoholism,rno05202:Transcriptional misregulation in cancer,rno05322:Systemic lupus erythematosus,			SM00428:H3,	Acetylation,Chromosome,Citrullination,Complete proteome,DNA-binding,Methylation,Nucleosome core,Nucleus,Phosphoprotein,Reference proteome,Ubl conjugation,
Q5F339	holocytochrome c synthase(HCCS)	Gallus gallus					GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,	GO:0004408~holocytochrome-c synthase activity,GO:0046872~metal ion binding,	IPR000511:Cytochrome c/c1 haem-lyase,	gga00860:Porphyrin and chlorophyll metabolism,				Complete proteome,Heme,Iron,Lyase,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Repeat,	chain:Cytochrome c-type heme lyase,repeat:HRM 1,repeat:HRM 2,
A4L9P5	homeodomain interacting protein kinase 1(Hipk1)	Rattus norvegicus				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0007224~smoothened signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0009952~anterior/posterior pattern specification,GO:0010803~regulation of tumor necrosis factor-mediated signaling pathway,GO:0010842~retina layer formation,GO:0030182~neuron differentiation,GO:0034333~adherens junction assembly,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0048596~embryonic camera-type eye morphogenesis,GO:0060059~embryonic retina morphogenesis in camera-type eye,GO:0060235~lens induction in camera-type eye,GO:0061072~iris morphogenesis,GO:0072577~endothelial cell apoptotic process,GO:0097191~extrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016605~PML body,GO:0016607~nuclear speck,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Isopeptide bond,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Reference proteome,Serine/threonine-protein kinase,Transcription,Transcription regulation,Transferase,Ubl conjugation,
O46629	hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit(HADHB)	Bos taurus				GO:0006635~fatty acid beta-oxidation,GO:0008152~metabolic process,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0005783~endoplasmic reticulum,GO:0042645~mitochondrial nucleoid,GO:0070062~extracellular exosome,	GO:0003857~3-hydroxyacyl-CoA dehydrogenase activity,GO:0003988~acetyl-CoA C-acyltransferase activity,GO:0004300~enoyl-CoA hydratase activity,GO:0016509~long-chain-3-hydroxyacyl-CoA dehydrogenase activity,GO:0016747~transferase activity, transferring acyl groups other than amino-acyl groups,GO:0044822~poly(A) RNA binding,	IPR002155:Thiolase,IPR016039:Thiolase-like,IPR020610:Thiolase, active site,IPR020613:Thiolase, conserved site,IPR020615:Thiolase, acyl-enzyme intermediate active site,IPR020616:Thiolase, N-terminal,IPR020617:Thiolase, C-terminal,	bta00062:Fatty acid elongation,bta00071:Fatty acid degradation,bta00280:Valine, leucine and isoleucine degradation,bta01100:Metabolic pathways,bta01130:Biosynthesis of antibiotics,bta01212:Fatty acid metabolism,				Acetylation,Acyltransferase,Complete proteome,Endoplasmic reticulum,Fatty acid metabolism,Lipid metabolism,Membrane,Mitochondrion,Mitochondrion inner membrane,Mitochondrion outer membrane,Reference proteome,Transferase,Transit peptide,	active site:Acyl-thioester intermediate,active site:Proton acceptor,chain:Trifunctional enzyme subunit beta, mitochondrial,modified residue,transit peptide:Mitochondrion,
P51659	hydroxysteroid 17-beta dehydrogenase 4(HSD17B4)	Homo sapiens		h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),		GO:0000038~very long-chain fatty acid metabolic process,GO:0001649~osteoblast differentiation,GO:0006635~fatty acid beta-oxidation,GO:0006699~bile acid biosynthetic process,GO:0008209~androgen metabolic process,GO:0008210~estrogen metabolic process,GO:0033540~fatty acid beta-oxidation using acyl-CoA oxidase,GO:0036109~alpha-linolenic acid metabolic process,GO:0036111~very long-chain fatty-acyl-CoA metabolic process,GO:0036112~medium-chain fatty-acyl-CoA metabolic process,GO:0060009~Sertoli cell development,	GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005782~peroxisomal matrix,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0003857~3-hydroxyacyl-CoA dehydrogenase activity,GO:0005102~receptor binding,GO:0016491~oxidoreductase activity,GO:0016508~long-chain-enoyl-CoA hydratase activity,GO:0016853~isomerase activity,GO:0033989~3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,GO:0042803~protein homodimerization activity,GO:0044594~17-beta-hydroxysteroid dehydrogenase (NAD+) activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR002539:MaoC-like domain,IPR003033:SCP2 sterol-binding domain,IPR016040:NAD(P)-binding domain,IPR020904:Short-chain dehydrogenase/reductase, conserved site,	hsa00120:Primary bile acid biosynthesis,hsa01100:Metabolic pathways,hsa04146:Peroxisome,	233400~Perrault syndrome 1,261515~D-bifunctional protein deficiency,			3D-structure,Acetylation,Alternative splicing,Complete proteome,Deafness,Direct protein sequencing,Disease mutation,Fatty acid metabolism,Isomerase,Lipid metabolism,Lyase,NAD,Oxidoreductase,Peroxisome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	active site:Proton acceptor,binding site:NAD,binding site:NAD; via amide nitrogen,binding site:NAD; via carbonyl oxygen,binding site:Substrate,chain:Peroxisomal multifunctional enzyme type 2,domain:SCP2,helix,modified residue,nucleotide phosphate-binding region:NAD,region of interest:3-alpha,7-alpha,12-alpha-trihydroxy-5- beta-cholest-24-enoyl-CoA hydratase,region of interest:3-hydroxyacyl-CoA dehydrogenase,sequence variant,strand,turn,
Q6P5L8	hydroxysteroid dehydrogenase like 2(hsdl2)	Danio rerio				GO:0055114~oxidation-reduction process,	GO:0005777~peroxisome,	GO:0008748~N-ethylmaleimide reductase activity,GO:0016491~oxidoreductase activity,GO:0043738~reduced coenzyme F420 dehydrogenase activity,GO:0043826~sulfur oxygenase reductase activity,GO:0043883~malolactic enzyme activity,GO:0043914~NADPH:sulfur oxidoreductase activity,GO:0052693~epoxyqueuosine reductase activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR003033:SCP2 sterol-binding domain,IPR016040:NAD(P)-binding domain,					Complete proteome,NADP,Oxidoreductase,Peroxisome,Proteomics identification,Reference proteome,	active site:Proton acceptor,chain:Hydroxysteroid dehydrogenase-like protein 2,domain:SCP2,nucleotide phosphate-binding region:NAD or NADP,
Q5AZY3	hypothetical protein(AN6147.2)	Aspergillus nidulans FGSC A4				GO:0006342~chromatin silencing,GO:0034613~cellular protein localization,GO:0034770~histone H4-K20 methylation,GO:0044773~mitotic DNA damage checkpoint,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005829~cytosol,GO:0032153~cell division site,GO:0044732~mitotic spindle pole body,	GO:0031491~nucleosome binding,GO:0042799~histone methyltransferase activity (H4-K20 specific),	IPR001214:SET domain,IPR025783:Histone-lysine N-methyltransferase SET9,	ani00310:Lysine degradation,			SM00317:SET,	Chromatin regulator,Chromosome,Complete proteome,Methyltransferase,Nucleus,Reference proteome,S-adenosyl-L-methionine,Transferase,	chain:Histone-lysine N-methyltransferase set9,domain:SET,
Q6FQF0	hypothetical protein(CAGL0I06765g)	Candida glabrata CBS 138				GO:0006275~regulation of DNA replication,GO:0006897~endocytosis,GO:0010992~ubiquitin homeostasis,GO:0010995~free ubiquitin chain depolymerization,GO:0016579~protein deubiquitination,GO:0043162~ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,GO:0070676~intralumenal vesicle formation,	GO:0000502~proteasome complex,GO:0005739~mitochondrion,GO:0031902~late endosome membrane,	GO:0004175~endopeptidase activity,GO:0004843~thiol-dependent ubiquitin-specific protease activity,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR001763:Rhodanese-like domain,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,	cgr04144:Endocytosis,			SM00450:RHOD,	Complete proteome,Cytoplasm,Endosome,Hydrolase,Membrane,Protease,Reference proteome,Thiol protease,Ubl conjugation pathway,	chain:Ubiquitin carboxyl-terminal hydrolase 4,domain:Rhodanese,
Q1NZ26	hypothetical protein(F13E9.13)	Caenorhabditis elegans				GO:0008152~metabolic process,	GO:0005739~mitochondrion,	GO:0003824~catalytic activity,	IPR005137:Photosystem I BtpA, assembly,IPR011060:Ribulose-phosphate binding barrel,IPR013785:Aldolase-type TIM barrel,			PIRSF005956:photosystem I biogenesis protein btpa,		Complete proteome,Mitochondrion,Reference proteome,Transit peptide,	chain:Uncharacterized protein F13E9.13, mitochondrial,transit peptide:Mitochondrion,
Q6CLY1	hypothetical protein(KLLA0E24575g)	Kluyveromyces lactis NRRL Y-1140			Nuclear structure,	GO:0030970~retrograde protein transport, ER to cytosol,GO:0051028~mRNA transport,GO:0051228~mitotic spindle disassembly,GO:0070651~nonfunctional rRNA decay,GO:0071629~cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process,GO:0071712~ER-associated misfolded protein catabolic process,GO:0072671~mitochondria-associated ubiquitin-dependent protein catabolic process,GO:1900182~positive regulation of protein localization to nucleus,GO:1990116~ribosome-associated ubiquitin-dependent protein catabolic process,	GO:0000837~Doa10p ubiquitin ligase complex,GO:0000839~Hrd1p ubiquitin ligase ERAD-L complex,GO:0005829~cytosol,GO:0031965~nuclear membrane,GO:0034098~VCP-NPL4-UFD1 AAA ATPase complex,GO:0036266~Cdc48p-Npl4p-Vms1p AAA ATPase complex,GO:0048471~perinuclear region of cytoplasm,GO:1990112~RQC complex,		IPR007716:NPL4, zinc-binding putative,IPR007717:Nuclear pore localisation protein NPL4,IPR016563:Polyubiquitin-tagged protein recognition complex, Npl4 component,IPR024682:Nuclear pore localisation protein Npl4, ubiquitin-like domain,	kla04141:Protein processing in endoplasmic reticulum,		PIRSF010052:polyubiquitin-tagged protein recognition complex, Npl4 component,		Complete proteome,Cytoplasm,Endoplasmic reticulum,Membrane,mRNA transport,Nucleus,Protein transport,Reference proteome,Translocation,Transport,	chain:Nuclear protein localization protein 4,
A5E047	hypothetical protein(LELG_02984)	Lodderomyces elongisporus NRRL YB-4239				GO:0030490~maturation of SSU-rRNA,	GO:0005743~mitochondrial inner membrane,	GO:0005525~GTP binding,	IPR006073:GTP binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,Mitochondrion,Reference proteome,Transit peptide,
Q58371	hypothetical protein(MJ_RS05180)	Methanocaldococcus jannaschii DSM 2661				GO:0006260~DNA replication,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007049~cell cycle,		GO:0003677~DNA binding,GO:0005524~ATP binding,	IPR001208:Mini-chromosome maintenance, DNA-dependent ATPase,IPR012340:Nucleic acid-binding, OB-fold,IPR018525:Mini-chromosome maintenance, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	mja03030:DNA replication,			SM00350:MCM,	ATP-binding,Cell cycle,Complete proteome,DNA replication,DNA-binding,Nucleotide-binding,Reference proteome,Transcription,Transcription regulation,
Q58818	hypothetical protein(MJ_RS07620)	Methanocaldococcus jannaschii DSM 2661						GO:0016491~oxidoreductase activity,	IPR000510:Nitrogenase/oxidoreductase, component 1,IPR017675:Putative methanogenesis marker 13 metalloprotein,					Complete proteome,Reference proteome,
C7ZA26	hypothetical protein(NECHADRAFT_94619)	Nectria haematococca mpVI 77-13-4				GO:0006412~translation,GO:0045727~positive regulation of translation,	GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0043022~ribosome binding,	IPR000640:Translation elongation factor EFG, V domain,IPR000795:Elongation factor, GTP-binding domain,IPR005225:Small GTP-binding protein domain,IPR006297:Elongation factor 4,IPR009022:Elongation factor G, III-V domain,IPR013842:GTP-binding protein LepA, C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,GTP-binding,Hydrolase,Membrane,Mitochondrion,Mitochondrion inner membrane,Nucleotide-binding,Protein biosynthesis,Reference proteome,Transit peptide,
A3LQ52	hypothetical protein(PICST_88098)	Scheffersomyces stipitis CBS 6054				GO:0030435~sporulation resulting in formation of a cellular spore,	GO:0005743~mitochondrial inner membrane,							Complete proteome,Membrane,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Sporulation,Transit peptide,	chain:Protein RMD9, mitochondrial,compositionally biased region:Asn-rich,transit peptide:Mitochondrion,
Q5UQ44	hypothetical protein(R390)	Acanthamoeba polyphaga mimivirus					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,
Q0W081	hypothetical protein(RCI_RS00290)	Methanocella arvoryzae MRE50							IPR007564:Uncharacterised protein family UPF0212,			PIRSF016934:uncharacterized conserved protein,		Complete proteome,Reference proteome,	chain:UPF0212 protein UNCMA_00570,
O86812	hypothetical protein(SCO5752)	Streptomyces coelicolor A3(2)				GO:0035600~tRNA methylthiolation,	GO:0005829~cytosol,	GO:0005506~iron ion binding,GO:0035599~aspartic acid methylthiotransferase activity,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR002792:TRAM domain,IPR005839:Methylthiotransferase,IPR005840:Ribosomal protein S12 methylthiotransferase RimO,IPR006638:Elongator protein 3/MiaB/NifB,IPR007197:Radical SAM,IPR012340:Nucleic acid-binding, OB-fold,IPR013848:Methylthiotransferase, N-terminal,IPR020612:Methylthiotransferase, conserved site,IPR023404:Radical SAM, alpha/beta horseshoe,IPR023970:Methylthiotransferase/radical SAM-type protein,				SM00729:Elp3,	4Fe-4S,Complete proteome,Cytoplasm,Iron,Iron-sulfur,Metal-binding,Reference proteome,S-adenosyl-L-methionine,Transferase,	chain:Ribosomal protein S12 methylthiotransferase rimO,domain:MTTase N-terminal,domain:TRAM,metal ion-binding site:Iron-sulfur (4Fe-4S),metal ion-binding site:Iron-sulfur (4Fe-4S-S-AdoMet),
P54527	hypothetical protein(yqiK)	Bacillus subtilis subsp. subtilis str. 168				GO:0006629~lipid metabolic process,		GO:0008889~glycerophosphodiester phosphodiesterase activity,	IPR004129:Glycerophosphoryl diester phosphodiesterase,IPR017946:PLC-like phosphodiesterase, TIM beta/alpha-barrel domain,	bsu00564:Glycerophospholipid metabolism,				Complete proteome,Reference proteome,	chain:Uncharacterized protein yqiK,domain:GDPD,sequence conflict,
Q9W719	hypoxanthine phosphoribosyltransferase 1(HPRT1)	Gallus gallus				GO:0001975~response to amphetamine,GO:0006164~purine nucleotide biosynthetic process,GO:0006166~purine ribonucleoside salvage,GO:0006168~adenine salvage,GO:0006178~guanine salvage,GO:0007625~grooming behavior,GO:0007626~locomotory behavior,GO:0019835~cytolysis,GO:0021756~striatum development,GO:0021895~cerebral cortex neuron differentiation,GO:0021954~central nervous system neuron development,GO:0032263~GMP salvage,GO:0032264~IMP salvage,GO:0042417~dopamine metabolic process,GO:0043103~hypoxanthine salvage,GO:0045964~positive regulation of dopamine metabolic process,GO:0046038~GMP catabolic process,GO:0046040~IMP metabolic process,GO:0046100~hypoxanthine metabolic process,GO:0046651~lymphocyte proliferation,GO:0048813~dendrite morphogenesis,GO:0051289~protein homotetramerization,	GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0002057~guanine binding,GO:0002060~purine nucleobase binding,GO:0004422~hypoxanthine phosphoribosyltransferase activity,GO:0042803~protein homodimerization activity,GO:0052657~guanine phosphoribosyltransferase activity,	IPR000836:Phosphoribosyltransferase domain,IPR005904:Hypoxanthine phosphoribosyl transferase,	gga00230:Purine metabolism,gga00983:Drug metabolism - other enzymes,gga01100:Metabolic pathways,				Complete proteome,Cytoplasm,Glycosyltransferase,Magnesium,Metal-binding,Nucleotide-binding,Purine salvage,Reference proteome,Transferase,	chain:Hypoxanthine-guanine phosphoribosyltransferase,metal ion-binding site:Magnesium 1,
B7SXM5	immediate early response 2(ier2)	Danio rerio				GO:0007368~determination of left/right symmetry,GO:0042384~cilium assembly,GO:0060026~convergent extension,GO:0060271~cilium morphogenesis,GO:0070121~Kupffer's vesicle development,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR008653:Immediate early response,					Complete proteome,Cytoplasm,Nucleus,Reference proteome,
Q32KW9	immunity related GTPase cinema(IRGC)	Bos taurus					GO:0016020~membrane,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0016787~hydrolase activity,	IPR007743:Interferon-inducible GTPase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,GTP-binding,Hydrolase,Nucleotide-binding,Phosphoprotein,Reference proteome,	chain:Interferon-inducible GTPase 5,compositionally biased region:Poly-Glu,nucleotide phosphate-binding region:GTP,
P01882	immunoglobulin heavy constant delta(Ighd)	Mus musculus				GO:0016064~immunoglobulin mediated immune response,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0030890~positive regulation of B cell proliferation,GO:0050776~regulation of immune response,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0019815~B cell receptor complex,	GO:0003823~antigen binding,GO:0042802~identical protein binding,	IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00407:IGc1,	Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin C region,Immunoglobulin domain,Membrane,Reference proteome,Repeat,Secreted,Transmembrane,Transmembrane helix,	chain:Ig delta chain C region membrane-bound form,chain:Ig delta chain C region secreted form,disulfide bond,domain:Ig-like 1,domain:Ig-like 2,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,transmembrane region,
P01836	immunoglobulin kappa constant(Igkc)	Rattus norvegicus				GO:0001895~retina homeostasis,GO:0006910~phagocytosis, recognition,GO:0006911~phagocytosis, engulfment,GO:0006958~complement activation, classical pathway,GO:0030183~B cell differentiation,GO:0042742~defense response to bacterium,GO:0045087~innate immune response,GO:0050853~B cell receptor signaling pathway,GO:0050871~positive regulation of B cell activation,	GO:0005615~extracellular space,GO:0009897~external side of plasma membrane,GO:0042571~immunoglobulin complex, circulating,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0003823~antigen binding,GO:0034987~immunoglobulin receptor binding,	IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00407:IGc1,	3D-structure,Complete proteome,Disulfide bond,Immunoglobulin C region,Immunoglobulin domain,Reference proteome,
P15814	immunoglobulin lambda like polypeptide 1(IGLL1)	Homo sapiens				GO:0006910~phagocytosis, recognition,GO:0006911~phagocytosis, engulfment,GO:0006955~immune response,GO:0006958~complement activation, classical pathway,GO:0042742~defense response to bacterium,GO:0045087~innate immune response,GO:0050853~B cell receptor signaling pathway,GO:0050871~positive regulation of B cell activation,	GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0042571~immunoglobulin complex, circulating,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0003823~antigen binding,GO:0034987~immunoglobulin receptor binding,	IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,		613500~Agammaglobulinemia 2,		SM00407:IGc1,	3D-structure,Alternative splicing,Complete proteome,Disease mutation,Disulfide bond,Immunoglobulin domain,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Immunoglobulin lambda-like polypeptide 1,disulfide bond,domain:Ig-like C1-type,helix,region of interest:C region (By similarity to lambda light- chain),region of interest:J region (By similarity to lambda light- chain),sequence variant,signal peptide,strand,turn,
B9A064	immunoglobulin lambda like polypeptide 5(IGLL5)	Homo sapiens				GO:0006910~phagocytosis, recognition,GO:0006911~phagocytosis, engulfment,GO:0006958~complement activation, classical pathway,GO:0042742~defense response to bacterium,GO:0045087~innate immune response,GO:0050853~B cell receptor signaling pathway,GO:0050871~positive regulation of B cell activation,	GO:0009897~external side of plasma membrane,GO:0042571~immunoglobulin complex, circulating,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0003823~antigen binding,GO:0034987~immunoglobulin receptor binding,	IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00407:IGc1,	Alternative splicing,Complete proteome,Disulfide bond,Immunoglobulin domain,Proteomics identification,Reference proteome,Secreted,Signal,
Q8CAQ8	inner membrane protein, mitochondrial(Immt)	Mus musculus				GO:0042407~cristae formation,GO:0051560~mitochondrial calcium ion homeostasis,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043209~myelin sheath,GO:0061617~MICOS complex,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR019133:Mitochondrial inner membrane protein Mitofilin,					Acetylation,Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,	chain:Mitochondrial inner membrane protein,modified residue,sequence conflict,splice variant,topological domain:Mitochondrial intermembrane,topological domain:Mitochondrial matrix,transmembrane region,
D0MY11	inosine triphosphate pyrophosphatase(PITG_03601)	Phytophthora infestans T30-4				GO:0009117~nucleotide metabolic process,GO:0009204~deoxyribonucleoside triphosphate catabolic process,	GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0046872~metal ion binding,GO:0047429~nucleoside-triphosphate diphosphatase activity,	IPR002637:Ham1-like protein,IPR027502:Inosine triphosphate pyrophosphatase,	pif00230:Purine metabolism,pif01100:Metabolic pathways,				Complete proteome,Cytoplasm,Hydrolase,Magnesium,Manganese,Metal-binding,Nucleotide metabolism,Nucleotide-binding,Reference proteome,
Q9Z329	inositol 1,4,5-triphosphate receptor 2(Itpr2)	Mus musculus				GO:0001666~response to hypoxia,GO:0006810~transport,GO:0006811~ion transport,GO:0006816~calcium ion transport,GO:0055085~transmembrane transport,GO:0070588~calcium ion transmembrane transport,GO:0071320~cellular response to cAMP,GO:0071361~cellular response to ethanol,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016529~sarcoplasmic reticulum,GO:0030424~axon,GO:0030667~secretory granule membrane,GO:0033017~sarcoplasmic reticulum membrane,GO:0043209~myelin sheath,GO:0043235~receptor complex,	GO:0005216~ion channel activity,GO:0005220~inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0015278~calcium-release channel activity,GO:0035091~phosphatidylinositol binding,GO:0070679~inositol 1,4,5 trisphosphate binding,	IPR000493:Inositol 1,4,5-trisphosphate-binding protein receptor,IPR000699:Intracellular calcium-release channel,IPR005821:Ion transport domain,IPR013662:RyR/IP3R Homology associated domain,IPR014821:Inositol 1,4,5-trisphosphate/ryanodine receptor,IPR015925:Ryanodine receptor-related,IPR016024:Armadillo-type fold,IPR016093:MIR motif,	mmu04020:Calcium signaling pathway,mmu04022:cGMP-PKG signaling pathway,mmu04070:Phosphatidylinositol signaling system,mmu04114:Oocyte meiosis,mmu04270:Vascular smooth muscle contraction,mmu04540:Gap junction,mmu04611:Platelet activation,mmu04720:Long-term potentiation,mmu04723:Retrograde endocannabinoid signaling,mmu04724:Glutamatergic synapse,mmu04725:Cholinergic synapse,mmu04726:Serotonergic synapse,mmu04728:Dopaminergic synapse,mmu04730:Long-term depression,mmu04750:Inflammatory mediator regulation of TRP channels,mmu04912:GnRH signaling pathway,mmu04915:Estrogen signaling pathway,mmu04918:Thyroid hormone synthesis,mmu04921:Oxytocin signaling pathway,mmu04922:Glucagon signaling pathway,mmu04924:Renin secretion,mmu04925:Aldosterone synthesis and secretion,mmu04970:Salivary secretion,mmu04971:Gastric acid secretion,mmu04972:Pancreatic secretion,mmu05010:Alzheimer's disease,mmu05205:Proteoglycans in cancer,			SM00472:MIR,	Alternative splicing,Calcium,Calcium channel,Calcium transport,Coiled coil,Complete proteome,Endoplasmic reticulum,Ion channel,Ion transport,Ligand-gated ion channel,Membrane,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Inositol 1,4,5-trisphosphate receptor type 2,domain:MIR 1,domain:MIR 2,domain:MIR 3,domain:MIR 4,domain:MIR 5,modified residue,mutagenesis site,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q66H52	inositol 1,4,5-trisphosphate receptor interacting protein-like 1(Itpripl1)	Rattus norvegicus					GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR024808:Inositol 1,4,5-triphosphate receptor-interacting protein-like 1,IPR024810:Mab-21 domain,IPR026250:Inositol 1,4,5-trisphosphate receptor-interacting protein,				SM01265:SM01265,	Coiled coil,Complete proteome,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Inositol 1,4,5-triphosphate receptor- interacting protein-like 1,modified residue,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P08169	insulin like growth factor 2 receptor(IGF2R)	Bos taurus				GO:0006810~transport,	GO:0005641~nuclear envelope lumen,GO:0005765~lysosomal membrane,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0030139~endocytic vesicle,GO:0030140~trans-Golgi network transport vesicle,GO:0070062~extracellular exosome,	GO:0001948~glycoprotein binding,GO:0005215~transporter activity,GO:0005515~protein binding,GO:0005520~insulin-like growth factor binding,GO:0005537~mannose binding,GO:0036143~kringle domain binding,GO:0051219~phosphoprotein binding,	IPR000479:Cation-independent mannose-6-phosphate receptor,IPR000562:Fibronectin, type II, collagen-binding,IPR009011:Mannose-6-phosphate receptor binding domain,IPR013806:Kringle-like fold,	bta04142:Lysosome,bta04144:Endocytosis,			SM00059:FN2,SM01404:SM01404,	3D-structure,Acetylation,Complete proteome,Disulfide bond,Glycoprotein,Lysosome,Membrane,Phosphoprotein,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Cation-independent mannose-6-phosphate receptor,disulfide bond,domain:Fibronectin type-II,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,turn,
Q75ZP3	insulin like growth factor binding protein 1(IGFBP1)	Sus scrofa				GO:0001558~regulation of cell growth,GO:0043567~regulation of insulin-like growth factor receptor signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0031994~insulin-like growth factor I binding,GO:0031995~insulin-like growth factor II binding,	IPR000716:Thyroglobulin type-1,IPR000867:Insulin-like growth factor-binding protein, IGFBP,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR009168:Insulin-like growth factor binding protein,IPR017891:Insulin-like growth factor binding protein, N-terminal, Cys-rich conserved site,IPR022321:Insulin-like growth factor-binding protein family 1-6, chordata,IPR022322:Insulin-like growth factor-binding protein 1,				SM00121:IB,SM00211:TY,	Complete proteome,Disulfide bond,Growth factor binding,Phosphoprotein,Reference proteome,Secreted,Signal,
O42204	integral membrane protein 2B(ITM2B)	Gallus gallus				GO:0007399~nervous system development,GO:0042985~negative regulation of amyloid precursor protein biosynthetic process,	GO:0000139~Golgi membrane,GO:0005615~extracellular space,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0030660~Golgi-associated vesicle membrane,GO:0031301~integral component of organelle membrane,GO:0070062~extracellular exosome,	GO:0001540~beta-amyloid binding,GO:0005524~ATP binding,	IPR007084:BRICHOS domain,				SM01039:SM01039,	Cell membrane,Complete proteome,Disulfide bond,Endosome,Glycoprotein,Golgi apparatus,Membrane,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Integral membrane protein 2B,domain:BRICHOS,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
O89051	integral membrane protein 2B(Itm2b)	Mus musculus				GO:0007399~nervous system development,GO:0042985~negative regulation of amyloid precursor protein biosynthetic process,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030660~Golgi-associated vesicle membrane,GO:0031301~integral component of organelle membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0001540~beta-amyloid binding,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR007084:BRICHOS domain,				SM01039:SM01039,	Cell membrane,Complete proteome,Disulfide bond,Endosome,Glycoprotein,Golgi apparatus,Membrane,Reference proteome,Secreted,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Integral membrane protein 2B,domain:BRICHOS,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
Q62469	integrin alpha 2(Itga2)	Mus musculus				GO:0001666~response to hypoxia,GO:0002687~positive regulation of leukocyte migration,GO:0006929~substrate-dependent cell migration,GO:0006971~hypotonic response,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007565~female pregnancy,GO:0008283~cell proliferation,GO:0010634~positive regulation of epithelial cell migration,GO:0010694~positive regulation of alkaline phosphatase activity,GO:0014075~response to amine,GO:0014850~response to muscle activity,GO:0014911~positive regulation of smooth muscle cell migration,GO:0030879~mammary gland development,GO:0031346~positive regulation of cell projection organization,GO:0031589~cell-substrate adhesion,GO:0032967~positive regulation of collagen biosynthetic process,GO:0033343~positive regulation of collagen binding,GO:0033591~response to L-ascorbic acid,GO:0033627~cell adhesion mediated by integrin,GO:0038065~collagen-activated signaling pathway,GO:0042060~wound healing,GO:0042493~response to drug,GO:0043388~positive regulation of DNA binding,GO:0043589~skin morphogenesis,GO:0045184~establishment of protein localization,GO:0045727~positive regulation of translation,GO:0045785~positive regulation of cell adhesion,GO:0045987~positive regulation of smooth muscle contraction,GO:0048041~focal adhesion assembly,GO:0048333~mesodermal cell differentiation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050729~positive regulation of inflammatory response,GO:0050927~positive regulation of positive chemotaxis,GO:0050966~detection of mechanical stimulus involved in sensory perception of pain,GO:0051971~positive regulation of transmission of nerve impulse,GO:0060100~positive regulation of phagocytosis, engulfment,GO:0070365~hepatocyte differentiation,GO:0071107~response to parathyroid hormone,GO:0071260~cellular response to mechanical stimulus,GO:0071392~cellular response to estradiol stimulus,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0008305~integrin complex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0034666~integrin alpha2-beta1 complex,GO:0042995~cell projection,GO:0043679~axon terminus,GO:0045178~basal part of cell,GO:0048471~perinuclear region of cytoplasm,	GO:0005178~integrin binding,GO:0005518~collagen binding,GO:0032403~protein complex binding,GO:0038064~collagen receptor activity,GO:0043236~laminin binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0098639~collagen binding involved in cell-matrix adhesion,	IPR000413:Integrin alpha chain,IPR002035:von Willebrand factor, type A,IPR013517:FG-GAP repeat,IPR013519:Integrin alpha beta-propellor,IPR013649:Integrin alpha-2,IPR018184:Integrin alpha chain, C-terminal cytoplasmic region, conserved site,	mmu04145:Phagosome,mmu04151:PI3K-Akt signaling pathway,mmu04510:Focal adhesion,mmu04512:ECM-receptor interaction,mmu04611:Platelet activation,mmu04640:Hematopoietic cell lineage,mmu04810:Regulation of actin cytoskeleton,mmu05200:Pathways in cancer,mmu05205:Proteoglycans in cancer,mmu05222:Small cell lung cancer,mmu05410:Hypertrophic cardiomyopathy (HCM),mmu05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),mmu05414:Dilated cardiomyopathy,			SM00191:Int_alpha,SM00327:VWA,	Calcium,Cell adhesion,Complete proteome,Disulfide bond,Glycoprotein,Integrin,Magnesium,Membrane,Metal-binding,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Integrin alpha-2,disulfide bond,domain:VWFA,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:FG-GAP 1,repeat:FG-GAP 2,repeat:FG-GAP 3,repeat:FG-GAP 4,repeat:FG-GAP 5,repeat:FG-GAP 6,repeat:FG-GAP 7,short sequence motif:Cell attachment site,short sequence motif:GFFKR motif,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P05107	integrin subunit beta 2(ITGB2)	Homo sapiens	125.T_Cells_CNS-APCs,55.Allergen_recognition_by_Th2_or_Th0_cell,60.IL-15_rheumatoid-arthritis_synovitis,78.B_Cell_Development,81.Structure_of_Caps_and_SMACs,	h_blymphocytePathway:B Lymphocyte Cell Surface Molecules,h_ctlPathway:CTL mediated immune response against target cells ,h_granulocytesPathway:Adhesion and Diapedesis of Granulocytes,h_LairPathway:Cells and Molecules involved in local acute inflammatory response,h_lymPathway:Adhesion and Diapedesis of Lymphocytes,h_lymphocytePathway:Adhesion Molecules on Lymphocyte,h_monocytePathway:Monocyte and its Surface Molecules,h_neutrophilPathway:Neutrophil and Its Surface Molecules,h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules,h_thelperPathway:T Helper Cell Surface Molecules,		GO:0002523~leukocyte migration involved in inflammatory response,GO:0006909~phagocytosis,GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007159~leukocyte cell-cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007267~cell-cell signaling,GO:0007568~aging,GO:0008360~regulation of cell shape,GO:0030101~natural killer cell activation,GO:0030198~extracellular matrix organization,GO:0030593~neutrophil chemotaxis,GO:0031623~receptor internalization,GO:0034113~heterotypic cell-cell adhesion,GO:0034142~toll-like receptor 4 signaling pathway,GO:0035987~endodermal cell differentiation,GO:0043113~receptor clustering,GO:0043542~endothelial cell migration,GO:0045123~cellular extravasation,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045766~positive regulation of angiogenesis,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0050776~regulation of immune response,GO:0050900~leukocyte migration,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0071404~cellular response to low-density lipoprotein particle stimulus,	GO:0005886~plasma membrane,GO:0008305~integrin complex,GO:0009986~cell surface,GO:0016020~membrane,GO:0030141~secretory granule,GO:0034687~integrin alphaL-beta2 complex,GO:0043235~receptor complex,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0001948~glycoprotein binding,GO:0004872~receptor activity,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0030369~ICAM-3 receptor activity,GO:0032403~protein complex binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0050839~cell adhesion molecule binding,	IPR002035:von Willebrand factor, type A,IPR002369:Integrin beta subunit, N-terminal,IPR012896:Integrin beta subunit, tail,IPR014836:Integrin beta subunit, cytoplasmic domain,IPR015439:Integrin beta-2 subunit,IPR015812:Integrin beta subunit,IPR016201:Plexin-like fold,	hsa04015:Rap1 signaling pathway,hsa04145:Phagosome,hsa04390:Hippo signaling pathway,hsa04514:Cell adhesion molecules (CAMs),hsa04650:Natural killer cell mediated cytotoxicity,hsa04670:Leukocyte transendothelial migration,hsa04810:Regulation of actin cytoskeleton,hsa05133:Pertussis,hsa05134:Legionellosis,hsa05140:Leishmaniasis,hsa05144:Malaria,hsa05146:Amoebiasis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05166:HTLV-I infection,hsa05323:Rheumatoid arthritis,hsa05416:Viral myocarditis,	116920~Leukocyte adhesion deficiency,	PIRSF002512:integrin, beta subunit,	SM00187:INB,SM00423:PSI,SM01241:SM01241,SM01242:SM01242,	3D-structure,Cell adhesion,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Integrin,Membrane,Metal-binding,Phagocytosis,Phosphoprotein,Proteomics identification,Pyrrolidone carboxylic acid,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Integrin beta-2,disulfide bond,domain:VWFA,glycosylation site:N-linked (GlcNAc...),helix,modified residue,region of interest:Cysteine-rich tandem repeats,repeat:I,repeat:II,repeat:III,repeat:IV,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
Q01628	interferon induced transmembrane protein 3(IFITM3)	Homo sapiens				GO:0006955~immune response,GO:0009607~response to biotic stimulus,GO:0009615~response to virus,GO:0032897~negative regulation of viral transcription,GO:0034341~response to interferon-gamma,GO:0035455~response to interferon-alpha,GO:0035456~response to interferon-beta,GO:0045071~negative regulation of viral genome replication,GO:0046597~negative regulation of viral entry into host cell,GO:0051607~defense response to virus,GO:0060337~type I interferon signaling pathway,	GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031902~late endosome membrane,GO:0070062~extracellular exosome,		IPR007593:Interferon-induced transmembrane protein,		614680~Influenza, severe, susceptibility to,			Antiviral defense,Cell membrane,Complete proteome,Endosome,Immunity,Innate immunity,Isopeptide bond,Lipoprotein,Lysosome,Membrane,Palmitate,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Interferon-induced transmembrane protein 3,sequence conflict,sequence variant,transmembrane region,
Q9CQW9	interferon induced transmembrane protein 3(Ifitm3)	Mus musculus				GO:0002376~immune system process,GO:0006898~receptor-mediated endocytosis,GO:0008285~negative regulation of cell proliferation,GO:0009607~response to biotic stimulus,GO:0009615~response to virus,GO:0032897~negative regulation of viral transcription,GO:0034341~response to interferon-gamma,GO:0035455~response to interferon-alpha,GO:0035456~response to interferon-beta,GO:0045071~negative regulation of viral genome replication,GO:0045087~innate immune response,GO:0046597~negative regulation of viral entry into host cell,GO:0051607~defense response to virus,GO:0060337~type I interferon signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031902~late endosome membrane,GO:0045177~apical part of cell,GO:0070062~extracellular exosome,		IPR007593:Interferon-induced transmembrane protein,					Antiviral defense,Cell membrane,Complete proteome,Endosome,Immunity,Innate immunity,Isopeptide bond,Lipoprotein,Lysosome,Membrane,Palmitate,Phosphoprotein,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,Ubl conjugation,
A6NNB3	interferon induced transmembrane protein 5(IFITM5)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0009607~response to biotic stimulus,GO:0030282~bone mineralization,GO:0030500~regulation of bone mineralization,GO:0060349~bone morphogenesis,	GO:0005887~integral component of plasma membrane,		IPR007593:Interferon-induced transmembrane protein,		610967~Osteogenesis imperfecta, type V,			Cell membrane,Complete proteome,Developmental protein,Disease mutation,Lipoprotein,Membrane,Mineral balance,Osteogenesis imperfecta,Palmitate,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Interferon-induced transmembrane protein 5,sequence variant,transmembrane region,
Q6NZT6	interferon regulatory factor 2 binding protein 2a(irf2bp2a)	Danio rerio				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0046872~metal ion binding,	IPR022750:Interferon regulatory factor 2-binding protein 1 & 2, zinc finger,					Complete proteome,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Interferon regulatory factor 2-binding protein 2-B,compositionally biased region:Pro-rich,region of interest:Cys-rich,sequence conflict,
Q8MJS1	interleukin 12 receptor subunit beta 2(IL12RB2)	Sus scrofa				GO:0018108~peptidyl-tyrosine phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0032496~response to lipopolysaccharide,GO:0032609~interferon-gamma production,GO:0032729~positive regulation of interferon-gamma production,	GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004896~cytokine receptor activity,	IPR003529:Long hematopoietin receptor, Gp130 family 2, conserved site,IPR003961:Fibronectin, type III,IPR010457:Immunoglobulin C2-set-like, ligand-binding,IPR013783:Immunoglobulin-like fold,	ssc04060:Cytokine-cytokine receptor interaction,ssc04630:Jak-STAT signaling pathway,ssc05321:Inflammatory bowel disease (IBD),			SM00060:FN3,	Complete proteome,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-12 receptor subunit beta-2,compositionally biased region:Poly-Pro,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,glycosylation site:N-linked (GlcNAc...),sequence conflict,short sequence motif:Box 1 motif,short sequence motif:WSXWS motif,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q60943	interleukin 17 receptor A(Il17ra)	Mus musculus				GO:0032747~positive regulation of interleukin-23 production,GO:0050729~positive regulation of inflammatory response,GO:0050832~defense response to fungus,GO:0071345~cellular response to cytokine stimulus,GO:0071621~granulocyte chemotaxis,GO:0072537~fibroblast activation,GO:1900017~positive regulation of cytokine production involved in inflammatory response,GO:2000664~positive regulation of interleukin-5 secretion,GO:2000667~positive regulation of interleukin-13 secretion,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005102~receptor binding,GO:0030368~interleukin-17 receptor activity,	IPR013568:SEFIR,	mmu04060:Cytokine-cytokine receptor interaction,				Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-17 receptor A,compositionally biased region:Poly-Glu,glycosylation site:N-linked (GlcNAc...),signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
A0MSX9	interleukin 7 receptor(IL7R)	Equus caballus				GO:0000902~cell morphogenesis,GO:0001915~negative regulation of T cell mediated cytotoxicity,GO:0002377~immunoglobulin production,GO:0008361~regulation of cell size,GO:0010628~positive regulation of gene expression,GO:0016049~cell growth,GO:0030217~T cell differentiation,GO:0033089~positive regulation of T cell differentiation in thymus,GO:0042100~B cell proliferation,GO:0048535~lymph node development,GO:0048872~homeostasis of number of cells,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,	GO:0004896~cytokine receptor activity,	IPR003531:Short hematopoietin receptor, family 1, conserved site,IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,	ecb04060:Cytokine-cytokine receptor interaction,ecb04068:FoxO signaling pathway,ecb04151:PI3K-Akt signaling pathway,ecb04630:Jak-STAT signaling pathway,ecb04640:Hematopoietic cell lineage,ecb05340:Primary immunodeficiency,				Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-7 receptor subunit alpha,domain:Fibronectin type-III,glycosylation site:N-linked (GlcNAc...),modified residue,short sequence motif:Box 1 motif,short sequence motif:WSXWS motif,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q9XSG3	isocitrate dehydrogenase (NADP(+)) 1, cytosolic(IDH1)	Bos taurus				GO:0006097~glyoxylate cycle,GO:0006099~tricarboxylic acid cycle,GO:0006102~isocitrate metabolic process,GO:0006103~2-oxoglutarate metabolic process,GO:0006979~response to oxidative stress,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000287~magnesium ion binding,GO:0004450~isocitrate dehydrogenase (NADP+) activity,GO:0051287~NAD binding,	IPR004790:Isocitrate dehydrogenase NADP-dependent,IPR019818:Isocitrate/isopropylmalate dehydrogenase, conserved site,IPR024084:Isopropylmalate dehydrogenase-like domain,	bta00020:Citrate cycle (TCA cycle),bta00480:Glutathione metabolism,bta01100:Metabolic pathways,bta01130:Biosynthesis of antibiotics,bta01200:Carbon metabolism,bta01210:2-Oxocarboxylic acid metabolism,bta01230:Biosynthesis of amino acids,bta04146:Peroxisome,		PIRSF000108:isocitrate dehydrogenase (NADP),	SM01329:SM01329,	Acetylation,Complete proteome,Cytoplasm,Glyoxylate bypass,Magnesium,Manganese,Metal-binding,NADP,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Tricarboxylic acid cycle,	binding site:NADP,binding site:NADP; via amide nitrogen and carbonyl oxygen,binding site:Substrate,chain:Isocitrate dehydrogenase [NADP] cytoplasmic,metal ion-binding site:Magnesium or manganese,modified residue,nucleotide phosphate-binding region:NADP,region of interest:Substrate binding,sequence conflict,site:Critical for catalysis,
P41562	isocitrate dehydrogenase (NADP(+)) 1, cytosolic(Idh1)	Rattus norvegicus				GO:0006097~glyoxylate cycle,GO:0006099~tricarboxylic acid cycle,GO:0006102~isocitrate metabolic process,GO:0006103~2-oxoglutarate metabolic process,GO:0006749~glutathione metabolic process,GO:0006979~response to oxidative stress,GO:0008585~female gonad development,GO:0014070~response to organic cyclic compound,GO:0048545~response to steroid hormone,GO:0060696~regulation of phospholipid catabolic process,GO:0071071~regulation of phospholipid biosynthetic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0004448~isocitrate dehydrogenase activity,GO:0004450~isocitrate dehydrogenase (NADP+) activity,GO:0005102~receptor binding,GO:0042803~protein homodimerization activity,GO:0050661~NADP binding,GO:0051287~NAD binding,GO:0051990~(R)-2-hydroxyglutarate dehydrogenase activity,	IPR004790:Isocitrate dehydrogenase NADP-dependent,IPR019818:Isocitrate/isopropylmalate dehydrogenase, conserved site,IPR024084:Isopropylmalate dehydrogenase-like domain,	rno00020:Citrate cycle (TCA cycle),rno00480:Glutathione metabolism,rno01100:Metabolic pathways,rno01130:Biosynthesis of antibiotics,rno01200:Carbon metabolism,rno01210:2-Oxocarboxylic acid metabolism,rno01230:Biosynthesis of amino acids,rno04146:Peroxisome,		PIRSF000108:isocitrate dehydrogenase (NADP),	SM01329:SM01329,	Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Glyoxylate bypass,Magnesium,Manganese,Metal-binding,NADP,Oxidoreductase,Phosphoprotein,Reference proteome,Tricarboxylic acid cycle,	binding site:NADP,binding site:NADP; via amide nitrogen and carbonyl oxygen,binding site:Substrate,chain:Isocitrate dehydrogenase [NADP] cytoplasmic,metal ion-binding site:Magnesium or manganese,modified residue,nucleotide phosphate-binding region:NADP,region of interest:Substrate binding,site:Critical for catalysis,
D4GU92	isocitrate dehydrogenase (NADP(+))(HVO_RS17200)	Haloferax volcanii DS2				GO:0006097~glyoxylate cycle,GO:0006099~tricarboxylic acid cycle,		GO:0000287~magnesium ion binding,GO:0004450~isocitrate dehydrogenase (NADP+) activity,GO:0051287~NAD binding,	IPR001804:Isocitrate and isopropylmalate dehydrogenases family,IPR004439:Isocitrate dehydrogenase NADP-dependent, dimeric, prokaryotic,IPR019818:Isocitrate/isopropylmalate dehydrogenase, conserved site,IPR024084:Isopropylmalate dehydrogenase-like domain,	hvo00020:Citrate cycle (TCA cycle),hvo00480:Glutathione metabolism,hvo00720:Carbon fixation pathways in prokaryotes,hvo01100:Metabolic pathways,hvo01110:Biosynthesis of secondary metabolites,hvo01120:Microbial metabolism in diverse environments,hvo01130:Biosynthesis of antibiotics,hvo01200:Carbon metabolism,hvo01210:2-Oxocarboxylic acid metabolism,hvo01230:Biosynthesis of amino acids,			SM01329:SM01329,	Complete proteome,Direct protein sequencing,Glyoxylate bypass,Magnesium,Manganese,Metal-binding,NADP,Oxidoreductase,Reference proteome,Tricarboxylic acid cycle,
O88844	isocitrate dehydrogenase 1 (NADP+), soluble(Idh1)	Mus musculus				GO:0006097~glyoxylate cycle,GO:0006099~tricarboxylic acid cycle,GO:0006102~isocitrate metabolic process,GO:0006103~2-oxoglutarate metabolic process,GO:0006749~glutathione metabolic process,GO:0006979~response to oxidative stress,GO:0008585~female gonad development,GO:0014070~response to organic cyclic compound,GO:0048545~response to steroid hormone,GO:0055114~oxidation-reduction process,GO:0060696~regulation of phospholipid catabolic process,GO:0071071~regulation of phospholipid biosynthetic process,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0004448~isocitrate dehydrogenase activity,GO:0004450~isocitrate dehydrogenase (NADP+) activity,GO:0005102~receptor binding,GO:0016491~oxidoreductase activity,GO:0016616~oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0050661~NADP binding,GO:0051287~NAD binding,GO:0051990~(R)-2-hydroxyglutarate dehydrogenase activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR004790:Isocitrate dehydrogenase NADP-dependent,IPR019818:Isocitrate/isopropylmalate dehydrogenase, conserved site,IPR024084:Isopropylmalate dehydrogenase-like domain,	mmu00020:Citrate cycle (TCA cycle),mmu00480:Glutathione metabolism,mmu01100:Metabolic pathways,mmu01130:Biosynthesis of antibiotics,mmu01200:Carbon metabolism,mmu01210:2-Oxocarboxylic acid metabolism,mmu01230:Biosynthesis of amino acids,mmu04146:Peroxisome,		PIRSF000108:isocitrate dehydrogenase (NADP),	SM01329:SM01329,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Glyoxylate bypass,Magnesium,Manganese,Metal-binding,NADP,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Tricarboxylic acid cycle,	binding site:NADP,binding site:NADP; via amide nitrogen and carbonyl oxygen,binding site:Substrate,chain:Isocitrate dehydrogenase [NADP] cytoplasmic,helix,metal ion-binding site:Magnesium or manganese,modified residue,nucleotide phosphate-binding region:NADP,region of interest:Substrate binding,site:Critical for catalysis,strand,turn,
P52293	karyopherin (importin) alpha 2(Kpna2)	Mus musculus		m_ranMSPathway:Role of Ran in mitotic spindle regulation,	Intracellular trafficking and secretion,	GO:0006606~protein import into nucleus,GO:0006607~NLS-bearing protein import into nucleus,	GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005515~protein binding,GO:0008139~nuclear localization sequence binding,GO:0008565~protein transporter activity,GO:0042826~histone deacetylase binding,GO:0044822~poly(A) RNA binding,	IPR000225:Armadillo,IPR002652:Importin-alpha, importin-beta-binding domain,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR024931:Importin subunit alpha,	mmu05164:Influenza A,		PIRSF005673:importin subunit alpha,	SM00185:ARM,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Repeat,Transport,	chain:60S ribosomal protein L38,chain:Importin subunit alpha-2,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Glu,domain:IBB,helix,modified residue,region of interest:NLS binding site (major),region of interest:NLS binding site (minor),repeat:ARM 10; atypical,repeat:ARM 1; truncated,repeat:ARM 2,repeat:ARM 3,repeat:ARM 4,repeat:ARM 5,repeat:ARM 6,repeat:ARM 7,repeat:ARM 8,repeat:ARM 9,sequence conflict,short sequence motif:Nuclear localization signal,strand,turn,
Q6NWF6	keratin 8(krt8)	Danio rerio					GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005882~intermediate filament,GO:0016363~nuclear matrix,GO:0045095~keratin filament,	GO:0005198~structural molecule activity,	IPR001664:Intermediate filament protein,IPR003054:Type II keratin,IPR018039:Intermediate filament protein, conserved site,				SM01391:SM01391,	Coiled coil,Complete proteome,Cytoplasm,Intermediate filament,Keratin,Nucleus,Phosphoprotein,Reference proteome,	chain:Keratin, type II cytoskeletal 8,modified residue,region of interest:Coil 1A,region of interest:Coil 1B,region of interest:Coil 2,region of interest:Head,region of interest:Linker 1,region of interest:Linker 12,region of interest:Rod,region of interest:Tail,site:Stutter,
Q60675	laminin, alpha 2(Lama2)	Mus musculus		m_agrPathway:Agrin in Postsynaptic Differentiation,	Cell motility and secretion / Signal transduction mechanisms,	GO:0007155~cell adhesion,GO:0007411~axon guidance,GO:0022011~myelination in peripheral nervous system,GO:0030155~regulation of cell adhesion,GO:0030198~extracellular matrix organization,GO:0030334~regulation of cell migration,GO:0032224~positive regulation of synaptic transmission, cholinergic,GO:0045995~regulation of embryonic development,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0005605~basal lamina,GO:0042383~sarcolemma,GO:0043197~dendritic spine,GO:0070062~extracellular exosome,	GO:0005102~receptor binding,	IPR000034:Laminin B type IV,IPR000742:Epidermal growth factor-like domain,IPR001791:Laminin G domain,IPR002049:EGF-like, laminin,IPR008211:Laminin, N-terminal,IPR008979:Galactose-binding domain-like,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR009254:Laminin I,IPR010307:Laminin II,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,	mmu04151:PI3K-Akt signaling pathway,mmu04510:Focal adhesion,mmu04512:ECM-receptor interaction,mmu05145:Toxoplasmosis,mmu05146:Amoebiasis,mmu05200:Pathways in cancer,mmu05222:Small cell lung cancer,			SM00136:LamNT,SM00180:EGF_Lam,SM00181:EGF,SM00281:LamB,SM00282:LamG,	3D-structure,Basement membrane,Cell adhesion,Coiled coil,Complete proteome,Direct protein sequencing,Disulfide bond,Extracellular matrix,Glycoprotein,Laminin EGF-like domain,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Laminin subunit alpha-2,disulfide bond,domain:Laminin EGF-like 1,domain:Laminin EGF-like 10,domain:Laminin EGF-like 11,domain:Laminin EGF-like 12,domain:Laminin EGF-like 13,domain:Laminin EGF-like 14; first part,domain:Laminin EGF-like 14; second part,domain:Laminin EGF-like 15,domain:Laminin EGF-like 16,domain:Laminin EGF-like 17,domain:Laminin EGF-like 2,domain:Laminin EGF-like 3,domain:Laminin EGF-like 4,domain:Laminin EGF-like 5; first part,domain:Laminin EGF-like 5; second part,domain:Laminin EGF-like 6,domain:Laminin EGF-like 7,domain:Laminin EGF-like 8,domain:Laminin EGF-like 9,domain:Laminin G-like 1,domain:Laminin G-like 2,domain:Laminin G-like 3,domain:Laminin G-like 4,domain:Laminin G-like 5,domain:Laminin IV type A 1,domain:Laminin IV type A 2,domain:Laminin N-terminal,glycosylation site:N-linked (GlcNAc...),helix,region of interest:Domain II and I,sequence conflict,signal peptide,strand,
Q4R8S6	lanosterol 14-alpha demethylase-like(LOC102146764)	Macaca fascicularis				GO:0006694~steroid biosynthetic process,GO:0006695~cholesterol biosynthetic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0008398~sterol 14-demethylase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0020037~heme binding,	IPR001128:Cytochrome P450,IPR002403:Cytochrome P450, E-class, group IV,IPR017972:Cytochrome P450, conserved site,	mcf00100:Steroid biosynthesis,mcf01100:Metabolic pathways,mcf01130:Biosynthesis of antibiotics,				Cholesterol biosynthesis,Cholesterol metabolism,Complete proteome,Endoplasmic reticulum,Heme,Iron,Lipid biosynthesis,Lipid metabolism,Membrane,Metal-binding,Microsome,Monooxygenase,NADP,Oxidoreductase,Reference proteome,Signal,Steroid biosynthesis,Steroid metabolism,Sterol biosynthesis,Sterol metabolism,Transmembrane,Transmembrane helix,
Q9BGL2	lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)(LRAT)	Bos taurus				GO:0006776~vitamin A metabolic process,GO:0007601~visual perception,GO:0032370~positive regulation of lipid transport,GO:0042572~retinol metabolic process,GO:0050896~response to stimulus,	GO:0005623~cell,GO:0005771~multivesicular body,GO:0005789~endoplasmic reticulum membrane,GO:0005791~rough endoplasmic reticulum,GO:0016021~integral component of membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0008374~O-acyltransferase activity,GO:0047173~phosphatidylcholine-retinol O-acyltransferase activity,GO:0102279~lecithin:11-cis retinol acyltransferase activity,	IPR007053:LRAT-like domain,	bta00830:Retinol metabolism,bta04977:Vitamin digestion and absorption,				Acyltransferase,Complete proteome,Cytoplasm,Direct protein sequencing,Endoplasmic reticulum,Endosome,Membrane,Reference proteome,Sensory transduction,Transferase,Transmembrane,Transmembrane helix,Vision,	chain:Lecithin retinol acyltransferase,transmembrane region,
Q8NAA5	leucine rich repeat containing 75A(LRRC75A)	Homo sapiens												Alternative splicing,Complete proteome,Leucine-rich repeat,Reference proteome,Repeat,	chain:Leucine-rich repeat-containing protein C17orf76,repeat:LRR 1,repeat:LRR 2,splice variant,
Q6P1C6	leucine-rich repeats and immunoglobulin-like domains 3(Lrig3)	Mus musculus				GO:0007275~multicellular organism development,GO:0032474~otolith morphogenesis,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031410~cytoplasmic vesicle,		IPR000483:Cysteine-rich flanking region, C-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,				SM00082:LRRCT,SM00369:LRR_TYP,SM00408:IGc2,SM00409:IG,	3D-structure,Cell membrane,Complete proteome,Cytoplasmic vesicle,Developmental protein,Disulfide bond,Glycoprotein,Immunoglobulin domain,Leucine-rich repeat,Membrane,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Leucine-rich repeats and immunoglobulin- like domains protein 3,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,glycosylation site:N-linked (GlcNAc...),repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 14,repeat:LRR 15,repeat:LRR 16,repeat:LRR 17,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,signal peptide,transmembrane region,
O75829	leukocyte cell derived chemotaxin 1(LECT1)	Homo sapiens				GO:0001501~skeletal system development,GO:0006029~proteoglycan metabolic process,GO:0016525~negative regulation of angiogenesis,GO:0030154~cell differentiation,GO:0051216~cartilage development,	GO:0005578~proteinaceous extracellular matrix,GO:0012505~endomembrane system,GO:0016021~integral component of membrane,		IPR007084:BRICHOS domain,				SM01039:SM01039,	Alternative splicing,Chondrogenesis,Cleavage on pair of basic residues,Complete proteome,Developmental protein,Differentiation,Disulfide bond,Extracellular matrix,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Secreted,Transmembrane,Transmembrane helix,	chain:Chondromodulin-1,chain:Chondrosurfactant protein,disulfide bond,domain:BRICHOS,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,transmembrane region,
Q9N261	leupaxin(LPXN)	Oryctolagus cuniculus				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007155~cell adhesion,GO:0007162~negative regulation of cell adhesion,GO:0033628~regulation of cell adhesion mediated by integrin,GO:0050859~negative regulation of B cell receptor signaling pathway,	GO:0002102~podosome,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0042995~cell projection,GO:0048471~perinuclear region of cytoplasm,	GO:0003712~transcription cofactor activity,GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,IPR017305:Leupaxin,			PIRSF037881:leupaxin ,	SM00132:LIM,	Acetylation,Activator,Cell adhesion,Cell junction,Cell membrane,Cell projection,Complete proteome,Cytoplasm,LIM domain,Membrane,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,
Q2TBI0	lipopolysaccharide binding protein(LBP)	Bos taurus				GO:0002232~leukocyte chemotaxis involved in inflammatory response,GO:0002281~macrophage activation involved in immune response,GO:0006869~lipid transport,GO:0006953~acute-phase response,GO:0015920~lipopolysaccharide transport,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032490~detection of molecule of bacterial origin,GO:0032720~negative regulation of tumor necrosis factor production,GO:0032722~positive regulation of chemokine production,GO:0032755~positive regulation of interleukin-6 production,GO:0032757~positive regulation of interleukin-8 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0034145~positive regulation of toll-like receptor 4 signaling pathway,GO:0042535~positive regulation of tumor necrosis factor biosynthetic process,GO:0043032~positive regulation of macrophage activation,GO:0044130~negative regulation of growth of symbiont in host,GO:0045087~innate immune response,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0060265~positive regulation of respiratory burst involved in inflammatory response,GO:0071222~cellular response to lipopolysaccharide,GO:0071223~cellular response to lipoteichoic acid,GO:0090023~positive regulation of neutrophil chemotaxis,	GO:0005615~extracellular space,GO:0009986~cell surface,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0001530~lipopolysaccharide binding,GO:0070891~lipoteichoic acid binding,	IPR001124:Lipid-binding serum glycoprotein, C-terminal,IPR017942:Lipid-binding serum glycoprotein, N-terminal,IPR017943:Bactericidal permeability-increasing protein, alpha/beta domain,IPR017954:Lipid-binding serum glycoprotein, conserved site,	bta04064:NF-kappa B signaling pathway,bta04620:Toll-like receptor signaling pathway,bta05132:Salmonella infection,bta05152:Tuberculosis,		PIRSF002417:lipid-binding protein, LBP type,	SM00328:BPI1,SM00329:BPI2,	Antibiotic,Antimicrobial,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Lipid transport,Membrane,Proteomics identification,Reference proteome,Secreted,Signal,Transport,	chain:Lipopolysaccharide-binding protein,glycosylation site:N-linked (GlcNAc...),signal peptide,
Q810T5	lysine acetyltransferase 7(Kat7)	Rattus norvegicus				GO:0006260~DNA replication,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016573~histone acetylation,GO:0043966~histone H3 acetylation,GO:0043981~histone H4-K5 acetylation,GO:0043982~histone H4-K8 acetylation,GO:0043983~histone H4-K12 acetylation,GO:0043984~histone H4-K16 acetylation,GO:1900182~positive regulation of protein localization to nucleus,	GO:0000123~histone acetyltransferase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004402~histone acetyltransferase activity,GO:0008270~zinc ion binding,	IPR002515:Zinc finger, C2HC-type,IPR002717:MOZ/SAS-like protein,IPR016181:Acyl-CoA N-acyltransferase,					Acetylation,Acyltransferase,Alternative splicing,Chromatin regulator,Complete proteome,DNA replication,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Transferase,Zinc,Zinc-finger,	chain:Histone acetyltransferase MYST2,compositionally biased region:Ser-rich,modified residue,splice variant,zinc finger region:C2HC-type,
P11941	lysozyme II(lyz2)	Oncorhynchus mykiss				GO:0008152~metabolic process,GO:0019835~cytolysis,GO:0042742~defense response to bacterium,	GO:0005615~extracellular space,	GO:0003796~lysozyme activity,	IPR000974:Glycoside hydrolase, family 22, lysozyme,IPR001916:Glycoside hydrolase, family 22,IPR019799:Glycoside hydrolase, family 22, conserved site,IPR023346:Lysozyme-like domain,				SM00263:LYZ1,	3D-structure,Antibiotic,Antimicrobial,Bacteriolytic enzyme,Direct protein sequencing,Disulfide bond,Glycosidase,Hydrolase,Secreted,Signal,	chain:Lysozyme C II,disulfide bond,helix,sequence conflict,signal peptide,strand,turn,
A1L1V4	lysyl oxidase-like 2a(loxl2a)	Danio rerio				GO:0001666~response to hypoxia,GO:0001837~epithelial to mesenchymal transition,GO:0001935~endothelial cell proliferation,GO:0002040~sprouting angiogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0030199~collagen fibril organization,GO:0032332~positive regulation of chondrocyte differentiation,GO:0043542~endothelial cell migration,GO:0045892~negative regulation of transcription, DNA-templated,GO:0055114~oxidation-reduction process,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0005634~nucleus,GO:0005694~chromosome,GO:0016020~membrane,	GO:0004720~protein-lysine 6-oxidase activity,GO:0005044~scavenger receptor activity,GO:0005507~copper ion binding,GO:0016491~oxidoreductase activity,GO:0016641~oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,GO:0046872~metal ion binding,	IPR001190:Speract/scavenger receptor,IPR001695:Lysyl oxidase,IPR017448:Speract/scavenger receptor-related,IPR019828:Lysyl oxidase, conserved site,				SM00202:SR,	Basement membrane,Chromatin regulator,Chromosome,Complete proteome,Copper,Disulfide bond,Extracellular matrix,Glycoprotein,LTQ,Metal-binding,Nucleus,Oxidoreductase,Reference proteome,Repeat,Repressor,Secreted,Signal,TPQ,Transcription,Transcription regulation,
Q60754	macrophage receptor with collagenous structure(Marco)	Mus musculus				GO:0002376~immune system process,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0043277~apoptotic cell clearance,GO:0045087~innate immune response,	GO:0005581~collagen trimer,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005044~scavenger receptor activity,	IPR001190:Speract/scavenger receptor,IPR008160:Collagen triple helix repeat,IPR017448:Speract/scavenger receptor-related,	mmu04145:Phagosome,			SM00202:SR,	3D-structure,Collagen,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Membrane,Proteomics identification,Receptor,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Macrophage receptor MARCO,disulfide bond,domain:Collagen-like,domain:SRCR,glycosylation site:N-linked (GlcNAc...),helix,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
Q95460	major histocompatibility complex, class I-related(MR1)	Homo sapiens				GO:0002367~cytokine production involved in immune response,GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0006955~immune response,GO:0007165~signal transduction,GO:0019882~antigen processing and presentation,GO:0032611~interleukin-1 beta production,GO:0032620~interleukin-17 production,GO:0045087~innate immune response,GO:0050829~defense response to Gram-negative bacterium,	GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0042612~MHC class I protein complex,	GO:0003823~antigen binding,GO:0032393~MHC class I receptor activity,GO:0042605~peptide antigen binding,	IPR001039:MHC class I, alpha chain, alpha1/alpha2,IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR011161:MHC class I-like antigen recognition,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,				SM00407:IGc1,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Immunity,Immunoglobulin domain,Innate immunity,Membrane,MHC I,Polymorphism,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Major histocompatibility complex class I- related gene protein,disulfide bond,domain:Ig-like C1-type,glycosylation site:N-linked (GlcNAc...),mutagenesis site,region of interest:Alpha-1,region of interest:Alpha-2,region of interest:Alpha-3,region of interest:Connecting peptide,region of interest:Ligand-binding,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
O19477	major histocompatibility complex, class I-related(Mr1)	Rattus norvegicus				GO:0002367~cytokine production involved in immune response,GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0019882~antigen processing and presentation,GO:0032611~interleukin-1 beta production,GO:0032620~interleukin-17 production,GO:0045087~innate immune response,GO:0050829~defense response to Gram-negative bacterium,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0042612~MHC class I protein complex,	GO:0003823~antigen binding,GO:0042605~peptide antigen binding,	IPR001039:MHC class I, alpha chain, alpha1/alpha2,IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR011161:MHC class I-like antigen recognition,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,				SM00407:IGc1,	Cell membrane,Complete proteome,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Immunity,Immunoglobulin domain,Innate immunity,Membrane,MHC I,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Major histocompatibility complex class I- related gene protein,disulfide bond,domain:Ig-like C1-type,glycosylation site:N-linked (GlcNAc...),region of interest:Alpha-1,region of interest:Alpha-2,region of interest:Alpha-3,region of interest:Connecting peptide,sequence conflict,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
O88989	malate dehydrogenase 1(Mdh1)	Rattus norvegicus				GO:0002230~positive regulation of defense response to virus by host,GO:0005975~carbohydrate metabolic process,GO:0006099~tricarboxylic acid cycle,GO:0006107~oxaloacetate metabolic process,GO:0006108~malate metabolic process,GO:0006734~NADH metabolic process,GO:0019674~NAD metabolic process,GO:0098779~mitophagy in response to mitochondrial depolarization,GO:0098792~xenophagy,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005813~centrosome,GO:0005829~cytosol,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0016615~malate dehydrogenase activity,GO:0030060~L-malate dehydrogenase activity,GO:0051287~NAD binding,	IPR001236:Lactate/malate dehydrogenase, N-terminal,IPR001252:Malate dehydrogenase, active site,IPR001557:L-lactate/malate dehydrogenase,IPR010945:Malate dehydrogenase, type 2,IPR011274:Malate dehydrogenase, NAD-dependent, cytosolic,IPR015955:Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal,IPR016040:NAD(P)-binding domain,IPR022383:Lactate/malate dehydrogenase, C-terminal,	rno00020:Citrate cycle (TCA cycle),rno00270:Cysteine and methionine metabolism,rno00620:Pyruvate metabolism,rno00630:Glyoxylate and dicarboxylate metabolism,rno01100:Metabolic pathways,rno01130:Biosynthesis of antibiotics,rno01200:Carbon metabolism,rno04964:Proximal tubule bicarbonate reclamation,		PIRSF000102:L-lactate/malate dehydrogenase,		Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,NAD,Oxidoreductase,Phosphoprotein,Reference proteome,Tricarboxylic acid cycle,Ubl conjugation,	active site:Proton acceptor,binding site:NAD,binding site:Substrate,chain:Malate dehydrogenase, cytoplasmic,modified residue,nucleotide phosphate-binding region:NAD,sequence conflict,
Q5NVR2	malate dehydrogenase 2(MDH2)	Pongo abelii				GO:0005975~carbohydrate metabolic process,GO:0006099~tricarboxylic acid cycle,GO:0006108~malate metabolic process,GO:0006475~internal protein amino acid acetylation,	GO:0005654~nucleoplasm,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005886~plasma membrane,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0030060~L-malate dehydrogenase activity,GO:0044822~poly(A) RNA binding,	IPR001236:Lactate/malate dehydrogenase, N-terminal,IPR001252:Malate dehydrogenase, active site,IPR001557:L-lactate/malate dehydrogenase,IPR010097:Malate dehydrogenase, type 1,IPR015955:Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal,IPR016040:NAD(P)-binding domain,IPR022383:Lactate/malate dehydrogenase, C-terminal,	pon00020:Citrate cycle (TCA cycle),pon00270:Cysteine and methionine metabolism,pon00620:Pyruvate metabolism,pon00630:Glyoxylate and dicarboxylate metabolism,pon01100:Metabolic pathways,pon01130:Biosynthesis of antibiotics,pon01200:Carbon metabolism,		PIRSF000102:L-lactate/malate dehydrogenase,		Acetylation,Complete proteome,Glycoprotein,Mitochondrion,NAD,Oxidoreductase,Phosphoprotein,Reference proteome,Transit peptide,Tricarboxylic acid cycle,	active site:Proton acceptor,binding site:NAD,binding site:Substrate,chain:Malate dehydrogenase, mitochondrial,modified residue,nucleotide phosphate-binding region:NAD,transit peptide:Mitochondrion,
Q9HCI7	male-specific lethal 2 homolog (Drosophila)(MSL2)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0043984~histone H4-K16 acetylation,	GO:0005654~nucleoplasm,GO:0072487~MSL complex,	GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,				SM01114:SM01114,	3D-structure,Alternative splicing,Complete proteome,Isopeptide bond,Ligase,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Male-specific lethal 2 homolog,compositionally biased region:Lys-rich,modified residue,sequence conflict,zinc finger region:RING-type,
Q8BMF3	malic enzyme 3, NADP(+)-dependent, mitochondrial(Me3)	Mus musculus				GO:0006090~pyruvate metabolic process,GO:0006108~malate metabolic process,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0004470~malic enzyme activity,GO:0004471~malate dehydrogenase (decarboxylating) (NAD+) activity,GO:0004473~malate dehydrogenase (decarboxylating) (NADP+) activity,GO:0008948~oxaloacetate decarboxylase activity,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,GO:0051287~NAD binding,	IPR001891:Malic oxidoreductase,IPR012301:Malic enzyme, N-terminal,IPR012302:Malic enzyme, NAD-binding,IPR015884:Malic enzyme, conserved site,IPR016040:NAD(P)-binding domain,	mmu00620:Pyruvate metabolism,mmu01100:Metabolic pathways,mmu01200:Carbon metabolism,		PIRSF000106:malic enzyme,	SM00919:SM00919,SM01274:SM01274,	Complete proteome,Direct protein sequencing,Metal-binding,Mitochondrion,NADP,Oxidoreductase,Proteomics identification,Reference proteome,Transit peptide,	active site:Proton acceptor,active site:Proton donor,binding site:NADP,chain:NADP-dependent malic enzyme, mitochondrial,metal ion-binding site:Divalent metal cation,site:Important for activity,transit peptide:Mitochondrion,
Q9NR34	mannosidase alpha class 1C member 1(MAN1C1)	Homo sapiens		h_aMANpathway:Steps in the Glycosylation of Mammalian N-linked Oligosaccarides,h_eradPathway:ERassociated degradation (ERAD) Pathway,		GO:0006487~protein N-linked glycosylation,GO:0006491~N-glycan processing,GO:0008152~metabolic process,GO:1904381~Golgi apparatus mannose trimming,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0016020~membrane,GO:0030173~integral component of Golgi membrane,GO:0070062~extracellular exosome,	GO:0004571~mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,GO:0005509~calcium ion binding,	IPR001382:Glycoside hydrolase, family 47,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,hsa04141:Protein processing in endoplasmic reticulum,				Calcium,Complete proteome,Disulfide bond,Glycoprotein,Glycosidase,Golgi apparatus,Hydrolase,Membrane,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Mannosyl-oligosaccharide 1,2-alpha- mannosidase IC,glycosylation site:N-linked (GlcNAc...),modified residue,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
P53690	matrix metallopeptidase 14 (membrane-inserted)(Mmp14)	Mus musculus		m_reckPathway:Inhibition of Matrix Metalloproteinases,		GO:0001503~ossification,GO:0001525~angiogenesis,GO:0001541~ovarian follicle development,GO:0001666~response to hypoxia,GO:0001935~endothelial cell proliferation,GO:0001958~endochondral ossification,GO:0006508~proteolysis,GO:0006979~response to oxidative stress,GO:0008584~male gonad development,GO:0009612~response to mechanical stimulus,GO:0009725~response to hormone,GO:0010831~positive regulation of myotube differentiation,GO:0016477~cell migration,GO:0030307~positive regulation of cell growth,GO:0030324~lung development,GO:0030335~positive regulation of cell migration,GO:0030574~collagen catabolic process,GO:0031638~zymogen activation,GO:0035987~endodermal cell differentiation,GO:0035988~chondrocyte proliferation,GO:0043615~astrocyte cell migration,GO:0043627~response to estrogen,GO:0045579~positive regulation of B cell differentiation,GO:0045746~negative regulation of Notch signaling pathway,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048754~branching morphogenesis of an epithelial tube,GO:0048771~tissue remodeling,GO:0051895~negative regulation of focal adhesion assembly,GO:0060348~bone development,GO:0097094~craniofacial suture morphogenesis,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031012~extracellular matrix,GO:0031410~cytoplasmic vesicle,GO:0042470~melanosome,GO:0044354~macropinosome,	GO:0004222~metalloendopeptidase activity,GO:0005178~integrin binding,GO:0005509~calcium ion binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0016504~peptidase activator activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,GO:0070006~metalloaminopeptidase activity,	IPR000585:Hemopexin-like domain,IPR001818:Peptidase M10, metallopeptidase,IPR002477:Peptidoglycan binding-like,IPR006026:Peptidase, metallopeptidase,IPR016293:Peptidase M10A, metazoans,IPR018486:Hemopexin, conserved site,IPR018487:Hemopexin-like repeats,IPR021158:Peptidase M10A, cysteine switch, zinc binding site,IPR021190:Peptidase M10A,IPR021805:Peptidase M10A, matrix metallopeptidase, C-terminal,IPR024079:Metallopeptidase, catalytic domain,	mmu04668:TNF signaling pathway,mmu04912:GnRH signaling pathway,		PIRSF001191:matrix metalloproteinase, stromelysin type,	SM00120:HX,SM00235:ZnMc,	Calcium,Cleavage on pair of basic residues,Collagen degradation,Complete proteome,Cytoplasm,Disulfide bond,Hydrolase,Membrane,Metal-binding,Metalloprotease,Phosphoprotein,Protease,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Zinc,Zymogen,	chain:Matrix metalloproteinase-14,disulfide bond,domain:Hemopexin-like 1,domain:Hemopexin-like 2,domain:Hemopexin-like 3,domain:Hemopexin-like 4,metal ion-binding site:Zinc; catalytic,metal ion-binding site:Zinc; in inhibited form,sequence conflict,short sequence motif:Cysteine switch,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q9P6L8	mediator complex subunit Srb8(srb8)	Schizosaccharomyces pombe 972h-				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:1900387~negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,	GO:0016592~mediator complex,	GO:0001104~RNA polymerase II transcription cofactor activity,GO:0001105~RNA polymerase II transcription coactivator activity,	IPR019035:Mediator complex, subunit Med12,				SM01281:SM01281,	Activator,Complete proteome,Nucleus,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Mediator of RNA polymerase II transcription subunit 12,
Q5ZKL6	membrane bound O-acyltransferase domain containing 2(MBOAT2)	Gallus gallus				GO:0008654~phospholipid biosynthetic process,	GO:0016021~integral component of membrane,	GO:0016746~transferase activity, transferring acyl groups,	IPR004299:Membrane bound O-acyl transferase, MBOAT,	gga00561:Glycerolipid metabolism,gga00564:Glycerophospholipid metabolism,gga01100:Metabolic pathways,				Acyltransferase,Complete proteome,Lipid biosynthesis,Lipid metabolism,Membrane,Phospholipid biosynthesis,Phospholipid metabolism,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Membrane-bound O-acyltransferase domain- containing protein 2,transmembrane region,
P49697	membrane palmitoylated protein 1(mpp1)	Takifugu rubripes					GO:0016020~membrane,		IPR001452:Src homology-3 domain,IPR001478:PDZ domain,IPR008144:Guanylate kinase,IPR008145:Guanylate kinase/L-type calcium channel,IPR011511:Variant SH3,IPR020590:Guanylate kinase, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00072:GuKc,SM00228:PDZ,SM00326:SH3,	Complete proteome,Lipoprotein,Membrane,Palmitate,Reference proteome,SH3 domain,
P44130	membrane protein(lapB)	Haemophilus influenzae Rd KW20				GO:0008653~lipopolysaccharide metabolic process,GO:0046890~regulation of lipid biosynthetic process,	GO:0016021~integral component of membrane,GO:0031235~intrinsic component of the cytoplasmic side of the plasma membrane,	GO:0005506~iron ion binding,	IPR007488:Protein of unknown function DUF535,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,	Cell inner membrane,Cell membrane,Complete proteome,Iron,Membrane,Metal-binding,Reference proteome,Repeat,TPR repeat,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein HI1119,
Q99N07	membrane-spanning 4-domains, subfamily A, member 6D(Ms4a6d)	Mus musculus					GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR007237:CD20-like,					Complete proteome,Membrane,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Transmembrane,Transmembrane helix,	chain:Membrane-spanning 4-domains subfamily A member 6D,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q2QLE0	met proto-oncogene (hepatocyte growth factor receptor)(MET)	Sus scrofa				GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0050918~positive chemotaxis,GO:0071526~semaphorin-plexin signaling pathway,GO:2001028~positive regulation of endothelial cell chemotaxis,	GO:0016021~integral component of membrane,	GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001627:Semaphorin/CD100 antigen,IPR002165:Plexin,IPR002909:Cell surface receptor IPT/TIG,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016201:Plexin-like fold,IPR016244:Tyrosine-protein kinase, HGF/MSP receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	ssc04014:Ras signaling pathway,ssc04015:Rap1 signaling pathway,ssc04060:Cytokine-cytokine receptor interaction,ssc04144:Endocytosis,ssc04151:PI3K-Akt signaling pathway,ssc04360:Axon guidance,ssc04510:Focal adhesion,ssc04520:Adherens junction,ssc05100:Bacterial invasion of epithelial cells,ssc05144:Malaria,ssc05200:Pathways in cancer,ssc05202:Transcriptional misregulation in cancer,ssc05205:Proteoglycans in cancer,ssc05206:MicroRNAs in cancer,ssc05211:Renal cell carcinoma,ssc05218:Melanoma,ssc05230:Central carbon metabolism in cancer,		PIRSF000617:tyrosine-protein kinase, HGF/MSP receptor type,	SM00219:TyrKc,SM00423:PSI,SM00429:IPT,SM00630:Sema,	ATP-binding,Complete proteome,Disulfide bond,Glycoprotein,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Proto-oncogene,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Hepatocyte growth factor receptor,domain:IPT/TIG 1,domain:IPT/TIG 2,domain:IPT/TIG 3,domain:Protein kinase,domain:Sema,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,region of interest:Interaction with MUC20,region of interest:Interaction with RANBP9,sequence conflict,signal peptide,site:Cleavage,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P68503	metallothionein A(mt-a)	Oncorhynchus mykiss				GO:0010043~response to zinc ion,GO:0046686~response to cadmium ion,GO:0046688~response to copper ion,GO:0046689~response to mercury ion,GO:0051259~protein oligomerization,	GO:0005623~cell,	GO:0008270~zinc ion binding,GO:0046870~cadmium ion binding,	IPR000006:Metallothionein, vertebrate,IPR003019:Metallothionein superfamily, eukaryotic,IPR017854:Metallothionein domain,IPR018064:Metallothionein, vertebrate, metal binding site,IPR023587:Metallothionein domain, vertebrate,					Metal-binding,Metal-thiolate cluster,	chain:Metallothionein A,metal ion-binding site:Divalent metal cation; cluster A,metal ion-binding site:Divalent metal cation; cluster B,region of interest:Alpha,region of interest:Beta,
P11586	methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1(MTHFD1)	Homo sapiens				GO:0000105~histidine biosynthetic process,GO:0001780~neutrophil homeostasis,GO:0001843~neural tube closure,GO:0006164~purine nucleotide biosynthetic process,GO:0006555~methionine metabolic process,GO:0006730~one-carbon metabolic process,GO:0007507~heart development,GO:0009069~serine family amino acid metabolic process,GO:0009070~serine family amino acid biosynthetic process,GO:0009086~methionine biosynthetic process,GO:0009257~10-formyltetrahydrofolate biosynthetic process,GO:0009396~folic acid-containing compound biosynthetic process,GO:0019346~transsulfuration,GO:0035999~tetrahydrofolate interconversion,GO:0046655~folic acid metabolic process,GO:0048702~embryonic neurocranium morphogenesis,GO:0048703~embryonic viscerocranium morphogenesis,GO:0055114~oxidation-reduction process,GO:0061053~somite development,	GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0004329~formate-tetrahydrofolate ligase activity,GO:0004477~methenyltetrahydrofolate cyclohydrolase activity,GO:0004486~methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,GO:0004487~methylenetetrahydrofolate dehydrogenase (NAD+) activity,GO:0004488~methylenetetrahydrofolate dehydrogenase (NADP+) activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,	IPR000559:Formate-tetrahydrofolate ligase, FTHFS,IPR000672:Tetrahydrofolate dehydrogenase/cyclohydrolase,IPR016040:NAD(P)-binding domain,IPR020628:Formate-tetrahydrofolate ligase, FTHFS, conserved site,IPR020630:Tetrahydrofolate dehydrogenase/cyclohydrolase, catalytic domain,IPR020631:Tetrahydrofolate dehydrogenase/cyclohydrolase, NAD(P)-binding domain,IPR020867:Tetrahydrofolate dehydrogenase/cyclohydrolase, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00670:One carbon pool by folate,hsa01100:Metabolic pathways,	601634~Spina bifida, folate-sensitive, susceptibility to,Abruptio placentae, susceptibility to~Abruptio placentae, susceptibility to,			3D-structure,Acetylation,Amino-acid biosynthesis,ATP-binding,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Histidine biosynthesis,Hydrolase,Ligase,Methionine biosynthesis,Multifunctional enzyme,NADP,Nucleotide-binding,One-carbon metabolism,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Purine biosynthesis,Reference proteome,	binding site:NADP,chain:C-1-tetrahydrofolate synthase, cytoplasmic,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,nucleotide phosphate-binding region:NADP,region of interest:Formyltetrahydrofolate synthetase,region of interest:Methylenetetrahydrofolate dehydrogenase and cyclohydrolase,region of interest:Substrate binding,sequence variant,site:Not acetylated,strand,turn,
Q7ZW77	methylsterol monooxygenase 1(msmo1)	Danio rerio				GO:0006629~lipid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0006694~steroid biosynthetic process,GO:0008202~steroid metabolic process,GO:0016126~sterol biosynthetic process,GO:0055114~oxidation-reduction process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0000254~C-4 methylsterol oxidase activity,GO:0005506~iron ion binding,GO:0016491~oxidoreductase activity,	IPR006694:Fatty acid hydroxylase,	dre00100:Steroid biosynthesis,dre01100:Metabolic pathways,dre01130:Biosynthesis of antibiotics,				Complete proteome,Endoplasmic reticulum,Iron,Lipid biosynthesis,Lipid metabolism,Membrane,NAD,Oxidoreductase,Reference proteome,Steroid biosynthesis,Steroid metabolism,Sterol biosynthesis,Sterol metabolism,Transmembrane,Transmembrane helix,	chain:C-4 methylsterol oxidase,short sequence motif:Histidine box-1,short sequence motif:Histidine box-2,short sequence motif:Histidine box-3,transmembrane region,
Q5U403	mevalonate (diphospho) decarboxylase a(mvda)	Danio rerio				GO:0006629~lipid metabolic process,GO:0006694~steroid biosynthetic process,GO:0006695~cholesterol biosynthetic process,GO:0008202~steroid metabolic process,GO:0008203~cholesterol metabolic process,GO:0008299~isoprenoid biosynthetic process,GO:0016126~sterol biosynthetic process,GO:0019287~isopentenyl diphosphate biosynthetic process, mevalonate pathway,	GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0004163~diphosphomevalonate decarboxylase activity,GO:0005524~ATP binding,GO:0016829~lyase activity,GO:0016831~carboxy-lyase activity,	IPR005935:Diphosphomevalonate decarboxylase,IPR006204:GHMP kinase N-terminal domain,IPR013750:GHMP kinase, C-terminal domain,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR020568:Ribosomal protein S5 domain 2-type fold,	dre00900:Terpenoid backbone biosynthesis,dre01100:Metabolic pathways,dre01130:Biosynthesis of antibiotics,		PIRSF015950:diphosphomevalonate decarboxylase,		ATP-binding,Cholesterol biosynthesis,Cholesterol metabolism,Complete proteome,Lipid biosynthesis,Lipid metabolism,Lyase,Nucleotide-binding,Proteomics identification,Reference proteome,Steroid biosynthesis,Steroid metabolism,Sterol biosynthesis,Sterol metabolism,	chain:Diphosphomevalonate decarboxylase,
Q3T100	microsomal glutathione S-transferase 3(MGST3)	Bos taurus				GO:0098869~cellular oxidant detoxification,	GO:0005635~nuclear envelope,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,GO:0070062~extracellular exosome,	GO:0004364~glutathione transferase activity,GO:0004602~glutathione peroxidase activity,	IPR001129:Membrane-associated, eicosanoid/glutathione metabolism (MAPEG) protein,IPR023352:Membrane associated eicosanoid/glutathione metabolism-like domain,	bta00480:Glutathione metabolism,bta00980:Metabolism of xenobiotics by cytochrome P450,bta00982:Drug metabolism - cytochrome P450,bta05204:Chemical carcinogenesis,				Complete proteome,Endoplasmic reticulum,Lipoprotein,Membrane,Microsome,Palmitate,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Microsomal glutathione S-transferase 3,transmembrane region,
Q9Y4B5	microtubule crosslinking factor 1(MTCL1)	Homo sapiens			Cell division and chromosome partitioning,	GO:0001578~microtubule bundle formation,GO:0010506~regulation of autophagy,GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity,GO:0090314~positive regulation of protein targeting to membrane,GO:2000576~positive regulation of microtubule motor activity,	GO:0000922~spindle pole,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0016324~apical plasma membrane,GO:0016327~apicolateral plasma membrane,GO:0016328~lateral plasma membrane,GO:0030496~midbody,GO:0097427~microtubule bundle,	GO:0008017~microtubule binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,						Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein KIAA0802,compositionally biased region:Poly-Glu,compositionally biased region:Pro-rich,modified residue,sequence variant,splice variant,
A4IG32	mitochondrial calcium uptake 1(micu1)	Danio rerio				GO:0006810~transport,GO:0006811~ion transport,GO:0006816~calcium ion transport,GO:0006851~mitochondrial calcium ion transport,GO:0051560~mitochondrial calcium ion homeostasis,GO:0051561~positive regulation of mitochondrial calcium ion concentration,GO:0070509~calcium ion import,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005758~mitochondrial intermembrane space,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0032592~integral component of mitochondrial membrane,GO:1990246~uniplex complex,	GO:0005509~calcium ion binding,GO:0046872~metal ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	Calcium,Calcium transport,Complete proteome,Disulfide bond,Ion transport,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Repeat,Transit peptide,Transmembrane,Transmembrane helix,Transport,	calcium-binding region:1,calcium-binding region:2,chain:Calcium-binding atopy-related autoantigen 1,domain:EF-hand 1,domain:EF-hand 2,transmembrane region,
Q9BQP7	mitochondrial genome maintenance exonuclease 1(MGME1)	Homo sapiens				GO:0000002~mitochondrial genome maintenance,GO:0006264~mitochondrial DNA replication,GO:0043504~mitochondrial DNA repair,GO:0090305~nucleic acid phosphodiester bond hydrolysis,	GO:0005739~mitochondrion,	GO:0008297~single-stranded DNA exodeoxyribonuclease activity,	IPR011335:Restriction endonuclease  type II-like,IPR026970:Uncharacterised protein C20orf72,		615084~Mitochondrial DNA depletion syndrome 11,			Complete proteome,Disease mutation,DNA damage,DNA repair,Exonuclease,Hydrolase,Mitochondrion,Nuclease,Phosphoprotein,Polymorphism,Progressive external ophthalmoplegia,Proteomics identification,Reference proteome,Transit peptide,	chain:Uncharacterized protein C20orf72,modified residue,sequence conflict,sequence variant,
Q99797	mitochondrial intermediate peptidase(MIPEP)	Homo sapiens				GO:0006518~peptide metabolic process,GO:0006627~protein processing involved in protein targeting to mitochondrion,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0004222~metalloendopeptidase activity,GO:0046872~metal ion binding,	IPR001567:Peptidase M3A/M3B,IPR024077:Neurolysin/Thimet oligopeptidase, domain 2,IPR024079:Metallopeptidase, catalytic domain,IPR024080:Neurolysin/Thimet oligopeptidase, N-terminal,					Acetylation,Calcium,Cobalt,Complete proteome,Hydrolase,Iron,Magnesium,Manganese,Metal-binding,Metalloprotease,Mitochondrion,Polymorphism,Protease,Reference proteome,Transit peptide,Zinc,	chain:Mitochondrial intermediate peptidase,metal ion-binding site:Zinc; catalytic,modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
O95563	mitochondrial pyruvate carrier 2(MPC2)	Homo sapiens				GO:0006850~mitochondrial pyruvate transport,GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0061732~mitochondrial acetyl-CoA biosynthetic process from pyruvate,GO:1902361~mitochondrial pyruvate transmembrane transport,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,	GO:0050833~pyruvate transmembrane transporter activity,	IPR005336:Uncharacterised protein family UPF0041,					Complete proteome,Membrane,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Brain protein 44,modified residue,
Q99N96	mitochondrial ribosomal protein L1(Mrpl1)	Mus musculus				GO:0000470~maturation of LSU-rRNA,GO:0006412~translation,	GO:0005739~mitochondrion,GO:0005762~mitochondrial large ribosomal subunit,GO:0005840~ribosome,GO:0015934~large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR005879:Ribosomal protein L1, mitochondrial,IPR016094:Ribosomal protein L1, 2-layer alpha/beta-sandwich,IPR016095:Ribosomal protein L1, 3-layer alpha/beta-sandwich,IPR023674:Ribosomal protein L1, superfamily,	mmu03010:Ribosome,				Complete proteome,Mitochondrion,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,Transit peptide,	chain:39S ribosomal protein L1, mitochondrial,compositionally biased region:Poly-Ala,modified residue,sequence conflict,transit peptide:Mitochondrion,
Q5T653	mitochondrial ribosomal protein L2(MRPL2)	Homo sapiens				GO:0002181~cytoplasmic translation,GO:0006412~translation,GO:0032543~mitochondrial translation,GO:0070125~mitochondrial translational elongation,GO:0070126~mitochondrial translational termination,	GO:0005743~mitochondrial inner membrane,GO:0005762~mitochondrial large ribosomal subunit,GO:0005840~ribosome,GO:0015934~large ribosomal subunit,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR002171:Ribosomal protein L2,IPR005880:Ribosomal protein L2, bacterial/organellar-type,IPR008991:Translation protein SH3-like domain,IPR012340:Nucleic acid-binding, OB-fold,IPR014722:Ribosomal protein L2 domain 2,IPR014726:Ribosomal protein L2, domain 3,IPR022666:Ribosomal Proteins L2, RNA binding domain,IPR022669:Ribosomal protein L2, C-terminal,	hsa03010:Ribosome,			SM01382:SM01382,SM01383:SM01383,	3D-structure,Complete proteome,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,Transit peptide,	chain:39S ribosomal protein L2, mitochondrial,sequence conflict,sequence variant,transit peptide:Mitochondrion,
Q2TBK2	mitochondrial ribosomal protein L9(MRPL9)	Bos taurus				GO:0006412~translation,GO:0070124~mitochondrial translational initiation,GO:0070125~mitochondrial translational elongation,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005840~ribosome,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR000244:Ribosomal protein L9,IPR009027:Ribosomal protein L9/RNase H1, N-terminal,IPR020070:Ribosomal protein L9, N-terminal,	bta03010:Ribosome,				Alternative splicing,Complete proteome,Mitochondrion,Reference proteome,Ribonucleoprotein,Ribosomal protein,Transit peptide,	chain:39S ribosomal protein L9, mitochondrial,modified residue,splice variant,transit peptide:Mitochondrion,
Q9CXW2	mitochondrial ribosomal protein S22(Mrps22)	Mus musculus					GO:0005739~mitochondrion,GO:0005763~mitochondrial small ribosomal subunit,GO:0005840~ribosome,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,	IPR019374:Ribosomal protein S22, mitochondrial,					Acetylation,Complete proteome,Mitochondrion,Phosphoprotein,Reference proteome,Ribonucleoprotein,Ribosomal protein,	chain:28S ribosomal protein S22, mitochondrial,modified residue,
P82669	mitochondrial ribosomal protein S25(MRPS25)	Bos taurus				GO:0032543~mitochondrial translation,GO:0070124~mitochondrial translational initiation,GO:0070125~mitochondrial translational elongation,	GO:0005743~mitochondrial inner membrane,GO:0005763~mitochondrial small ribosomal subunit,	GO:0003735~structural constituent of ribosome,	IPR007741:Ribosomal protein/NADH dehydrogenase domain,IPR012336:Thioredoxin-like fold,				SM00916:SM00916,	Complete proteome,Direct protein sequencing,Mitochondrion,Reference proteome,Ribonucleoprotein,Ribosomal protein,	chain:28S ribosomal protein S25, mitochondrial,
Q498P2	mitochondrial ribosomal protein S35(mrps35)	Danio rerio					GO:0005739~mitochondrion,GO:0005763~mitochondrial small ribosomal subunit,GO:0005840~ribosome,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,	IPR019349:Ribosomal protein S24/S35, mitochondrial, conserved domain,					Complete proteome,Mitochondrion,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,Transit peptide,	chain:28S ribosomal protein S35, mitochondrial,sequence conflict,transit peptide:Mitochondrion,
Q58DQ5	mitochondrial ribosomal protein S9(MRPS9)	Bos taurus				GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006412~translation,GO:0070124~mitochondrial translational initiation,GO:0070125~mitochondrial translational elongation,	GO:0005730~nucleolus,GO:0005743~mitochondrial inner membrane,GO:0005763~mitochondrial small ribosomal subunit,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR000754:Ribosomal protein S9,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR020574:Ribosomal protein S9, conserved site,	bta03010:Ribosome,				3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Mitochondrion,Reference proteome,Ribonucleoprotein,Ribosomal protein,Transit peptide,	chain:28S ribosomal protein S9, mitochondrial,modified residue,sequence conflict,splice variant,transit peptide:Mitochondrion,
Q4L8D2	moaA(SH_RS03665)	Staphylococcus haemolyticus JCSC1435				GO:0006777~Mo-molybdopterin cofactor biosynthetic process,	GO:0019008~molybdopterin synthase complex,	GO:0005525~GTP binding,GO:0046872~metal ion binding,GO:0051539~4 iron, 4 sulfur cluster binding,GO:0061597~cyclic pyranopterin monophosphate synthase activity,	IPR000385:MoaA/nifB/pqqE, iron-sulphur binding, conserved site,IPR006638:Elongator protein 3/MiaB/NifB,IPR007197:Radical SAM,IPR010505:Molybdenum cofactor synthesis C-terminal,IPR013483:Molybdenum cofactor biosynthesis protein A,IPR013785:Aldolase-type TIM barrel,				SM00729:Elp3,	4Fe-4S,Complete proteome,GTP-binding,Iron,Iron-sulfur,Lyase,Metal-binding,Molybdenum cofactor biosynthesis,Nucleotide-binding,Reference proteome,S-adenosyl-L-methionine,
Q15546	monocyte to macrophage differentiation associated(MMD)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0019835~cytolysis,GO:0032880~regulation of protein localization,GO:0045666~positive regulation of neuron differentiation,GO:0045860~positive regulation of protein kinase activity,	GO:0005765~lysosomal membrane,GO:0005794~Golgi apparatus,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031902~late endosome membrane,	GO:0004672~protein kinase activity,GO:0004872~receptor activity,	IPR004254:Hly-III-related,IPR005744:HylII,					Complete proteome,Endosome,Lysosome,Membrane,Receptor,Reference proteome,Transmembrane,Transmembrane helix,	chain:Monocyte to macrophage differentiation protein,sequence conflict,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
Q9C8G9	multidrug resistance-associated protein 1(ABCC1)	Arabidopsis thaliana			Defense mechanisms,	GO:0006855~drug transmembrane transport,GO:0015700~arsenite transport,GO:0016042~lipid catabolic process,GO:0042908~xenobiotic transport,GO:0046685~response to arsenic-containing substance,GO:0055085~transmembrane transport,GO:1902418~(+)-abscisic acid D-glucopyranosyl ester transmembrane transport,	GO:0000325~plant-type vacuole,GO:0005634~nucleus,GO:0005773~vacuole,GO:0005774~vacuolar membrane,GO:0009506~plasmodesma,GO:0009514~glyoxysome,GO:0016021~integral component of membrane,GO:0046861~glyoxysomal membrane,	GO:0005325~peroxisomal fatty-acyl-CoA transporter activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008559~xenobiotic-transporting ATPase activity,GO:0015446~arsenite-transmembrane transporting ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0071992~phytochelatin transmembrane transporter activity,GO:1902417~(+)-abscisic acid D-glucopyranosyl ester transmembrane transporter activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00382:AAA,	Alternative splicing,ATP-binding,Calmodulin-binding,Complete proteome,Glyoxysome,Hydrolase,Membrane,Nucleotide-binding,Peroxisome,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,Vacuole,	chain:ABC transporter C family member 1,domain:ABC transmembrane type-1 1,domain:ABC transmembrane type-1 2,domain:ABC transporter 1,domain:ABC transporter 2,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,region of interest:Interaction with calmodulin and FKP42/TWD1,sequence conflict,transmembrane region,
Q9UNW1	multiple inositol-polyphosphate phosphatase 1(MINPP1)	Homo sapiens				GO:0001503~ossification,GO:0006797~polyphosphate metabolic process,GO:0016311~dephosphorylation,GO:0030282~bone mineralization,GO:0043647~inositol phosphate metabolic process,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0070062~extracellular exosome,	GO:0003993~acid phosphatase activity,GO:0008969~phosphohistidine phosphatase activity,GO:0030351~inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,GO:0034417~bisphosphoglycerate 3-phosphatase activity,GO:0051717~inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,GO:0052745~inositol phosphate phosphatase activity,GO:0052826~inositol hexakisphosphate 2-phosphatase activity,	IPR000560:Histidine phosphatase superfamily, clade-2,IPR016274:Histidine acid phosphatase, eukaryotic,	hsa00010:Glycolysis / Gluconeogenesis,hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,	188470~Thyroid carcinoma, follicular,	PIRSF000894:acid phosphatase,		Alternative splicing,Complete proteome,Disease mutation,Endoplasmic reticulum,Glycoprotein,Hydrolase,Polymorphism,Reference proteome,Signal,	chain:Multiple inositol polyphosphate phosphatase 1,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence conflict,sequence variant,short sequence motif:Prevents secretion from ER,signal peptide,splice variant,
Q8C854	myelin basic protein expression factor 2, repressor(Myef2)	Mus musculus				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	Alternative splicing,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-binding,Transcription,	chain:Myelin expression factor 2,compositionally biased region:Gly-rich,domain:RRM 1,domain:RRM 2,domain:RRM 3,modified residue,sequence conflict,splice variant,
P02607	myosin, light chain 6, alkali, smooth muscle and non-muscle(MYL6)	Gallus gallus				GO:0031032~actomyosin structure organization,	GO:0005829~cytosol,GO:0016460~myosin II complex,GO:0042641~actomyosin,GO:0097513~myosin II filament,	GO:0005509~calcium ion binding,GO:0008307~structural constituent of muscle,GO:0030898~actin-dependent ATPase activity,GO:0051015~actin filament binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,				SM00054:EFh,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Motor protein,Muscle protein,Myosin,Reference proteome,Repeat,
Q7T2B9	myotrophin(mtpn)	Danio rerio					GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0048471~perinuclear region of cytoplasm,		IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	ANK repeat,Complete proteome,Cytoplasm,Nucleus,Reference proteome,Repeat,	chain:Myotrophin,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,
Q15843	neural precursor cell expressed, developmentally down-regulated 8(NEDD8)	Homo sapiens		h_p27Pathway:Regulation of p27 Phosphorylation during Cell Cycle Progression,		GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006464~cellular protein modification process,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0008104~protein localization,GO:0009653~anatomical structure morphogenesis,GO:0014070~response to organic cyclic compound,GO:0045116~protein neddylation,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,	IPR000626:Ubiquitin,IPR019954:Ubiquitin conserved site,IPR019956:Ubiquitin subgroup,				SM00213:UBQ,	3D-structure,Acetylation,Complete proteome,Direct protein sequencing,Isopeptide bond,Nucleus,Reference proteome,Ubl conjugation pathway,	chain:NEDD8,cross-link:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins),helix,modified residue,mutagenesis site,region of interest:Interaction with UBE1C,sequence conflict,site:Interaction with UBE1C,strand,
P55067	neurocan(Ncan)	Rattus norvegicus				GO:0001501~skeletal system development,GO:0007155~cell adhesion,GO:0007417~central nervous system development,GO:0051823~regulation of synapse structural plasticity,	GO:0005578~proteinaceous extracellular matrix,GO:0005886~plasma membrane,	GO:0005201~extracellular matrix structural constituent,GO:0005509~calcium ion binding,GO:0005540~hyaluronic acid binding,GO:0030246~carbohydrate binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000436:Sushi/SCR/CCP,IPR000538:Link,IPR000742:Epidermal growth factor-like domain,IPR001304:C-type lectin,IPR001881:EGF-like calcium-binding,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013032:EGF-like, conserved site,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018097:EGF-like calcium-binding, conserved site,IPR018378:C-type lectin, conserved site,				SM00032:CCP,SM00034:CLECT,SM00179:EGF_CA,SM00181:EGF,SM00409:IG,SM00445:LINK,	Calcium,Cell adhesion,Complete proteome,Direct protein sequencing,Disulfide bond,EGF-like domain,Glycoprotein,Hyaluronic acid,Immunoglobulin domain,Lectin,Proteoglycan,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:150 kDa adult core glycoprotein,chain:Neurocan core protein,disulfide bond,domain:C-type lectin,domain:EGF-like 1,domain:EGF-like 2; calcium-binding,domain:Ig-like V-type,domain:Link 1,domain:Link 2,domain:Sushi,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Xyl...) (chondroitin sulfate),signal peptide,
Q5R412	neuronal growth regulator 1(NEGR1)	Pongo abelii				GO:0007155~cell adhesion,GO:0007626~locomotory behavior,GO:0007631~feeding behavior,GO:0010976~positive regulation of neuron projection development,GO:0016337~single organismal cell-cell adhesion,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	pon04514:Cell adhesion molecules (CAMs),			SM00408:IGc2,SM00409:IG,	Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Phosphoprotein,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Neuronal growth regulator 1,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated glycine,modified residue,propeptide:Removed in mature form,sequence conflict,signal peptide,
Q5ZL67	nuclear factor, erythroid 2 like 1(NFE2L1)	Gallus gallus				GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0030218~erythrocyte differentiation,GO:0034599~cellular response to oxidative stress,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001190~transcriptional activator activity, RNA polymerase II transcription factor binding,GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR004826:Basic leucine zipper domain, Maf-type,IPR004827:Basic-leucine zipper domain,IPR008917:Eukaryotic transcription factor, Skn-1-like, DNA-binding,				SM00338:BRLZ,	Activator,Coiled coil,Complete proteome,DNA-binding,Endoplasmic reticulum,Membrane,Nucleus,Reference proteome,Signal-anchor,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,	chain:Nuclear factor erythroid 2-related factor 1,compositionally biased region:Ser-rich,DNA-binding region:Basic motif,domain:Leucine-zipper,short sequence motif:Nuclear localization signal,
B8M0Q1	nuclear migration protein NudF(TSTA_086670)	Talaromyces stipitatus ATCC 10500				GO:0000132~establishment of mitotic spindle orientation,GO:0006810~transport,GO:0007067~mitotic nuclear division,GO:0051301~cell division,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0005875~microtubule associated complex,		IPR001680:WD40 repeat,IPR006594:LisH dimerisation motif,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017252:Dynein regulator LIS1,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,			PIRSF037647:dynein regulator, Lis1 type,	SM00320:WD40,	Cell cycle,Cell division,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Mitosis,Reference proteome,Repeat,Transport,WD repeat,
Q04913	nuclear receptor subfamily 4 group A member 1 L homeolog(nr4a1.L)	Xenopus laevis				GO:0006351~transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003707~steroid hormone receptor activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR003070:Orphan nuclear receptor,IPR003071:Orphan nuclear receptor, HMR type,IPR013088:Zinc finger, NHR/GATA-type,	xla04010:MAPK signaling pathway,			SM00399:ZnF_C4,SM00430:HOLI,	DNA-binding,Metal-binding,Nucleus,Receptor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Nuclear receptor subfamily 4 group A member 1,DNA-binding region:Nuclear receptor,region of interest:Ligand-binding,zinc finger region:NR C4-type,
Q5JGR7	nucleoside-diphosphate kinase(TK_RS06485)	Thermococcus kodakarensis KOD1				GO:0006183~GTP biosynthetic process,GO:0006228~UTP biosynthetic process,GO:0006241~CTP biosynthetic process,	GO:0005737~cytoplasm,	GO:0004550~nucleoside diphosphate kinase activity,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR001564:Nucleoside diphosphate kinase,IPR023005:Nucleoside diphosphate kinase, active site,	tko00230:Purine metabolism,tko00240:Pyrimidine metabolism,tko01100:Metabolic pathways,tko01110:Biosynthesis of secondary metabolites,tko01130:Biosynthesis of antibiotics,			SM00562:NDK,	ATP-binding,Complete proteome,Cytoplasm,Kinase,Magnesium,Metal-binding,Nucleotide metabolism,Nucleotide-binding,Phosphoprotein,Reference proteome,Transferase,	active site:Pros-phosphohistidine intermediate,binding site:ATP,chain:Nucleoside diphosphate kinase,
Q86X67	nudix hydrolase 13(NUDT13)	Homo sapiens			DNA replication, recombination, and repair,	GO:0015949~nucleobase-containing small molecule interconversion,	GO:0005759~mitochondrial matrix,	GO:0016462~pyrophosphatase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR000086:NUDIX hydrolase domain,IPR015375:NADH pyrophosphatase-like, N-terminal,IPR015376:Zinc ribbon, NADH pyrophosphatase,IPR015797:NUDIX hydrolase domain-like,IPR020084:NUDIX hydrolase, conserved site,					Alternative splicing,Complete proteome,Hydrolase,Polymorphism,Proteomics identification,Reference proteome,	chain:Nucleoside diphosphate-linked moiety X motif 13,domain:Nudix hydrolase,sequence variant,short sequence motif:Nudix box,splice variant,
Q7T3C6	nudix hydrolase 21(nudt21)	Danio rerio				GO:0006378~mRNA polyadenylation,GO:0006397~mRNA processing,	GO:0005634~nucleus,GO:0005849~mRNA cleavage factor complex,GO:0042382~paraspeckles,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0016787~hydrolase activity,GO:0017091~AU-rich element binding,	IPR000086:NUDIX hydrolase domain,IPR015797:NUDIX hydrolase domain-like,IPR016706:Cleavage/polyadenylation specificity factor subunit 5,	dre03015:mRNA surveillance pathway,		PIRSF017888:cleavage and polyadenylation specificity factor subunit 5,		Complete proteome,mRNA processing,Nucleus,Reference proteome,RNA-binding,	chain:Cleavage and polyadenylation specificity factor subunit 5,domain:Nudix hydrolase,short sequence motif:Nudix box,
Q16625	occludin(OCLN)	Homo sapiens				GO:0006461~protein complex assembly,GO:0045216~cell-cell junction organization,GO:0046498~S-adenosylhomocysteine metabolic process,GO:0046500~S-adenosylmethionine metabolic process,GO:0070830~bicellular tight junction assembly,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~bicellular tight junction,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0016327~apicolateral plasma membrane,GO:0030054~cell junction,GO:0030139~endocytic vesicle,GO:0031410~cytoplasmic vesicle,	GO:0005515~protein binding,GO:0008119~thiopurine S-methyltransferase activity,GO:0019904~protein domain specific binding,	IPR002958:Occludin,IPR008253:Marvel,IPR010844:Occludin/RNA polymerase II elongation factor, ELL domain,IPR020846:Major facilitator superfamily domain,	hsa04514:Cell adhesion molecules (CAMs),hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,hsa05130:Pathogenic Escherichia coli infection,hsa05160:Hepatitis C,	251290~Band-like calcification with simplified gyration and polymicrogyria,	PIRSF005993:occludin,		3D-structure,Alternative splicing,Cell junction,Cell membrane,Coiled coil,Complete proteome,Disease mutation,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Tight junction,Transmembrane,Transmembrane helix,
Q8R197	oleoyl-ACP hydrolase(Olah)	Mus musculus				GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0008610~lipid biosynthetic process,GO:0009058~biosynthetic process,		GO:0004320~oleoyl-[acyl-carrier-protein] hydrolase activity,GO:0016295~myristoyl-[acyl-carrier-protein] hydrolase activity,GO:0016296~palmitoyl-[acyl-carrier-protein] hydrolase activity,GO:0016297~acyl-[acyl-carrier-protein] hydrolase activity,GO:0016787~hydrolase activity,GO:0016788~hydrolase activity, acting on ester bonds,	IPR001031:Thioesterase,IPR012223:Thioesterase type II, NRPS/PKS/S-FAS,	mmu00061:Fatty acid biosynthesis,mmu01100:Metabolic pathways,				Acetylation,Complete proteome,Fatty acid biosynthesis,Fatty acid metabolism,Hydrolase,Lipid biosynthesis,Lipid metabolism,Reference proteome,	chain:S-acyl fatty acid synthase thioesterase, medium chain,modified residue,
Q3UZZ4	olfactomedin 4(Olfm4)	Mus musculus				GO:0007155~cell adhesion,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0050777~negative regulation of immune response,GO:0051260~protein homooligomerization,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0042581~specific granule,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0045296~cadherin binding,	IPR003112:Olfactomedin-like,				SM00284:OLF,	Cell adhesion,Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Mitochondrion,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Olfactomedin-4,compositionally biased region:Poly-Pro,disulfide bond,domain:Olfactomedin-like,glycosylation site:N-linked (GlcNAc...),signal peptide,
Q6V0K7	oncoprotein induced transcript 3(Oit3)	Rattus norvegicus				GO:1903118~urate homeostasis,	GO:0005635~nuclear envelope,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000742:Epidermal growth factor-like domain,IPR001507:Zona pellucida domain,IPR001881:EGF-like calcium-binding,				SM00179:EGF_CA,SM00181:EGF,SM00241:ZP,	Calcium,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Nucleus,Proteomics identification,Reference proteome,Signal,	chain:Oncoprotein-induced transcript 3 protein,compositionally biased region:Cys-rich,disulfide bond,domain:EGF-like; calcium-binding,domain:ZP,glycosylation site:N-linked (GlcNAc...),signal peptide,
P04181	ornithine aminotransferase(OAT)	Homo sapiens		h_argininecPathway:Catabolic Pathways for Arginine , Histidine, Glutamate, Glutamine, and Proline,		GO:0007601~visual perception,GO:0008652~cellular amino acid biosynthetic process,GO:0010121~arginine catabolic process to proline via ornithine,GO:0019544~arginine catabolic process to glutamate,GO:0034214~protein hexamerization,GO:0055129~L-proline biosynthetic process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0004587~ornithine-oxo-acid transaminase activity,GO:0008483~transaminase activity,GO:0030170~pyridoxal phosphate binding,GO:0042802~identical protein binding,	IPR005814:Aminotransferase class-III,IPR010164:Ornithine aminotransferase,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,	hsa00330:Arginine and proline metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,	258870~Gyrate atrophy of choroid and retina with or without ornithinemia,			3D-structure,Acetylation,Alternative splicing,Aminotransferase,Complete proteome,Direct protein sequencing,Disease mutation,Mitochondrion,Polymorphism,Pyridoxal phosphate,Reference proteome,Transferase,Transit peptide,	chain:Ornithine aminotransferase, hepatic form,chain:Ornithine aminotransferase, renal form,helix,modified residue,sequence variant,strand,transit peptide:Mitochondrion; in hepatic form,transit peptide:Mitochondrion; in renal form,turn,
Q71SY6	out at first homolog(OAF)	Gallus gallus					GO:0070062~extracellular exosome,		IPR026315:Out at first protein,					Complete proteome,Reference proteome,Signal,	chain:Out at first protein homolog,signal peptide,
P25695	p40(Ac-p40)	Autographa californica nucleopolyhedrovirus					GO:0042025~host cell nucleus,		IPR008562:Autographa californica nuclear polyhedrosis virus (AcMNPV), Orf101,					Complete proteome,Host nucleus,Late protein,Virion,	chain:Uncharacterized 41.5 kDa protein in P6.9- VP48 intergenic region,sequence conflict,
Q9RN20	pXO2-12(pxo2_12)	Bacillus anthracis					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Plasmid,Reference proteome,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein pXO2- 12/BXB0011/GBAA_pXO2_0011,transmembrane region,
Q923S8	pantothenate kinase 4(Pank4)	Rattus norvegicus				GO:0015937~coenzyme A biosynthetic process,GO:0016310~phosphorylation,	GO:0005737~cytoplasm,	GO:0004594~pantothenate kinase activity,GO:0005524~ATP binding,	IPR002791:Domain of unknown function DUF89,IPR004567:Type II pantothenate kinase,IPR015844:Pantothenate kinase, acetyl-CoA regulated, two-domain type,	rno00770:Pantothenate and CoA biosynthesis,rno01100:Metabolic pathways,		PIRSF036939:pantothenate kinase, acetyl-CoA regulated, two-domain type,		Acetylation,ATP-binding,Coenzyme A biosynthesis,Complete proteome,Cytoplasm,Kinase,Nitration,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,	chain:Pantothenate kinase 4,modified residue,
Q6VEU3	partner of NOB1 homolog(pno1)	Danio rerio			General function prediction only,		GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,				SM00322:KH,	Complete proteome,Nucleus,Proteomics identification,Reference proteome,RNA-binding,	chain:RNA-binding protein pno1,domain:KH,sequence conflict,
Q6H236	paternally expressed 3(PEG3)	Bos taurus				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR003309:Transcription regulator SCAN,IPR007087:Zinc finger, C2H2,IPR008916:Retrovirus capsid, C-terminal,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,SM00431:SCAN,	Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Metal-binding,Nucleus,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Paternally-expressed gene 3 protein,compositionally biased region:Arg-rich,compositionally biased region:Glu-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gly,domain:SCAN box,region of interest:13 X 9 AA repeat of P-X-Q-T-S-C-X-E-E,region of interest:3 X 9 AA repeat of P-A-Q-T-S-Y-T-E-A,region of interest:37 X 9 AA repeat of P-A-Q-T-X-Y-X-X-E,region of interest:4 X 9 AA repeat of P-A-Q-T-S-Y-T-X P,repeat:1-1,repeat:1-10,repeat:1-11,repeat:1-12,repeat:1-13,repeat:1-14,repeat:1-15,repeat:1-16,repeat:1-17,repeat:1-18,repeat:1-19,repeat:1-2,repeat:1-20,repeat:1-21,repeat:1-22,repeat:1-23,repeat:1-24,repeat:1-25,repeat:1-26,repeat:1-27,repeat:1-28,repeat:1-29,repeat:1-3,repeat:1-30,repeat:1-31,repeat:1-32,repeat:1-33,repeat:1-34,repeat:1-35,repeat:1-36,repeat:1-37,repeat:1-4,repeat:1-5,repeat:1-6,repeat:1-7,repeat:1-8,repeat:1-9,repeat:2-1,repeat:2-10,repeat:2-11,repeat:2-12,repeat:2-13,repeat:2-2,repeat:2-3,repeat:2-4,repeat:2-5,repeat:2-6,repeat:2-7,repeat:2-8,repeat:2-9,repeat:3-1,repeat:3-2,repeat:3-3,repeat:4-1,repeat:4-2,repeat:4-3,repeat:4-4,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4; degenerate,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6; degenerate,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
Q63HM2	pecanex homolog 4 (Drosophila)(PCNX4)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR007735:Pecanex,					Complete proteome,Glycoprotein,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Pecanex-like protein C14orf135,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,transmembrane region,
P45286	peptide ABC transporter permease(sapB)	Haemophilus influenzae Rd KW20				GO:0015031~protein transport,GO:0055085~transmembrane transport,	GO:0005887~integral component of plasma membrane,	GO:0022857~transmembrane transporter activity,GO:0042936~dipeptide transporter activity,	IPR000515:Binding-protein-dependent transport systems inner membrane component,	hin01503:Cationic antimicrobial peptide (CAMP) resistance,hin02010:ABC transporters,				Cell inner membrane,Cell membrane,Complete proteome,Membrane,Peptide transport,Protein transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Peptide transport system permease protein sapB,domain:ABC transmembrane type-1,transmembrane region,
P62937	peptidylprolyl isomerase A(PPIA)	Homo sapiens		h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,		GO:0000413~protein peptidyl-prolyl isomerization,GO:0006278~RNA-dependent DNA biosynthetic process,GO:0006457~protein folding,GO:0019058~viral life cycle,GO:0019061~uncoating of virus,GO:0019064~fusion of virus membrane with host plasma membrane,GO:0019068~virion assembly,GO:0019076~viral release from host cell,GO:0030260~entry into host cell,GO:0034389~lipid particle organization,GO:0045069~regulation of viral genome replication,GO:0045070~positive regulation of viral genome replication,GO:0050714~positive regulation of protein secretion,GO:0050900~leukocyte migration,GO:0075713~establishment of integrated proviral latency,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0042277~peptide binding,GO:0044822~poly(A) RNA binding,GO:0046790~virion binding,GO:0051082~unfolded protein binding,	IPR002130:Cyclophilin-like peptidyl-prolyl cis-trans isomerase domain,IPR020892:Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site,IPR024936:Cyclophilin-type peptidyl-prolyl cis-trans isomerase,			PIRSF001467:peptidyl-prolyl cis-trans isomerase,		3D-structure,Acetylation,Alternative splicing,Complete proteome,Cyclosporin,Cytoplasm,Direct protein sequencing,Glycoprotein,Host-virus interaction,Isomerase,Isopeptide bond,Phosphoprotein,Proteomics identification,Reference proteome,Rotamase,Secreted,Ubl conjugation,	chain:Peptidyl-prolyl cis-trans isomerase A,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:PPIase cyclophilin-type,helix,modified residue,mutagenesis site,sequence conflict,strand,turn,
P14222	perforin 1(PRF1)	Homo sapiens		h_caspasePathway:Caspase Cascade in Apoptosis,h_ctlPathway:CTL mediated immune response against target cells ,h_d4gdiPathway:D4-GDI Signaling Pathway,h_setPathway:Granzyme A mediated Apoptosis Pathway,		GO:0001771~immunological synapse formation,GO:0002357~defense response to tumor cell,GO:0002418~immune response to tumor cell,GO:0006915~apoptotic process,GO:0006968~cellular defense response,GO:0019835~cytolysis,GO:0051260~protein homooligomerization,GO:0051607~defense response to virus,GO:0055085~transmembrane transport,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031904~endosome lumen,GO:0044194~cytolytic granule,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0022829~wide pore channel activity,	IPR000008:C2 calcium-dependent membrane targeting,IPR020863:Membrane attack complex component/perforin domain, conserved site,IPR020864:Membrane attack complex component/perforin (MACPF) domain,	hsa04650:Natural killer cell mediated cytotoxicity,hsa04940:Type I diabetes mellitus,hsa05320:Autoimmune thyroid disease,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,hsa05416:Viral myocarditis,	603553~Hemophagocytic lymphohistiocytosis, familial, 2,605027~Lymphoma, non-Hodgkin,609135~Aplastic anemia,		SM00239:C2,SM00457:MACPF,	Calcium,Cell membrane,Complete proteome,Cytolysis,Disease mutation,Disulfide bond,EGF-like domain,Endosome,Familial hemophagocytic lymphohistiocytosis,Glycoprotein,Membrane,Metal-binding,Polymorphism,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane beta strand,	chain:Perforin-1,disulfide bond,domain:C2,domain:EGF-like,domain:MACPF,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,site:Important for oligomerization,transmembrane region,
Q6B4U9	peroxiredoxin 1(PRDX1)	Myotis lucifugus				GO:0001895~retina homeostasis,GO:0008283~cell proliferation,GO:0019430~removal of superoxide radicals,GO:0032872~regulation of stress-activated MAPK cascade,GO:0034101~erythrocyte homeostasis,GO:0042267~natural killer cell mediated cytotoxicity,GO:0042345~regulation of NF-kappaB import into nucleus,GO:0042744~hydrogen peroxide catabolic process,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0042470~melanosome,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0008379~thioredoxin peroxidase activity,GO:0044822~poly(A) RNA binding,	IPR000866:Alkyl hydroperoxide reductase subunit C/ Thiol specific antioxidant,IPR012336:Thioredoxin-like fold,IPR013766:Thioredoxin domain,IPR019479:Peroxiredoxin, C-terminal,IPR024706:Peroxiredoxin, AhpC-type,			PIRSF000239:peroxiredoxin, AhpC type,		Acetylation,Antioxidant,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Isopeptide bond,Oxidoreductase,Peroxidase,Phosphoprotein,Redox-active center,Reference proteome,Ubl conjugation,
Q5ZJF4	peroxiredoxin 6(PRDX6)	Gallus gallus			Posttranslational modification, protein turnover, chaperones,	GO:0006979~response to oxidative stress,GO:0009395~phospholipid catabolic process,GO:0016042~lipid catabolic process,GO:0045454~cell redox homeostasis,GO:0055114~oxidation-reduction process,GO:0098869~cellular oxidant detoxification,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0016020~membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0070062~extracellular exosome,	GO:0004601~peroxidase activity,GO:0004623~phospholipase A2 activity,GO:0016787~hydrolase activity,GO:0051920~peroxiredoxin activity,	IPR000866:Alkyl hydroperoxide reductase subunit C/ Thiol specific antioxidant,IPR012336:Thioredoxin-like fold,IPR013766:Thioredoxin domain,IPR019479:Peroxiredoxin, C-terminal,IPR024706:Peroxiredoxin, AhpC-type,	gga01100:Metabolic pathways,		PIRSF000239:peroxiredoxin, AhpC type,		Antioxidant,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Disulfide bond,Hydrolase,Lipid degradation,Lipid metabolism,Lysosome,Multifunctional enzyme,Oxidoreductase,Peroxidase,Phosphoprotein,Redox-active center,Reference proteome,	active site:Cysteine sulfenic acid (-SOH) intermediate,active site:For phospholipase activity,chain:Peroxiredoxin-6,disulfide bond,domain:Thioredoxin,modified residue,
Q60415	peroxisomal biogenesis factor 19(Pex19)	Cricetulus griseus				GO:0006625~protein targeting to peroxisome,GO:0007031~peroxisome organization,GO:0016557~peroxisome membrane biogenesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0016021~integral component of membrane,		IPR006708:Pex19 protein,	cge04146:Peroxisome,				Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Lipoprotein,Membrane,Methylation,Peroxisome,Peroxisome biogenesis,Phosphoprotein,Prenylation,Reference proteome,
Q98CQ1	phenylalanine--tRNA ligase subunit beta(MAFF_RS20720)	Mesorhizobium loti MAFF303099				GO:0006432~phenylalanyl-tRNA aminoacylation,GO:0008033~tRNA processing,	GO:0005737~cytoplasm,	GO:0000049~tRNA binding,GO:0000287~magnesium ion binding,GO:0004826~phenylalanine-tRNA ligase activity,GO:0005524~ATP binding,	IPR002547:tRNA-binding domain,IPR004532:Phenylalanine-tRNA ligase, class IIc, beta subunit, bacterial,IPR005121:Phenylalanine-tRNA ligase, beta subunit, ferrodoxin-fold anticodon-binding,IPR005146:B3/B4 tRNA-binding domain,IPR005147:tRNA synthetase, B5-domain,IPR009061:DNA binding domain, putative,IPR012340:Nucleic acid-binding, OB-fold,IPR020825:Phenylalanyl-tRNA synthetase, B3/B4,				SM00873:SM00873,SM00874:SM00874,SM00896:SM00896,	Aminoacyl-tRNA synthetase,ATP-binding,Complete proteome,Cytoplasm,Ligase,Magnesium,Metal-binding,Nucleotide-binding,Protein biosynthesis,Reference proteome,RNA-binding,tRNA-binding,	chain:Phenylalanyl-tRNA synthetase beta chain,domain:FDX-ACB,domain:tRNA-binding,metal ion-binding site:Magnesium,metal ion-binding site:Magnesium; via carbonyl oxygen,
Q5M9N4	phosphatidylinositol glycan anchor biosynthesis, class H(Pigh)	Mus musculus				GO:0006506~GPI anchor biosynthetic process,	GO:0000506~glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,	GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0017176~phosphatidylinositol N-acetylglucosaminyltransferase activity,	IPR019328:GPI-GlcNAc transferase complex, PIG-H component, conserved domain,	mmu00563:Glycosylphosphatidylinositol(GPI)-anchor biosynthesis,mmu01100:Metabolic pathways,				Complete proteome,Cytoplasm,Glycosyltransferase,Membrane,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Phosphatidylinositol N- acetylglucosaminyltransferase subunit H,modified residue,
Q9M149	phosphatidylinositol phosphate kinase 10(PIPK10)	Arabidopsis thaliana				GO:0046854~phosphatidylinositol phosphorylation,	GO:0005634~nucleus,	GO:0005524~ATP binding,GO:0016308~1-phosphatidylinositol-4-phosphate 5-kinase activity,	IPR002498:Phosphatidylinositol-4-phosphate 5-kinase, core,IPR023610:Phosphatidylinositol-4-phosphate 5-kinase,IPR027483:Phosphatidylinositol-4-phosphate 5-kinase, C-terminal,IPR027484:Phosphatidylinositol-4-phosphate 5-kinase, N-terminal domain,	ath00562:Inositol phosphate metabolism,ath01100:Metabolic pathways,ath04070:Phosphatidylinositol signaling system,ath04144:Endocytosis,			SM00330:PIPKc,	ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Reference proteome,Transferase,	chain:Putative phosphatidylinositol-4-phosphate 5-kinase 11,compositionally biased region:Ser-rich,domain:PIPK,region of interest:Activation loop,
Q9QYJ6	phosphodiesterase 10A(Pde10a)	Rattus norvegicus				GO:0006198~cAMP catabolic process,GO:0007165~signal transduction,GO:0010738~regulation of protein kinase A signaling,GO:0043949~regulation of cAMP-mediated signaling,GO:0046069~cGMP catabolic process,	GO:0005737~cytoplasm,GO:0016020~membrane,GO:0043025~neuronal cell body,GO:0043204~perikaryon,	GO:0004112~cyclic-nucleotide phosphodiesterase activity,GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004118~cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,GO:0008144~drug binding,GO:0030552~cAMP binding,GO:0030553~cGMP binding,GO:0046872~metal ion binding,GO:0047555~3',5'-cyclic-GMP phosphodiesterase activity,	IPR002073:3'5'-cyclic nucleotide phosphodiesterase, catalytic domain,IPR003018:GAF domain,IPR003607:HD/PDEase domain,IPR023088:3'5'-cyclic nucleotide phosphodiesterase,IPR023174:3'5'-cyclic nucleotide phosphodiesterase, conserved site,	rno00230:Purine metabolism,rno05032:Morphine addiction,			SM00065:GAF,SM00471:HDc,	3D-structure,Allosteric enzyme,Alternative splicing,cAMP,cAMP-binding,cGMP,cGMP-binding,Complete proteome,Cytoplasm,Hydrolase,Metal-binding,Nucleotide-binding,Reference proteome,Repeat,	active site:Proton donor,binding site:Allosteric effector,binding site:Substrate,chain:cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A,helix,metal ion-binding site:Divalent metal cation 1,metal ion-binding site:Divalent metal cation 2,region of interest:Allosteric effector binding,splice variant,strand,turn,
P05153	phosphoenolpyruvate carboxykinase 1 (soluble)(PCK1)	Gallus gallus				GO:0006089~lactate metabolic process,GO:0006090~pyruvate metabolic process,GO:0006094~gluconeogenesis,GO:0006111~regulation of gluconeogenesis,GO:0006475~internal protein amino acid acetylation,GO:0006522~alanine metabolic process,GO:0006531~aspartate metabolic process,GO:0006536~glutamate metabolic process,GO:0006541~glutamine metabolic process,GO:0006544~glycine metabolic process,GO:0006560~proline metabolic process,GO:0006735~NADH regeneration,GO:0007296~vitellogenesis,GO:0007568~aging,GO:0007586~digestion,GO:0008343~adult feeding behavior,GO:0009069~serine family amino acid metabolic process,GO:0009792~embryo development ending in birth or egg hatching,GO:0015701~bicarbonate transport,GO:0015743~malate transport,GO:0016042~lipid catabolic process,GO:0016310~phosphorylation,GO:0018984~naphthalenesulfonate metabolic process,GO:0018991~oviposition,GO:0019543~propionate catabolic process,GO:0019563~glycerol catabolic process,GO:0019953~sexual reproduction,GO:0030703~eggshell formation,GO:0032496~response to lipopolysaccharide,GO:0032868~response to insulin,GO:0032869~cellular response to insulin stimulus,GO:0033993~response to lipid,GO:0042149~cellular response to glucose starvation,GO:0042594~response to starvation,GO:0043950~positive regulation of cAMP-mediated signaling,GO:0045722~positive regulation of gluconeogenesis,GO:0045912~negative regulation of carbohydrate metabolic process,GO:0045913~positive regulation of carbohydrate metabolic process,GO:0046015~regulation of transcription by glucose,GO:0046327~glycerol biosynthetic process from pyruvate,GO:0046898~response to cycloheximide,GO:0048562~embryonic organ morphogenesis,GO:0048589~developmental growth,GO:0050892~intestinal absorption,GO:0051365~cellular response to potassium ion starvation,GO:0051384~response to glucocorticoid,GO:0051591~response to cAMP,GO:0060259~regulation of feeding behavior,GO:0061402~positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,GO:0070365~hepatocyte differentiation,GO:0070741~response to interleukin-6,GO:0071300~cellular response to retinoic acid,GO:0071320~cellular response to cAMP,GO:0071332~cellular response to fructose stimulus,GO:0071333~cellular response to glucose stimulus,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071361~cellular response to ethanol,GO:0071374~cellular response to parathyroid hormone stimulus,GO:0071377~cellular response to glucagon stimulus,GO:0071456~cellular response to hypoxia,GO:0071549~cellular response to dexamethasone stimulus,GO:0072071~kidney interstitial fibroblast differentiation,GO:1904640~response to methionine,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0003729~mRNA binding,GO:0004613~phosphoenolpyruvate carboxykinase (GTP) activity,GO:0005525~GTP binding,GO:0008906~inosine kinase activity,GO:0019157~malate oxidase activity,GO:0019904~protein domain specific binding,GO:0030145~manganese ion binding,GO:0031406~carboxylic acid binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0047134~protein-disulfide reductase activity,GO:0050692~DBD domain binding,GO:0051379~epinephrine binding,	IPR008209:Phosphoenolpyruvate carboxykinase, GTP-utilising,IPR008210:Phosphoenolpyruvate carboxykinase, N-terminal,IPR013035:Phosphoenolpyruvate carboxykinase, C-terminal,IPR018091:Phosphoenolpyruvate carboxykinase, GTP-utilising, conserved site,	gga00010:Glycolysis / Gluconeogenesis,gga00020:Citrate cycle (TCA cycle),gga00620:Pyruvate metabolism,gga01100:Metabolic pathways,gga01130:Biosynthesis of antibiotics,gga03320:PPAR signaling pathway,gga04068:FoxO signaling pathway,gga04910:Insulin signaling pathway,gga04920:Adipocytokine signaling pathway,gga04931:Insulin resistance,		PIRSF001348:phosphoenolpyruvate carboxykinase (GTP),		Complete proteome,Cytoplasm,Decarboxylase,Gluconeogenesis,GTP-binding,Lyase,Manganese,Metal-binding,Nucleotide-binding,Reference proteome,	binding site:GTP,binding site:Substrate,binding site:Substrate; via amide nitrogen,chain:Phosphoenolpyruvate carboxykinase, cytosolic [GTP],metal ion-binding site:Manganese,nucleotide phosphate-binding region:GTP,region of interest:Substrate binding,
P35558	phosphoenolpyruvate carboxykinase 1(PCK1)	Homo sapiens				GO:0006006~glucose metabolic process,GO:0006094~gluconeogenesis,GO:0006107~oxaloacetate metabolic process,GO:0006165~nucleoside diphosphate phosphorylation,GO:0006475~internal protein amino acid acetylation,GO:0007568~aging,GO:0014823~response to activity,GO:0032496~response to lipopolysaccharide,GO:0032868~response to insulin,GO:0032869~cellular response to insulin stimulus,GO:0042593~glucose homeostasis,GO:0046327~glycerol biosynthetic process from pyruvate,GO:0051365~cellular response to potassium ion starvation,GO:0061402~positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,GO:0070741~response to interleukin-6,GO:0071300~cellular response to retinoic acid,GO:0071320~cellular response to cAMP,GO:0071332~cellular response to fructose stimulus,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071377~cellular response to glucagon stimulus,GO:0071456~cellular response to hypoxia,GO:1904640~response to methionine,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0004550~nucleoside diphosphate kinase activity,GO:0004613~phosphoenolpyruvate carboxykinase (GTP) activity,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0030145~manganese ion binding,GO:0031406~carboxylic acid binding,	IPR008209:Phosphoenolpyruvate carboxykinase, GTP-utilising,IPR008210:Phosphoenolpyruvate carboxykinase, N-terminal,IPR013035:Phosphoenolpyruvate carboxykinase, C-terminal,IPR018091:Phosphoenolpyruvate carboxykinase, GTP-utilising, conserved site,	hsa00010:Glycolysis / Gluconeogenesis,hsa00020:Citrate cycle (TCA cycle),hsa00620:Pyruvate metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa03320:PPAR signaling pathway,hsa04068:FoxO signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04910:Insulin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04922:Glucagon signaling pathway,hsa04931:Insulin resistance,hsa04964:Proximal tubule bicarbonate reclamation,	261680~Phosphoenolpyruvate carboxykinase-1, cytosolic, deficiency,	PIRSF001348:phosphoenolpyruvate carboxykinase (GTP),		3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Decarboxylase,Gluconeogenesis,GTP-binding,Lyase,Manganese,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	binding site:GTP,binding site:Substrate,binding site:Substrate; via amide nitrogen,chain:Phosphoenolpyruvate carboxykinase, cytosolic [GTP],helix,metal ion-binding site:Manganese,nucleotide phosphate-binding region:GTP,region of interest:Substrate binding,sequence conflict,sequence variant,strand,turn,
Q9Z2V4	phosphoenolpyruvate carboxykinase 1, cytosolic(Pck1)	Mus musculus				GO:0006006~glucose metabolic process,GO:0006094~gluconeogenesis,GO:0006107~oxaloacetate metabolic process,GO:0006475~internal protein amino acid acetylation,GO:0006629~lipid metabolic process,GO:0014823~response to activity,GO:0032868~response to insulin,GO:0042593~glucose homeostasis,GO:0046327~glycerol biosynthetic process from pyruvate,GO:0051365~cellular response to potassium ion starvation,GO:0061402~positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0004550~nucleoside diphosphate kinase activity,GO:0004611~phosphoenolpyruvate carboxykinase activity,GO:0004613~phosphoenolpyruvate carboxykinase (GTP) activity,GO:0005525~GTP binding,GO:0016301~kinase activity,GO:0016829~lyase activity,GO:0016831~carboxy-lyase activity,GO:0017076~purine nucleotide binding,GO:0019003~GDP binding,GO:0030145~manganese ion binding,GO:0031406~carboxylic acid binding,GO:0046872~metal ion binding,	IPR008209:Phosphoenolpyruvate carboxykinase, GTP-utilising,IPR008210:Phosphoenolpyruvate carboxykinase, N-terminal,IPR013035:Phosphoenolpyruvate carboxykinase, C-terminal,IPR018091:Phosphoenolpyruvate carboxykinase, GTP-utilising, conserved site,	mmu00010:Glycolysis / Gluconeogenesis,mmu00020:Citrate cycle (TCA cycle),mmu00620:Pyruvate metabolism,mmu01100:Metabolic pathways,mmu01130:Biosynthesis of antibiotics,mmu03320:PPAR signaling pathway,mmu04068:FoxO signaling pathway,mmu04151:PI3K-Akt signaling pathway,mmu04152:AMPK signaling pathway,mmu04910:Insulin signaling pathway,mmu04920:Adipocytokine signaling pathway,mmu04922:Glucagon signaling pathway,mmu04931:Insulin resistance,mmu04964:Proximal tubule bicarbonate reclamation,		PIRSF001348:phosphoenolpyruvate carboxykinase (GTP),		Acetylation,Complete proteome,Cytoplasm,Decarboxylase,Gluconeogenesis,GTP-binding,Kinase,Lyase,Manganese,Metal-binding,Nucleotide-binding,Phosphoprotein,Pyruvate,Reference proteome,Transferase,Ubl conjugation,	binding site:GTP,binding site:Substrate,binding site:Substrate; via amide nitrogen,chain:Phosphoenolpyruvate carboxykinase, cytosolic [GTP],metal ion-binding site:Manganese,nucleotide phosphate-binding region:GTP,region of interest:Substrate binding,
Q5ZLN1	phosphoglycerate mutase 1 (brain)(PGAM1)	Gallus gallus				GO:0006094~gluconeogenesis,GO:0006096~glycolytic process,GO:0043456~regulation of pentose-phosphate shunt,	GO:0005829~cytosol,GO:0043209~myelin sheath,	GO:0004082~bisphosphoglycerate mutase activity,GO:0004083~bisphosphoglycerate 2-phosphatase activity,GO:0004619~phosphoglycerate mutase activity,GO:0016787~hydrolase activity,GO:0046538~2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,	IPR001345:Phosphoglycerate/bisphosphoglycerate mutase, active site,IPR005952:Phosphoglycerate mutase 1,IPR013078:Histidine phosphatase superfamily, clade-1,	gga00010:Glycolysis / Gluconeogenesis,gga00260:Glycine, serine and threonine metabolism,gga01100:Metabolic pathways,gga01130:Biosynthesis of antibiotics,gga01200:Carbon metabolism,gga01230:Biosynthesis of amino acids,			SM00855:SM00855,	Acetylation,Complete proteome,Glycolysis,Hydrolase,Isomerase,Phosphoprotein,Reference proteome,	active site:Tele-phosphohistidine intermediate,chain:Phosphoglycerate mutase 1,compositionally biased region:Poly-Pro,modified residue,site:Interaction with carboxyl group of phosphoglycerates,
Q9BZM1	phospholipase A2 group XIIA(PLA2G12A)	Homo sapiens				GO:0006654~phosphatidic acid biosynthetic process,GO:0016042~lipid catabolic process,GO:0036148~phosphatidylglycerol acyl-chain remodeling,GO:0036149~phosphatidylinositol acyl-chain remodeling,GO:0036150~phosphatidylserine acyl-chain remodeling,GO:0036151~phosphatidylcholine acyl-chain remodeling,GO:0036152~phosphatidylethanolamine acyl-chain remodeling,GO:0050482~arachidonic acid secretion,	GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,	GO:0004623~phospholipase A2 activity,GO:0005509~calcium ion binding,GO:0047498~calcium-dependent phospholipase A2 activity,	IPR010711:Phospholipase A2, group XII secretory,IPR016090:Phospholipase A2 domain,	hsa00564:Glycerophospholipid metabolism,hsa00565:Ether lipid metabolism,hsa00590:Arachidonic acid metabolism,hsa00591:Linoleic acid metabolism,hsa00592:alpha-Linolenic acid metabolism,hsa01100:Metabolic pathways,hsa04014:Ras signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04972:Pancreatic secretion,hsa04975:Fat digestion and absorption,				Calcium,Complete proteome,Cytoplasm,Hydrolase,Lipid degradation,Lipid metabolism,Metal-binding,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Group XIIA secretory phospholipase A2,metal ion-binding site:Calcium,metal ion-binding site:Calcium; via carbonyl oxygen,sequence conflict,signal peptide,
Q8NRS1	phosphopyruvate hydratase(eno)	Corynebacterium glutamicum ATCC 13032				GO:0006096~glycolytic process,	GO:0000015~phosphopyruvate hydratase complex,GO:0005576~extracellular region,GO:0009986~cell surface,	GO:0000287~magnesium ion binding,GO:0004634~phosphopyruvate hydratase activity,	IPR000941:Enolase,IPR020809:Enolase, conserved site,IPR020810:Enolase, C-terminal,IPR020811:Enolase, N-terminal,	cgl00010:Glycolysis / Gluconeogenesis,cgl00680:Methane metabolism,cgl01100:Metabolic pathways,cgl01110:Biosynthesis of secondary metabolites,cgl01120:Microbial metabolism in diverse environments,cgl01130:Biosynthesis of antibiotics,cgl01200:Carbon metabolism,cgl01230:Biosynthesis of amino acids,cgl03018:RNA degradation,		PIRSF001400:enolase,	SM01192:SM01192,SM01193:SM01193,	Complete proteome,Cytoplasm,Glycolysis,Lyase,Magnesium,Metal-binding,Reference proteome,Secreted,	active site:Proton acceptor,active site:Proton donor,binding site:Substrate,binding site:Substrate (covalent); in inhibited form,chain:Enolase,metal ion-binding site:Magnesium,modified residue,region of interest:Substrate binding,
Q0VCM4	phosphorylase, glycogen, liver(PYGL)	Bos taurus				GO:0005980~glycogen catabolic process,GO:0042593~glucose homeostasis,GO:0070266~necroptotic process,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0002060~purine nucleobase binding,GO:0005524~ATP binding,GO:0008144~drug binding,GO:0008184~glycogen phosphorylase activity,GO:0016208~AMP binding,GO:0019842~vitamin binding,GO:0030170~pyridoxal phosphate binding,GO:0032052~bile acid binding,	IPR000811:Glycosyl transferase, family 35,IPR011833:Glycogen/starch/alpha-glucan phosphorylase,	bta00500:Starch and sucrose metabolism,bta01100:Metabolic pathways,bta04910:Insulin signaling pathway,bta04922:Glucagon signaling pathway,bta04931:Insulin resistance,		PIRSF000460:glucan phosphorylase,		Acetylation,Allosteric enzyme,Carbohydrate metabolism,Complete proteome,Glycogen metabolism,Glycosyltransferase,Nucleotide-binding,Phosphoprotein,Pyridoxal phosphate,Reference proteome,Transferase,	binding site:AMP,chain:Glycogen phosphorylase, liver form,modified residue,site:Involved in the association of subunits,site:May be involved in allosteric control,
Q5RB83	phosphoserine phosphatase(PSPH)	Pongo abelii				GO:0006563~L-serine metabolic process,GO:0006564~L-serine biosynthetic process,		GO:0000287~magnesium ion binding,GO:0004647~phosphoserine phosphatase activity,GO:0005509~calcium ion binding,GO:0016791~phosphatase activity,	IPR006383:HAD-superfamily hydrolase, subfamily IB, PSPase-like,IPR023190:Phosphoserine phosphatase, domain 2,IPR023214:HAD-like domain,	pon00260:Glycine, serine and threonine metabolism,pon01100:Metabolic pathways,pon01130:Biosynthesis of antibiotics,pon01200:Carbon metabolism,pon01230:Biosynthesis of amino acids,				Acetylation,Amino-acid biosynthesis,Complete proteome,Hydrolase,Magnesium,Metal-binding,Reference proteome,Serine biosynthesis,
Q9UTL4	pig-W(gwt1)	Schizosaccharomyces pombe 972h-				GO:0006506~GPI anchor biosynthetic process,GO:0051321~meiotic cell cycle,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0032216~glucosaminyl-phosphotidylinositol O-acyltransferase activity,	IPR009447:GWT1,	spo00563:Glycosylphosphatidylinositol(GPI)-anchor biosynthesis,spo01100:Metabolic pathways,		PIRSF017321:GPI-anchored wall transfer protein 1,		Acyltransferase,Complete proteome,Endoplasmic reticulum,Glycoprotein,GPI-anchor biosynthesis,Meiosis,Membrane,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:GPI-anchored wall transfer protein 1,glycosylation site:N-linked (GlcNAc...),transmembrane region,
P19637	plasminogen activator, tissue type(Plat)	Rattus norvegicus				GO:0001666~response to hypoxia,GO:0006508~proteolysis,GO:0014909~smooth muscle cell migration,GO:0031639~plasminogen activation,GO:0035249~synaptic transmission, glutamatergic,GO:0042060~wound healing,GO:0043434~response to peptide hormone,GO:0045861~negative regulation of proteolysis,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048167~regulation of synaptic plasticity,GO:0051591~response to cAMP,GO:0060279~positive regulation of ovulation,GO:0070542~response to fatty acid,GO:0071549~cellular response to dexamethasone stimulus,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0009986~cell surface,GO:0030141~secretory granule,GO:0031012~extracellular matrix,GO:0045177~apical part of cell,GO:0045202~synapse,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,GO:0005102~receptor binding,GO:0051219~phosphoprotein binding,	IPR000001:Kringle,IPR000083:Fibronectin, type I,IPR000742:Epidermal growth factor-like domain,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR013032:EGF-like, conserved site,IPR013806:Kringle-like fold,IPR018056:Kringle, conserved site,IPR018114:Peptidase S1, trypsin family, active site,IPR026280:Tissue plasminogen activator,	rno04610:Complement and coagulation cascades,rno05202:Transcriptional misregulation in cancer,		PIRSF001145:tissue plasminogen activator,	SM00020:Tryp_SPc,SM00058:FN1,SM00130:KR,SM00181:EGF,	Cleavage on pair of basic residues,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Hydrolase,Kringle,Plasminogen activation,Protease,Reference proteome,Repeat,Secreted,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Tissue-type plasminogen activator,chain:Tissue-type plasminogen activator chain A,chain:Tissue-type plasminogen activator chain B,disulfide bond,domain:EGF-like,domain:Fibronectin type-I,domain:Kringle 1,domain:Kringle 2,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),propeptide:Removed by plasmin,region of interest:Important for binding to annexin A2,sequence conflict,signal peptide,site:Important for binding to LRP1,site:Important for single-chain activity,
P13797	plastin 3(PLS3)	Homo sapiens			Cytoskeleton,	GO:0042491~auditory receptor cell differentiation,GO:0051017~actin filament bundle assembly,GO:0051639~actin filament network formation,GO:0051764~actin crosslink formation,GO:0060348~bone development,	GO:0005737~cytoplasm,GO:0005884~actin filament,GO:0032420~stereocilium,GO:0032432~actin filament bundle,	GO:0005509~calcium ion binding,GO:0051015~actin filament binding,	IPR001589:Actinin-type, actin-binding, conserved site,IPR001715:Calponin homology domain,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,		300910~Bone mineral density QTL18, osteoporosis,		SM00033:CH,SM00054:EFh,	3D-structure,Acetylation,Actin-binding,Alternative splicing,Calcium,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Isopeptide bond,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,	calcium-binding region:1,calcium-binding region:2,chain:Plastin-3,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:Actin-binding 1,domain:Actin-binding 2,domain:CH 1,domain:CH 2,domain:CH 3,domain:CH 4,domain:EF-hand 1,domain:EF-hand 2,helix,modified residue,sequence variant,strand,turn,
Q6Q308	pleckstrin(PLEK)	Canis lupus familiaris				GO:0002244~hematopoietic progenitor cell differentiation,GO:0006904~vesicle docking involved in exocytosis,GO:0007229~integrin-mediated signaling pathway,GO:0010572~positive regulation of platelet activation,GO:0010920~negative regulation of inositol phosphate biosynthetic process,GO:0010925~positive regulation of inositol-polyphosphate 5-phosphatase activity,GO:0030836~positive regulation of actin filament depolymerization,GO:0030845~phospholipase C-inhibiting G-protein coupled receptor signaling pathway,GO:0030866~cortical actin cytoskeleton organization,GO:0031529~ruffle organization,GO:0031532~actin cytoskeleton reorganization,GO:0032233~positive regulation of actin filament bundle assembly,GO:0033625~positive regulation of integrin activation,GO:0045744~negative regulation of G-protein coupled receptor protein signaling pathway,GO:0046488~phosphatidylinositol metabolic process,GO:0060305~regulation of cell diameter,GO:0070493~thrombin receptor signaling pathway,GO:0070527~platelet aggregation,GO:0070528~protein kinase C signaling,GO:0070560~protein secretion by platelet,	GO:0005737~cytoplasm,GO:0032587~ruffle membrane,	GO:0005080~protein kinase C binding,GO:0042803~protein homodimerization activity,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,	IPR000591:DEP domain,IPR001849:Pleckstrin homology domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR011993:Pleckstrin homology-like domain,				SM00049:DEP,SM00233:PH,	Acetylation,Complete proteome,Phosphoprotein,Reference proteome,Repeat,	chain:Pleckstrin,domain:DEP,domain:PH 1,domain:PH 2,modified residue,
Q9H4B4	polo like kinase 3(PLK3)	Homo sapiens		h_plk3Pathway:Regulation of cell cycle progression by Plk3,		GO:0000082~G1/S transition of mitotic cell cycle,GO:0000086~G2/M transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000302~response to reactive oxygen species,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0006970~response to osmotic stress,GO:0006974~cellular response to DNA damage stimulus,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007093~mitotic cell cycle checkpoint,GO:0007113~endomitotic cell cycle,GO:0009314~response to radiation,GO:0031122~cytoplasmic microtubule organization,GO:0032465~regulation of cytokinesis,GO:0043066~negative regulation of apoptotic process,GO:0043491~protein kinase B signaling,GO:0044819~mitotic G1/S transition checkpoint,GO:0051302~regulation of cell division,GO:0090166~Golgi disassembly,GO:0090316~positive regulation of intracellular protein transport,GO:1901796~regulation of signal transduction by p53 class mediator,GO:2000777~positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005795~Golgi stack,GO:0005813~centrosome,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0002039~p53 binding,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR000959:POLO box duplicated domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020658:Serine/threonine-protein kinase Plk3,	hsa04068:FoxO signaling pathway,hsa05152:Tuberculosis,			SM00220:S_TKc,	3D-structure,Apoptosis,ATP-binding,Cell cycle,Complete proteome,Cytoplasm,Cytoskeleton,DNA damage,Golgi apparatus,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase PLK3,domain:POLO box 1,domain:POLO box 2,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,
Q9R012	polo-like kinase 2(Plk2)	Rattus norvegicus				GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0006468~protein phosphorylation,GO:0007052~mitotic spindle organization,GO:0007093~mitotic cell cycle checkpoint,GO:0007265~Ras protein signal transduction,GO:0007613~memory,GO:0010508~positive regulation of autophagy,GO:0018105~peptidyl-serine phosphorylation,GO:0032092~positive regulation of protein binding,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032486~Rap protein signal transduction,GO:0043066~negative regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045732~positive regulation of protein catabolic process,GO:0046599~regulation of centriole replication,GO:0048167~regulation of synaptic plasticity,GO:0060291~long-term synaptic potentiation,GO:0060292~long term synaptic depression,GO:0061000~negative regulation of dendritic spine development,	GO:0000785~chromatin,GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0030425~dendrite,	GO:0004674~protein serine/threonine kinase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0032403~protein complex binding,GO:0043008~ATP-dependent protein binding,	IPR000719:Protein kinase, catalytic domain,IPR000959:POLO box duplicated domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	rno04068:FoxO signaling pathway,			SM00220:S_TKc,	ATP-binding,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Kinase,Nucleotide-binding,Phosphoprotein,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,Tumor suppressor,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase PLK2,compositionally biased region:Poly-His,domain:POLO box 1,domain:POLO box 2,domain:Protein kinase,nucleotide phosphate-binding region:ATP,
Q5R596	poly(A) binding protein interacting protein 2(PAIP2)	Pongo abelii				GO:0006417~regulation of translation,GO:0007283~spermatogenesis,GO:0007613~memory,GO:0045947~negative regulation of translational initiation,GO:1900271~regulation of long-term synaptic potentiation,	GO:0005737~cytoplasm,	GO:0003729~mRNA binding,GO:0030371~translation repressor activity,	IPR009818:Ataxin-2, C-terminal,					Complete proteome,Cytoplasm,Reference proteome,Translation regulation,Ubl conjugation,	chain:Polyadenylate-binding protein-interacting protein 2,region of interest:PABPC1-interacting motif-1 (PAM1),region of interest:PABPC1-interacting motif-2 (PAM2),
Q7ZU92	poly(A)-specific ribonuclease (deadenylation nuclease)(parn)	Danio rerio				GO:0006402~mRNA catabolic process,GO:0030097~hemopoiesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0004535~poly(A)-specific ribonuclease activity,GO:0016787~hydrolase activity,GO:0043169~cation binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR001374:Single-stranded nucleic acid binding R3H,IPR006941:Ribonuclease CAF1,IPR012337:Ribonuclease H-like domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR014789:Poly(A)-specific ribonuclease, RNA-binding,	dre03018:RNA degradation,				Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Exonuclease,Hydrolase,Metal-binding,Nuclease,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,	chain:Poly(A)-specific ribonuclease PARN,domain:R3H,metal ion-binding site:Divalent metal cation; catalytic,modified residue,sequence conflict,site:Interaction with poly(A),splice variant,
B3DK16	polycomb group ring finger 5a(pcgf5a)	Danio rerio			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0031519~PcG protein complex,	GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,				SM00184:RING,	Complete proteome,Metal-binding,Nucleus,Reference proteome,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,
Q8QFV0	potassium channel, subfamily T, member 1(KCNT1)	Gallus gallus				GO:0071805~potassium ion transmembrane transport,	GO:0008076~voltage-gated potassium channel complex,GO:0016021~integral component of membrane,	GO:0005249~voltage-gated potassium channel activity,GO:0015269~calcium-activated potassium channel activity,	IPR003929:Potassium channel, calcium-activated, BK, alpha subunit,IPR013099:Ion transport 2,IPR016040:NAD(P)-binding domain,					3D-structure,Calcium,Cell membrane,Complete proteome,Glycoprotein,Ion channel,Ion transport,Membrane,Potassium,Potassium channel,Potassium transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Potassium channel subfamily T member 1,domain:RCK N-terminal,glycosylation site:N-linked (GlcNAc...),region of interest:Pore-forming, in membrane,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
A1JQS2	potassium-transporting ATPase subunit B(kdpB)	Yersinia enterocolitica subsp. enterocolitica 8081					GO:0005887~integral component of plasma membrane,	GO:0000287~magnesium ion binding,GO:0005524~ATP binding,GO:0008556~potassium-transporting ATPase activity,	IPR001757:Cation-transporting P-type ATPase,IPR006391:Potassium-transporting P-type ATPase, B chain, subfamily IA,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,	yen02020:Two-component system,				ATP-binding,Cell inner membrane,Cell membrane,Complete proteome,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Potassium,Potassium transport,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Potassium-transporting ATPase B chain,metal ion-binding site:Magnesium,transmembrane region,
O70460	predicted gene 2023(Gm2023)	Mus musculus				GO:0001768~establishment of T cell polarity,GO:0001771~immunological synapse formation,GO:0002407~dendritic cell chemotaxis,GO:0002408~myeloid dendritic cell chemotaxis,GO:0002548~monocyte chemotaxis,GO:0002606~positive regulation of dendritic cell antigen processing and presentation,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007257~activation of JUN kinase activity,GO:0010560~positive regulation of glycoprotein biosynthetic process,GO:0030593~neutrophil chemotaxis,GO:0031295~T cell costimulation,GO:0032735~positive regulation of interleukin-12 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0034695~response to prostaglandin E,GO:0042102~positive regulation of T cell proliferation,GO:0042346~positive regulation of NF-kappaB import into nucleus,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043547~positive regulation of GTPase activity,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0045627~positive regulation of T-helper 1 cell differentiation,GO:0045807~positive regulation of endocytosis,GO:0045860~positive regulation of protein kinase activity,GO:0046330~positive regulation of JNK cascade,GO:0048247~lymphocyte chemotaxis,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0048469~cell maturation,GO:0050718~positive regulation of interleukin-1 beta secretion,GO:0050921~positive regulation of chemotaxis,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051897~positive regulation of protein kinase B signaling,GO:0060326~cell chemotaxis,GO:0060491~regulation of cell projection assembly,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071731~response to nitric oxide,GO:0072610~interleukin-12 secretion,GO:0090023~positive regulation of neutrophil chemotaxis,GO:0097029~mature conventional dendritic cell differentiation,GO:0098586~cellular response to virus,GO:2000107~negative regulation of leukocyte apoptotic process,GO:2000147~positive regulation of cell motility,GO:2000549~positive regulation of dendritic cell dendrite assembly,	GO:0005615~extracellular space,GO:0005622~intracellular,GO:0009897~external side of plasma membrane,	GO:0008009~chemokine activity,GO:0031732~CCR7 chemokine receptor binding,GO:0031735~CCR10 chemokine receptor binding,GO:0042379~chemokine receptor binding,GO:0048020~CCR chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	mmu04060:Cytokine-cytokine receptor interaction,mmu04062:Chemokine signaling pathway,mmu04064:NF-kappa B signaling pathway,			SM00199:SCY,	Chemotaxis,Complete proteome,Cytokine,Disulfide bond,Glycoprotein,Inflammatory response,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 19,disulfide bond,glycosylation site:N-linked (GlcNAc...),signal peptide,
Q3V3I5	predicted gene 525(Gm525)	Mus musculus					GO:0005576~extracellular region,							Complete proteome,Reference proteome,Secreted,Signal,	chain:Uncharacterized protein C17orf67 homolog,signal peptide,
Q12796	proline rich nuclear receptor coactivator 1(PNRC1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,		IPR026780:Proline-rich nuclear receptor coactivator 1/2,					Activator,Alternative splicing,Complete proteome,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Proline-rich nuclear receptor coactivator 1,mutagenesis site,sequence variant,short sequence motif:Nuclear localization signal,short sequence motif:SH3-binding,
O94903	proline synthetase cotranscribed homolog (bacterial)(PROSC)	Homo sapiens					GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0070062~extracellular exosome,	GO:0030170~pyridoxal phosphate binding,	IPR001608:Alanine racemase, N-terminal,IPR011078:Uncharacterised protein family UPF0001,			PIRSF004848:pyridoxal 5'-phosphate-dependent enzyme, YBL036c type,		Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Pyridoxal phosphate,Reference proteome,	chain:Proline synthetase co-transcribed bacterial homolog protein,modified residue,sequence variant,
Q5R5B6	prolyl 4-hydroxylase subunit beta(P4HB)	Pongo abelii				GO:0006457~protein folding,GO:0018401~peptidyl-proline hydroxylation to 4-hydroxy-L-proline,GO:0034976~response to endoplasmic reticulum stress,GO:0045454~cell redox homeostasis,GO:0046598~positive regulation of viral entry into host cell,GO:0071456~cellular response to hypoxia,GO:1902175~regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0009897~external side of plasma membrane,GO:0016222~procollagen-proline 4-dioxygenase complex,GO:0034663~endoplasmic reticulum chaperone complex,GO:0042470~melanosome,GO:0070062~extracellular exosome,	GO:0003756~protein disulfide isomerase activity,GO:0004656~procollagen-proline 4-dioxygenase activity,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,	IPR005788:Disulphide isomerase,IPR005792:Protein disulphide isomerase,IPR012336:Thioredoxin-like fold,IPR013766:Thioredoxin domain,IPR017937:Thioredoxin, conserved site,	pon04141:Protein processing in endoplasmic reticulum,				Acetylation,Cell membrane,Chaperone,Complete proteome,Disulfide bond,Endoplasmic reticulum,Isomerase,Membrane,Phosphoprotein,Redox-active center,Reference proteome,Repeat,Signal,	active site:Nucleophile,chain:Protein disulfide-isomerase,compositionally biased region:Poly-Asp,disulfide bond,domain:Thioredoxin 1,domain:Thioredoxin 2,short sequence motif:Prevents secretion from ER,signal peptide,site:Contributes to redox potential value,site:Lowers pKa of C-terminal Cys of first active site,site:Lowers pKa of C-terminal Cys of second active site,
Q99MN9	propionyl Coenzyme A carboxylase, beta polypeptide(Pccb)	Mus musculus				GO:0006633~fatty acid biosynthetic process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0009317~acetyl-CoA carboxylase complex,	GO:0000166~nucleotide binding,GO:0003989~acetyl-CoA carboxylase activity,GO:0004658~propionyl-CoA carboxylase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,	IPR000022:Carboxyl transferase,IPR000438:Acetyl-CoA carboxylase carboxyl transferase, beta subunit,IPR011762:Acetyl-coenzyme A carboxyltransferase, N-terminal,IPR011763:Acetyl-coenzyme A carboxyltransferase, C-terminal,	mmu00280:Valine, leucine and isoleucine degradation,mmu00630:Glyoxylate and dicarboxylate metabolism,mmu00640:Propanoate metabolism,mmu01100:Metabolic pathways,mmu01130:Biosynthesis of antibiotics,mmu01200:Carbon metabolism,				Acetylation,ATP-binding,Complete proteome,Ligase,Mitochondrion,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transit peptide,	chain:Propionyl-CoA carboxylase beta chain, mitochondrial,domain:Carboxyltransferase,modified residue,region of interest:Acyl-CoA binding,transit peptide:Mitochondrion,
P05166	propionyl-CoA carboxylase beta subunit(PCCB)	Homo sapiens				GO:0006633~fatty acid biosynthetic process,GO:0006768~biotin metabolic process,GO:0019626~short-chain fatty acid catabolic process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0009317~acetyl-CoA carboxylase complex,	GO:0003989~acetyl-CoA carboxylase activity,GO:0004658~propionyl-CoA carboxylase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,	IPR000022:Carboxyl transferase,IPR000438:Acetyl-CoA carboxylase carboxyl transferase, beta subunit,IPR011762:Acetyl-coenzyme A carboxyltransferase, N-terminal,IPR011763:Acetyl-coenzyme A carboxyltransferase, C-terminal,	hsa00280:Valine, leucine and isoleucine degradation,hsa00630:Glyoxylate and dicarboxylate metabolism,hsa00640:Propanoate metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,	606054~Propionicacidemia,			Acetylation,Alternative splicing,ATP-binding,Complete proteome,Direct protein sequencing,Disease mutation,Ligase,Mitochondrion,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transit peptide,	chain:Propionyl-CoA carboxylase beta chain, mitochondrial,domain:Carboxyltransferase,modified residue,region of interest:Acyl-CoA binding,sequence conflict,sequence variant,transit peptide:Mitochondrion,
Q2TBR0	propionyl-CoA carboxylase beta subunit(PCCB)	Bos taurus					GO:0005759~mitochondrial matrix,	GO:0004658~propionyl-CoA carboxylase activity,GO:0005524~ATP binding,	IPR000022:Carboxyl transferase,IPR011762:Acetyl-coenzyme A carboxyltransferase, N-terminal,IPR011763:Acetyl-coenzyme A carboxyltransferase, C-terminal,	bta00280:Valine, leucine and isoleucine degradation,bta00630:Glyoxylate and dicarboxylate metabolism,bta00640:Propanoate metabolism,bta01100:Metabolic pathways,bta01130:Biosynthesis of antibiotics,bta01200:Carbon metabolism,				Acetylation,ATP-binding,Complete proteome,Ligase,Mitochondrion,Nucleotide-binding,Phosphoprotein,Reference proteome,Transit peptide,	chain:Propionyl-CoA carboxylase beta chain, mitochondrial,domain:Carboxyltransferase,modified residue,region of interest:Acyl-CoA binding,transit peptide:Mitochondrion,
Q62928	prostaglandin E receptor 2(Ptger2)	Rattus norvegicus				GO:0001501~skeletal system development,GO:0006954~inflammatory response,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0032496~response to lipopolysaccharide,GO:0032570~response to progesterone,GO:0042127~regulation of cell proliferation,GO:0071380~cellular response to prostaglandin E stimulus,	GO:0005887~integral component of plasma membrane,	GO:0004957~prostaglandin E receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR001923:Prostanoid EP2 receptor,IPR008365:Prostanoid receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	rno04024:cAMP signaling pathway,rno04080:Neuroactive ligand-receptor interaction,rno04750:Inflammatory mediator regulation of TRP channels,rno04924:Renin secretion,rno05200:Pathways in cancer,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Prostaglandin E2 receptor EP2 subtype,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P56113	protease(HP0169)	Helicobacter pylori 26695			Posttranslational modification, protein turnover, chaperones,			GO:0008233~peptidase activity,	IPR001539:Peptidase U32,	hpy05120:Epithelial cell signaling in Helicobacter pylori infection,				Complete proteome,Hydrolase,Protease,Reference proteome,Signal,	chain:Uncharacterized protease HP_0169,signal peptide,
P31579	protease(lce)	Oryzias latipes					GO:0030133~transport vesicle,	GO:0004222~metalloendopeptidase activity,GO:0008270~zinc ion binding,	IPR001506:Peptidase M12A, astacin,IPR006026:Peptidase, metallopeptidase,IPR024079:Metallopeptidase, catalytic domain,				SM00235:ZnMc,	Complete proteome,Cytoplasmic vesicle,Direct protein sequencing,Glycoprotein,Hydrolase,Metal-binding,Metalloprotease,Protease,Reference proteome,Signal,Zinc,Zymogen,	chain:Low choriolytic enzyme,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,propeptide:Activation peptide,sequence conflict,signal peptide,
Q3ZBD0	proteasome 26S subunit, non-ATPase 7(PSMD7)	Bos taurus				GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,	GO:0000502~proteasome complex,GO:0005654~nucleoplasm,GO:0005838~proteasome regulatory particle,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0042803~protein homodimerization activity,	IPR000555:JAB1/Mov34/MPN/PAD-1,IPR024969:Rpn11/EIF3F C-terminal domain,	bta03050:Proteasome,bta05169:Epstein-Barr virus infection,			SM00232:JAB_MPN,	Acetylation,Complete proteome,Isopeptide bond,Proteasome,Reference proteome,Ubl conjugation,	chain:26S proteasome non-ATPase regulatory subunit 7,compositionally biased region:Glu/Lys-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:MPN,modified residue,
P28075	proteasome subunit beta 5(Psmb5)	Rattus norvegicus				GO:0006508~proteolysis,GO:0006979~response to oxidative stress,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005839~proteasome core complex,GO:0070062~extracellular exosome,	GO:0004298~threonine-type endopeptidase activity,GO:0008233~peptidase activity,	IPR000243:Peptidase T1A, proteasome beta-subunit,IPR001353:Proteasome, subunit alpha/beta,IPR016050:Proteasome, beta-type subunit, conserved site,IPR023333:Proteasome B-type subunit,	rno03050:Proteasome,				Complete proteome,Cytoplasm,Direct protein sequencing,Hydrolase,Nucleus,Protease,Proteasome,Proteomics identification,Reference proteome,Threonine protease,Zymogen,	active site:Nucleophile,binding site:Bortezomib; via amide nitrogen,chain:Proteasome subunit beta type-5,propeptide:Removed in mature form,sequence conflict,
Q5QT17	protein LEG1 homolog(leg1)	Oncorhynchus mykiss				GO:0007275~multicellular organism development,	GO:0005576~extracellular region,		IPR008499:Protein of unknown function DUF781,					Developmental protein,Glycoprotein,Secreted,Signal,	chain:Uncharacterized protein C6orf58 homolog,glycosylation site:N-linked (GlcNAc...),signal peptide,
P61292	protein phosphatase 1 catalytic subunit beta(PPP1CB)	Sus scrofa				GO:0005977~glycogen metabolic process,GO:0006470~protein dephosphorylation,GO:0007049~cell cycle,GO:0030155~regulation of cell adhesion,GO:0032922~circadian regulation of gene expression,GO:0042752~regulation of circadian rhythm,GO:0043153~entrainment of circadian clock by photoperiod,GO:0051301~cell division,	GO:0000781~chromosome, telomeric region,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005925~focal adhesion,GO:0070062~extracellular exosome,GO:0070688~MLL5-L complex,GO:0072357~PTW/PP1 phosphatase complex,	GO:0004722~protein serine/threonine phosphatase activity,GO:0016791~phosphatase activity,GO:0017018~myosin phosphatase activity,GO:0046872~metal ion binding,GO:0050115~myosin-light-chain-phosphatase activity,	IPR004843:Metallophosphoesterase domain,IPR006186:Serine/threonine-specific protein phosphatase/bis(5-nucleosyl)-tetraphosphatase,	ssc03015:mRNA surveillance pathway,ssc04022:cGMP-PKG signaling pathway,ssc04024:cAMP signaling pathway,ssc04114:Oocyte meiosis,ssc04261:Adrenergic signaling in cardiomyocytes,ssc04270:Vascular smooth muscle contraction,ssc04390:Hippo signaling pathway,ssc04510:Focal adhesion,ssc04611:Platelet activation,ssc04720:Long-term potentiation,ssc04728:Dopaminergic synapse,ssc04750:Inflammatory mediator regulation of TRP channels,ssc04810:Regulation of actin cytoskeleton,ssc04910:Insulin signaling pathway,ssc04921:Oxytocin signaling pathway,ssc04931:Insulin resistance,ssc05031:Amphetamine addiction,ssc05034:Alcoholism,ssc05168:Herpes simplex infection,ssc05205:Proteoglycans in cancer,			SM00156:PP2Ac,	Acetylation,Biological rhythms,Carbohydrate metabolism,Cell cycle,Cell division,Complete proteome,Cytoplasm,Glycogen metabolism,Hydrolase,Manganese,Metal-binding,Nucleus,Phosphoprotein,Protein phosphatase,Proteomics identification,Reference proteome,	active site:Proton donor,chain:Serine/threonine-protein phosphatase PP1- beta catalytic subunit,metal ion-binding site:Iron,metal ion-binding site:Manganese,modified residue,
Q5SWA1	protein phosphatase 1 regulatory subunit 15B(PPP1R15B)	Homo sapiens				GO:0001933~negative regulation of protein phosphorylation,GO:0006983~ER overload response,GO:0042542~response to hydrogen peroxide,GO:0070262~peptidyl-serine dephosphorylation,GO:1903898~negative regulation of PERK-mediated unfolded protein response,GO:1903912~negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,	GO:0000164~protein phosphatase type 1 complex,	GO:0004722~protein serine/threonine phosphatase activity,	IPR019512:Protein phosphatase 1, regulatory subunit 15B, N-terminal,IPR019523:Protein phosphatase 1, regulatory subunit 15A/B, C-terminal,					3D-structure,Complete proteome,Diabetes mellitus,Disease mutation,Dwarfism,Mental retardation,Phosphoprotein,Polymorphism,Reference proteome,Translation regulation,	chain:Protein phosphatase 1 regulatory subunit 15B,sequence conflict,sequence variant,
Q9ULJ8	protein phosphatase 1 regulatory subunit 9A(PPP1R9A)	Homo sapiens				GO:0007015~actin filament organization,GO:0007568~aging,GO:0019722~calcium-mediated signaling,GO:0030833~regulation of actin filament polymerization,GO:0031175~neuron projection development,GO:0045860~positive regulation of protein kinase activity,GO:0051489~regulation of filopodium assembly,GO:0051497~negative regulation of stress fiber assembly,GO:0051823~regulation of synapse structural plasticity,GO:0051963~regulation of synapse assembly,GO:0060079~excitatory postsynaptic potential,GO:0060999~positive regulation of dendritic spine development,GO:0061001~regulation of dendritic spine morphogenesis,GO:0097237~cellular response to toxic substance,GO:1900272~negative regulation of long-term synaptic potentiation,GO:1900454~positive regulation of long term synaptic depression,GO:1904049~negative regulation of spontaneous neurotransmitter secretion,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0014069~postsynaptic density,GO:0015629~actin cytoskeleton,GO:0030054~cell junction,GO:0030175~filopodium,GO:0030425~dendrite,GO:0030864~cortical actin cytoskeleton,GO:0031594~neuromuscular junction,GO:0043025~neuronal cell body,GO:0044326~dendritic spine neck,GO:1990761~growth cone lamellipodium,	GO:0008022~protein C-terminus binding,GO:0008157~protein phosphatase 1 binding,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,GO:0042803~protein homodimerization activity,GO:0044325~ion channel binding,GO:0051015~actin filament binding,GO:0051020~GTPase binding,	IPR001478:PDZ domain,IPR001660:Sterile alpha motif domain,IPR013761:Sterile alpha motif/pointed domain,				SM00228:PDZ,SM00454:SAM,	3D-structure,Actin-binding,Alternative splicing,Cell junction,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Differentiation,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Synapse,Synaptosome,	chain:Neurabin-1,compositionally biased region:Poly-Asn,compositionally biased region:Poly-Glu,domain:PDZ,domain:SAM,helix,modified residue,region of interest:Actin-binding,region of interest:Interacts with protein phosphatase 1,region of interest:Interacts with TGN38,sequence conflict,sequence variant,splice variant,strand,
P67776	protein phosphatase 2 catalytic subunit alpha(PPP2CA)	Sus scrofa				GO:0006470~protein dephosphorylation,GO:0007498~mesoderm development,GO:0010719~negative regulation of epithelial to mesenchymal transition,GO:0051321~meiotic cell cycle,GO:0071902~positive regulation of protein serine/threonine kinase activity,	GO:0000159~protein phosphatase type 2A complex,GO:0000775~chromosome, centromeric region,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0004721~phosphoprotein phosphatase activity,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR004843:Metallophosphoesterase domain,IPR006186:Serine/threonine-specific protein phosphatase/bis(5-nucleosyl)-tetraphosphatase,	ssc03015:mRNA surveillance pathway,ssc04071:Sphingolipid signaling pathway,ssc04114:Oocyte meiosis,ssc04151:PI3K-Akt signaling pathway,ssc04152:AMPK signaling pathway,ssc04261:Adrenergic signaling in cardiomyocytes,ssc04350:TGF-beta signaling pathway,ssc04390:Hippo signaling pathway,ssc04530:Tight junction,ssc04728:Dopaminergic synapse,ssc04730:Long-term depression,ssc05142:Chagas disease (American trypanosomiasis),ssc05160:Hepatitis C,			SM00156:PP2Ac,	Centromere,Chromosome,Complete proteome,Cytoplasm,Cytoskeleton,Hydrolase,Manganese,Meiosis,Metal-binding,Methylation,Nucleus,Phosphoprotein,Protein phosphatase,Reference proteome,Ubl conjugation,	active site:Proton donor,chain:Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,metal ion-binding site:Iron,metal ion-binding site:Manganese,modified residue,
O75170	protein phosphatase 6 regulatory subunit 2(PPP6R2)	Homo sapiens					GO:0005737~cytoplasm,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,	IPR007587:SIT4 phosphatase-associated protein family,IPR016024:Armadillo-type fold,					Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Serine/threonine-protein phosphatase 6 regulatory subunit 2,compositionally biased region:Poly-Ser,modified residue,sequence conflict,sequence variant,splice variant,
Q12923	protein tyrosine phosphatase, non-receptor type 13(PTPN13)	Homo sapiens		h_fasPathway:FAS signaling pathway ( CD95 ),		GO:0006470~protein dephosphorylation,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0070830~bicellular tight junction assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0030027~lamellipodium,GO:0043005~neuron projection,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0036312~phosphatidylinositol 3-kinase regulatory subunit binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000299:FERM domain,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR001478:PDZ domain,IPR003100:Argonaute/Dicer protein, PAZ,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR011019:KIND,IPR011993:Pleckstrin homology-like domain,IPR012153:Protein-tyrosine phosphatase, non-receptor type-13,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR018979:FERM, N-terminal,IPR018980:FERM, C-terminal PH-like domain,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,			PIRSF000933:non-receptor tyrosine-protein phosphatase, type 13,	SM00194:PTPc,SM00228:PDZ,SM00295:B41,SM00404:PTPc_motif,SM00750:KIND,SM01196:SM01196,	3D-structure,Alternative splicing,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Hydrolase,Nucleus,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,Repeat,	active site:Phosphocysteine intermediate,chain:Tyrosine-protein phosphatase non-receptor type 13,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Ser,domain:FERM,domain:KIND,domain:PDZ 1,domain:PDZ 2,domain:PDZ 3,domain:PDZ 4,domain:PDZ 5,domain:Tyrosine-protein phosphatase,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
Q88W33	protein-methionine-S-oxide reductase(mrsB)	Lactobacillus plantarum WCFS1				GO:0006979~response to oxidative stress,GO:0030091~protein repair,		GO:0033743~peptide-methionine (R)-S-oxide reductase activity,	IPR002579:Peptide methionine sulphoxide reductase MrsB,IPR011057:Mss4-like,					Complete proteome,Oxidoreductase,Reference proteome,	active site:Nucleophile,chain:Peptide methionine sulfoxide reductase msrB,
P53450	proto-oncogene c-Fos-like(LOC101078177)	Takifugu rubripes				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0033555~multicellular organismal response to stress,GO:0060218~hematopoietic stem cell differentiation,	GO:0005634~nucleus,GO:0005667~transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR000837:Fos transforming protein,IPR004827:Basic-leucine zipper domain,	tru04010:MAPK signaling pathway,tru04620:Toll-like receptor signaling pathway,tru05132:Salmonella infection,tru05168:Herpes simplex infection,			SM00338:BRLZ,	Coiled coil,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proto-oncogene,Reference proteome,
Q62F61	protoheme IX farnesyltransferase(BMA3188)	Burkholderia mallei ATCC 23344				GO:0048034~heme O biosynthetic process,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0008495~protoheme IX farnesyltransferase activity,	IPR000537:UbiA prenyltransferase family,IPR006369:Protohaem IX farnesyltransferase,	bma00190:Oxidative phosphorylation,bma00860:Porphyrin and chlorophyll metabolism,bma01100:Metabolic pathways,bma01110:Biosynthesis of secondary metabolites,				Cell inner membrane,Cell membrane,Complete proteome,Heme biosynthesis,Membrane,Transferase,Transmembrane,Transmembrane helix,	chain:Protoheme IX farnesyltransferase,transmembrane region,
P55859	purine nucleoside phosphorylase(PNP)	Bos taurus				GO:0009116~nucleoside metabolic process,GO:0043101~purine-containing compound salvage,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,	GO:0004731~purine-nucleoside phosphorylase activity,	IPR000845:Nucleoside phosphorylase domain,IPR001369:PNP/MTAP phosphorylase,IPR011268:Purine nucleoside phosphorylase,IPR011270:Purine nucleoside phosphorylase I, inosine/guanosine-specific,IPR018099:Purine phosphorylase, family 2, conserved site,	bta00230:Purine metabolism,bta00240:Pyrimidine metabolism,bta00760:Nicotinate and nicotinamide metabolism,bta01100:Metabolic pathways,		PIRSF000477:purine nucleoside phosphorylase,		3D-structure,Acetylation,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Glycosyltransferase,Phosphoprotein,Reference proteome,Transferase,	chain:Purine nucleoside phosphorylase,helix,modified residue,sequence conflict,strand,turn,
Q5UQX8	putative ankyrin repeat protein(R880)	Acanthamoeba polyphaga mimivirus							IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	ANK repeat,Complete proteome,Reference proteome,Repeat,
Q8N2H3	pyridine nucleotide-disulphide oxidoreductase domain 2(PYROXD2)	Homo sapiens				GO:0055114~oxidation-reduction process,		GO:0016491~oxidoreductase activity,	IPR002937:Amine oxidase,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,					Complete proteome,FAD,Flavoprotein,Oxidoreductase,Polymorphism,Reference proteome,	chain:Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2,nucleotide phosphate-binding region:FAD,sequence variant,
Q5RE79	pyruvate dehydrogenase (lipoamide) beta(PDHB)	Pongo abelii				GO:0006006~glucose metabolic process,GO:0006086~acetyl-CoA biosynthetic process from pyruvate,GO:0006099~tricarboxylic acid cycle,	GO:0005654~nucleoplasm,GO:0005759~mitochondrial matrix,GO:0045254~pyruvate dehydrogenase complex,GO:0070062~extracellular exosome,	GO:0004738~pyruvate dehydrogenase activity,GO:0004739~pyruvate dehydrogenase (acetyl-transferring) activity,GO:0034604~pyruvate dehydrogenase (NAD+) activity,	IPR005475:Transketolase-like, pyrimidine-binding domain,IPR009014:Transketolase, C-terminal/Pyruvate-ferredoxin oxidoreductase, domain II,IPR027110:Pyruvate dehydrogenase E1 component subunit beta,	pon00010:Glycolysis / Gluconeogenesis,pon00020:Citrate cycle (TCA cycle),pon00620:Pyruvate metabolism,pon01100:Metabolic pathways,pon01130:Biosynthesis of antibiotics,pon01200:Carbon metabolism,pon04066:HIF-1 signaling pathway,pon04922:Glucagon signaling pathway,pon05230:Central carbon metabolism in cancer,			SM00861:SM00861,	Acetylation,Carbohydrate metabolism,Complete proteome,Glucose metabolism,Mitochondrion,Oxidoreductase,Phosphoprotein,Pyruvate,Reference proteome,Thiamine pyrophosphate,Transit peptide,Tricarboxylic acid cycle,	binding site:Thiamine pyrophosphate,chain:Pyruvate dehydrogenase E1 component subunit beta, mitochondrial,modified residue,transit peptide:Mitochondrion,
Q466A4	radical SAM protein(cofG)	Methanosarcina barkeri str. Fusaro				GO:0009108~coenzyme biosynthetic process,		GO:0005506~iron ion binding,GO:0044689~7,8-didemethyl-8-hydroxy-5-deazariboflavin synthase activity,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR006638:Elongator protein 3/MiaB/NifB,IPR007197:Radical SAM,IPR013785:Aldolase-type TIM barrel,IPR019939:CofG family,	mba00680:Methane metabolism,mba01120:Microbial metabolism in diverse environments,			SM00729:Elp3,	4Fe-4S,Complete proteome,Iron,Iron-sulfur,Metal-binding,Reference proteome,S-adenosyl-L-methionine,Transferase,	chain:FO synthase subunit 1,metal ion-binding site:Iron-sulfur (4Fe-4S-S-AdoMet),
A5D7J5	ras homolog family member U(RHOU)	Bos taurus				GO:0000082~G1/S transition of mitotic cell cycle,GO:0007010~cytoskeleton organization,GO:0008360~regulation of cell shape,GO:0016601~Rac protein signal transduction,GO:0030036~actin cytoskeleton organization,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0000139~Golgi membrane,GO:0002102~podosome,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0042995~cell projection,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0046872~metal ion binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Cell junction,Cell membrane,Cell projection,Complete proteome,Golgi apparatus,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Palmitate,Phosphoprotein,Reference proteome,	chain:Rho-related GTP-binding protein RhoU,lipid moiety-binding region:S-palmitoyl cysteine,nucleotide phosphate-binding region:GTP,
Q9EQT3	ras homolog family member U(Rhou)	Mus musculus				GO:0000082~G1/S transition of mitotic cell cycle,GO:0007010~cytoskeleton organization,GO:0007264~small GTPase mediated signal transduction,GO:0008360~regulation of cell shape,GO:0016601~Rac protein signal transduction,GO:0030036~actin cytoskeleton organization,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0000139~Golgi membrane,GO:0002102~podosome,GO:0005622~intracellular,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0030054~cell junction,GO:0042995~cell projection,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0046872~metal ion binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Cell junction,Cell membrane,Cell projection,Complete proteome,Golgi apparatus,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Palmitate,Phosphoprotein,Reference proteome,	chain:Rho-related GTP-binding protein RhoU,lipid moiety-binding region:S-palmitoyl cysteine,nucleotide phosphate-binding region:GTP,
Q9NS28	regulator of G-protein signaling 18(RGS18)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0009968~negative regulation of signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0005096~GTPase activator activity,	IPR016137:Regulator of G protein signalling superfamily,IPR024066:Regulator of G-protein signaling, domain 1,				SM00315:RGS,	3D-structure,Complete proteome,Cytoplasm,Phosphoprotein,Reference proteome,Signal transduction inhibitor,	chain:Regulator of G-protein signaling 18,domain:RGS,helix,sequence conflict,strand,turn,
Q0P5H5	regulator of G-protein signaling 2, 24kDa(RGS2)	Bos taurus				GO:0006417~regulation of translation,GO:0007049~cell cycle,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0009968~negative regulation of signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0005096~GTPase activator activity,	IPR016137:Regulator of G protein signalling superfamily,IPR024066:Regulator of G-protein signaling, domain 1,	bta04022:cGMP-PKG signaling pathway,bta04921:Oxytocin signaling pathway,			SM00315:RGS,	Cell cycle,Cell membrane,Complete proteome,Cytoplasm,GTPase activation,Membrane,Nucleus,Phosphoprotein,Reference proteome,Signal transduction inhibitor,Translation regulation,	chain:Regulator of G-protein signaling 2,domain:RGS,
Q6NY74	replication protein A1(rpa1)	Danio rerio				GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0007507~heart development,	GO:0005634~nucleus,GO:0005662~DNA replication factor A complex,GO:0016605~PML body,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0046872~metal ion binding,	IPR004365:Nucleic acid binding, OB-fold, tRNA/helicase-type,IPR004591:Replication factor-a protein 1 Rpa1,IPR007199:Replication factor-A protein 1, N-terminal,IPR012340:Nucleic acid-binding, OB-fold,IPR013955:Replication factor A, C-terminal,	dre03030:DNA replication,dre03420:Nucleotide excision repair,dre03430:Mismatch repair,dre03440:Homologous recombination,dre03460:Fanconi anemia pathway,				Complete proteome,DNA replication,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Zinc,Zinc-finger,	chain:Replication protein A 70 kDa DNA-binding subunit,modified residue,
Q6PR54	replication timing regulatory factor 1(Rif1)	Mus musculus				GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0019827~stem cell population maintenance,GO:2001034~positive regulation of double-strand break repair via nonhomologous end joining,	GO:0000781~chromosome, telomeric region,GO:0001939~female pronucleus,GO:0001940~male pronucleus,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,	GO:0005515~protein binding,	IPR016024:Armadillo-type fold,IPR022031:Rap1-interacting factor 1 N-terminal,	mmu04550:Signaling pathways regulating pluripotency of stem cells,				Alternative splicing,Cell cycle,Chromosome,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,DNA damage,Nucleus,Phosphoprotein,Reference proteome,Telomere,	chain:Telomere-associated protein RIF1,modified residue,region of interest:Interaction with condensed chromosomes in telophase,sequence conflict,splice variant,
Q9JK11	reticulon 4(Rtn4)	Rattus norvegicus				GO:0001525~angiogenesis,GO:0007399~nervous system development,GO:0007413~axonal fasciculation,GO:0007568~aging,GO:0010977~negative regulation of neuron projection development,GO:0014823~response to activity,GO:0021553~olfactory nerve development,GO:0021801~cerebral cortex radial glia guided migration,GO:0030308~negative regulation of cell growth,GO:0030334~regulation of cell migration,GO:0030517~negative regulation of axon extension,GO:0033603~positive regulation of dopamine secretion,GO:0045665~negative regulation of neuron differentiation,GO:0045687~positive regulation of glial cell differentiation,GO:0048709~oligodendrocyte differentiation,GO:0050771~negative regulation of axonogenesis,GO:0051292~nuclear pore complex assembly,GO:0051930~regulation of sensory perception of pain,GO:0051960~regulation of nervous system development,GO:0060317~cardiac epithelial to mesenchymal transition,GO:0070571~negative regulation of neuron projection regeneration,GO:0071786~endoplasmic reticulum tubular network organization,GO:0071787~endoplasmic reticulum tubular network assembly,GO:2000172~regulation of branching morphogenesis of a nerve,	GO:0005622~intracellular,GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043209~myelin sheath,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0044822~poly(A) RNA binding,	IPR003388:Reticulon,					Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Membrane,Neurogenesis,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Reticulon-4,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Pro,domain:Reticulon,modified residue,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
Q7ZTY4	retinoblastoma binding protein 4, like(rbb4l)	Danio rerio				GO:0006260~DNA replication,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0031101~fin regeneration,	GO:0005634~nucleus,GO:0035098~ESC/E(Z) complex,		IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,IPR022052:Histone-binding protein RBBP4,				SM00320:WD40,	Chaperone,Chromatin regulator,Complete proteome,DNA replication,Nucleus,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,WD repeat,	chain:Histone-binding protein RBBP7,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,
Q99969	retinoic acid receptor responder 2(RARRES2)	Homo sapiens				GO:0001523~retinoid metabolic process,GO:0001701~in utero embryonic development,GO:0001934~positive regulation of protein phosphorylation,GO:0002576~platelet degranulation,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0010759~positive regulation of macrophage chemotaxis,GO:0045600~positive regulation of fat cell differentiation,GO:0048566~embryonic digestive tract development,GO:0050873~brown fat cell differentiation,GO:0050921~positive regulation of chemotaxis,GO:0050994~regulation of lipid catabolic process,GO:2001275~positive regulation of glucose import in response to insulin stimulus,	GO:0005576~extracellular region,GO:0031012~extracellular matrix,GO:0031089~platelet dense granule lumen,GO:0070062~extracellular exosome,	GO:0005102~receptor binding,GO:0005515~protein binding,						Chemotaxis,Complete proteome,Differentiation,Direct protein sequencing,Disulfide bond,Inflammatory response,Proteomics identification,Receptor,Reference proteome,Secreted,Signal,	chain:Retinoic acid receptor responder protein 2,signal peptide,
Q9UL19	retinoic acid receptor responder 3(RARRES3)	Homo sapiens				GO:0006644~phospholipid metabolic process,GO:0008285~negative regulation of cell proliferation,GO:0016042~lipid catabolic process,	GO:0016021~integral component of membrane,	GO:0004623~phospholipase A2 activity,GO:0005515~protein binding,	IPR007053:LRAT-like domain,					3D-structure,Alternative splicing,Complete proteome,Hydrolase,Lipid degradation,Lipid metabolism,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Retinoic acid receptor responder protein 3,sequence conflict,sequence variant,
P50169	retinol dehydrogenase 7(Rdh7)	Rattus norvegicus				GO:0042572~retinol metabolic process,GO:0055114~oxidation-reduction process,	GO:0005783~endoplasmic reticulum,	GO:0004745~retinol dehydrogenase activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR016040:NAD(P)-binding domain,IPR020904:Short-chain dehydrogenase/reductase, conserved site,	rno00830:Retinol metabolism,rno01100:Metabolic pathways,				Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Microsome,NAD,NADP,Oxidoreductase,Reference proteome,	active site:Proton acceptor,binding site:Substrate,chain:Retinol dehydrogenase 3,chain:Retinol dehydrogenase 7,nucleotide phosphate-binding region:NADP,sequence conflict,
P20350	rhomboid(rho)	Drosophila melanogaster				GO:0000281~mitotic cytokinesis,GO:0001763~morphogenesis of a branching structure,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007409~axonogenesis,GO:0007420~brain development,GO:0007422~peripheral nervous system development,GO:0007424~open tracheal system development,GO:0007431~salivary gland development,GO:0007432~salivary gland boundary specification,GO:0007436~larval salivary gland morphogenesis,GO:0007438~oenocyte development,GO:0007474~imaginal disc-derived wing vein specification,GO:0007476~imaginal disc-derived wing morphogenesis,GO:0007479~leg disc proximal/distal pattern formation,GO:0007611~learning or memory,GO:0008355~olfactory learning,GO:0008586~imaginal disc-derived wing vein morphogenesis,GO:0010629~negative regulation of gene expression,GO:0016337~single organismal cell-cell adhesion,GO:0030707~ovarian follicle cell development,GO:0035160~maintenance of epithelial integrity, open tracheal system,GO:0035202~tracheal pit formation in open tracheal system,GO:0035225~determination of genital disc primordium,GO:0035311~wing cell fate specification,GO:0038005~peptide bond cleavage involved in epidermal growth factor receptor ligand maturation,GO:0042058~regulation of epidermal growth factor receptor signaling pathway,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0046845~branched duct epithelial cell fate determination, open tracheal system,GO:0048149~behavioral response to ethanol,GO:0048865~stem cell fate commitment,GO:0061331~epithelial cell proliferation involved in Malpighian tubule morphogenesis,	GO:0000139~Golgi membrane,GO:0005743~mitochondrial inner membrane,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0045177~apical part of cell,	GO:0004252~serine-type endopeptidase activity,	IPR002610:Peptidase S54, rhomboid,IPR017213:Peptidase S54, rhomboid, metazoan,IPR022764:Peptidase S54, rhomboid domain,			PIRSF037470:rhomboid protein,		Complete proteome,Developmental protein,Golgi apparatus,Hydrolase,Membrane,Protease,Reference proteome,Serine protease,Transmembrane,Transmembrane helix,	active site:Nucleophile,chain:Protein rhomboid,mutagenesis site,sequence conflict,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
B8XY56	ribonuclease T2(rnaset2)	Danio rerio				GO:0016075~rRNA catabolic process,	GO:0005576~extracellular region,GO:0005764~lysosome,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0043202~lysosomal lumen,	GO:0003723~RNA binding,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0016787~hydrolase activity,GO:0033897~ribonuclease T2 activity,	IPR001568:Ribonuclease T2-like,IPR018188:Ribonuclease T2, active site,					Complete proteome,Disulfide bond,Endonuclease,Endoplasmic reticulum,Glycoprotein,Hydrolase,Lysosome,Nuclease,Proteomics identification,Reference proteome,Secreted,Signal,
A5HAK0	ribonuclease like 3(rnasel3)	Danio rerio				GO:0001525~angiogenesis,GO:0002376~immune system process,GO:0007275~multicellular organism development,GO:0030154~cell differentiation,GO:0042742~defense response to bacterium,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,	GO:0005576~extracellular region,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004540~ribonuclease activity,GO:0016787~hydrolase activity,	IPR001427:Ribonuclease A,IPR023411:Ribonuclease A, active site,IPR023412:Ribonuclease A-domain,				SM00092:RNAse_Pc,	3D-structure,Angiogenesis,Antibiotic,Antimicrobial,Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Disulfide bond,Endonuclease,Hydrolase,Immunity,Nuclease,Polymorphism,Pyrrolidone carboxylic acid,Reference proteome,Secreted,Signal,
Q90YV8	ribosomal protein L10a(rpl10a)	Ictalurus punctatus				GO:0006412~translation,	GO:0015934~large ribosomal subunit,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0016787~hydrolase activity,	IPR002143:Ribosomal protein L1,IPR016094:Ribosomal protein L1, 2-layer alpha/beta-sandwich,IPR016095:Ribosomal protein L1, 3-layer alpha/beta-sandwich,IPR023673:Ribosomal protein L1, conserved site,IPR023674:Ribosomal protein L1, superfamily,			PIRSF002155:ribosomal protein, L1p/L1a/L10e/organellar L1 types,		Hydrolase,Ribonucleoprotein,Ribosomal protein,
P46742	ribosomal protein S10(rps10)	Prototheca wickerhamii				GO:0006412~translation,	GO:0005739~mitochondrion,GO:0005840~ribosome,	GO:0003735~structural constituent of ribosome,	IPR001848:Ribosomal protein S10,IPR027486:Ribosomal protein S10 domain,				SM01403:SM01403,	Mitochondrion,Ribonucleoprotein,Ribosomal protein,	chain:Ribosomal protein S10, mitochondrial,
P18660	ribosomal protein, large, P1(RPLP1)	Gallus gallus				GO:0002181~cytoplasmic translation,GO:0006414~translational elongation,GO:0032147~activation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,	GO:0005925~focal adhesion,GO:0022625~cytosolic large ribosomal subunit,GO:0030687~preribosome, large subunit precursor,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0030295~protein kinase activator activity,GO:0070180~large ribosomal subunit rRNA binding,	IPR027534:Ribosomal protein L12 family,	gga03010:Ribosome,				Complete proteome,Phosphoprotein,Reference proteome,Ribonucleoprotein,Ribosomal protein,	chain:60S acidic ribosomal protein P1,modified residue,
Q9H9V4	ring finger protein 122(RNF122)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,	GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,	GO:0008270~zinc ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,	Complete proteome,Endoplasmic reticulum,Golgi apparatus,Membrane,Metal-binding,Reference proteome,Transmembrane,Transmembrane helix,Zinc,Zinc-finger,	chain:RING finger protein 122,sequence conflict,transmembrane region,zinc finger region:RING-type; atypical,
Q7TMV1	ring finger protein 139(Rnf139)	Mus musculus			Posttranslational modification, protein turnover, chaperones,	GO:0000209~protein polyubiquitination,GO:0008285~negative regulation of cell proliferation,GO:0016567~protein ubiquitination,GO:0017148~negative regulation of translation,GO:0031396~regulation of protein ubiquitination,GO:0031648~protein destabilization,GO:0036503~ERAD pathway,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0060628~regulation of ER to Golgi vesicle-mediated transport,GO:0070613~regulation of protein processing,GO:2000060~positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0005783~endoplasmic reticulum,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0036513~Derlin-1 retrotranslocation complex,	GO:0002020~protease binding,GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0019787~ubiquitin-like protein transferase activity,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR011016:Zinc finger, RING-CH-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR025754:TRC8 N-terminal domain,				SM00184:RING,SM00744:RINGv,	Acetylation,Complete proteome,Endoplasmic reticulum,Ligase,Membrane,Metal-binding,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Transmembrane,Transmembrane helix,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:RING finger protein 139,modified residue,sequence conflict,transmembrane region,zinc finger region:RING-type; atypical,
F1LMY4	ryanodine receptor 1(Ryr1)	Rattus norvegicus				GO:0001666~response to hypoxia,GO:0003151~outflow tract morphogenesis,GO:0006816~calcium ion transport,GO:0006936~muscle contraction,GO:0014808~release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,GO:0031000~response to caffeine,GO:0043588~skin development,GO:0043931~ossification involved in bone maturation,GO:0048741~skeletal muscle fiber development,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0070296~sarcoplasmic reticulum calcium ion transport,GO:0071313~cellular response to caffeine,	GO:0005622~intracellular,GO:0005623~cell,GO:0005737~cytoplasm,GO:0005790~smooth endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016529~sarcoplasmic reticulum,GO:0030018~Z disc,GO:0030314~junctional membrane complex,GO:0030315~T-tubule,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0031674~I band,GO:0033017~sarcoplasmic reticulum membrane,GO:0034704~calcium channel complex,GO:0042383~sarcolemma,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0002020~protease binding,GO:0005219~ryanodine-sensitive calcium-release channel activity,GO:0005245~voltage-gated calcium channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0019899~enzyme binding,GO:0048763~calcium-induced calcium release activity,	IPR000699:Intracellular calcium-release channel,IPR001870:B30.2/SPRY domain,IPR002048:EF-hand domain,IPR003032:Ryanodine receptor Ryr,IPR003877:SPla/RYanodine receptor SPRY,IPR005821:Ion transport domain,IPR009460:Ryanodine Receptor TM 4-6,IPR011992:EF-hand-like domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR013333:Ryanodine receptor,IPR013662:RyR/IP3R Homology associated domain,IPR014821:Inositol 1,4,5-trisphosphate/ryanodine receptor,IPR015925:Ryanodine receptor-related,IPR016093:MIR motif,	rno04020:Calcium signaling pathway,rno04713:Circadian entrainment,rno04730:Long-term depression,rno04921:Oxytocin signaling pathway,			SM00449:SPRY,SM00472:MIR,	Calcium,Calcium channel,Calcium transport,Calmodulin-binding,Coiled coil,Complete proteome,Developmental protein,Ion channel,Ion transport,Ligand-gated ion channel,Membrane,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Repeat,S-nitrosylation,Sarcoplasmic reticulum,Transmembrane,Transmembrane helix,Transport,
Q9QX96	sal-like 2 (Drosophila)(Sall2)	Mus musculus				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001654~eye development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007165~signal transduction,GO:0021915~neural tube development,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0016581~NuRD complex,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Sal-like protein 2,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,
Q9UL12	sarcosine dehydrogenase(SARDH)	Homo sapiens			Amino acid transport and metabolism,	GO:0035999~tetrahydrofolate interconversion,GO:0042426~choline catabolic process,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0005542~folic acid binding,GO:0008480~sarcosine dehydrogenase activity,GO:0016491~oxidoreductase activity,GO:0050660~flavin adenine dinucleotide binding,	IPR006076:FAD dependent oxidoreductase,IPR006222:Glycine cleavage T-protein, N-terminal,IPR013977:Glycine cleavage T-protein, C-terminal barrel,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,IPR027266:GTP-binding protein TrmE/Glycine cleavage system T protein, domain 1,	hsa00260:Glycine, serine and threonine metabolism,hsa01100:Metabolic pathways,	268900~Sarcosinemia,			Acetylation,Alternative splicing,Complete proteome,Disease mutation,FAD,Flavoprotein,Mitochondrion,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	chain:Sarcosine dehydrogenase, mitochondrial,modified residue,sequence variant,transit peptide:Mitochondrion,
Q99LB7	sarcosine dehydrogenase(Sardh)	Mus musculus			Amino acid transport and metabolism,	GO:0035999~tetrahydrofolate interconversion,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0005542~folic acid binding,GO:0008480~sarcosine dehydrogenase activity,GO:0016491~oxidoreductase activity,GO:0050660~flavin adenine dinucleotide binding,	IPR006076:FAD dependent oxidoreductase,IPR006222:Glycine cleavage T-protein, N-terminal,IPR013977:Glycine cleavage T-protein, C-terminal barrel,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,IPR027266:GTP-binding protein TrmE/Glycine cleavage system T protein, domain 1,	mmu00260:Glycine, serine and threonine metabolism,mmu01100:Metabolic pathways,				Acetylation,Complete proteome,FAD,Flavoprotein,Mitochondrion,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Transit peptide,	chain:Sarcosine dehydrogenase, mitochondrial,modified residue,transit peptide:Mitochondrion,
Q70I47	secreted phosphoprotein 24(spp2)	Oncorhynchus mykiss				GO:0046849~bone remodeling,	GO:0005576~extracellular region,		IPR010892:Secreted phosphoprotein 24,					Disulfide bond,Phosphoprotein,Secreted,Signal,	chain:Secreted phosphoprotein 24,disulfide bond,signal peptide,
Q7ZW38	selenophosphate synthetase 1(sephs1)	Danio rerio				GO:0016310~phosphorylation,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031965~nuclear membrane,	GO:0000166~nucleotide binding,GO:0004756~selenide, water dikinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR004536:Selenide water dikinase,IPR010918:AIR synthase-related protein, C-terminal domain,IPR016188:PurM, N-terminal-like,	dre00450:Selenocompound metabolism,dre01100:Metabolic pathways,		PIRSF036407:selenophosphate synthetase,		ATP-binding,Cell membrane,Complete proteome,Kinase,Membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Selenium,Transferase,	chain:Selenide, water dikinase 1,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,site:Important for catalytic activity,
A1YIZ1	selenophosphate synthetase 2(SEPHS2)	Sus scrofa				GO:0016260~selenocysteine biosynthetic process,GO:0016310~phosphorylation,		GO:0004756~selenide, water dikinase activity,GO:0005524~ATP binding,	IPR004536:Selenide water dikinase,IPR010918:AIR synthase-related protein, C-terminal domain,IPR016188:PurM, N-terminal-like,	ssc00450:Selenocompound metabolism,ssc01100:Metabolic pathways,				Acetylation,ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Selenium,Selenocysteine,Transferase,	chain:Selenide, water dikinase 2,modified residue,nucleotide phosphate-binding region:ATP,site:Important for catalytic activity,
Q5EA85	semaphorin 4A(SEMA4A)	Bos taurus				GO:0001525~angiogenesis,GO:0001755~neural crest cell migration,GO:0002250~adaptive immune response,GO:0007409~axonogenesis,GO:0008360~regulation of cell shape,GO:0010594~regulation of endothelial cell migration,GO:0016525~negative regulation of angiogenesis,GO:0030335~positive regulation of cell migration,GO:0045063~T-helper 1 cell differentiation,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0050919~negative chemotaxis,GO:0071526~semaphorin-plexin signaling pathway,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0030215~semaphorin receptor binding,GO:0038191~neuropilin binding,GO:0045499~chemorepellent activity,	IPR001627:Semaphorin/CD100 antigen,IPR002165:Plexin,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016201:Plexin-like fold,IPR027231:Semaphorin,	bta04360:Axon guidance,			SM00423:PSI,SM00630:Sema,	Adaptive immunity,Angiogenesis,Cell membrane,Complete proteome,Developmental protein,Differentiation,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Neurogenesis,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Semaphorin-4A,disulfide bond,domain:Ig-like C2-type,domain:PSI,domain:Sema,glycosylation site:N-linked (GlcNAc...),modified residue,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P13609	serglycin(Srgn)	Mus musculus				GO:0006915~apoptotic process,GO:0008626~granzyme-mediated apoptotic signaling pathway,GO:0016485~protein processing,GO:0030502~negative regulation of bone mineralization,GO:0031214~biomineral tissue development,GO:0033364~mast cell secretory granule organization,GO:0033371~T cell secretory granule organization,GO:0033373~maintenance of protease location in mast cell secretory granule,GO:0033382~maintenance of granzyme B location in T cell secretory granule,GO:0050710~negative regulation of cytokine secretion,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005794~Golgi apparatus,GO:0042588~zymogen granule,GO:0042629~mast cell granule,	GO:0005515~protein binding,GO:0005518~collagen binding,	IPR007455:Serglycin,					Apoptosis,Biomineralization,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Golgi apparatus,Proteoglycan,Reference proteome,Repeat,Secreted,Signal,	chain:Serglycin,disulfide bond,glycosylation site:O-linked (Xyl...) (glycosaminoglycan),propeptide:Activation peptide,region of interest:10 X 2 AA tandem repeats of G-S,repeat:1,repeat:10,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,signal peptide,
Q05519	serine and arginine rich splicing factor 11(SRSF11)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0006369~termination of RNA polymerase II transcription,GO:0006397~mRNA processing,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0008380~RNA splicing,GO:0031124~mRNA 3'-end processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	Acetylation,Alternative splicing,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:Splicing factor, arginine/serine-rich 11,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Lys,domain:RRM,modified residue,region of interest:10 X 8 AA approximate repeats of R-R-S-R- S-R-S-R,repeat:1,repeat:10,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,
O43291	serine peptidase inhibitor, Kunitz type 2(SPINT2)	Homo sapiens				GO:0001843~neural tube closure,GO:0006928~movement of cell or subcellular component,GO:0007163~establishment or maintenance of cell polarity,GO:0010951~negative regulation of endopeptidase activity,GO:0022408~negative regulation of cell-cell adhesion,GO:0060672~epithelial cell morphogenesis involved in placental branching,GO:0071711~basement membrane organization,GO:0071773~cellular response to BMP stimulus,GO:2000146~negative regulation of cell motility,GO:2000178~negative regulation of neural precursor cell proliferation,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004866~endopeptidase inhibitor activity,GO:0004867~serine-type endopeptidase inhibitor activity,	IPR002223:Proteinase inhibitor I2, Kunitz metazoa,IPR020901:Proteinase inhibitor I2, Kunitz, conserved site,		270420~Diarrhea 3, secretory sodium, congenital, syndromic,		SM00131:KU,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Protease inhibitor,Proteomics identification,Reference proteome,Repeat,Serine protease inhibitor,Signal,Transmembrane,Transmembrane helix,	chain:Kunitz-type protease inhibitor 2,disulfide bond,domain:BPTI/Kunitz inhibitor 1,domain:BPTI/Kunitz inhibitor 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,site:Reactive bond,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q7SXP4	serine/arginine-rich splicing factor 1a(srsf1a)	Danio rerio				GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	dre03040:Spliceosome,dre05168:Herpes simplex infection,			SM00360:RRM,	Complete proteome,mRNA processing,mRNA splicing,Nucleus,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:Splicing factor, arginine/serine-rich 1A,chain:Splicing factor, arginine/serine-rich 1B,compositionally biased region:Arg-rich,compositionally biased region:Gly-rich,domain:RRM 1,domain:RRM 2,sequence conflict,
O94537	serine/threonine protein kinase Ppk4/ sensor for unfolded proteins in the ER (predicted)(ire1)	Schizosaccharomyces pombe 972h-			Function unknown,	GO:0006397~mRNA processing,GO:0030968~endoplasmic reticulum unfolded protein response,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0004521~endoribonuclease activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR010513:KEN domain,IPR011009:Protein kinase-like domain,IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR018391:Pyrrolo-quinoline quinone beta-propeller repeat,IPR018997:PUB domain,IPR027295:Quinonprotein alcohol dehydrogenase-like domain,	spo04141:Protein processing in endoplasmic reticulum,			SM00220:S_TKc,SM00564:PQQ,SM00580:PUG,	ATP-binding,Complete proteome,Endoplasmic reticulum,Kinase,Membrane,Nucleotide-binding,Reference proteome,Serine/threonine-protein kinase,Signal,Transferase,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase ppk4,domain:KEN,domain:Protein kinase,nucleotide phosphate-binding region:ATP,signal peptide,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
Q6J9G1	serine/threonine/tyrosine kinase 1(Styk1)	Mus musculus				GO:0006468~protein phosphorylation,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0016310~phosphorylation,GO:0016477~cell migration,GO:0030154~cell differentiation,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0042127~regulation of cell proliferation,GO:0045087~innate immune response,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005102~receptor binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,					Alternative splicing,ATP-binding,Complete proteome,Kinase,Membrane,Nucleotide-binding,Proto-oncogene,Reference proteome,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase STYK1,domain:Protein kinase,nucleotide phosphate-binding region:ATP,sequence conflict,splice variant,transmembrane region,
P50450	serpin family A member 7(SERPINA7)	Ovis aries				GO:0070327~thyroid hormone transport,	GO:0005615~extracellular space,GO:0070062~extracellular exosome,		IPR000215:Serpin family,IPR023795:Protease inhibitor I4, serpin, conserved site,IPR023796:Serpin domain,				SM00093:SERPIN,	Complete proteome,Glycoprotein,Reference proteome,Secreted,Signal,	binding site:Thyroxine,chain:Thyroxine-binding globulin,glycosylation site:N-linked (GlcNAc...),signal peptide,
P13731	serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)(SERPINH1)	Gallus gallus				GO:0003433~chondrocyte development involved in endochondral bone morphogenesis,GO:0010951~negative regulation of endopeptidase activity,GO:0030199~collagen fibril organization,GO:0032964~collagen biosynthetic process,GO:0051604~protein maturation,	GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005518~collagen binding,GO:0044822~poly(A) RNA binding,GO:0051082~unfolded protein binding,	IPR000215:Serpin family,IPR023795:Protease inhibitor I4, serpin, conserved site,IPR023796:Serpin domain,				SM00093:SERPIN,	Chaperone,Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Glycoprotein,Reference proteome,Signal,Stress response,	chain:Serpin H1,glycosylation site:N-linked (GlcNAc...),short sequence motif:Prevents secretion from ER,signal peptide,site:Reactive bond homolog,
Q5JJ64	serpin(TK_RS08920)	Thermococcus kodakarensis KOD1					GO:0005615~extracellular space,	GO:0004867~serine-type endopeptidase inhibitor activity,	IPR000215:Serpin family,IPR023795:Protease inhibitor I4, serpin, conserved site,IPR023796:Serpin domain,				SM00093:SERPIN,	Complete proteome,Protease inhibitor,Reference proteome,Serine protease inhibitor,	chain:Uncharacterized serpin-like protein TK1782,site:Reactive bond,
Q7TQA3	short chain dehydrogenase/reductase family 16C, member 5(Sdr16c5)	Mus musculus			General function prediction only,	GO:0042572~retinol metabolic process,GO:0042574~retinal metabolic process,GO:0043616~keratinocyte proliferation,GO:0055114~oxidation-reduction process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004745~retinol dehydrogenase activity,GO:0016491~oxidoreductase activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR016040:NAD(P)-binding domain,	mmu00830:Retinol metabolism,				Complete proteome,Endoplasmic reticulum,Membrane,NAD,NADP,Oxidoreductase,Reference proteome,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:Substrate,chain:Epidermal retinol dehydrogenase 2,nucleotide phosphate-binding region:NAD or NADP,transmembrane region,
Q5RII3	si:dkey-15j16.2(si:dkey-15j16.2)	Danio rerio					GO:0016020~membrane,GO:0016021~integral component of membrane,							Complete proteome,Glycoprotein,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein C6orf72 homolog,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P57473	signal recognition particle protein(ffh)	Buchnera aphidicola str. APS (Acyrthosiphon pisum)				GO:0006614~SRP-dependent cotranslational protein targeting to membrane,	GO:0048500~signal recognition particle,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0008312~7S RNA binding,	IPR000897:Signal recognition particle, SRP54 subunit, GTPase domain,IPR003593:AAA+ ATPase domain,IPR004125:Signal recognition particle, SRP54 subunit, M-domain,IPR004780:Signal recognition particle protein Ffh,IPR013822:Signal recognition particle, SRP54 subunit, helical bundle,IPR022941:Signal recognition particle, SRP54 subunit,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	buc03060:Protein export,buc03070:Bacterial secretion system,			SM00382:AAA,SM00962:SM00962,SM00963:SM00963,	Complete proteome,Cytoplasm,GTP-binding,Nucleotide-binding,Reference proteome,Ribonucleoprotein,RNA-binding,Signal recognition particle,	chain:Signal recognition particle protein,nucleotide phosphate-binding region:GTP,region of interest:G-domain,region of interest:M-domain,sequence conflict,
Q6DV79	signal transducer and activator of transcription 3 (acute-phase response factor)(STAT3)	Gallus gallus				GO:0001659~temperature homeostasis,GO:0001754~eye photoreceptor cell differentiation,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006606~protein import into nucleus,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0016310~phosphorylation,GO:0019827~stem cell population maintenance,GO:0019953~sexual reproduction,GO:0030522~intracellular receptor signaling pathway,GO:0032355~response to estradiol,GO:0033210~leptin-mediated signaling pathway,GO:0035278~miRNA mediated inhibition of translation,GO:0040014~regulation of multicellular organism growth,GO:0042593~glucose homeostasis,GO:0042755~eating behavior,GO:0043066~negative regulation of apoptotic process,GO:0045747~positive regulation of Notch signaling pathway,GO:0045820~negative regulation of glycolytic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048708~astrocyte differentiation,GO:0051726~regulation of cell cycle,GO:0060019~radial glial cell differentiation,GO:0060259~regulation of feeding behavior,GO:0060397~JAK-STAT cascade involved in growth hormone signaling pathway,GO:0070102~interleukin-6-mediated signaling pathway,GO:0097009~energy homeostasis,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1904685~positive regulation of metalloendopeptidase activity,GO:2000637~positive regulation of gene silencing by miRNA,GO:2000737~negative regulation of stem cell differentiation,GO:2001223~negative regulation of neuron migration,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0003677~DNA binding,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0008134~transcription factor binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0031490~chromatin DNA binding,GO:0042802~identical protein binding,GO:0046983~protein dimerization activity,	IPR000980:SH2 domain,IPR001217:STAT transcription factor, core,IPR008967:p53-like transcription factor, DNA-binding,IPR011992:EF-hand-like domain,IPR012345:STAT transcription factor, DNA-binding, subdomain,IPR013799:STAT transcription factor, protein interaction,IPR013800:STAT transcription factor, all-alpha,IPR013801:STAT transcription factor, DNA-binding,IPR015988:STAT transcription factor, coiled coil,	gga04068:FoxO signaling pathway,gga04630:Jak-STAT signaling pathway,gga04920:Adipocytokine signaling pathway,gga04931:Insulin resistance,			SM00964:SM00964,	Activator,Complete proteome,Cytoplasm,DNA-binding,Nucleus,Phosphoprotein,Reference proteome,SH2 domain,Transcription,Transcription regulation,	chain:Signal transducer and activator of transcription 3,domain:SH2,modified residue,sequence conflict,short sequence motif:Essential for nuclear import,
Q7ZXK3	signal transducer and activator of transcription 3 (acute-phase response factor), gene 2 L homeolog(stat3.2.L)	Xenopus laevis				GO:0001707~mesoderm formation,GO:0006351~transcription, DNA-templated,GO:0014033~neural crest cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004871~signal transducer activity,GO:0019901~protein kinase binding,GO:0043565~sequence-specific DNA binding,	IPR000980:SH2 domain,IPR001217:STAT transcription factor, core,IPR008967:p53-like transcription factor, DNA-binding,IPR011992:EF-hand-like domain,IPR012345:STAT transcription factor, DNA-binding, subdomain,IPR013799:STAT transcription factor, protein interaction,IPR013800:STAT transcription factor, all-alpha,IPR013801:STAT transcription factor, DNA-binding,IPR015988:STAT transcription factor, coiled coil,	xla04068:FoxO signaling pathway,xla04630:Jak-STAT signaling pathway,xla04920:Adipocytokine signaling pathway,xla04931:Insulin resistance,			SM00964:SM00964,	Activator,Cytoplasm,Developmental protein,DNA-binding,Nucleus,Phosphoprotein,SH2 domain,Transcription,Transcription regulation,	chain:Signal transducer and activator of transcription 3.2,domain:SH2,modified residue,short sequence motif:Essential for nuclear import,
P84101	small EDRK-rich factor 2(SERF2)	Homo sapiens					GO:0005634~nucleus,GO:0005829~cytosol,		IPR007513:Uncharacterised protein family SERF,					Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Huntingtin-interacting protein K,chain:Small EDRK-rich factor 2,compositionally biased region:Poly-Pro,modified residue,sequence variant,splice variant,
Q5SXM2	small nuclear RNA activating complex polypeptide 4(SNAPC4)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006383~transcription from RNA polymerase III promoter,GO:0009301~snRNA transcription,GO:0030154~cell differentiation,GO:0042795~snRNA transcription from RNA polymerase II promoter,GO:0042796~snRNA transcription from RNA polymerase III promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0019185~snRNA-activating protein complex,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001135~transcription factor activity, RNA polymerase II transcription factor recruiting,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR017877:Myb-like domain,IPR017930:Myb domain,				SM00717:SANT,	Coiled coil,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:snRNA-activating protein complex subunit 4,compositionally biased region:Pro-rich,DNA-binding region:H-T-H motif,domain:HTH myb-type 1,domain:HTH myb-type 2,domain:HTH myb-type 3,domain:Myb-like 1,domain:Myb-like 2,modified residue,mutagenesis site,region of interest:SNAPC2-binding,region of interest:SNAPC5-binding,sequence conflict,sequence variant,
P62314	small nuclear ribonucleoprotein D1 polypeptide(SNRPD1)	Homo sapiens		h_smPathway:Spliceosomal Assembly,		GO:0000245~spliceosomal complex assembly,GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0002230~positive regulation of defense response to virus by host,GO:0006396~RNA processing,GO:0008380~RNA splicing,GO:0051170~nuclear import,GO:0098779~mitophagy in response to mitochondrial depolarization,GO:0098792~xenophagy,	GO:0000243~commitment complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005682~U5 snRNP,GO:0005685~U1 snRNP,GO:0005686~U2 snRNP,GO:0005687~U4 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0005829~cytosol,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0030532~small nuclear ribonucleoprotein complex,GO:0034709~methylosome,GO:0034715~pICln-Sm protein complex,GO:0034719~SMN-Sm protein complex,GO:0071010~prespliceosome,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:0097526~spliceosomal tri-snRNP complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:1990446~U1 snRNP binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,IPR027141:U6 snRNA-associated Sm-like protein LSm4/Small nuclear ribonucleoprotein Sm D1/D3,	hsa03040:Spliceosome,hsa05322:Systemic lupus erythematosus,			SM00651:Sm,	3D-structure,Complete proteome,Cytoplasm,Direct protein sequencing,Methylation,mRNA processing,mRNA splicing,Nucleus,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,Spliceosome,Viral nucleoprotein,Virion,	chain:Small nuclear ribonucleoprotein Sm D1,compositionally biased region:Arg/Lys-rich (basic),helix,strand,
Q6NT16	solute carrier family 18 member B1(SLC18B1)	Homo sapiens				GO:0055085~transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0022857~transmembrane transporter activity,	IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,					Acetylation,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Uncharacterized MFS-type transporter C6orf192,sequence variant,transmembrane region,
O76082	solute carrier family 22 member 5(SLC22A5)	Homo sapiens				GO:0006814~sodium ion transport,GO:0006855~drug transmembrane transport,GO:0009437~carnitine metabolic process,GO:0015697~quaternary ammonium group transport,GO:0015879~carnitine transport,GO:0015893~drug transport,GO:0052106~quorum sensing involved in interaction with host,GO:0060731~positive regulation of intestinal epithelial structure maintenance,GO:0070715~sodium-dependent organic cation transport,GO:0098655~cation transmembrane transport,GO:1902603~carnitine transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0031526~brush border membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015226~carnitine transmembrane transporter activity,GO:0015238~drug transmembrane transporter activity,GO:0015293~symporter activity,GO:0015491~cation:cation antiporter activity,GO:0015651~quaternary ammonium group transmembrane transporter activity,GO:0022857~transmembrane transporter activity,GO:0030165~PDZ domain binding,	IPR004749:Organic cation transport protein,IPR005828:General substrate transporter,IPR005829:Sugar transporter, conserved site,IPR020846:Major facilitator superfamily domain,	hsa05231:Choline metabolism in cancer,	212140~Carnitine deficiency, systemic primary,			Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Glycoprotein,Ion transport,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 22 member 5,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P79110	solute carrier family 25 member 1(SLC25A1)	Bos taurus				GO:0006412~translation,GO:0055085~transmembrane transport,	GO:0005634~nucleus,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,	IPR002067:Mitochondrial carrier protein,IPR018108:Mitochondrial substrate/solute carrier,IPR023395:Mitochondrial carrier domain,					Complete proteome,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Reference proteome,Repeat,Transit peptide,Transmembrane,Transmembrane helix,Transport,	chain:Tricarboxylate transport protein, mitochondrial,modified residue,repeat:Solcar 1,repeat:Solcar 2,repeat:Solcar 3,transit peptide:Mitochondrion,transmembrane region,
O95847	solute carrier family 25 member 27(SLC25A27)	Homo sapiens				GO:0006091~generation of precursor metabolites and energy,GO:0006412~translation,GO:0006810~transport,GO:0008284~positive regulation of cell proliferation,GO:0010917~negative regulation of mitochondrial membrane potential,GO:0015992~proton transport,GO:0035356~cellular triglyceride homeostasis,GO:0043066~negative regulation of apoptotic process,GO:0046324~regulation of glucose import,GO:0048839~inner ear development,GO:0051562~negative regulation of mitochondrial calcium ion concentration,GO:0070997~neuron death,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0043025~neuronal cell body,GO:0045177~apical part of cell,	GO:0003735~structural constituent of ribosome,	IPR018108:Mitochondrial substrate/solute carrier,IPR023395:Mitochondrial carrier domain,					Alternative splicing,Complete proteome,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Mitochondrial uncoupling protein 4,compositionally biased region:Poly-Glu,repeat:Solcar 1,repeat:Solcar 2,repeat:Solcar 3,sequence variant,transmembrane region,
Q6DGU5	solute carrier family 25, member 46(slc25a46)	Danio rerio				GO:0000266~mitochondrial fission,GO:0006810~transport,GO:0031175~neuron projection development,GO:0061564~axon development,GO:0090149~mitochondrial membrane fission,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043005~neuron projection,		IPR018108:Mitochondrial substrate/solute carrier,IPR023395:Mitochondrial carrier domain,					Complete proteome,Membrane,Mitochondrion,Mitochondrion outer membrane,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 25 member 46,repeat:Solcar 1,repeat:Solcar 2,transmembrane region,
O14975	solute carrier family 27 member 2(SLC27A2)	Homo sapiens				GO:0001561~fatty acid alpha-oxidation,GO:0001676~long-chain fatty acid metabolic process,GO:0006635~fatty acid beta-oxidation,GO:0006699~bile acid biosynthetic process,GO:0015908~fatty acid transport,GO:0042760~very long-chain fatty acid catabolic process,GO:0044539~long-chain fatty acid import,GO:0097089~methyl-branched fatty acid metabolic process,	GO:0005739~mitochondrion,GO:0005778~peroxisomal membrane,GO:0005779~integral component of peroxisomal membrane,GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0070062~extracellular exosome,	GO:0004467~long-chain fatty acid-CoA ligase activity,GO:0005102~receptor binding,GO:0005524~ATP binding,GO:0015245~fatty acid transporter activity,GO:0019899~enzyme binding,GO:0031957~very long-chain fatty acid-CoA ligase activity,GO:0050197~phytanate-CoA ligase activity,GO:0070251~pristanate-CoA ligase activity,GO:0102391~decanoate--CoA ligase activity,	IPR000873:AMP-dependent synthetase/ligase,IPR020845:AMP-binding, conserved site,IPR025110:Domain of unknown function DUF4009,	hsa03320:PPAR signaling pathway,hsa04146:Peroxisome,hsa04931:Insulin resistance,				Acetylation,Alternative splicing,ATP-binding,Complete proteome,Endoplasmic reticulum,Fatty acid metabolism,Ligase,Lipid metabolism,Membrane,Nucleotide-binding,Peroxisome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Very long-chain acyl-CoA synthetase,modified residue,nucleotide phosphate-binding region:AMP,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
Q4R6K2	solute carrier family 30 member 1(SLC30A1)	Macaca fascicularis				GO:0006829~zinc II ion transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0008324~cation transmembrane transporter activity,	IPR002524:Cation efflux protein,IPR027469:Cation efflux protein transmembrane domain,	mcf04978:Mineral absorption,				Cell membrane,Ion transport,Membrane,Phosphoprotein,Repeat,Transmembrane,Transmembrane helix,Transport,Zinc,Zinc transport,
Q9JK41	solute carrier family 31 member 1(Slc31a1)	Rattus norvegicus				GO:0006855~drug transmembrane transport,GO:0006878~cellular copper ion homeostasis,GO:0015677~copper ion import,GO:0035434~copper ion transmembrane transport,GO:0072719~cellular response to cisplatin,GO:1902861~copper ion import into cell,	GO:0005737~cytoplasm,GO:0005770~late endosome,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0043025~neuronal cell body,GO:0055037~recycling endosome,	GO:0005375~copper ion transmembrane transporter activity,GO:0015088~copper uptake transmembrane transporter activity,	IPR007274:Ctr copper transporter,	rno04978:Mineral absorption,				Cell membrane,Complete proteome,Copper,Copper transport,Glycoprotein,Ion transport,Membrane,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:High affinity copper uptake protein 1,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (GalNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q5SPB1	solute carrier family 38, member 2(slc38a2)	Danio rerio				GO:0003333~amino acid transmembrane transport,GO:0006810~transport,GO:0006811~ion transport,GO:0006814~sodium ion transport,GO:0006865~amino acid transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0015171~amino acid transmembrane transporter activity,GO:0015293~symporter activity,	IPR013057:Amino acid transporter, transmembrane,					Amino-acid transport,Cell membrane,Complete proteome,Glycoprotein,Ion transport,Membrane,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium-coupled neutral amino acid transporter 2,glycosylation site:N-linked (GlcNAc...),region of interest:Regulates protein turnover upon amino acid deprivation,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q86UD5	solute carrier family 9 member B2(SLC9B2)	Homo sapiens				GO:0006814~sodium ion transport,GO:0034220~ion transmembrane transport,GO:1902600~hydrogen ion transmembrane transport,GO:2001206~positive regulation of osteoclast development,	GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,	GO:0005451~monovalent cation:proton antiporter activity,GO:0015299~solute:proton antiporter activity,GO:0016491~oxidoreductase activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR006153:Cation/H+ exchanger,IPR016040:NAD(P)-binding domain,IPR020904:Short-chain dehydrogenase/reductase, conserved site,					Alternative splicing,Antiport,Complete proteome,Hydrogen ion transport,Ion transport,Membrane,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Sodium,Sodium transport,Transmembrane,Transmembrane helix,Transport,	chain:Mitochondrial sodium/hydrogen exchanger NHA2,mutagenesis site,sequence variant,site:Important for cation transport,splice variant,transmembrane region,
Q91ZR2	sorting nexin 18(Snx18)	Mus musculus				GO:0000281~mitotic cytokinesis,GO:0006810~transport,GO:0006886~intracellular protein transport,GO:0006897~endocytosis,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0015031~protein transport,GO:0016050~vesicle organization,GO:0016197~endosomal transport,GO:0036089~cleavage furrow formation,GO:0043547~positive regulation of GTPase activity,GO:0051301~cell division,	GO:0005654~nucleoplasm,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0019898~extrinsic component of membrane,GO:0030136~clathrin-coated vesicle,GO:0030426~growth cone,GO:0030659~cytoplasmic vesicle membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0043025~neuronal cell body,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0008289~lipid binding,GO:0035091~phosphatidylinositol binding,	IPR001452:Src homology-3 domain,IPR001683:Phox homologous domain,IPR014536:Sorting nexin, Snx9 type,IPR019497:Sorting nexin protein, WASP-binding domain,			PIRSF027744:sorting nexin, Snx9 type,	SM00312:PX,SM00326:SH3,	Cell cycle,Cell division,Cell membrane,Complete proteome,Cytoplasmic vesicle,Endocytosis,Endosome,Lipid-binding,Membrane,Mitosis,Protein transport,Proteomics identification,Reference proteome,SH3 domain,Transport,	chain:Sorting nexin-18,domain:PX,domain:SH3,modified residue,
Q96N96	spermatogenesis associated 13(SPATA13)	Homo sapiens				GO:0016477~cell migration,GO:0030032~lamellipodium assembly,GO:0030334~regulation of cell migration,GO:0035023~regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0046847~filopodium assembly,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0032587~ruffle membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0030676~Rac guanyl-nucleotide exchange factor activity,	IPR000219:Dbl homology (DH) domain,IPR001452:Src homology-3 domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,SM00325:RhoGEF,SM00326:SH3,	Alternative splicing,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Guanine-nucleotide releasing factor,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH3 domain,	chain:Spermatogenesis-associated protein 13,compositionally biased region:Poly-Arg,domain:DH,domain:PH,domain:SH3,sequence variant,
Q8AXL1	spermidine/spermine N1-acetyltransferase 1(SAT1)	Gallus gallus			General function prediction only,	GO:0001525~angiogenesis,GO:0009447~putrescine catabolic process,GO:0032918~spermidine acetylation,GO:0032919~spermine acetylation,GO:0032920~putrescine acetylation,GO:0042127~regulation of cell proliferation,GO:0046204~nor-spermidine metabolic process,GO:0046208~spermine catabolic process,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004145~diamine N-acetyltransferase activity,GO:0019809~spermidine binding,	IPR000182:GNAT domain,IPR016181:Acyl-CoA N-acyltransferase,	gga00330:Arginine and proline metabolism,gga01100:Metabolic pathways,				Acyltransferase,Complete proteome,Cytoplasm,Reference proteome,Transferase,	binding site:Substrate,binding site:Substrate; via carbonyl oxygen,chain:Diamine acetyltransferase 1,domain:N-acetyltransferase,region of interest:Acetyl-CoA binding,region of interest:Substrate binding,
Q7PCJ8	spermidine/spermine N1-acetyltransferase family member 2(SAT2)	Bos taurus				GO:0009447~putrescine catabolic process,GO:0032918~spermidine acetylation,GO:0032919~spermine acetylation,GO:0032920~putrescine acetylation,GO:0046204~nor-spermidine metabolic process,GO:0046208~spermine catabolic process,	GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0004145~diamine N-acetyltransferase activity,GO:0019809~spermidine binding,	IPR000182:GNAT domain,IPR016181:Acyl-CoA N-acyltransferase,	bta00330:Arginine and proline metabolism,bta01100:Metabolic pathways,				Acetylation,Acyltransferase,Complete proteome,Cytoplasm,Reference proteome,Transferase,	binding site:Acetyl-CoA,binding site:Substrate,binding site:Substrate; via carbonyl oxygen,chain:Diamine acetyltransferase 2,domain:N-acetyltransferase,modified residue,region of interest:Acetyl-CoA binding,region of interest:Substrate binding,
Q7ZVF3	succinate dehydrogenase complex, subunit A, flavoprotein (Fp)(sdha)	Danio rerio				GO:0006099~tricarboxylic acid cycle,GO:0006105~succinate metabolic process,GO:0006121~mitochondrial electron transport, succinate to ubiquinone,GO:0006810~transport,GO:0009061~anaerobic respiration,GO:0022900~electron transport chain,GO:0022904~respiratory electron transport chain,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005749~mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),GO:0016020~membrane,	GO:0000104~succinate dehydrogenase activity,GO:0008177~succinate dehydrogenase (ubiquinone) activity,GO:0009055~electron carrier activity,GO:0016491~oxidoreductase activity,GO:0016627~oxidoreductase activity, acting on the CH-CH group of donors,GO:0050660~flavin adenine dinucleotide binding,	IPR003952:Fumarate reductase/succinate dehydrogenase, FAD-binding site,IPR003953:FAD binding domain,IPR011281:Succinate dehydrogenase, flavoprotein subunit,IPR014006:Succinate dehydrogenase/fumarate reductase, flavoprotein subunit,IPR015939:Fumarate reductase/succinate dehydrogenase flavoprotein-like, C-terminal,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,IPR027477:Succinate dehydrogenase/fumarate reductase flavoprotein, catalytic domain,	dre00020:Citrate cycle (TCA cycle),dre00190:Oxidative phosphorylation,dre01100:Metabolic pathways,dre01130:Biosynthesis of antibiotics,dre01200:Carbon metabolism,		PIRSF000171:succinate dehydrogenase, flavoprotein subunit (SDHA/APRA/LASPO),		Complete proteome,Electron transport,FAD,Flavoprotein,Membrane,Mitochondrion,Mitochondrion inner membrane,Oxidoreductase,Proteomics identification,Reference proteome,Transit peptide,Transport,Tricarboxylic acid cycle,	active site:Proton acceptor,binding site:Substrate,chain:Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial,modified residue,sequence conflict,transit peptide:Mitochondrion,
A5PL98	succinate dehydrogenase complex, subunit B, iron sulfur (Ip)(sdhb)	Danio rerio				GO:0006099~tricarboxylic acid cycle,GO:0006810~transport,GO:0009060~aerobic respiration,GO:0022904~respiratory electron transport chain,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005749~mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),GO:0016020~membrane,GO:0031966~mitochondrial membrane,GO:0045273~respiratory chain complex II,	GO:0000104~succinate dehydrogenase activity,GO:0008177~succinate dehydrogenase (ubiquinone) activity,GO:0009055~electron carrier activity,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,GO:0048039~ubiquinone binding,GO:0051536~iron-sulfur cluster binding,GO:0051537~2 iron, 2 sulfur cluster binding,GO:0051538~3 iron, 4 sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR001041:2Fe-2S ferredoxin-type domain,IPR004489:Succinate dehydrogenase/fumarate reductase iron-sulphur protein,IPR006058:2Fe-2S ferredoxin, iron-sulphur binding site,IPR009051:Alpha-helical ferredoxin,IPR012675:Beta-grasp domain,IPR017896:4Fe-4S ferredoxin-type, iron-sulpur binding domain,IPR017900:4Fe-4S ferredoxin, iron-sulphur binding, conserved site,IPR025192:Succinate dehydogenase/fumarate reductase N-terminal,	dre00020:Citrate cycle (TCA cycle),dre00190:Oxidative phosphorylation,dre01100:Metabolic pathways,dre01130:Biosynthesis of antibiotics,dre01200:Carbon metabolism,				2Fe-2S,3Fe-4S,4Fe-4S,Complete proteome,Electron transport,Iron,Iron-sulfur,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Oxidoreductase,Reference proteome,Transit peptide,Transport,Tricarboxylic acid cycle,	binding site:Ubiquinone; shared with DHSD,chain:Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial,domain:2Fe-2S ferredoxin-type,domain:4Fe-4S ferredoxin-type,metal ion-binding site:Iron-sulfur 1 (2Fe-2S),metal ion-binding site:Iron-sulfur 2 (4Fe-4S),metal ion-binding site:Iron-sulfur 3 (3Fe-4S),transit peptide:Mitochondrion,
Q96I99	succinate-CoA ligase GDP-forming beta subunit(SUCLG2)	Homo sapiens				GO:0006099~tricarboxylic acid cycle,GO:0006104~succinyl-CoA metabolic process,GO:0006105~succinate metabolic process,GO:0008152~metabolic process,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005815~microtubule organizing center,GO:0005886~plasma membrane,GO:0045244~succinate-CoA ligase complex (GDP-forming),	GO:0003824~catalytic activity,GO:0004776~succinate-CoA ligase (GDP-forming) activity,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0016874~ligase activity,GO:0019003~GDP binding,GO:0046982~protein heterodimerization activity,	IPR005809:Succinyl-CoA synthetase, beta subunit,IPR005811:ATP-citrate lyase/succinyl-CoA ligase,IPR013650:ATP-grasp fold, succinyl-CoA synthetase-type,IPR013815:ATP-grasp fold, subdomain 1,IPR013816:ATP-grasp fold, subdomain 2,IPR016102:Succinyl-CoA synthetase-like,IPR017866:Succinyl-CoA synthetase, beta subunit, conserved site,	hsa00020:Citrate cycle (TCA cycle),hsa00640:Propanoate metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,		PIRSF001554:succinyl-CoA synthetase, beta subunit,		Acetylation,Alternative splicing,Complete proteome,GTP-binding,Ligase,Mitochondrion,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,Tricarboxylic acid cycle,	chain:Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial,domain:ATP-grasp,modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
P53597	succinate-CoA ligase alpha subunit(SUCLG1)	Homo sapiens				GO:0006099~tricarboxylic acid cycle,GO:0006104~succinyl-CoA metabolic process,GO:0006105~succinate metabolic process,GO:0008152~metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0004775~succinate-CoA ligase (ADP-forming) activity,GO:0004776~succinate-CoA ligase (GDP-forming) activity,GO:0005525~GTP binding,GO:0016874~ligase activity,GO:0044822~poly(A) RNA binding,GO:0048037~cofactor binding,	IPR003781:CoA-binding,IPR005810:Succinyl-CoA ligase, alpha subunit,IPR005811:ATP-citrate lyase/succinyl-CoA ligase,IPR016040:NAD(P)-binding domain,IPR016102:Succinyl-CoA synthetase-like,IPR017440:ATP-citrate lyase/succinyl-CoA ligase, active site,	hsa00020:Citrate cycle (TCA cycle),hsa00640:Propanoate metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,	245400~Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria),	PIRSF001553:succinyl-CoA synthetase, alpha subunit,	SM00881:SM00881,	Acetylation,Complete proteome,Disease mutation,GTP-binding,Isopeptide bond,Ligase,Mitochondrion,Nucleotide-binding,Proteomics identification,Reference proteome,Transit peptide,Tricarboxylic acid cycle,Ubl conjugation,	active site:Tele-phosphohistidine intermediate,chain:Succinyl-CoA ligase [GDP-forming] subunit alpha, mitochondrial,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,sequence conflict,transit peptide:Mitochondrion,
Q9YGD2	succinate-CoA ligase alpha subunit(SUCLG1)	Columba livia				GO:0006099~tricarboxylic acid cycle,	GO:0005739~mitochondrion,	GO:0004775~succinate-CoA ligase (ADP-forming) activity,GO:0004776~succinate-CoA ligase (GDP-forming) activity,GO:0005525~GTP binding,GO:0048037~cofactor binding,	IPR003781:CoA-binding,IPR005810:Succinyl-CoA ligase, alpha subunit,IPR005811:ATP-citrate lyase/succinyl-CoA ligase,IPR016040:NAD(P)-binding domain,IPR016102:Succinyl-CoA synthetase-like,IPR017440:ATP-citrate lyase/succinyl-CoA ligase, active site,	clv00020:Citrate cycle (TCA cycle),clv00640:Propanoate metabolism,clv01100:Metabolic pathways,clv01130:Biosynthesis of antibiotics,clv01200:Carbon metabolism,		PIRSF001553:succinyl-CoA synthetase, alpha subunit,	SM00881:SM00881,	GTP-binding,Ligase,Mitochondrion,Nucleotide-binding,Phosphoprotein,Tricarboxylic acid cycle,
Q9WUM5	succinate-CoA ligase, GDP-forming, alpha subunit(Suclg1)	Mus musculus				GO:0006099~tricarboxylic acid cycle,GO:0006104~succinyl-CoA metabolic process,GO:0006105~succinate metabolic process,GO:0008152~metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005886~plasma membrane,GO:0043234~protein complex,GO:0045244~succinate-CoA ligase complex (GDP-forming),GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003824~catalytic activity,GO:0004775~succinate-CoA ligase (ADP-forming) activity,GO:0004776~succinate-CoA ligase (GDP-forming) activity,GO:0005525~GTP binding,GO:0016874~ligase activity,GO:0019003~GDP binding,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,GO:0048037~cofactor binding,	IPR003781:CoA-binding,IPR005810:Succinyl-CoA ligase, alpha subunit,IPR005811:ATP-citrate lyase/succinyl-CoA ligase,IPR016040:NAD(P)-binding domain,IPR016102:Succinyl-CoA synthetase-like,IPR017440:ATP-citrate lyase/succinyl-CoA ligase, active site,	mmu00020:Citrate cycle (TCA cycle),mmu00640:Propanoate metabolism,mmu01100:Metabolic pathways,mmu01130:Biosynthesis of antibiotics,mmu01200:Carbon metabolism,		PIRSF001553:succinyl-CoA synthetase, alpha subunit,	SM00881:SM00881,	Acetylation,Complete proteome,Direct protein sequencing,GTP-binding,Isopeptide bond,Ligase,Mitochondrion,Nucleotide-binding,Proteomics identification,Reference proteome,Transit peptide,Tricarboxylic acid cycle,Ubl conjugation,	active site:Tele-phosphohistidine intermediate,chain:Succinyl-CoA ligase [GDP-forming] subunit alpha, mitochondrial,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,sequence conflict,transit peptide:Mitochondrion,
Q7ZUS4	sulfotransferase family 1, cytosolic sulfotransferase 2(sult1st2)	Danio rerio				GO:0006584~catecholamine metabolic process,GO:0006629~lipid metabolic process,GO:0006805~xenobiotic metabolic process,GO:0008202~steroid metabolic process,GO:0008210~estrogen metabolic process,	GO:0005737~cytoplasm,	GO:0001517~N-acetylglucosamine 6-O-sulfotransferase activity,GO:0001537~N-acetylgalactosamine 4-O-sulfotransferase activity,GO:0004304~estrone sulfotransferase activity,GO:0004394~heparan sulfate 2-O-sulfotransferase activity,GO:0008146~sulfotransferase activity,GO:0016232~HNK-1 sulfotransferase activity,GO:0016740~transferase activity,GO:0017095~heparan sulfate 6-O-sulfotransferase activity,GO:0018721~trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity,GO:0018722~1-phenanthrol sulfotransferase activity,GO:0018723~3-phenanthrol sulfotransferase activity,GO:0018724~4-phenanthrol sulfotransferase activity,GO:0018725~trans-3,4-dihydrodiolphenanthrene sulfotransferase activity,GO:0018726~9-phenanthrol sulfotransferase activity,GO:0018727~2-phenanthrol sulfotransferase activity,GO:0019111~phenanthrol sulfotransferase activity,GO:0034930~1-hydroxypyrene sulfotransferase activity,GO:0050694~galactose 3-O-sulfotransferase activity,GO:0050698~proteoglycan sulfotransferase activity,GO:0051922~cholesterol sulfotransferase activity,GO:0080131~hydroxyjasmonate sulfotransferase activity,	IPR000863:Sulfotransferase domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Catecholamine metabolism,Complete proteome,Cytoplasm,Lipid metabolism,Reference proteome,Steroid metabolism,Transferase,	active site:Proton acceptor,chain:Cytosolic sulfotransferase 2,nucleotide phosphate-binding region:PAPS,sequence conflict,
Q7T2V2	sulfotransferase family 1, cytosolic sulfotransferase 3(sult1st3)	Danio rerio				GO:0006584~catecholamine metabolic process,GO:0006629~lipid metabolic process,GO:0006805~xenobiotic metabolic process,GO:0008202~steroid metabolic process,	GO:0005737~cytoplasm,	GO:0001517~N-acetylglucosamine 6-O-sulfotransferase activity,GO:0001537~N-acetylgalactosamine 4-O-sulfotransferase activity,GO:0004394~heparan sulfate 2-O-sulfotransferase activity,GO:0008146~sulfotransferase activity,GO:0016232~HNK-1 sulfotransferase activity,GO:0016740~transferase activity,GO:0017095~heparan sulfate 6-O-sulfotransferase activity,GO:0018721~trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity,GO:0018722~1-phenanthrol sulfotransferase activity,GO:0018723~3-phenanthrol sulfotransferase activity,GO:0018724~4-phenanthrol sulfotransferase activity,GO:0018725~trans-3,4-dihydrodiolphenanthrene sulfotransferase activity,GO:0018726~9-phenanthrol sulfotransferase activity,GO:0018727~2-phenanthrol sulfotransferase activity,GO:0019111~phenanthrol sulfotransferase activity,GO:0034930~1-hydroxypyrene sulfotransferase activity,GO:0050694~galactose 3-O-sulfotransferase activity,GO:0050698~proteoglycan sulfotransferase activity,GO:0051922~cholesterol sulfotransferase activity,GO:0080131~hydroxyjasmonate sulfotransferase activity,	IPR000863:Sulfotransferase domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Catecholamine metabolism,Complete proteome,Cytoplasm,Lipid metabolism,Reference proteome,Steroid metabolism,Transferase,	active site:Proton acceptor,chain:Cytosolic sulfotransferase 3,nucleotide phosphate-binding region:PAPS,
O73872	superoxide dismutase 1, soluble(sod1)	Danio rerio				GO:0006801~superoxide metabolic process,GO:0009410~response to xenobiotic stimulus,GO:0010038~response to metal ion,GO:0051597~response to methylmercury,GO:0055114~oxidation-reduction process,GO:0070050~neuron cellular homeostasis,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004784~superoxide dismutase activity,GO:0005507~copper ion binding,GO:0008270~zinc ion binding,GO:0016209~antioxidant activity,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,	IPR001424:Superoxide dismutase, copper/zinc binding domain,IPR018152:Superoxide dismutase, copper/zinc, binding site,IPR024134:Superoxide dismutase (Cu/Zn) / chaperones,	dre04146:Peroxisome,				Antioxidant,Complete proteome,Copper,Cytoplasm,Disulfide bond,Lipoprotein,Metal-binding,Nucleus,Oxidoreductase,Palmitate,Reference proteome,Zinc,	chain:Superoxide dismutase [Cu-Zn],disulfide bond,metal ion-binding site:Copper; catalytic,metal ion-binding site:Zinc; structural,
Q924W7	suppression of tumorigenicity 5(St5)	Mus musculus				GO:0070374~positive regulation of ERK1 and ERK2 cascade,		GO:0005085~guanyl-nucleotide exchange factor activity,GO:0017112~Rab guanyl-nucleotide exchange factor activity,	IPR001194:DENN domain,IPR005112:dDENN domain,IPR005113:uDENN domain,				SM00799:DENN,SM00800:uDENN,SM00801:dDENN,	Alternative promoter usage,Alternative splicing,Complete proteome,Guanine-nucleotide releasing factor,Phosphoprotein,Reference proteome,	chain:Suppression of tumorigenicity 5 protein,compositionally biased region:Pro-rich,domain:dDENN,domain:DENN,domain:uDENN,modified residue,splice variant,
O15524	suppressor of cytokine signaling 1(SOCS1)	Homo sapiens	12.IL-6_type_cytok-signal-transduct,	h_ghPathway:Growth Hormone Signaling Pathway,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,		GO:0001932~regulation of protein phosphorylation,GO:0006469~negative regulation of protein kinase activity,GO:0007259~JAK-STAT cascade,GO:0010534~regulation of activation of JAK2 kinase activity,GO:0016567~protein ubiquitination,GO:0019221~cytokine-mediated signaling pathway,GO:0031100~organ regeneration,GO:0032355~response to estradiol,GO:0032496~response to lipopolysaccharide,GO:0032570~response to progesterone,GO:0040008~regulation of growth,GO:0042493~response to drug,GO:0042510~regulation of tyrosine phosphorylation of Stat1 protein,GO:0042512~negative regulation of tyrosine phosphorylation of Stat1 protein,GO:0042518~negative regulation of tyrosine phosphorylation of Stat3 protein,GO:0043434~response to peptide hormone,GO:0045444~fat cell differentiation,GO:0046426~negative regulation of JAK-STAT cascade,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0050707~regulation of cytokine secretion,GO:0060334~regulation of interferon-gamma-mediated signaling pathway,GO:0071230~cellular response to amino acid stimulus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016023~cytoplasmic, membrane-bounded vesicle,	GO:0004860~protein kinase inhibitor activity,GO:0005159~insulin-like growth factor receptor binding,GO:0005515~protein binding,GO:0019210~kinase inhibitor activity,GO:0019901~protein kinase binding,	IPR000980:SH2 domain,IPR001496:SOCS protein, C-terminal,	hsa04120:Ubiquitin mediated proteolysis,hsa04380:Osteoclast differentiation,hsa04630:Jak-STAT signaling pathway,hsa04910:Insulin signaling pathway,hsa04917:Prolactin signaling pathway,hsa04930:Type II diabetes mellitus,hsa05145:Toxoplasmosis,hsa05206:MicroRNAs in cancer,			SM00252:SH2,SM00253:SOCS,SM00969:SM00969,	Complete proteome,Cytoplasmic vesicle,Growth regulation,Nucleus,Polymorphism,Reference proteome,SH2 domain,Signal transduction inhibitor,Ubl conjugation pathway,	chain:Suppressor of cytokine signaling 1,compositionally biased region:Poly-Ser,domain:SH2,domain:SOCS box,region of interest:Extended SH2 subdomain (ESS),region of interest:Interaction with Elongin BC complex,region of interest:Kinase inhibitory region (KIR),sequence conflict,sequence variant,
Q90X67	suppressor of cytokine signaling 3(SOCS3)	Gallus gallus				GO:0001932~regulation of protein phosphorylation,GO:0006469~negative regulation of protein kinase activity,GO:0007259~JAK-STAT cascade,GO:0016567~protein ubiquitination,GO:0019221~cytokine-mediated signaling pathway,GO:0040008~regulation of growth,GO:0043066~negative regulation of apoptotic process,GO:0045597~positive regulation of cell differentiation,GO:0046426~negative regulation of JAK-STAT cascade,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0050728~negative regulation of inflammatory response,	GO:0005622~intracellular,GO:0005737~cytoplasm,	GO:0004860~protein kinase inhibitor activity,	IPR000980:SH2 domain,IPR001496:SOCS protein, C-terminal,	gga04120:Ubiquitin mediated proteolysis,gga04630:Jak-STAT signaling pathway,gga04910:Insulin signaling pathway,gga04920:Adipocytokine signaling pathway,gga04931:Insulin resistance,gga05164:Influenza A,gga05168:Herpes simplex infection,			SM00252:SH2,SM00253:SOCS,SM00969:SM00969,	Complete proteome,Growth regulation,Phosphoprotein,Reference proteome,SH2 domain,Signal transduction inhibitor,Ubl conjugation pathway,	chain:Suppressor of cytokine signaling 3,domain:SH2,domain:SOCS box,region of interest:Extended SH2 subdomain (ESS),region of interest:Kinase inhibitory region (KIR),
O88583	suppressor of cytokine signaling 3(Socs3)	Rattus norvegicus				GO:0001558~regulation of cell growth,GO:0001666~response to hypoxia,GO:0001932~regulation of protein phosphorylation,GO:0006469~negative regulation of protein kinase activity,GO:0007165~signal transduction,GO:0007259~JAK-STAT cascade,GO:0007568~aging,GO:0009408~response to heat,GO:0009617~response to bacterium,GO:0009725~response to hormone,GO:0009968~negative regulation of signal transduction,GO:0010332~response to gamma radiation,GO:0014070~response to organic cyclic compound,GO:0016567~protein ubiquitination,GO:0019221~cytokine-mediated signaling pathway,GO:0031100~organ regeneration,GO:0032094~response to food,GO:0032355~response to estradiol,GO:0032496~response to lipopolysaccharide,GO:0032570~response to progesterone,GO:0032868~response to insulin,GO:0034097~response to cytokine,GO:0035556~intracellular signal transduction,GO:0042493~response to drug,GO:0043066~negative regulation of apoptotic process,GO:0043434~response to peptide hormone,GO:0045595~regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0046426~negative regulation of JAK-STAT cascade,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0050728~negative regulation of inflammatory response,GO:0051384~response to glucocorticoid,GO:0060670~branching involved in labyrinthine layer morphogenesis,GO:0060674~placenta blood vessel development,GO:0060707~trophoblast giant cell differentiation,GO:0060708~spongiotrophoblast differentiation,	GO:0005622~intracellular,GO:0005737~cytoplasm,	GO:0004860~protein kinase inhibitor activity,	IPR000980:SH2 domain,IPR001496:SOCS protein, C-terminal,	rno04120:Ubiquitin mediated proteolysis,rno04380:Osteoclast differentiation,rno04630:Jak-STAT signaling pathway,rno04668:TNF signaling pathway,rno04910:Insulin signaling pathway,rno04917:Prolactin signaling pathway,rno04920:Adipocytokine signaling pathway,rno04930:Type II diabetes mellitus,rno04931:Insulin resistance,rno04932:Non-alcoholic fatty liver disease (NAFLD),rno05160:Hepatitis C,rno05164:Influenza A,rno05168:Herpes simplex infection,			SM00252:SH2,SM00253:SOCS,SM00969:SM00969,	Complete proteome,Growth regulation,Phosphoprotein,Reference proteome,SH2 domain,Signal transduction inhibitor,Ubl conjugation pathway,	chain:Suppressor of cytokine signaling 3,domain:SH2,domain:SOCS box,region of interest:Extended SH2 subdomain (ESS),region of interest:Kinase inhibitory region (KIR),sequence conflict,
A4IFJ1	synapse differentiation inducing 1 like(SYNDIG1L)	Bos taurus				GO:0009607~response to biotic stimulus,	GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,		IPR007593:Interferon-induced transmembrane protein,					Complete proteome,Golgi apparatus,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Capucin,compositionally biased region:Poly-Glu,transmembrane region,
A0RPR6	tRNA (guanine-N(1)-)-methyltransferase(CFF8240_RS05090)	Campylobacter fetus subsp. fetus 82-40					GO:0005737~cytoplasm,	GO:0052906~tRNA (guanine(37)-N(1))-methyltransferase activity,	IPR002649:tRNA (guanine-N1-)-methyltransferase, bacteria,IPR016009:tRNA (guanine-N1-)-methyltransferase,IPR023148:tRNA (guanine-N1-)-methyltransferase, C-terminal,			PIRSF000386:tRNA-(m1G37) methyltransferase,		Complete proteome,Cytoplasm,Methyltransferase,Reference proteome,S-adenosyl-L-methionine,Transferase,tRNA processing,	binding site:S-adenosyl-L-methionine; via amide nitrogen,chain:tRNA (guanine-N(1)-)-methyltransferase,region of interest:S-adenosyl-L-methionine binding,
Q4V7E0	tRNA methyltransferase O(Trmo)	Rattus norvegicus				GO:0030488~tRNA methylation,		GO:0003723~RNA binding,GO:0016430~tRNA (adenine-N6-)-methyltransferase activity,	IPR023368:Uncharacterised protein family UPF0066, conserved site,IPR023370:Uncharacterised domain UPF0066, YaeB-like domain,					Complete proteome,Methyltransferase,Reference proteome,RNA-binding,S-adenosyl-L-methionine,Transferase,tRNA processing,	chain:Nef-associated protein 1,
Q97B59	tRNA(Ile2) 2-agmatinylcytidine synthetase(TVG_RS03160)	Thermoplasma volcanium GSS1			General function prediction only,	GO:0002101~tRNA wobble cytosine modification,	GO:0005737~cytoplasm,	GO:0005524~ATP binding,GO:0016879~ligase activity, forming carbon-nitrogen bonds,	IPR013696:Domain of unknown function DUF1743,IPR024913:tRNA(Ile2) 2-agmatinylcytidine synthetase TiaS,					ATP-binding,Complete proteome,Cytoplasm,Ligase,Nucleotide-binding,tRNA processing,
A4SHG2	tRNA/tmRNA (uracil-C(5))-methyltransferase(ASA_RS00820)	Aeromonas salmonicida subsp. salmonicida A449						GO:0030697~S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,	IPR010280:(Uracil-5)-methyltransferase,IPR011869:tRNA (uracil(54)-C(5))-methyltransferase,TrmA,  proteobacteria,					Complete proteome,Methyltransferase,S-adenosyl-L-methionine,Transferase,tRNA processing,	active site:Nucleophile,binding site:S-adenosyl-L-methionine,binding site:S-adenosyl-L-methionine; via carbonyl oxygen,chain:tRNA (uracil-5-)-methyltransferase,
P67934	tachykinin 3(TAC3)	Sus scrofa				GO:0007217~tachykinin receptor signaling pathway,GO:0007218~neuropeptide signaling pathway,	GO:0005576~extracellular region,GO:0070062~extracellular exosome,		IPR003635:Neurokinin,IPR013055:Tachykinin/Neurokinin-like, conserved site,			PIRSF001843:neurokinin B,		Amidation,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Neuropeptide,Reference proteome,Secreted,Signal,
Q6PFX9	tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase(Tnks)	Mus musculus		m_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,		GO:0000209~protein polyubiquitination,GO:0006471~protein ADP-ribosylation,GO:0006810~transport,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0015031~protein transport,GO:0016055~Wnt signaling pathway,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051028~mRNA transport,GO:0051225~spindle assembly,GO:0051301~cell division,GO:0051973~positive regulation of telomerase activity,GO:0070198~protein localization to chromosome, telomeric region,GO:0070212~protein poly-ADP-ribosylation,GO:0070213~protein auto-ADP-ribosylation,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1904355~positive regulation of telomere capping,GO:1904357~negative regulation of telomere maintenance via telomere lengthening,GO:1904743~negative regulation of telomeric DNA binding,GO:1904908~negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,	GO:0000139~Golgi membrane,GO:0000775~chromosome, centromeric region,GO:0000781~chromosome, telomeric region,GO:0000784~nuclear chromosome, telomeric region,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0016020~membrane,	GO:0003950~NAD+ ADP-ribosyltransferase activity,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0042393~histone binding,GO:0046872~metal ion binding,	IPR001660:Sterile alpha motif domain,IPR002110:Ankyrin repeat,IPR012317:Poly(ADP-ribose) polymerase, catalytic domain,IPR013761:Sterile alpha motif/pointed domain,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,SM00454:SAM,	3D-structure,ADP-ribosylation,Alternative splicing,ANK repeat,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,Cytoplasm,Cytoskeleton,Glycosyltransferase,Golgi apparatus,Membrane,Metal-binding,Mitosis,mRNA transport,NAD,Nuclear pore complex,Nucleus,Phosphoprotein,Protein transport,Reference proteome,Repeat,Telomere,Transferase,Translocation,Transport,Ubl conjugation,Wnt signaling pathway,Zinc,
Q68CZ2	tensin 3(TNS3)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0016477~cell migration,GO:0035556~intracellular signal transduction,GO:0048286~lung alveolus development,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005925~focal adhesion,	GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR000980:SH2 domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,IPR013625:Tensin phosphotyrosine-binding domain,IPR014020:Tensin phosphatase, C2 domain,IPR020454:Diacylglycerol/phorbol-ester binding,				SM00109:C1,SM00252:SH2,SM00404:PTPc_motif,SM00462:PTB,SM01326:SM01326,	Alternative splicing,Cell junction,Complete proteome,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH2 domain,Zinc,	chain:Tensin-3,compositionally biased region:Poly-Ser,domain:C2 tensin-type,domain:Phosphatase tensin-type,domain:SH2,modified residue,sequence conflict,sequence variant,splice variant,
Q99J59	tetraspanin 1(Tspan1)	Mus musculus				GO:0007166~cell surface receptor signaling pathway,GO:0008283~cell proliferation,GO:0016477~cell migration,GO:0045807~positive regulation of endocytosis,GO:0050821~protein stabilization,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031982~vesicle,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,		IPR000301:Tetraspanin,IPR008952:Tetraspanin, EC2 domain,IPR018499:Tetraspanin/Peripherin,IPR018503:Tetraspanin, conserved site,			PIRSF002419:tetraspanin,		Complete proteome,Glycoprotein,Lysosome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Tetraspanin-1,glycosylation site:N-linked (GlcNAc...),transmembrane region,
Q9CSP9	tetratricopeptide repeat domain 14(Ttc14)	Mus musculus						GO:0003676~nucleic acid binding,GO:0005515~protein binding,	IPR003029:Ribosomal protein S1, RNA-binding domain,IPR011990:Tetratricopeptide-like helical,IPR012340:Nucleic acid-binding, OB-fold,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,	Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:Tetratricopeptide repeat protein 14,compositionally biased region:Ser-rich,domain:S1 motif,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,sequence conflict,splice variant,
Q9DAC7	tetratricopeptide repeat domain 32(Ttc32)	Mus musculus							IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR013105:Tetratricopeptide TPR2,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,	Complete proteome,Reference proteome,Repeat,TPR repeat,	chain:Tetratricopeptide repeat protein 32,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,
Q5R811	thioredoxin interacting protein(TXNIP)	Pongo abelii				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006606~protein import into nucleus,GO:0006979~response to oxidative stress,GO:0007049~cell cycle,GO:0030216~keratinocyte differentiation,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0051782~negative regulation of cell division,GO:0071228~cellular response to tumor cell,	GO:0005737~cytoplasm,	GO:0004857~enzyme inhibitor activity,	IPR011021:Arrestin-like, N-terminal,IPR011022:Arrestin C-terminal-like domain,IPR014756:Immunoglobulin E-set,				SM01017:SM01017,	Cell cycle,Complete proteome,Cytoplasm,Disulfide bond,Isopeptide bond,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,Tumor suppressor,Ubl conjugation,	chain:Thioredoxin-interacting protein,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,
Q9FPH3	threonine aldolase 2(THA2)	Arabidopsis thaliana				GO:0006520~cellular amino acid metabolic process,GO:0006545~glycine biosynthetic process,GO:0006567~threonine catabolic process,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0004793~threonine aldolase activity,GO:0008732~L-allo-threonine aldolase activity,GO:0016829~lyase activity,	IPR001597:Aromatic amino acid beta-eliminating lyase/threonine aldolase,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,IPR023603:Threonine aldolase,	ath00260:Glycine, serine and threonine metabolism,ath01100:Metabolic pathways,ath01110:Biosynthesis of secondary metabolites,ath01130:Biosynthesis of antibiotics,ath01230:Biosynthesis of amino acids,		PIRSF017617:threonine aldolase,		Alternative splicing,Complete proteome,Lyase,Pyridoxal phosphate,Reference proteome,
Q62733	thymopoietin(Tmpo)	Rattus norvegicus				GO:0006355~regulation of transcription, DNA-templated,GO:0031468~nuclear envelope reassembly,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005637~nuclear inner membrane,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0005521~lamin binding,	IPR003887:LEM domain,IPR011015:LEM/LEM-like domain,IPR013146:LEM-like domain,				SM00540:LEM,SM01261:SM01261,	Acetylation,Chromosome,Complete proteome,Direct protein sequencing,DNA-binding,Membrane,Nucleus,Phosphoprotein,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Lamina-associated polypeptide 2, isoform beta,domain:LEM,domain:LEM-like,modified residue,region of interest:Binds lamins B,region of interest:Linker,region of interest:NAKAP95-binding C,region of interest:NAKAP95-binding N,region of interest:Nucleoplasmic,topological domain:Lumenal,transmembrane region,
Q569Z6	thyroid hormone receptor associated protein 3(Thrap3)	Mus musculus				GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006397~mRNA processing,GO:0007623~circadian rhythm,GO:0008380~RNA splicing,GO:0030518~intracellular steroid hormone receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0042753~positive regulation of circadian rhythm,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048026~positive regulation of mRNA splicing, via spliceosome,GO:0048255~mRNA stabilization,GO:0048511~rhythmic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016592~mediator complex,GO:0016607~nuclear speck,GO:0035145~exon-exon junction complex,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001104~RNA polymerase II transcription cofactor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0004872~receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,GO:0046966~thyroid hormone receptor binding,GO:0051219~phosphoprotein binding,	IPR018545:Btz domain,IPR026667:Thyroid hormone receptor-associated protein 3,					Acetylation,Activator,ATP-binding,Biological rhythms,Complete proteome,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Thyroid hormone receptor-associated protein 3,compositionally biased region:Arg-rich,compositionally biased region:Ser-rich,modified residue,nucleotide phosphate-binding region:ATP,
F1LP64	thyroid hormone receptor interactor 12(Trip12)	Rattus norvegicus				GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0009790~embryo development,GO:0016567~protein ubiquitination,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:1901315~negative regulation of histone H2A K63-linked ubiquitination,GO:2000780~negative regulation of double-strand break repair,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0046966~thyroid hormone receptor binding,	IPR000569:HECT,IPR004170:WWE domain,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR018123:WWE domain, subgroup,	rno04120:Ubiquitin mediated proteolysis,			SM00119:HECTc,SM00678:WWE,	Acetylation,Alternative splicing,Complete proteome,DNA damage,DNA repair,Ligase,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation pathway,
P14650	thyroid peroxidase(Tpo)	Rattus norvegicus				GO:0006590~thyroid hormone generation,GO:0006979~response to oxidative stress,GO:0033993~response to lipid,GO:0035162~embryonic hemopoiesis,GO:0042446~hormone biosynthetic process,GO:0042744~hydrogen peroxide catabolic process,GO:0055114~oxidation-reduction process,GO:0071732~cellular response to nitric oxide,GO:0098869~cellular oxidant detoxification,	GO:0005615~extracellular space,GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0004447~iodide peroxidase activity,GO:0005509~calcium ion binding,GO:0020037~heme binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000436:Sushi/SCR/CCP,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR010255:Haem peroxidase,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR019791:Haem peroxidase, animal, subgroup,	rno00350:Tyrosine metabolism,rno01100:Metabolic pathways,rno04918:Thyroid hormone synthesis,rno05320:Autoimmune thyroid disease,			SM00032:CCP,SM00179:EGF_CA,SM00181:EGF,	Calcium,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Heme,Hydrogen peroxide,Iron,Membrane,Metal-binding,Oxidoreductase,Peroxidase,Reference proteome,Signal,Sushi,Thyroid hormones biosynthesis,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:Heme (covalent; via 2 links),chain:Thyroid peroxidase,disulfide bond,domain:EGF-like; calcium-binding,domain:Sushi,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Calcium,metal ion-binding site:Calcium; via carbonyl oxygen,metal ion-binding site:Iron (heme axial ligand),sequence conflict,signal peptide,site:Transition state stabilizer,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q02445	tissue factor pathway inhibitor(Tfpi)	Rattus norvegicus				GO:0007596~blood coagulation,GO:0010951~negative regulation of endopeptidase activity,GO:0032355~response to estradiol,GO:0032496~response to lipopolysaccharide,GO:0071222~cellular response to lipopolysaccharide,GO:0071347~cellular response to interleukin-1,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0009986~cell surface,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0030414~peptidase inhibitor activity,	IPR002223:Proteinase inhibitor I2, Kunitz metazoa,IPR020901:Proteinase inhibitor I2, Kunitz, conserved site,	rno04610:Complement and coagulation cascades,			SM00131:KU,	Blood coagulation,Complete proteome,Disulfide bond,Glycoprotein,Hemostasis,Protease inhibitor,Reference proteome,Repeat,Secreted,Serine protease inhibitor,Signal,	chain:Tissue factor pathway inhibitor,disulfide bond,domain:BPTI/Kunitz inhibitor 1,domain:BPTI/Kunitz inhibitor 2,domain:BPTI/Kunitz inhibitor 3,glycosylation site:N-linked (GlcNAc...),signal peptide,site:Reactive bond,
P03012	tnpR(tnpR)	Escherichia coli K-12			DNA replication, recombination, and repair,	GO:0015074~DNA integration,		GO:0000150~recombinase activity,GO:0003677~DNA binding,	IPR006118:Recombinase, conserved site,IPR006119:Resolvase, N-terminal,IPR006120:Resolvase, HTH domain,IPR009057:Homeodomain-like,				SM00857:SM00857,	3D-structure,DNA integration,DNA recombination,DNA-binding,Plasmid,Transposable element,	active site:O-(5'-phospho-DNA)-serine intermediate,chain:Transposon gamma-delta resolvase,DNA-binding region:H-T-H motif,helix,strand,turn,
Q9ER41	torsin family 1, member B(Tor1b)	Mus musculus				GO:0007029~endoplasmic reticulum organization,GO:0051085~chaperone mediated protein folding requiring cofactor,GO:0051260~protein homooligomerization,GO:0071763~nuclear membrane organization,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0016020~membrane,GO:0031965~nuclear membrane,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,	IPR003593:AAA+ ATPase domain,IPR010448:Torsin,IPR017378:Torsin, subgroup,IPR027417:P-loop containing nucleoside triphosphate hydrolase,			PIRSF038079:torsin,	SM00382:AAA,	ATP-binding,Chaperone,Complete proteome,Endoplasmic reticulum,Glycoprotein,Hydrolase,Membrane,Nucleotide-binding,Nucleus,Proteomics identification,Reference proteome,Signal,	chain:Torsin-1B,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP,signal peptide,
Q9NZ01	trans-2,3-enoyl-CoA reductase(TECR)	Homo sapiens				GO:0006629~lipid metabolic process,GO:0030497~fatty acid elongation,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0042761~very long-chain fatty acid biosynthetic process,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,	GO:0005515~protein binding,GO:0016627~oxidoreductase activity, acting on the CH-CH group of donors,GO:0017099~very-long-chain-acyl-CoA dehydrogenase activity,	IPR001104:3-oxo-5-alpha-steroid 4-dehydrogenase, C-terminal,	hsa00062:Fatty acid elongation,hsa01040:Biosynthesis of unsaturated fatty acids,hsa01212:Fatty acid metabolism,	614020~Mental retardation, autosomal recessive 14,			3D-structure,Acetylation,Alternative splicing,Complete proteome,Disease mutation,Endoplasmic reticulum,Fatty acid biosynthesis,Fatty acid metabolism,Glycoprotein,Lipid biosynthesis,Lipid metabolism,Membrane,Mental retardation,NADP,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Trans-2,3-enoyl-CoA reductase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,splice variant,strand,transmembrane region,turn,
P02786	transferrin receptor(TFRC)	Homo sapiens	104.Insulin_signaling,106.Glycogen_synthase-synthesis,108.Regulating_glucose_transport,	h_eea1Pathway:The role of FYVE-finger proteins in vesicle transport,		GO:0001558~regulation of cell growth,GO:0001666~response to hypoxia,GO:0006879~cellular iron ion homeostasis,GO:0006953~acute-phase response,GO:0007568~aging,GO:0007584~response to nutrient,GO:0010039~response to iron ion,GO:0010042~response to manganese ion,GO:0030316~osteoclast differentiation,GO:0030890~positive regulation of B cell proliferation,GO:0031623~receptor internalization,GO:0032526~response to retinoic acid,GO:0033572~transferrin transport,GO:0035690~cellular response to drug,GO:0042102~positive regulation of T cell proliferation,GO:0042127~regulation of cell proliferation,GO:0045780~positive regulation of bone resorption,GO:0045830~positive regulation of isotype switching,GO:0046688~response to copper ion,GO:0046718~viral entry into host cell,GO:0097286~iron ion import,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005739~mitochondrion,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005905~clathrin-coated pit,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0016323~basolateral plasma membrane,GO:0042470~melanosome,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,GO:0055037~recycling endosome,GO:0055038~recycling endosome membrane,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,GO:1903561~extracellular vesicle,GO:1990712~HFE-transferrin receptor complex,	GO:0001618~virus receptor activity,GO:0001948~glycoprotein binding,GO:0003725~double-stranded RNA binding,GO:0004998~transferrin receptor activity,GO:0005515~protein binding,GO:0033570~transferrin transmembrane transporter activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,	IPR003137:Protease-associated domain, PA,IPR007365:Transferrin receptor-like, dimerisation domain,IPR007484:Peptidase M28,	hsa04066:HIF-1 signaling pathway,hsa04144:Endocytosis,hsa04145:Phagosome,hsa04640:Hematopoietic cell lineage,	Immunodeficiency 46, 616740~Immunodeficiency 46, 616740,			3D-structure,Cell membrane,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Endocytosis,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Secreted,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Transferrin receptor protein 1,chain:Transferrin receptor protein 1, serum form,disulfide bond,domain:PA,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (GalNAc...),helix,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,region of interest:Ligand-binding,region of interest:Mediates interaction with SH3BP4,sequence conflict,sequence variant,short sequence motif:Cell attachment site; required for binding to transferrin,short sequence motif:Endocytosis signal,short sequence motif:Stop-transfer sequence,site:Cleavage; by trypsin; to produce soluble form,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
P55906	transforming growth factor beta induced(TGFBI)	Bos taurus				GO:0001525~angiogenesis,GO:0007155~cell adhesion,GO:0008283~cell proliferation,GO:0030198~extracellular matrix organization,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005802~trans-Golgi network,GO:0070062~extracellular exosome,	GO:0005178~integrin binding,GO:0005518~collagen binding,GO:0050840~extracellular matrix binding,	IPR000782:FAS1 domain,IPR011489:EMI domain,IPR016666:TGF beta-induced protein bIGH3/osteoblast-specific factor 2,			PIRSF016553:TGF beta-induced protein bIGH3/osteoblast-specific factor 2,	SM00554:FAS1,	Cell adhesion,Complete proteome,Direct protein sequencing,Disulfide bond,Extracellular matrix,Gamma-carboxyglutamic acid,Phosphoprotein,Reference proteome,Repeat,Secreted,Signal,	chain:Transforming growth factor-beta-induced protein ig-h3,
O93449	transforming growth factor, beta 1(tgf)	Oncorhynchus mykiss				GO:0016049~cell growth,GO:0051781~positive regulation of cell division,	GO:0005615~extracellular space,		IPR001111:Transforming growth factor-beta, N-terminal,IPR001839:Transforming growth factor-beta, C-terminal,IPR003939:Transforming growth factor, beta 1,IPR015615:Transforming growth factor-beta-related,IPR016319:Transforming growth factor-beta,IPR017948:Transforming growth factor beta, conserved site,			PIRSF001787:transforming growth factor-beta [Parent=PIRSF800009],	SM00204:TGFB,	Cleavage on pair of basic residues,Disulfide bond,Glycoprotein,Growth factor,Mitogen,Secreted,Signal,
Q9Y5S1	transient receptor potential cation channel subfamily V member 2(TRPV2)	Homo sapiens				GO:0006810~transport,GO:0007600~sensory perception,GO:0008285~negative regulation of cell proliferation,GO:0009266~response to temperature stimulus,GO:0009408~response to heat,GO:0045773~positive regulation of axon extension,GO:0070588~calcium ion transmembrane transport,GO:0090280~positive regulation of calcium ion import,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0030027~lamellipodium,GO:0032584~growth cone membrane,GO:0042470~melanosome,GO:0044295~axonal growth cone,GO:0044297~cell body,	GO:0005216~ion channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0015075~ion transmembrane transporter activity,	IPR002110:Ankyrin repeat,IPR004729:Transient receptor potential channel,IPR005821:Ion transport domain,IPR008347:Transient receptor potential channel, vanilloid 1-4,IPR020683:Ankyrin repeat-containing domain,IPR024865:Transient receptor potential channel, vanilloid 2,	hsa04750:Inflammatory mediator regulation of TRP channels,			SM00248:ANK,	3D-structure,ANK repeat,Calcium,Calcium channel,Calcium transport,Cell membrane,Complete proteome,Cytoplasm,Glycoprotein,Ion channel,Ion transport,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Transient receptor potential cation channel subfamily V member 2,glycosylation site:N-linked (GlcNAc...),helix,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,topological domain:Pore forming,transmembrane region,turn,
Q9QZC1	transient receptor potential cation channel, subfamily C, member 3(Trpc3)	Mus musculus				GO:0006810~transport,GO:0006811~ion transport,GO:0006816~calcium ion transport,GO:0006828~manganese ion transport,GO:0007338~single fertilization,GO:0010524~positive regulation of calcium ion transport into cytosol,GO:0033198~response to ATP,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0051592~response to calcium ion,GO:0055085~transmembrane transport,GO:0070588~calcium ion transmembrane transport,GO:1903244~positive regulation of cardiac muscle hypertrophy in response to stress,	GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005216~ion channel activity,GO:0005227~calcium activated cation channel activity,GO:0005262~calcium channel activity,GO:0015279~store-operated calcium channel activity,GO:0070679~inositol 1,4,5 trisphosphate binding,	IPR002110:Ankyrin repeat,IPR002153:Transient receptor potential channel, canonical,IPR004729:Transient receptor potential channel,IPR005459:Transient receptor potential channel, canonical  3,IPR005821:Ion transport domain,IPR013555:Transient receptor ion channel domain,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	ANK repeat,Calcium,Calcium channel,Calcium transport,Complete proteome,Glycoprotein,Ion channel,Ion transport,Membrane,Proteomics identification,Receptor,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Short transient receptor potential channel 3,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q6B855	transketolase(TKT)	Bos taurus				GO:0008152~metabolic process,GO:0040008~regulation of growth,GO:0046166~glyceraldehyde-3-phosphate biosynthetic process,	GO:0005654~nucleoplasm,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0004802~transketolase activity,GO:0046872~metal ion binding,GO:0048037~cofactor binding,	IPR005474:Transketolase, N-terminal,IPR005475:Transketolase-like, pyrimidine-binding domain,IPR009014:Transketolase, C-terminal/Pyruvate-ferredoxin oxidoreductase, domain II,IPR020826:Transketolase binding site,	bta00030:Pentose phosphate pathway,bta01100:Metabolic pathways,bta01130:Biosynthesis of antibiotics,bta01200:Carbon metabolism,bta01230:Biosynthesis of amino acids,			SM00861:SM00861,	Acetylation,Calcium,Complete proteome,Magnesium,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Thiamine pyrophosphate,Transferase,	chain:Transketolase,metal ion-binding site:Calcium,modified residue,
O51741	translation initiation factor IF-2(BB_0801)	Borrelia burgdorferi B31					GO:0005737~cytoplasm,	GO:0003743~translation initiation factor activity,GO:0003924~GTPase activity,GO:0005525~GTP binding,	IPR000178:Translation initiation factor aIF-2, bacterial-like,IPR000795:Elongation factor, GTP-binding domain,IPR005225:Small GTP-binding protein domain,IPR006847:Translation initiation factor IF-2, N-terminal,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR023115:Translation initiation factor IF- 2, domain 3,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,Cytoplasm,GTP-binding,Initiation factor,Nucleotide-binding,Protein biosynthesis,Reference proteome,	chain:Translation initiation factor IF-2,nucleotide phosphate-binding region:GTP,region of interest:G-domain,
Q9DA39	transmembrane BAX inhibitor motif containing 4(Tmbim4)	Mus musculus				GO:0006915~apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0050848~regulation of calcium-mediated signaling,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR006214:Bax inhibitor 1-related,					Apoptosis,Complete proteome,Golgi apparatus,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane BAX inhibitor motif- containing protein 4,transmembrane region,
Q3UV71	transmembrane and tetratricopeptide repeat containing 1(Tmtc1)	Mus musculus			General function prediction only,	GO:0006396~RNA processing,	GO:0005739~mitochondrion,GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR003107:RNA-processing protein, HAT helix,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR013618:Domain of unknown function DUF1736,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,SM00386:HAT,	Alternative splicing,Complete proteome,Membrane,Proteomics identification,Reference proteome,Repeat,TPR repeat,Transmembrane,Transmembrane helix,	chain:Transmembrane and TPR repeat-containing protein 1,repeat:TPR 1,repeat:TPR 10,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,repeat:TPR 9,sequence conflict,splice variant,transmembrane region,
Q6XPS3	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2(TPTE2)	Homo sapiens				GO:0006661~phosphatidylinositol biosynthetic process,GO:0035335~peptidyl-tyrosine dephosphorylation,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0004725~protein tyrosine phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0016314~phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,GO:0051800~phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,	IPR000008:C2 calcium-dependent membrane targeting,IPR000340:Dual specificity phosphatase, catalytic domain,IPR014020:Tensin phosphatase, C2 domain,IPR016130:Protein-tyrosine phosphatase, active site,				SM01326:SM01326,	Alternative splicing,Complete proteome,Cytoplasm,Endoplasmic reticulum,Hydrolase,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	active site:Phosphocysteine intermediate,chain:Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase TPTE2,domain:C2 tensin-type,domain:Phosphatase tensin-type,mutagenesis site,sequence conflict,sequence variant,splice variant,transmembrane region,
O15393	transmembrane protease, serine 2(TMPRSS2)	Homo sapiens				GO:0006508~proteolysis,GO:0006898~receptor-mediated endocytosis,GO:0016540~protein autoprocessing,GO:0046598~positive regulation of viral entry into host cell,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,GO:0005044~scavenger receptor activity,GO:0005515~protein binding,GO:0008236~serine-type peptidase activity,	IPR001190:Speract/scavenger receptor,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR017448:Speract/scavenger receptor-related,IPR018114:Peptidase S1, trypsin family, active site,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,	hsa05164:Influenza A,hsa05202:Transcriptional misregulation in cancer,			SM00020:Tryp_SPc,SM00192:LDLa,SM00202:SR,	Alternative splicing,Autocatalytic cleavage,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Polymorphism,Protease,Proteomics identification,Reference proteome,Secreted,Serine protease,Signal-anchor,Transmembrane,Transmembrane helix,Zymogen,	active site:Charge relay system,chain:Transmembrane protease, serine 2 catalytic chain,chain:Transmembrane protease, serine 2 non- catalytic chain,disulfide bond,domain:LDL-receptor class A,domain:Peptidase S1,domain:SRCR,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence conflict,sequence variant,site:Cleavage,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q1LWC2	transmembrane protein 106Bb(tmem106bb)	Danio rerio				GO:0006810~transport,GO:0032418~lysosome localization,GO:0048813~dendrite morphogenesis,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031902~late endosome membrane,		IPR009790:Protein of unknown function DUF1356, TMEM106,					Complete proteome,Endosome,Glycoprotein,Lysosome,Membrane,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,Transport,
Q6PGS5	transmembrane protein 56 S homeolog(tmem56.S)	Xenopus laevis					GO:0016021~integral component of membrane,		IPR006634:TRAM/LAG1/CLN8 homology domain,				SM00724:TLC,	Membrane,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 56-B,domain:TLC,transmembrane region,
Q5XG04	transmembrane protein 82 L homeolog(tmem82.L)	Xenopus laevis					GO:0016021~integral component of membrane,							Membrane,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 82,transmembrane region,
Q91590	transmembrane protein with EGF-like and two follistatin-like domains 1 S homeolog(tmeff1.S)	Xenopus laevis				GO:0007275~multicellular organism development,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR000742:Epidermal growth factor-like domain,IPR002350:Kazal domain,IPR013032:EGF-like, conserved site,				SM00280:KAZAL,	Cell membrane,Developmental protein,Disulfide bond,EGF-like domain,Membrane,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Tomoregulin-1,disulfide bond,domain:EGF-like,domain:Kazal-like 1,domain:Kazal-like 2,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q9UPQ4	tripartite motif containing 35(TRIM35)	Homo sapiens				GO:0006915~apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0045087~innate immune response,GO:0045930~negative regulation of mitotic cell cycle,GO:1902187~negative regulation of viral release from host cell,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0008270~zinc ion binding,	IPR000315:Zinc finger, B-box,IPR001841:Zinc finger, RING-type,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR003879:Butyrophylin-like,IPR006574:SPRY-associated,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR017907:Zinc finger, RING-type, conserved site,				SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00589:PRY,	Acetylation,Alternative splicing,Apoptosis,Coiled coil,Complete proteome,Cytoplasm,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:Tripartite motif-containing protein 35,domain:B30.2/SPRY,modified residue,splice variant,zinc finger region:B box-type,zinc finger region:RING-type,
A7MBU6	tryptophan 2,3-dioxygenase a(tdo2a)	Danio rerio				GO:0006569~tryptophan catabolic process,GO:0019441~tryptophan catabolic process to kynurenine,GO:0019442~tryptophan catabolic process to acetyl-CoA,GO:0055114~oxidation-reduction process,		GO:0004833~tryptophan 2,3-dioxygenase activity,GO:0016491~oxidoreductase activity,GO:0020037~heme binding,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,	IPR004981:Tryptophan 2,3-dioxygenase,	dre00380:Tryptophan metabolism,dre01100:Metabolic pathways,				Complete proteome,Dioxygenase,Heme,Iron,Metal-binding,Oxidoreductase,Reference proteome,Tryptophan catabolism,	binding site:Heme,binding site:Substrate,chain:Tryptophan 2,3-dioxygenase A,metal ion-binding site:Iron (heme axial ligand),region of interest:Substrate binding,sequence conflict,
Q13509	tubulin beta 3 class III(TUBB3)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007067~mitotic nuclear division,GO:0007411~axon guidance,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0070062~extracellular exosome,GO:0071944~cell periphery,	GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,GO:0042277~peptide binding,	IPR000217:Tubulin,IPR002453:Beta tubulin,IPR003008:Tubulin/FtsZ, GTPase domain,IPR008280:Tubulin/FtsZ, C-terminal,IPR013838:Beta tubulin, autoregulation binding site,IPR017975:Tubulin, conserved site,IPR018316:Tubulin/FtsZ, 2-layer sandwich domain,IPR023123:Tubulin, C-terminal,	hsa04145:Phagosome,hsa04540:Gap junction,hsa05130:Pathogenic Escherichia coli infection,	600638~Fibrosis of extraocular muscles, congenital, 3A,614039~Cortical dysplasia, complex, with other brain malformations 1,		SM00864:SM00864,SM00865:SM00865,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Disease mutation,GTP-binding,Isopeptide bond,Microtubule,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Melanocyte-stimulating hormone receptor,chain:Tubulin beta-3 chain,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q5E951	tubulin folding cofactor B(TBCB)	Bos taurus				GO:0007023~post-chaperonin tubulin folding pathway,GO:0007399~nervous system development,GO:0030154~cell differentiation,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005874~microtubule,		IPR000626:Ubiquitin,IPR000938:CAP Gly-rich domain,				SM01052:SM01052,	Acetylation,Chaperone,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Differentiation,Microtubule,Neurogenesis,Phosphoprotein,Reference proteome,Ubl conjugation,	chain:Tubulin-folding cofactor B,domain:CAP-Gly,modified residue,
P09645	tubulin, alpha 3e(TUBA3E)	Gallus gallus				GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,	GO:0005737~cytoplasm,GO:0005874~microtubule,	GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,	IPR000217:Tubulin,IPR002452:Alpha tubulin,IPR003008:Tubulin/FtsZ, GTPase domain,IPR008280:Tubulin/FtsZ, C-terminal,IPR017975:Tubulin, conserved site,IPR018316:Tubulin/FtsZ, 2-layer sandwich domain,IPR023123:Tubulin, C-terminal,	gga04145:Phagosome,gga04540:Gap junction,			SM00864:SM00864,SM00865:SM00865,	Complete proteome,Cytoplasm,Cytoskeleton,GTP-binding,Microtubule,Nucleotide-binding,Reference proteome,	chain:Tubulin alpha-8 chain,nucleotide phosphate-binding region:GTP,site:Involved in polymerization,
Q6P1U3	tudor domain containing 3(tdrd3)	Xenopus tropicalis				GO:0016568~chromatin modification,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003682~chromatin binding,GO:0003713~transcription coactivator activity,GO:0035064~methylated histone binding,	IPR002999:Tudor domain,IPR009060:UBA-like,IPR013894:Domain of unknown function DUF1767,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,				SM00165:UBA,SM00333:TUDOR,SM01161:SM01161,	Chromatin regulator,Complete proteome,Cytoplasm,Nucleus,Reference proteome,	chain:Tudor domain-containing protein 3,domain:Tudor,domain:UBA,
P17735	tyrosine aminotransferase(TAT)	Homo sapiens	59.L-type_Ca2+_Tat_immune_cells,			GO:0006103~2-oxoglutarate metabolic process,GO:0006536~glutamate metabolic process,GO:0006559~L-phenylalanine catabolic process,GO:0006572~tyrosine catabolic process,GO:0006979~response to oxidative stress,GO:0009058~biosynthetic process,GO:0009074~aromatic amino acid family catabolic process,GO:0046689~response to mercury ion,GO:0051384~response to glucocorticoid,	GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0004838~L-tyrosine:2-oxoglutarate aminotransferase activity,GO:0016597~amino acid binding,GO:0030170~pyridoxal phosphate binding,GO:0080130~L-phenylalanine:2-oxoglutarate aminotransferase activity,	IPR004838:Aminotransferases, class-I, pyridoxal-phosphate-binding site,IPR004839:Aminotransferase, class I/classII,IPR005957:Tyrosine aminotransferase,IPR005958:Tyrosine/nicotianamine aminotransferase,IPR011715:Tyrosine aminotransferase ubiquitination region,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,	hsa00130:Ubiquinone and other terpenoid-quinone biosynthesis,hsa00270:Cysteine and methionine metabolism,hsa00350:Tyrosine metabolism,hsa00360:Phenylalanine metabolism,hsa00400:Phenylalanine, tyrosine and tryptophan biosynthesis,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01230:Biosynthesis of amino acids,	276600~Tyrosinemia, type II,	PIRSF000517:tyrosine transaminase,		3D-structure,Acetylation,Aminotransferase,Complete proteome,Disease mutation,Mental retardation,Palmoplantar keratoderma,Phenylalanine catabolism,Phosphoprotein,Polymorphism,Pyridoxal phosphate,Reference proteome,Transferase,Tyrosine catabolism,	chain:Tyrosine aminotransferase,helix,modified residue,sequence variant,strand,turn,
Q5RC24	ubiquinol-cytochrome c reductase binding protein(UQCRB)	Pongo abelii				GO:0006122~mitochondrial electron transport, ubiquinol to cytochrome c,	GO:0005750~mitochondrial respiratory chain complex III,		IPR003197:Cytochrome b-c1 complex subunit 7,	pon00190:Oxidative phosphorylation,pon01100:Metabolic pathways,pon04260:Cardiac muscle contraction,pon04932:Non-alcoholic fatty liver disease (NAFLD),pon05010:Alzheimer's disease,pon05012:Parkinson's disease,pon05016:Huntington's disease,		PIRSF000022:ubiquinol-cytochrome-c reductase 14 kDa protein,		Acetylation,Complete proteome,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Respiratory chain,Transport,	chain:Cytochrome b-c1 complex subunit 7,modified residue,
Q9CZ13	ubiquinol-cytochrome c reductase core protein 1(Uqcrc1)	Mus musculus			General function prediction only,	GO:0006122~mitochondrial electron transport, ubiquinol to cytochrome c,GO:0006810~transport,GO:0009060~aerobic respiration,GO:0014823~response to activity,GO:0016485~protein processing,GO:0043279~response to alkaloid,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005750~mitochondrial respiratory chain complex III,GO:0016020~membrane,GO:0043209~myelin sheath,GO:0070469~respiratory chain,	GO:0003824~catalytic activity,GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0031625~ubiquitin protein ligase binding,GO:0032403~protein complex binding,GO:0046872~metal ion binding,	IPR007863:Peptidase M16, C-terminal domain,IPR011237:Peptidase M16 domain,IPR011249:Metalloenzyme, LuxS/M16 peptidase-like,IPR011765:Peptidase M16, N-terminal,	mmu00190:Oxidative phosphorylation,mmu01100:Metabolic pathways,mmu04260:Cardiac muscle contraction,mmu04932:Non-alcoholic fatty liver disease (NAFLD),mmu05010:Alzheimer's disease,mmu05012:Parkinson's disease,mmu05016:Huntington's disease,				Acetylation,Complete proteome,Direct protein sequencing,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Proteomics identification,Reference proteome,Respiratory chain,Transit peptide,Transport,	chain:Cytochrome b-c1 complex subunit 1, mitochondrial,modified residue,sequence conflict,transit peptide:Mitochondrion,
P31800	ubiquinol-cytochrome c reductase core protein I(UQCRC1)	Bos taurus			General function prediction only,	GO:0006122~mitochondrial electron transport, ubiquinol to cytochrome c,GO:0009060~aerobic respiration,GO:0016485~protein processing,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005750~mitochondrial respiratory chain complex III,GO:0043209~myelin sheath,	GO:0003824~catalytic activity,GO:0004222~metalloendopeptidase activity,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR007863:Peptidase M16, C-terminal domain,IPR011237:Peptidase M16 domain,IPR011249:Metalloenzyme, LuxS/M16 peptidase-like,IPR011765:Peptidase M16, N-terminal,	bta00190:Oxidative phosphorylation,bta01100:Metabolic pathways,bta04260:Cardiac muscle contraction,bta04932:Non-alcoholic fatty liver disease (NAFLD),bta05010:Alzheimer's disease,bta05012:Parkinson's disease,bta05016:Huntington's disease,				3D-structure,Acetylation,Complete proteome,Direct protein sequencing,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Proteomics identification,Reference proteome,Respiratory chain,Transit peptide,Transport,	chain:Cytochrome b-c1 complex subunit 1, mitochondrial,helix,modified residue,strand,transit peptide:Mitochondrion,turn,
P23004	ubiquinol-cytochrome c reductase core protein II(UQCRC2)	Bos taurus			General function prediction only,	GO:0006122~mitochondrial electron transport, ubiquinol to cytochrome c,GO:0009060~aerobic respiration,GO:0016485~protein processing,	GO:0005654~nucleoplasm,GO:0005750~mitochondrial respiratory chain complex III,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0004222~metalloendopeptidase activity,GO:0008270~zinc ion binding,	IPR001431:Peptidase M16, zinc-binding site,IPR007863:Peptidase M16, C-terminal domain,IPR011237:Peptidase M16 domain,IPR011249:Metalloenzyme, LuxS/M16 peptidase-like,IPR011765:Peptidase M16, N-terminal,	bta00190:Oxidative phosphorylation,bta01100:Metabolic pathways,bta04260:Cardiac muscle contraction,bta04932:Non-alcoholic fatty liver disease (NAFLD),bta05010:Alzheimer's disease,bta05012:Parkinson's disease,bta05016:Huntington's disease,				3D-structure,Acetylation,Complete proteome,Direct protein sequencing,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Respiratory chain,Transit peptide,Transport,	chain:Cytochrome b-c1 complex subunit 2, mitochondrial,helix,modified residue,sequence variant,strand,transit peptide:Mitochondrion,turn,
Q7SXG4	ubiquitin-like modifier activating enzyme 2(uba2)	Danio rerio				GO:0016925~protein sumoylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031510~SUMO activating enzyme complex,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0008641~small protein activating enzyme activity,GO:0008766~UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity,GO:0016874~ligase activity,GO:0018169~ribosomal S6-glutamic acid ligase activity,GO:0019948~SUMO activating enzyme activity,GO:0043773~coenzyme F420-0 gamma-glutamyl ligase activity,GO:0043774~coenzyme F420-2 alpha-glutamyl ligase activity,GO:0046872~metal ion binding,GO:0070735~protein-glycine ligase activity,GO:0070736~protein-glycine ligase activity, initiating,GO:0070737~protein-glycine ligase activity, elongating,GO:0070738~tubulin-glycine ligase activity,GO:0070739~protein-glutamic acid ligase activity,GO:0070740~tubulin-glutamic acid ligase activity,	IPR000594:UBA/THIF-type NAD/FAD binding fold,IPR016040:NAD(P)-binding domain,IPR019572:Ubiquitin-activating enzyme,	dre04120:Ubiquitin mediated proteolysis,				Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Isopeptide bond,Ligase,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,	active site:Glycyl thioester intermediate,chain:SUMO-activating enzyme subunit 2,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,splice variant,
Q5SPF7	unc-93 homolog A (C. elegans)(unc93a)	Danio rerio					GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR010291:Ion channel regulatory protein, UNC-93,IPR020846:Major facilitator superfamily domain,					Complete proteome,Glycoprotein,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein unc-93 homolog A,glycosylation site:N-linked (GlcNAc...),transmembrane region,
P0DMT8	uncharacterized LOC102569507(LOC102569507)	Alligator mississippiensis				GO:0006869~lipid transport,GO:0042157~lipoprotein metabolic process,	GO:0034361~very-low-density lipoprotein particle,		IPR006781:Apolipoprotein C-I,					Lipid transport,Secreted,Signal,Transport,VLDL,
P17480	upstream binding transcription factor, RNA polymerase I(UBTF)	Homo sapiens				GO:0006356~regulation of transcription from RNA polymerase I promoter,GO:0006360~transcription from RNA polymerase I promoter,GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0006362~transcription elongation from RNA polymerase I promoter,GO:0006363~termination of RNA polymerase I transcription,GO:0045943~positive regulation of transcription from RNA polymerase I promoter,GO:1902659~regulation of glucose mediated signaling pathway,	GO:0001650~fibrillar center,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0001164~RNA polymerase I CORE element sequence-specific DNA binding,GO:0001165~RNA polymerase I upstream control element sequence-specific DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR009071:High mobility group (HMG) box domain,				SM00398:HMG,	3D-structure,Acetylation,Activator,Alternative splicing,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:Nucleolar transcription factor 1,compositionally biased region:Asp/Glu/Ser-rich (acidic),DNA-binding region:HMG box 1,DNA-binding region:HMG box 2,DNA-binding region:HMG box 3,DNA-binding region:HMG box 4,DNA-binding region:HMG box 5,DNA-binding region:HMG box 6,helix,modified residue,splice variant,strand,turn,
Q06S87	urate (5-hydroxyiso-) hydrolase(urah)	Danio rerio				GO:0006144~purine nucleobase metabolic process,GO:0019628~urate catabolic process,	GO:0005777~peroxisome,	GO:0016787~hydrolase activity,GO:0016811~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,GO:0033971~hydroxyisourate hydrolase activity,	IPR000895:Transthyretin/hydroxyisourate hydrolase,IPR014306:Hydroxyisourate hydrolase,IPR023416:Transthyretin/hydroxyisourate hydrolase, superfamily,IPR023418:Transthyretin, thyroxine binding site,	dre00230:Purine metabolism,dre01100:Metabolic pathways,			SM00095:TR_THY,	3D-structure,Alternative splicing,Complete proteome,Hydrolase,Peroxisome,Proteomics identification,Purine metabolism,Reference proteome,	binding site:Substrate,chain:5-hydroxyisourate hydrolase,helix,mutagenesis site,splice variant,strand,turn,
P13439	uridine monophosphate synthetase(Umps)	Mus musculus				GO:0006207~'de novo' pyrimidine nucleobase biosynthetic process,GO:0006221~pyrimidine nucleotide biosynthetic process,GO:0006222~UMP biosynthetic process,GO:0007565~female pregnancy,GO:0007595~lactation,GO:0008152~metabolic process,GO:0009116~nucleoside metabolic process,GO:0035690~cellular response to drug,GO:0044205~'de novo' UMP biosynthetic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003824~catalytic activity,GO:0004588~orotate phosphoribosyltransferase activity,GO:0004590~orotidine-5'-phosphate decarboxylase activity,GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0016829~lyase activity,GO:0016831~carboxy-lyase activity,	IPR000836:Phosphoribosyltransferase domain,IPR001754:Orotidine 5'-phosphate decarboxylase domain,IPR004467:Orotate phosphoribosyl transferase domain,IPR011060:Ribulose-phosphate binding barrel,IPR013785:Aldolase-type TIM barrel,IPR014732:Orotidine 5'-phosphate decarboxylase,IPR018089:Orotidine 5'-phosphate decarboxylase, active site,IPR023031:Orotate phosphoribosyltransferase,	mmu00240:Pyrimidine metabolism,mmu00983:Drug metabolism - other enzymes,mmu01100:Metabolic pathways,			SM00934:SM00934,	Complete proteome,Decarboxylase,Glycosyltransferase,Lyase,Multifunctional enzyme,Phosphoprotein,Proteomics identification,Pyrimidine biosynthesis,Reference proteome,Transferase,	active site:For OMPdecase activity,chain:Uridine 5'-monophosphate synthase,modified residue,region of interest:Domain linker,region of interest:OMPdecase,region of interest:OPRTase,
P10157	v-ets avian erythroblastosis virus E26 oncogene homolog 2(ETS2)	Gallus gallus				GO:0001569~patterning of blood vessels,GO:0001712~ectodermal cell fate commitment,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007498~mesoderm development,GO:0010595~positive regulation of endothelial cell migration,GO:0030154~cell differentiation,GO:0030578~PML body organization,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045765~regulation of angiogenesis,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048870~cell motility,GO:0050728~negative regulation of inflammatory response,GO:0050729~positive regulation of inflammatory response,GO:0060982~coronary artery morphogenesis,GO:0061614~pri-miRNA transcription from RNA polymerase II promoter,GO:0090009~primitive streak formation,GO:1904996~positive regulation of leukocyte adhesion to vascular endothelial cell,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,IPR016311:Transforming protein C-ets,IPR027276:Transforming protein C-ets-2,	gga04320:Dorso-ventral axis formation,		PIRSF001698:transforming factor C-ets,PIRSF501032:transforming protein C-ets-2 [Parent=PIRSF001698],	SM00251:SAM_PNT,SM00413:ETS,	Complete proteome,DNA-binding,Nucleus,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,	chain:Protein C-ets-2,DNA-binding region:ETS,domain:PNT,
Q61827	v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian)(Mafk)	Mus musculus		m_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2,		GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007399~nervous system development,GO:0007596~blood coagulation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0001221~transcription cofactor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0071535~RING-like zinc finger domain binding,	IPR004826:Basic leucine zipper domain, Maf-type,IPR004827:Basic-leucine zipper domain,IPR008917:Eukaryotic transcription factor, Skn-1-like, DNA-binding,IPR024874:Transcription factor Maf,				SM00338:BRLZ,	Coiled coil,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Transcription factor MafK,DNA-binding region:Basic motif,domain:Leucine-zipper,modified residue,sequence conflict,
Q7ZVS9	v-myc avian myelocytomatosis viral oncogene homolog b(mycb)	Danio rerio				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046983~protein dimerization activity,	IPR002418:Transcription regulator Myc,IPR003327:Leucine zipper, Myc,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR012682:Transcription regulator Myc, N-terminal,	dre04010:MAPK signaling pathway,dre04012:ErbB signaling pathway,dre04110:Cell cycle,dre04310:Wnt signaling pathway,dre04350:TGF-beta signaling pathway,dre04630:Jak-STAT signaling pathway,		PIRSF001705:myc protein,	SM00353:HLH,	Activator,Complete proteome,DNA-binding,Glycoprotein,Nucleus,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,	chain:Transcriptional regulator Myc-B,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Ser,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Leucine-zipper,glycosylation site:O-linked (GlcNAc),
Q05404	v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog L homeolog(mycl.L)	Xenopus laevis					GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR002418:Transcription regulator Myc,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR012682:Transcription regulator Myc, N-terminal,				SM00353:HLH,	DNA-binding,Nucleus,Phosphoprotein,	chain:Protein L-myc A,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Leucine-zipper,
Q6NYY9	vacuole membrane protein 1(vmp1)	Danio rerio				GO:0006887~exocytosis,GO:0007029~endoplasmic reticulum organization,GO:0007030~Golgi organization,GO:0010506~regulation of autophagy,	GO:0000407~pre-autophagosomal structure,GO:0005773~vacuole,GO:0005774~vacuolar membrane,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,							Cell membrane,Complete proteome,Endoplasmic reticulum,Membrane,Reference proteome,Transmembrane,Transmembrane helix,Vacuole,	chain:Transmembrane protein 49,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
P98165	very low density lipoprotein receptor(VLDLR)	Gallus gallus				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006869~lipid transport,GO:0006898~receptor-mediated endocytosis,GO:0008203~cholesterol metabolic process,GO:0021517~ventral spinal cord development,GO:0034447~very-low-density lipoprotein particle clearance,GO:0045860~positive regulation of protein kinase activity,GO:0048813~dendrite morphogenesis,GO:1900006~positive regulation of dendrite development,	GO:0005615~extracellular space,GO:0005905~clathrin-coated pit,GO:0016021~integral component of membrane,GO:0034361~very-low-density lipoprotein particle,GO:0043235~receptor complex,	GO:0005509~calcium ion binding,GO:0030228~lipoprotein particle receptor activity,GO:0030229~very-low-density lipoprotein particle receptor activity,GO:0034185~apolipoprotein binding,GO:0034437~glycoprotein transporter activity,GO:0038025~reelin receptor activity,	IPR000033:LDLR class B repeat,IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011042:Six-bladed beta-propeller, TolB-like,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,				SM00135:LY,SM00179:EGF_CA,SM00181:EGF,SM00192:LDLa,	Cholesterol metabolism,Coated pit,Complete proteome,Direct protein sequencing,Disulfide bond,EGF-like domain,Endocytosis,Glycoprotein,Lipid metabolism,Lipid transport,Membrane,Receptor,Reference proteome,Repeat,Signal,Steroid metabolism,Sterol metabolism,Transmembrane,Transmembrane helix,Transport,VLDL,	chain:Very low-density lipoprotein receptor,disulfide bond,domain:EGF-like 1; calcium-binding,domain:EGF-like 2; calcium-binding,domain:EGF-like 3,domain:LDL-receptor class A 1,domain:LDL-receptor class A 2,domain:LDL-receptor class A 3,domain:LDL-receptor class A 4,domain:LDL-receptor class A 5,domain:LDL-receptor class A 6,domain:LDL-receptor class A 7,domain:LDL-receptor class A 8,glycosylation site:N-linked (GlcNAc...),repeat:LDL-receptor class B 1,repeat:LDL-receptor class B 2,repeat:LDL-receptor class B 3,repeat:LDL-receptor class B 4,repeat:LDL-receptor class B 5,repeat:LDL-receptor class B 6,short sequence motif:Endocytosis signal,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
Q9Z2P8	vesicle-associated membrane protein 5(Vamp5)	Mus musculus				GO:0006887~exocytosis,GO:0006906~vesicle fusion,GO:0007275~multicellular organism development,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0016192~vesicle-mediated transport,GO:0030154~cell differentiation,GO:0043001~Golgi to plasma membrane protein transport,	GO:0005770~late endosome,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0014704~intercalated disc,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031201~SNARE complex,GO:0031301~integral component of organelle membrane,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0000149~SNARE binding,GO:0005484~SNAP receptor activity,	IPR001388:Synaptobrevin,IPR016444:Synaptobrevin, metazoa/fungi,	mmu04130:SNARE interactions in vesicular transport,		PIRSF005409:synaptobrevin,		Cell membrane,Coiled coil,Complete proteome,Developmental protein,Differentiation,Golgi apparatus,Membrane,Myogenesis,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Vesicle-associated membrane protein 5,domain:v-SNARE coiled-coil homology,modified residue,topological domain:Cytoplasmic,topological domain:Vesicular,transmembrane region,
P82013	voltage dependent anion channel 2(VDAC2)	Meleagris gallopavo				GO:0032272~negative regulation of protein polymerization,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0042645~mitochondrial nucleoid,GO:0043209~myelin sheath,GO:0045121~membrane raft,GO:0046930~pore complex,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0008308~voltage-gated anion channel activity,GO:0015288~porin activity,	IPR001925:Porin, eukaryotic type,IPR023614:Porin domain,IPR027246:Eukaryotic porin/Tom40,	mgp04020:Calcium signaling pathway,				Acetylation,Complete proteome,Direct protein sequencing,Ion transport,Membrane,Mitochondrion,Mitochondrion outer membrane,NAD,Nucleotide-binding,Porin,Reference proteome,Transmembrane,Transmembrane beta strand,Transport,
Q9FKK7	xylose isomerase family protein(AT5G57655)	Arabidopsis thaliana				GO:0005975~carbohydrate metabolic process,GO:0006098~pentose-phosphate shunt,GO:0042732~D-xylose metabolic process,	GO:0005737~cytoplasm,GO:0005773~vacuole,GO:0005774~vacuolar membrane,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0016020~membrane,	GO:0009045~xylose isomerase activity,GO:0046872~metal ion binding,	IPR001998:Xylose isomerase,IPR013022:Xylose isomerase-like, TIM barrel domain,IPR013452:Xylose isomerase, bacterial-type,	ath00040:Pentose and glucuronate interconversions,ath00051:Fructose and mannose metabolism,ath01100:Metabolic pathways,				Alternative splicing,Carbohydrate metabolism,Complete proteome,Isomerase,Magnesium,Manganese,Metal-binding,Pentose shunt,Reference proteome,Signal,Xylose metabolism,	chain:Xylose isomerase,metal ion-binding site:Manganese 1,metal ion-binding site:Manganese 2,
Q6NWE0	zgc:85789(zgc:85789)	Danio rerio					GO:0005634~nucleus,	GO:0004518~nuclease activity,GO:0016787~hydrolase activity,GO:0042578~phosphoric ester hydrolase activity,GO:0043765~T/G mismatch-specific endonuclease activity,GO:0044824~retroviral 3' processing activity,GO:0046872~metal ion binding,	IPR015021:Domain of unknown function DUF1907,				SM01168:SM01168,	Complete proteome,Hydrolase,Metal-binding,Nucleus,Reference proteome,Zinc,	chain:Ester hydrolase C11orf54 homolog,metal ion-binding site:Zinc; catalytic,
O76080	zinc finger AN1-type containing 5(ZFAND5)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0001944~vasculature development,GO:0003016~respiratory system process,GO:0010761~fibroblast migration,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048705~skeletal system morphogenesis,GO:0048745~smooth muscle tissue development,GO:0060324~face development,	GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0008270~zinc ion binding,	IPR000058:Zinc finger, AN1-type,IPR002653:Zinc finger, A20-type,				SM00154:ZnF_AN1,SM00259:ZnF_A20,	Acetylation,Complete proteome,Cytoplasm,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:AN1-type zinc finger protein 5,modified residue,zinc finger region:A20-type,zinc finger region:AN1-type,
Q3SZY7	zinc finger AN1-type containing 6(ZFAND6)	Bos taurus				GO:0043066~negative regulation of apoptotic process,GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling,GO:0071356~cellular response to tumor necrosis factor,		GO:0003677~DNA binding,GO:0008270~zinc ion binding,	IPR000058:Zinc finger, AN1-type,IPR002653:Zinc finger, A20-type,				SM00154:ZnF_AN1,SM00259:ZnF_A20,	Acetylation,Complete proteome,Metal-binding,Phosphoprotein,Reference proteome,Zinc,Zinc-finger,	chain:AN1-type zinc finger protein 6,zinc finger region:A20-type,zinc finger region:AN1-type,
Q0IH98	zinc finger and BTB domain containing 8A, gene 1 L homeolog(zbtb8a.1.L)	Xenopus laevis				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ-like,IPR007087:Zinc finger, C2H2,IPR011333:BTB/POZ fold,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00225:BTB,SM00355:ZnF_C2H2,	DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger and BTB domain-containing protein 8A-A,domain:BTB,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,
P23950	zinc finger protein 36, C3H type-like 1(Zfp36l1)	Mus musculus				GO:0000165~MAPK cascade,GO:0000288~nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:0001570~vasculogenesis,GO:0003342~proepicardium development,GO:0006402~mRNA catabolic process,GO:0006417~regulation of translation,GO:0006915~apoptotic process,GO:0007507~heart development,GO:0008283~cell proliferation,GO:0009611~response to wounding,GO:0010468~regulation of gene expression,GO:0010837~regulation of keratinocyte proliferation,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0021915~neural tube development,GO:0031086~nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,GO:0031440~regulation of mRNA 3'-end processing,GO:0032869~cellular response to insulin stimulus,GO:0033077~T cell differentiation in thymus,GO:0035264~multicellular organism growth,GO:0038066~p38MAPK cascade,GO:0043488~regulation of mRNA stability,GO:0043491~protein kinase B signaling,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045577~regulation of B cell differentiation,GO:0045600~positive regulation of fat cell differentiation,GO:0045616~regulation of keratinocyte differentiation,GO:0045647~negative regulation of erythrocyte differentiation,GO:0045657~positive regulation of monocyte differentiation,GO:0045661~regulation of myoblast differentiation,GO:0048382~mesendoderm development,GO:0048568~embryonic organ development,GO:0051028~mRNA transport,GO:0060710~chorio-allantoic fusion,GO:0060712~spongiotrophoblast layer development,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0070371~ERK1 and ERK2 cascade,GO:0071320~cellular response to cAMP,GO:0071356~cellular response to tumor necrosis factor,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0071375~cellular response to peptide hormone stimulus,GO:0071385~cellular response to glucocorticoid stimulus,GO:0071456~cellular response to hypoxia,GO:0071472~cellular response to salt stress,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0072091~regulation of stem cell proliferation,GO:0097403~cellular response to raffinose,GO:1900153~positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:1901991~negative regulation of mitotic cell cycle phase transition,GO:1902172~regulation of keratinocyte apoptotic process,GO:1904582~positive regulation of intracellular mRNA localization,GO:1904628~cellular response to phorbol 13-acetate 12-myristate,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003677~DNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0017091~AU-rich element binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0071889~14-3-3 protein binding,	IPR000571:Zinc finger, CCCH-type,IPR007635:Tis11B-like protein, N-terminal,				SM00356:ZnF_C3H1,	Complete proteome,Cytoplasm,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Butyrate response factor 1,compositionally biased region:Poly-Ser,modified residue,zinc finger region:C3H1-type 1,zinc finger region:C3H1-type 2,
P17431	zinc finger protein 36, C3H type-like 1(Zfp36l1)	Rattus norvegicus				GO:0000165~MAPK cascade,GO:0000288~nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:0001570~vasculogenesis,GO:0003342~proepicardium development,GO:0006402~mRNA catabolic process,GO:0006417~regulation of translation,GO:0006915~apoptotic process,GO:0007507~heart development,GO:0008283~cell proliferation,GO:0009611~response to wounding,GO:0010468~regulation of gene expression,GO:0010837~regulation of keratinocyte proliferation,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0021915~neural tube development,GO:0031086~nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,GO:0032869~cellular response to insulin stimulus,GO:0033077~T cell differentiation in thymus,GO:0035264~multicellular organism growth,GO:0038066~p38MAPK cascade,GO:0043488~regulation of mRNA stability,GO:0043491~protein kinase B signaling,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045577~regulation of B cell differentiation,GO:0045600~positive regulation of fat cell differentiation,GO:0045616~regulation of keratinocyte differentiation,GO:0045647~negative regulation of erythrocyte differentiation,GO:0045657~positive regulation of monocyte differentiation,GO:0045661~regulation of myoblast differentiation,GO:0048382~mesendoderm development,GO:0048568~embryonic organ development,GO:0051028~mRNA transport,GO:0060710~chorio-allantoic fusion,GO:0060712~spongiotrophoblast layer development,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0070371~ERK1 and ERK2 cascade,GO:0071320~cellular response to cAMP,GO:0071356~cellular response to tumor necrosis factor,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0071375~cellular response to peptide hormone stimulus,GO:0071385~cellular response to glucocorticoid stimulus,GO:0071456~cellular response to hypoxia,GO:0071472~cellular response to salt stress,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0072091~regulation of stem cell proliferation,GO:0097403~cellular response to raffinose,GO:1900153~positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:1901991~negative regulation of mitotic cell cycle phase transition,GO:1902172~regulation of keratinocyte apoptotic process,GO:1904582~positive regulation of intracellular mRNA localization,GO:1904628~cellular response to phorbol 13-acetate 12-myristate,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003677~DNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0017091~AU-rich element binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0071889~14-3-3 protein binding,	IPR000571:Zinc finger, CCCH-type,IPR007635:Tis11B-like protein, N-terminal,				SM00356:ZnF_C3H1,	Complete proteome,Cytoplasm,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Butyrate response factor 1,compositionally biased region:Poly-Ser,modified residue,zinc finger region:C3H1-type 1,zinc finger region:C3H1-type 2,
